<?xml version="1.0"?>
<!DOCTYPE rdf:RDF [
<!ENTITY DTO "http://dto.org/DTO/" >
<!ENTITY foaf "http://xmlns.com/foaf/0.1/" >
<!ENTITY life "http://www.lifekb.org/life#" >
<!ENTITY owl "http://www.w3.org/2002/07/owl#" >
<!ENTITY obo "http://purl.obolibrary.org/obo/" >
<!ENTITY xsd "http://www.w3.org/2001/XMLSchema#" >
<!ENTITY bto "http://purl.obolibrary.org/obo/bto#" >
<!ENTITY rdfs "http://www.w3.org/2000/01/rdf-schema#" >
<!ENTITY dto "http://www.drugtargetontology.org/dto/" >
<!ENTITY rdf "http://www.w3.org/1999/02/22-rdf-syntax-ns#" >
<!ENTITY core "http://purl.obolibrary.org/obo/uberon/core#" >
<!ENTITY dc "http://purl.org/dc/elements/1.1/" >
<!ENTITY oboInOwl "http://www.geneontology.org/formats/oboInOwl#">]>
<rdf:RDF xmlns="http://www.drugtargetontology.org/dto/dto_vocabulary_kinase_gene.owl#"
	xml:base="http://www.drugtargetontology.org/dto/dto_vocabulary_kinase_gene.owl"
	xmlns:owl="http://www.w3.org/2002/07/owl#"
	xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#"
	xmlns:xsd="http://www.w3.org/2001/XMLSchema#"
	xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#"
	xmlns:life="http://www.lifekb.org/life#"
	xmlns:core="&obo;uberon/core#"
	xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
	xmlns:bto="&obo;bto#"
	xmlns:obo="http://purl.obolibrary.org/obo/"
	xmlns:dto="http://www.drugtargetontology.org/dto/"
	xmlns:DTO="http://dto.org/DTO/"
	xmlns:foaf="http://xmlns.com/foaf/0.1/"
	xmlns:dc="http://purl.org/dc/elements/1.1/">
	<owl:Ontology rdf:about="http://www.drugtargetontology.org/dto/dto_vocabulary_kinase_gene.owl">
		<owl:versionIRI rdf:resource="http://www.drugtargetontology.org/dto/dto_vocabulary_kinase_gene.owl"/>
		<rdfs:label>Drug Target Ontology</rdfs:label>
		<rdfs:label>DTO</rdfs:label>
		<owl:versionInfo>1.0</owl:versionInfo>
		<dc:date>2 Nov 2017</dc:date>
		<dc:contributor>Yu Lin, Saurabh Mehta, Hande Küçük- McGinty, John Paul Turner, Dusica Vidovic, Michele Forlin, Amar Koleti, Dac-Trung Nguyen, Lars Juhl Jensen, Rajarshi Guha, Stephen L. Mathias, Oleg Ursu, Vasileios Stathias, Jianbin Duan, Nooshin Nabizadeh, Caty Chung, Christopher Mader, Ubbo Visser, Jeremy J. Yang, Cristian G. Bologa, Tudor Oprea*, Stephan C. Schürer*</dc:contributor>
		<rdfs:comment xml:lang="en">contact: Stephan Schurer:  stephan dot schurer at gmail dot com</rdfs:comment>
		<dc:description>
		Drug target ontology files Drug Target Ontology (DTO) is being developed at the University of Miami in the research group of Stephan Schürer. 
		DTO is supported by grant U54CA189205 (Illuminating the Druggable Genome Knowledge Management Center, Tudor Oprea, PI) awarded by the NCI through
		the NIH Common Fund. It is a component of the Illuminating the Druggable Genome (IDG) project (https://commonfund.nih.gov/idg). The DTO project 
		develops a novel semantic framework to formalize knowledge about drug targets with a focus on the current IDG protein families. The DTO is developed
		as a reference for drug targets with the longer-term goal to create a community standard that will facilitate the integration of diverse drug discovery
		information from numerous heterogeneous resources. The first version of the DTO consists of asserted class hierarchies of the four IDG protein families,
		GPCRs, kinases, ion channels, and nuclear hormone receptors. Protein classes are linked to tissue and disease via different levels of confidence. DTO 
		also contains drug target development classifications, a large collection of cell lines from the LINCS project and relevant cell-disease and cell-tissue
		relations. DTO is modeled in OWL2-DL to enable further classification by inference reasoning and SPARQL queries. DTO is implemented following a 
		modularization approach. DTO will serve as the organizational framework for drug targets in the IDG PHAROS User Interface Portal (https://pharos.nih.gov).
		</dc:description>
		<dc:license rdf:resource="https://creativecommons.org/licenses/by-sa/4.0/"/>
	</owl:Ontology>


    <!--
    ///////////////////////////////////////////////////////////////////////////////////////
    //
    // Annotation properties
    //
    ///////////////////////////////////////////////////////////////////////////////////////
     -->

	<!-- http://www.drugtargetontology.org/dto/entrez_xref -->

	<owl:AnnotationProperty rdf:about="http://www.drugtargetontology.org/dto/entrez_xref"/>
	<!-- http://www.drugtargetontology.org/dto/geneSymbol -->

	<owl:AnnotationProperty rdf:about="http://www.drugtargetontology.org/dto/geneSymbol"/>
	<!-- http://www.drugtargetontology.org/dto/geneSynonym -->

	<owl:AnnotationProperty rdf:about="http://www.drugtargetontology.org/dto/geneSynonym"/>



    <!--
    ///////////////////////////////////////////////////////////////////////////////////////
    //
    // Classes
    //
    ///////////////////////////////////////////////////////////////////////////////////////
     -->

	<!-- http://www.drugtargetontology.org/dto/DTO_03200001 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200001">
		<rdfs:label rdf:datatype="&xsd;string">AAK1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400115"/>
		<dto:entrez_xref>22848</dto:entrez_xref>
		<dto:geneSymbol>AAK1</dto:geneSymbol>
		<obo:IAO_0000115>Adaptor-related protein complex 2 (AP-2 complexes) functions during receptor-mediated endocytosis to trigger clathrin assembly, interact with membrane-bound receptors, and recruit encodytic accessory factors. This gene encodes a member of the SNF1 subfamily of Ser/Thr protein kinases. The protein interacts with and phosphorylates a subunit of the AP-2 complex, which promotes binding of AP-2 to sorting signals found in membrane-bound receptors and subsequent receptor endocytosis. Its kinase activity is stimulated by clathrin. Alternatively spliced transcript variants have been described, but their biological validity has not been determined. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>KIAA1048</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200002 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200002">
		<rdfs:label rdf:datatype="&xsd;string">PRKAB1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400116"/>
		<dto:entrez_xref>5564</dto:entrez_xref>
		<dto:geneSymbol>PRKAB1</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is a regulatory subunit of the AMP-activated protein kinase (AMPK). AMPK is a heterotrimer consisting of an alpha catalytic subunit, and non-catalytic beta and gamma subunits. AMPK is an important energy-sensing enzyme that monitors cellular energy status. In response to cellular metabolic stresses, AMPK is activated, and thus phosphorylates and inactivates acetyl-CoA carboxylase (ACC) and beta-hydroxy beta-methylglutaryl-CoA reductase (HMGCR), key enzymes involved in regulating de novo biosynthesis of fatty acid and cholesterol. This subunit may be a positive regulator of AMPK activity. The myristoylation and phosphorylation of this subunit have been shown to affect the enzyme activity and cellular localization of AMPK. This subunit may also serve as an adaptor molecule mediating the association of the AMPK complex. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>AMPK</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200003 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200003">
		<rdfs:label rdf:datatype="&xsd;string">PRKAG1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400116"/>
		<dto:entrez_xref>5571</dto:entrez_xref>
		<dto:geneSymbol>PRKAG1</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is a regulatory subunit of the AMP-activated protein kinase (AMPK). AMPK is a heterotrimer consisting of an alpha catalytic subunit, and non-catalytic beta and gamma subunits. AMPK is an important energy-sensing enzyme that monitors cellular energy status. In response to cellular metabolic stresses, AMPK is activated, and thus phosphorylates and inactivates acetyl-CoA carboxylase (ACC) and beta-hydroxy beta-methylglutaryl-CoA reductase (HMGCR), key enzymes involved in regulating de novo biosynthesis of fatty acid and cholesterol. This subunit is one of the gamma regulatory subunits of AMPK. Alternatively spliced transcript variants encoding distinct isoforms have been observed. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200004 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200004">
		<rdfs:label rdf:datatype="&xsd;string">PRKAA1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400245"/>
		<dto:entrez_xref>5562</dto:entrez_xref>
		<dto:geneSymbol>PRKAA1</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene belongs to the ser/thr protein kinase family. It is the catalytic subunit of the 5&apos;-prime-AMP-activated protein kinase (AMPK). AMPK is a cellular energy sensor conserved in all eukaryotic cells. The kinase activity of AMPK is activated by the stimuli that increase the cellular AMP/ATP ratio. AMPK regulates the activities of a number of key metabolic enzymes through phosphorylation. It protects cells from stresses that cause ATP depletion by switching off ATP-consuming biosynthetic pathways. Alternatively spliced transcript variants encoding distinct isoforms have been observed. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>AMPK1</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200005 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200005">
		<rdfs:label rdf:datatype="&xsd;string">PRKAA2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400245"/>
		<dto:entrez_xref>5563</dto:entrez_xref>
		<dto:geneSymbol>PRKAA2</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is a catalytic subunit of the AMP-activated protein kinase (AMPK). AMPK is a heterotrimer consisting of an alpha catalytic subunit, and non-catalytic beta and gamma subunits. AMPK is an important energy-sensing enzyme that monitors cellular energy status. In response to cellular metabolic stresses, AMPK is activated, and thus phosphorylates and inactivates acetyl-CoA carboxylase (ACC) and beta-hydroxy beta-methylglutaryl-CoA reductase (HMGCR), key enzymes involved in regulating de novo biosynthesis of fatty acid and cholesterol. Studies of the mouse counterpart suggest that this catalytic subunit may control whole-body insulin sensitivity and is necessary for maintaining myocardial energy homeostasis during ischemia. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>AMPK</dto:geneSynonym>
		<dto:geneSynonym>AMPK2</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200006 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200006">
		<rdfs:label rdf:datatype="&xsd;string">ABL1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400117"/>
		<dto:entrez_xref>25</dto:entrez_xref>
		<dto:geneSymbol>ABL1</dto:geneSymbol>
		<obo:IAO_0000115>This gene is a protooncogene that encodes a protein tyrosine kinase involved in a variety of cellular processes, including cell division, adhesion, differentiation, and response to stress. The activity of the protein is negatively regulated by its SH3 domain, whereby deletion of the region encoding this domain results in an oncogene. The ubiquitously expressed protein has DNA-binding activity that is regulated by CDC2-mediated phosphorylation, suggesting a cell cycle function. This gene has been found fused to a variety of translocation partner genes in various leukemias, most notably the t(9;22) translocation that results in a fusion with the 5&apos; end of the breakpoint cluster region gene (BCR; MIM:151410). Alternative splicing of this gene results in two transcript variants, which contain alternative first exons that are spliced to the remaining common exons. [provided by RefSeq, Aug 2014]</obo:IAO_0000115>
		<dto:geneSynonym>ABL</dto:geneSynonym>
		<dto:geneSynonym>JTK7</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200007 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200007">
		<rdfs:label rdf:datatype="&xsd;string">ABL2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400117"/>
		<dto:entrez_xref>27</dto:entrez_xref>
		<dto:geneSymbol>ABL2</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the Abelson family of nonreceptor tyrosine protein kinases. The protein is highly similar to the c-abl oncogene 1 protein, including the tyrosine kinase, SH2 and SH3 domains, and it plays a role in cytoskeletal rearrangements through its C-terminal F-actin- and microtubule-binding sequences. This gene is expressed in both normal and tumor cells, and is involved in translocation with the ets variant 6 gene in leukemia. Multiple alternatively spliced transcript variants encoding different protein isoforms have been found for this gene. [provided by RefSeq, Nov 2009]</obo:IAO_0000115>
		<dto:geneSynonym>ABLL</dto:geneSynonym>
		<dto:geneSynonym>ARG</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200008 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200008">
		<rdfs:label rdf:datatype="&xsd;string">TNK2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400118"/>
		<dto:entrez_xref>10188</dto:entrez_xref>
		<dto:geneSymbol>TNK2</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a tyrosine kinase that binds Cdc42Hs in its GTP-bound form and inhibits both the intrinsic and GTPase-activating protein (GAP)-stimulated GTPase activity of Cdc42Hs. This binding is mediated by a unique sequence of 47 amino acids C-terminal to an SH3 domain. The protein may be involved in a regulatory mechanism that sustains the GTP-bound active form of Cdc42Hs and which is directly linked to a tyrosine phosphorylation signal transduction pathway. Several alternatively spliced transcript variants have been identified from this gene, but the full-length nature of only two transcript variants has been determined. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>ACK1</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200009 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200009">
		<rdfs:label rdf:datatype="&xsd;string">ACVR1B gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400246"/>
		<dto:entrez_xref>91</dto:entrez_xref>
		<dto:geneSymbol>ACVR1B</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes an activin A type IB receptor. Activins are dimeric growth and differentiation factors which belong to the transforming growth factor-beta (TGF-beta) superfamily of structurally related signaling proteins. Activins signal through a heteromeric complex of receptor serine kinases which include at least two type I and two type II receptors. This protein is a type I receptor which is essential for signaling. Mutations in this gene are associated with pituitary tumors. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Jun 2010]</obo:IAO_0000115>
		<dto:geneSynonym>ACVRLK4</dto:geneSynonym>
		<dto:geneSynonym>ALK4</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200010 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200010">
		<rdfs:label rdf:datatype="&xsd;string">ACVR1C gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400246"/>
		<dto:entrez_xref>130399</dto:entrez_xref>
		<dto:geneSymbol>ACVR1C</dto:geneSymbol>
		<obo:IAO_0000115>ACVR1C is a type I receptor for the TGFB (see MIM 190180) family of signaling molecules. Upon ligand binding, type I receptors phosphorylate cytoplasmic SMAD transcription factors, which then translocate to the nucleus and interact directly with DNA or in complex with other transcription factors (Bondestam et al., 2001 [PubMed 12063393]).[supplied by OMIM, Mar 2008]</obo:IAO_0000115>
		<dto:geneSynonym>ALK7</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200011 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200011">
		<rdfs:label rdf:datatype="&xsd;string">ACVRL1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400246"/>
		<dto:entrez_xref>94</dto:entrez_xref>
		<dto:geneSymbol>ACVRL1</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a type I cell-surface receptor for the TGF-beta superfamily of ligands. It shares with other type I receptors a high degree of similarity in serine-threonine kinase subdomains, a glycine- and serine-rich region (called the GS domain) preceding the kinase domain, and a short C-terminal tail. The encoded protein, sometimes termed ALK1, shares similar domain structures with other closely related ALK or activin receptor-like kinase proteins that form a subfamily of receptor serine/threonine kinases. Mutations in this gene are associated with hemorrhagic telangiectasia type 2, also known as Rendu-Osler-Weber syndrome 2. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>ACVRLK1</dto:geneSynonym>
		<dto:geneSynonym>ALK1</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200012 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200012">
		<rdfs:label rdf:datatype="&xsd;string">ACVR1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400246"/>
		<dto:entrez_xref>90</dto:entrez_xref>
		<dto:geneSymbol>ACVR1</dto:geneSymbol>
		<obo:IAO_0000115>Activins are dimeric growth and differentiation factors which belong to the transforming growth factor-beta (TGF-beta) superfamily of structurally related signaling proteins. Activins signal through a heteromeric complex of receptor serine kinases which include at least two type I ( I and IB) and two type II (II and IIB) receptors. These receptors are all transmembrane proteins, composed of a ligand-binding extracellular domain with cysteine-rich region, a transmembrane domain, and a cytoplasmic domain with predicted serine/threonine specificity. Type I receptors are essential for signaling; and type II receptors are required for binding ligands and for expression of type I receptors. Type I and II receptors form a stable complex after ligand binding, resulting in phosphorylation of type I receptors by type II receptors. This gene encodes activin A type I receptor which signals a particular transcriptional response in concert with activin type II receptors. Mutations in this gene are associated with fibrodysplasia ossificans progressive. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>ACVRLK2</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200013 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200013">
		<rdfs:label rdf:datatype="&xsd;string">ADCK1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400247"/>
		<dto:entrez_xref>57143</dto:entrez_xref>
		<dto:geneSymbol>ADCK1</dto:geneSymbol>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200014 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200014">
		<rdfs:label rdf:datatype="&xsd;string">ADCK2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400248"/>
		<dto:entrez_xref>90956</dto:entrez_xref>
		<dto:geneSymbol>ADCK2</dto:geneSymbol>
		<dto:geneSynonym>AARF</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200015 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200015">
		<rdfs:label rdf:datatype="&xsd;string">ADCK3 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400249"/>
		<dto:entrez_xref>56997</dto:entrez_xref>
		<dto:geneSymbol>ADCK3</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a mitochondrial protein similar to yeast ABC1, which functions in an electron-transferring membrane protein complex in the respiratory chain. It is not related to the family of ABC transporter proteins. Expression of this gene is induced by the tumor suppressor p53 and in response to DNA damage, and inhibiting its expression partially suppresses p53-induced apoptosis. Alternatively spliced transcript variants have been found; however, their full-length nature has not been determined. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>CABC1</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200016 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200016">
		<rdfs:label rdf:datatype="&xsd;string">ADCK4 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400249"/>
		<dto:entrez_xref>79934</dto:entrez_xref>
		<dto:geneSymbol>ADCK4</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a protein with two copies of a domain found in protein kinases. The encoded protein has a complete protein kinase catalytic domain, and a truncated domain that contains only the active and binding sites of the protein kinase domain, however, it is not known whether the protein has any kinase activity. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2011]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200017 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200017">
		<rdfs:label rdf:datatype="&xsd;string">ADCK5 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400247"/>
		<dto:entrez_xref>203054</dto:entrez_xref>
		<dto:geneSymbol>ADCK5</dto:geneSymbol>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200018 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200018">
		<rdfs:label rdf:datatype="&xsd;string">ADK gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400322"/>
		<dto:entrez_xref>132</dto:entrez_xref>
		<dto:geneSymbol>ADK</dto:geneSymbol>
		<obo:IAO_0000115>This gene an enzyme which catalyzes the transfer of the gamma-phosphate from ATP to adenosine, thereby serving as a regulator of concentrations of both extracellular adenosine and intracellular adenine nucleotides. Adenosine has widespread effects on the cardiovascular, nervous, respiratory, and immune systems and inhibitors of the enzyme could play an important pharmacological role in increasing intravascular adenosine concentrations and acting as anti-inflammatory agents. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2011]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200019 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200019">
		<rdfs:label rdf:datatype="&xsd;string">AKT1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400121"/>
		<dto:entrez_xref>207</dto:entrez_xref>
		<dto:geneSymbol>AKT1</dto:geneSymbol>
		<obo:IAO_0000115>The serine-threonine protein kinase encoded by the AKT1 gene is catalytically inactive in serum-starved primary and immortalized fibroblasts. AKT1 and the related AKT2 are activated by platelet-derived growth factor. The activation is rapid and specific, and it is abrogated by mutations in the pleckstrin homology domain of AKT1. It was shown that the activation occurs through phosphatidylinositol 3-kinase. In the developing nervous system AKT is a critical mediator of growth factor-induced neuronal survival. Survival factors can suppress apoptosis in a transcription-independent manner by activating the serine/threonine kinase AKT1, which then phosphorylates and inactivates components of the apoptotic machinery. Mutations in this gene have been associated with the Proteus syndrome. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jul 2011]</obo:IAO_0000115>
		<dto:geneSynonym>PKB</dto:geneSynonym>
		<dto:geneSynonym>RAC</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200020 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200020">
		<rdfs:label rdf:datatype="&xsd;string">AKT2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400121"/>
		<dto:entrez_xref>208</dto:entrez_xref>
		<dto:geneSymbol>AKT2</dto:geneSymbol>
		<obo:IAO_0000115>This gene is a putative oncogene encoding a protein belonging to a subfamily of serine/threonine kinases containing SH2-like (Src homology 2-like) domains. The gene was shown to be amplified and overexpressed in 2 of 8 ovarian carcinoma cell lines and 2 of 15 primary ovarian tumors. Overexpression contributes to the malignant phenotype of a subset of human ductal pancreatic cancers. The encoded protein is a general protein kinase capable of phophorylating several known proteins. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200021 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200021">
		<rdfs:label rdf:datatype="&xsd;string">AKT3 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400121"/>
		<dto:entrez_xref>10000</dto:entrez_xref>
		<dto:geneSymbol>AKT3</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is a member of the AKT, also called PKB,  serine/threonine protein kinase family. AKT kinases are known to be regulators of cell signaling in response to insulin and growth factors. They are involved in a wide variety of biological processes including cell proliferation, differentiation, apoptosis, tumorigenesis, as well as glycogen synthesis and glucose uptake. This kinase has been shown to be stimulated by platelet-derived growth factor (PDGF), insulin, and insulin-like growth factor 1 (IGF1). Alternatively splice transcript variants encoding distinct isoforms have been described. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>PKBG</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200022 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200022">
		<rdfs:label rdf:datatype="&xsd;string">ALK gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400122"/>
		<dto:entrez_xref>238</dto:entrez_xref>
		<dto:geneSymbol>ALK</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a receptor tyrosine kinase, which belongs to the insulin receptor superfamily. This protein comprises an extracellular domain, an hydrophobic stretch corresponding to a single pass transmembrane region, and an intracellular kinase domain. It plays an important role in the development of the brain and exerts its effects on specific neurons in the nervous system. This gene has been found to be rearranged, mutated, or amplified in a series of tumours including anaplastic large cell lymphomas, neuroblastoma, and non-small cell lung cancer. The chromosomal rearrangements are the most common genetic alterations in this gene, which result in creation of multiple fusion genes in tumourigenesis, including ALK (chromosome 2)/EML4 (chromosome 2), ALK/RANBP2 (chromosome 2), ALK/ATIC (chromosome 2), ALK/TFG (chromosome 3), ALK/NPM1 (chromosome 5), ALK/SQSTM1 (chromosome 5), ALK/KIF5B (chromosome 10), ALK/CLTC (chromosome 17), ALK/TPM4 (chromosome 19), and ALK/MSN (chromosome X).[provided by RefSeq, Jan 2011]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200023 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200023">
		<rdfs:label rdf:datatype="&xsd;string">ALPK1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400123"/>
		<dto:entrez_xref>80216</dto:entrez_xref>
		<dto:geneSymbol>ALPK1</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes an alpha kinase. Mice which were homozygous for disrupted copies of this gene exhibited coordination defects (PMID: 21208416). Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2011]</obo:IAO_0000115>
		<dto:geneSynonym>KIAA1527</dto:geneSynonym>
		<dto:geneSynonym>LAK</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200024 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200024">
		<rdfs:label rdf:datatype="&xsd;string">ALPK2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400123"/>
		<dto:entrez_xref>115701</dto:entrez_xref>
		<dto:geneSymbol>ALPK2</dto:geneSymbol>
		<dto:geneSynonym>HAK</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200025 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200025">
		<rdfs:label rdf:datatype="&xsd;string">ALPK3 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400123"/>
		<dto:entrez_xref>57538</dto:entrez_xref>
		<dto:geneSymbol>ALPK3</dto:geneSymbol>
		<dto:geneSynonym>KIAA1330</dto:geneSynonym>
		<dto:geneSynonym>MAK</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200026 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200026">
		<rdfs:label rdf:datatype="&xsd;string">AMHR2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400252"/>
		<dto:entrez_xref>269</dto:entrez_xref>
		<dto:geneSymbol>AMHR2</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes the receptor for the anti-Mullerian hormone (AMH) which, in addition to testosterone, results in male sex differentiation. AMH and testosterone are produced in the testes by different cells and have different effects. Testosterone promotes the development of male genitalia while the binding of AMH to the encoded receptor prevents the development of the mullerian ducts into uterus and Fallopian tubes. Mutations in this gene are associated with persistent Mullerian duct syndrome type II. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Sep 2009]</obo:IAO_0000115>
		<dto:geneSynonym>AMHR</dto:geneSynonym>
		<dto:geneSynonym>MISR2</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200027 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200027">
		<rdfs:label rdf:datatype="&xsd;string">ANKK1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400124"/>
		<dto:entrez_xref>255239</dto:entrez_xref>
		<dto:geneSymbol>ANKK1</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene belongs to the Ser/Thr protein kinase family, and protein kinase superfamily involved in signal transduction pathways. This gene is closely linked to DRD2 gene (GeneID:1813) on chr 11, and a well studied restriction fragment length polymorphism (RFLP) designated TaqIA, was originally associated with the DRD2 gene, however, later was determined to be located in exon 8 of ANKK1 gene (PMIDs: 18621654, 15146457), where it causes a nonconservative amino acid substitution. It is not clear if this gene plays any role in neuropsychiatric disorders previously associated with Taq1A RFLP. [provided by RefSeq, Sep 2009]</obo:IAO_0000115>
		<dto:geneSynonym>PKK2</dto:geneSynonym>
		<dto:geneSynonym>SGK288</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200028 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200028">
		<rdfs:label rdf:datatype="&xsd;string">NPR1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400125"/>
		<dto:entrez_xref>4881</dto:entrez_xref>
		<dto:geneSymbol>NPR1</dto:geneSymbol>
		<obo:IAO_0000115>Guanylyl cyclases, catalyzing the production of cGMP from GTP, are classified as soluble and membrane forms (Garbers and Lowe, 1994 [PubMed 7982997]). The membrane guanylyl cyclases, often termed guanylyl cyclases A through F, form a family of cell-surface receptors with a similar topographic structure: an extracellular ligand-binding domain, a single membrane-spanning domain, and an intracellular region that contains a protein kinase-like domain and a cyclase catalytic domain. GC-A and GC-B function as receptors for natriuretic peptides; they are also referred to as atrial natriuretic peptide receptor A (NPR1) and type B (NPR2; MIM 108961). Also see NPR3 (MIM 108962), which encodes a protein with only the ligand-binding transmembrane and 37-amino acid cytoplasmic domains. NPR1 is a membrane-bound guanylate cyclase that serves as the receptor for both atrial and brain natriuretic peptides (ANP (MIM 108780) and BNP (MIM 600295), respectively).[supplied by OMIM, May 2009]</obo:IAO_0000115>
		<dto:geneSynonym>ANPRA</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200029 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200029">
		<rdfs:label rdf:datatype="&xsd;string">NPR2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400125"/>
		<dto:entrez_xref>4882</dto:entrez_xref>
		<dto:geneSymbol>NPR2</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes natriuretic peptide receptor B, one of two integral membrane receptors for natriuretic peptides. Both NPR1 and NPR2 contain five functional domains: an extracellular ligand-binding domain, a single membrane-spanning region, and intracellularly a protein kinase homology domain, a helical hinge region involved in oligomerization, and a carboxyl-terminal guanylyl cyclase catalytic domain. The protein is the primary receptor for C-type natriuretic peptide (CNP), which upon ligand binding exhibits greatly increased guanylyl cyclase activity. Mutations in this gene are the cause of acromesomelic dysplasia Maroteaux type. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>ANPRB</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200030 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200030">
		<rdfs:label rdf:datatype="&xsd;string">ARAF gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400126"/>
		<dto:entrez_xref>369</dto:entrez_xref>
		<dto:geneSymbol>ARAF</dto:geneSymbol>
		<obo:IAO_0000115>This proto-oncogene belongs to the RAF subfamily of the Ser/Thr protein kinase family, and maybe involved in cell growth and development. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Jan 2012]</obo:IAO_0000115>
		<dto:geneSynonym>ARAF1</dto:geneSynonym>
		<dto:geneSynonym>PKS</dto:geneSynonym>
		<dto:geneSynonym>PKS2</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200031 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200031">
		<rdfs:label rdf:datatype="&xsd;string">ADRBK1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400250"/>
		<dto:entrez_xref>156</dto:entrez_xref>
		<dto:geneSymbol>ADRBK1</dto:geneSymbol>
		<obo:IAO_0000115>The product of this gene phosphorylates the beta-2-adrenergic receptor and appears to mediate agonist-specific desensitization observed at high agonist concentrations. This protein is an ubiquitous cytosolic enzyme that specifically phosphorylates the activated form of the beta-adrenergic and related G-protein-coupled receptors. Abnormal coupling of beta-adrenergic receptor to G protein is involved in the pathogenesis of the failing heart. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>BARK</dto:geneSynonym>
		<dto:geneSynonym>BARK1</dto:geneSynonym>
		<dto:geneSynonym>GRK2</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200032 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200032">
		<rdfs:label rdf:datatype="&xsd;string">ADRBK2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400250"/>
		<dto:entrez_xref>157</dto:entrez_xref>
		<dto:geneSymbol>ADRBK2</dto:geneSymbol>
		<obo:IAO_0000115>The beta-adrenergic receptor kinase specifically phosphorylates the agonist-occupied form of the beta-adrenergic and related G protein-coupled receptors. Overall, the beta adrenergic receptor kinase 2 has 85% amino acid similarity with beta adrenergic receptor kinase 1, with the protein kinase catalytic domain having 95% similarity. These data suggest the existence of a family of receptor kinases which may serve broadly to regulate receptor function. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>BARK2</dto:geneSynonym>
		<dto:geneSynonym>GRK3</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200033 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200033">
		<rdfs:label rdf:datatype="&xsd;string">ATM gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400129"/>
		<dto:entrez_xref>472</dto:entrez_xref>
		<dto:geneSymbol>ATM</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene belongs to the PI3/PI4-kinase family. This protein is an important cell cycle checkpoint kinase that phosphorylates; thus, it functions as a regulator of a wide variety of downstream proteins, including tumor suppressor proteins p53 and BRCA1, checkpoint kinase CHK2, checkpoint proteins RAD17 and RAD9, and DNA repair protein NBS1. This protein and the closely related kinase ATR are thought to be master controllers of cell cycle checkpoint signaling pathways that are required for cell response to DNA damage and for genome stability. Mutations in this gene are associated with ataxia telangiectasia, an autosomal recessive disorder. [provided by RefSeq, Aug 2010]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200034 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200034">
		<rdfs:label rdf:datatype="&xsd;string">ATR gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400251"/>
		<dto:entrez_xref>545</dto:entrez_xref>
		<dto:geneSymbol>ATR</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene belongs the PI3/PI4-kinase family, and is most closely related to ATM, a protein kinase encoded by the gene mutated in ataxia telangiectasia. This protein and ATM share similarity with Schizosaccharomyces pombe rad3, a cell cycle checkpoint gene required for cell cycle arrest and DNA damage repair in response to DNA damage. This kinase has been shown to phosphorylate checkpoint kinase CHK1, checkpoint proteins RAD17, and RAD9, as well as tumor suppressor protein BRCA1. Mutations of this gene are associated with Seckel syndrome. An alternatively spliced transcript variant of this gene has been reported, however, its full length nature is not known. Transcript variants utilizing alternative polyA sites exist. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>FRP1</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200035 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200035">
		<rdfs:label rdf:datatype="&xsd;string">AURKA gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400130"/>
		<dto:entrez_xref>6790</dto:entrez_xref>
		<dto:geneSymbol>AURKA</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is a cell cycle-regulated kinase that appears to be involved in microtubule formation and/or stabilization at the spindle pole during chromosome segregation. The encoded protein is found at the centrosome in interphase cells and at the spindle poles in mitosis. This gene may play a role in tumor development and progression. A processed pseudogene of this gene has been found on chromosome 1, and an unprocessed pseudogene has been found on chromosome 10. Multiple transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>AIK</dto:geneSynonym>
		<dto:geneSynonym>AIRK1</dto:geneSynonym>
		<dto:geneSynonym>ARK1</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200036 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200036">
		<rdfs:label rdf:datatype="&xsd;string">AURKB gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400130"/>
		<dto:entrez_xref>9212</dto:entrez_xref>
		<dto:geneSymbol>AURKB</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the aurora kinase subfamily of serine/threonine kinases. The genes encoding the other two members of this subfamily are located on chromosomes 19 and 20. These kinases participate in the regulation of segregation of chromosomes during mitosis and meiosis through association with microtubules. A pseudogene of this gene is located on chromosome 8. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2013]</obo:IAO_0000115>
		<dto:geneSynonym>AIK2</dto:geneSynonym>
		<dto:geneSynonym>AIM1</dto:geneSynonym>
		<dto:geneSynonym>AIRK2</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200037 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200037">
		<rdfs:label rdf:datatype="&xsd;string">AURKC gene</rdfs:label>
		<dto:entrez_xref>6795</dto:entrez_xref>
		<dto:geneSymbol>AURKC</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the Aurora subfamily of serine/threonine protein kinases. The encoded protein is a chromosomal passenger protein that forms complexes with Aurora-B and inner centromere proteins and may play a role in organizing microtubules in relation to centrosome/spindle function during mitosis. This gene is overexpressed in several cancer cell lines, suggesting an involvement in oncogenic signal transduction. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>AIE2</dto:geneSynonym>
		<dto:geneSynonym>AIK3</dto:geneSynonym>
		<dto:geneSynonym>AIRK3</dto:geneSynonym>
		<dto:geneSynonym>ARK3</dto:geneSynonym>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400130"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200038 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200038">
		<rdfs:label rdf:datatype="&xsd;string">ACVR2A gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400252"/>
		<dto:entrez_xref>92</dto:entrez_xref>
		<dto:geneSymbol>ACVR2A</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a receptor that mediates the functions of activins, which are members of the transforming growth factor-beta (TGF-beta) superfamily involved in diverse biological processes. The encoded protein is a transmembrane serine-threonine kinase receptor which mediates signaling by forming heterodimeric complexes with various combinations of type I and type II receptors and ligands in a cell-specific manner. The encoded type II receptor is primarily involved in ligand-binding and includes an extracellular ligand-binding domain, a transmembrane domain and a cytoplasmic serine-threonine kinase domain. This gene may be associated with susceptibility to preeclampsia, a pregnancy-related disease which can result in maternal and fetal morbidity and mortality. Alternative splicing results in multiple transcript variants of this gene. [provided by RefSeq, Jun 2013]</obo:IAO_0000115>
		<dto:geneSynonym>ACVR2</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200039 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200039">
		<rdfs:label rdf:datatype="&xsd;string">ACVR2B gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400252"/>
		<dto:entrez_xref>93</dto:entrez_xref>
		<dto:geneSymbol>ACVR2B</dto:geneSymbol>
		<obo:IAO_0000115>Activins are dimeric growth and differentiation factors which belong to the transforming growth factor-beta (TGF-beta) superfamily of structurally related signaling proteins. Activins signal through a heteromeric complex of receptor serine kinases which include at least two type I (I and IB) and two type II (II and IIB) receptors. These receptors are all transmembrane proteins, composed of a ligand-binding extracellular domain with cysteine-rich region, a transmembrane domain, and a cytoplasmic domain with predicted serine/threonine specificity. Type I receptors are essential for signaling; and type II receptors are required for binding ligands and for expression of type I receptors. Type I and II receptors form a stable complex after ligand binding, resulting in phosphorylation of type I receptors by type II receptors. Type II receptors are considered to be constitutively active kinases. This gene encodes activin A type IIB receptor, which displays a 3- to 4-fold higher affinity for the ligand than activin A type II receptor. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200040 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200040">
		<rdfs:label rdf:datatype="&xsd;string">BCKDK gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400131"/>
		<dto:entrez_xref>10295</dto:entrez_xref>
		<dto:geneSymbol>BCKDK</dto:geneSymbol>
		<obo:IAO_0000115>The branched-chain alpha-ketoacid dehydrogenase complex (BCKD) is an important regulator of the valine, leucine, and isoleucine catabolic pathways. The protein encoded by this gene is found in the mitochondrion, where it phosphorylates and inactivates BCKD. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2012]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200041 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200041">
		<rdfs:label rdf:datatype="&xsd;string">BLK gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400132"/>
		<dto:entrez_xref>640</dto:entrez_xref>
		<dto:geneSymbol>BLK</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a nonreceptor tyrosine-kinase of the src family of proto-oncogenes that are typically involved in cell proliferation and differentiation. The protein has a role in B-cell receptor signaling and B-cell development. The protein also stimulates insulin synthesis and secretion in response to glucose and enhances the expression of several pancreatic beta-cell transcription factors. [provided by RefSeq, Aug 2010]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200042 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200042">
		<rdfs:label rdf:datatype="&xsd;string">BMP2K gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400115"/>
		<dto:entrez_xref>55589</dto:entrez_xref>
		<dto:geneSymbol>BMP2K</dto:geneSymbol>
		<obo:IAO_0000115>This gene is the human homolog of mouse BMP-2-inducible kinase. Bone morphogenic proteins (BMPs) play a key role in skeletal development and patterning. Expression of the mouse gene is increased during BMP-2 induced differentiation and the gene product is a putative serine/threonine protein kinase containing a nuclear localization signal. Therefore, the protein encoded by this human homolog is thought to be a protein kinase with a putative regulatory role in attenuating the program of osteoblast differentiation. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>BIKE</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200043 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200043">
		<rdfs:label rdf:datatype="&xsd;string">BMPR2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400252"/>
		<dto:entrez_xref>659</dto:entrez_xref>
		<dto:geneSymbol>BMPR2</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the bone morphogenetic protein (BMP) receptor family of transmembrane serine/threonine kinases. The ligands of this receptor are BMPs, which are members of the TGF-beta superfamily. BMPs are involved in endochondral bone formation and embryogenesis. These proteins transduce their signals through the formation of heteromeric complexes of two different types of serine (threonine) kinase receptors: type I receptors of about 50-55 kD and type II receptors of about 70-80 kD. Type II receptors bind ligands in the absence of type I receptors, but they require their respective type I receptors for signaling, whereas type I receptors require their respective type II receptors for ligand binding. Mutations in this gene have been associated with primary pulmonary hypertension, both familial and fenfluramine-associated, and with pulmonary venoocclusive disease. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>PPH1</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200044 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200044">
		<rdfs:label rdf:datatype="&xsd;string">BMPR1A gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400246"/>
		<dto:entrez_xref>657</dto:entrez_xref>
		<dto:geneSymbol>BMPR1A</dto:geneSymbol>
		<obo:IAO_0000115>The bone morphogenetic protein (BMP) receptors are a family of transmembrane serine/threonine kinases that include the type I receptors BMPR1A and BMPR1B and the type II receptor BMPR2. These receptors are also closely related to the activin receptors, ACVR1 and ACVR2. The ligands of these receptors are members of the TGF-beta superfamily. TGF-betas and activins transduce their signals through the formation of heteromeric complexes with 2 different types of serine (threonine) kinase receptors: type I receptors of about 50-55 kD and type II receptors of about 70-80 kD. Type II receptors bind ligands in the absence of type I receptors, but they require their respective type I receptors for signaling, whereas type I receptors require their respective type II receptors for ligand binding. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>ACVRLK3</dto:geneSynonym>
		<dto:geneSynonym>ALK3</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200045 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200045">
		<rdfs:label rdf:datatype="&xsd;string">BMPR1B gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400246"/>
		<dto:entrez_xref>658</dto:entrez_xref>
		<dto:geneSymbol>BMPR1B</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the bone morphogenetic protein (BMP) receptor family of transmembrane serine/threonine kinases. The ligands of this receptor are BMPs, which are members of the TGF-beta superfamily. BMPs are involved in endochondral bone formation and embryogenesis. These proteins transduce their signals through the formation of heteromeric complexes of 2 different types of serine (threonine) kinase receptors: type I receptors of about 50-55 kD and type II receptors of about 70-80 kD. Type II receptors bind ligands in the absence of type I receptors, but they require their respective type I receptors for signaling, whereas type I receptors require their respective type II receptors for ligand binding. Mutations in this gene have been associated with primary pulmonary hypertension. Several transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Feb 2012]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200046 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200046">
		<rdfs:label rdf:datatype="&xsd;string">BMX gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400133"/>
		<dto:entrez_xref>660</dto:entrez_xref>
		<dto:geneSymbol>BMX</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a non-receptor tyrosine kinase belonging to the Tec kinase family. The protein contains a PH-like domain, which mediates membrane targeting by binding to phosphatidylinositol 3,4,5-triphosphate (PIP3), and a SH2 domain that binds to tyrosine-phosphorylated proteins and functions in signal transduction. The protein is implicated in several signal transduction pathways including the Stat pathway, and regulates differentiation and tumorigenicity of several types of cancer cells. Multiple alternatively spliced variants, encoding the same protein, have been identified.[provided by RefSeq, Sep 2009]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200047 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200047">
		<rdfs:label rdf:datatype="&xsd;string">BRAF gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400126"/>
		<dto:entrez_xref>673</dto:entrez_xref>
		<dto:geneSymbol>BRAF</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a protein belonging to the raf/mil family of serine/threonine protein kinases. This protein plays a role in regulating the MAP kinase/ERKs signaling pathway, which affects cell division, differentiation, and secretion. Mutations in this gene are associated with cardiofaciocutaneous syndrome, a disease characterized by heart defects, mental retardation and a distinctive facial appearance. Mutations in this gene have also been associated with various cancers, including non-Hodgkin lymphoma, colorectal cancer, malignant melanoma, thyroid carcinoma, non-small cell lung carcinoma, and adenocarcinoma of lung. A pseudogene, which is located on chromosome X, has been identified for this gene. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>BRAF1</dto:geneSynonym>
		<dto:geneSynonym>RAFB1</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200048 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200048">
		<rdfs:label rdf:datatype="&xsd;string">BRSK1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400253"/>
		<dto:entrez_xref>84446</dto:entrez_xref>
		<dto:geneSymbol>BRSK1</dto:geneSymbol>
		<dto:geneSynonym>KIAA1811</dto:geneSynonym>
		<dto:geneSynonym>SAD1</dto:geneSynonym>
		<dto:geneSynonym>SADB</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200049 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200049">
		<rdfs:label rdf:datatype="&xsd;string">BRSK2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400253"/>
		<dto:entrez_xref>9024</dto:entrez_xref>
		<dto:geneSymbol>BRSK2</dto:geneSymbol>
		<dto:geneSynonym>C11orf7</dto:geneSynonym>
		<dto:geneSynonym>PEN11B</dto:geneSynonym>
		<dto:geneSynonym>SADA</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200050 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200050">
		<rdfs:label rdf:datatype="&xsd;string">BTK gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400133"/>
		<dto:entrez_xref>695</dto:entrez_xref>
		<dto:geneSymbol>BTK</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene plays a crucial role in B-cell development. Mutations in this gene cause X-linked agammaglobulinemia type 1, which is an immunodeficiency characterized by the failure to produce mature B lymphocytes, and associated with a failure of Ig heavy chain rearrangement. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Dec 2013]</obo:IAO_0000115>
		<dto:geneSynonym>AGMX1</dto:geneSynonym>
		<dto:geneSynonym>ATK</dto:geneSynonym>
		<dto:geneSynonym>BPK</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200051 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200051">
		<rdfs:label rdf:datatype="&xsd;string">BUB1B gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400134"/>
		<dto:entrez_xref>701</dto:entrez_xref>
		<dto:geneSymbol>BUB1B</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a kinase involved in spindle checkpoint function. The protein has been localized to the kinetochore and plays a role in the inhibition of the anaphase-promoting complex/cyclosome (APC/C), delaying the onset of anaphase and ensuring proper chromosome segregation. Impaired spindle checkpoint function has been found in many forms of cancer. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>BUBR1</dto:geneSynonym>
		<dto:geneSynonym>MAD3L</dto:geneSynonym>
		<dto:geneSynonym>SSK1</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200052 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200052">
		<rdfs:label rdf:datatype="&xsd;string">BUB1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400134"/>
		<dto:entrez_xref>699</dto:entrez_xref>
		<dto:geneSymbol>BUB1</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a serine/threonine-protein kinase that play a central role in mitosis. The encoded protein functions in part by phosphorylating members of the mitotic checkpoint complex and activating the spindle checkpoint. This protein also plays a role in inhibiting the activation of the anaphase promoting complex/cyclosome. This protein may also function in the DNA damage response. Mutations in this gene have been associated with aneuploidy and several forms of cancer. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013]</obo:IAO_0000115>
		<dto:geneSynonym>BUB1L</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200053 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200053">
		<rdfs:label rdf:datatype="&xsd;string">CAMKV gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400135"/>
		<dto:entrez_xref>79012</dto:entrez_xref>
		<dto:geneSymbol>CAMKV</dto:geneSymbol>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200054 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200054">
		<rdfs:label rdf:datatype="&xsd;string">CDK11A gene</rdfs:label>
		<dto:entrez_xref>728642</dto:entrez_xref>
		<dto:geneSymbol>CDK11A</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the p34Cdc2 protein kinase family. p34Cdc2 kinase family members are known to be essential for eukaryotic cell cycle control. This gene is in close proximity to CDC2L1, a nearly identical gene in the same chromosomal region. The gene loci including this gene, CDC2L1, as well as metalloprotease MMP21/22, consist of two identical, tandemly linked genomic regions, which are thought to be a part of the larger region that has been duplicated. This gene and CDC2L1 were shown to be deleted or altered frequently in neuroblastoma with amplified MYCN genes. The protein kinase encoded by this gene could be cleaved by caspases and was demonstrated to play roles in cell apoptosis. Many transcript variants encoding several different isoforms have been found for this gene, but the full-length nature of only two have been determined so far. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>CDC2L2</dto:geneSynonym>
		<dto:geneSynonym>CDC2L3</dto:geneSynonym>
		<dto:geneSynonym>PITSLREB</dto:geneSynonym>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400254"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200055 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200055">
		<rdfs:label rdf:datatype="&xsd;string">CDK11B gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400254"/>
		<dto:entrez_xref>984</dto:entrez_xref>
		<dto:geneSymbol>CDK11B</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the serine/threonine protein kinase family. Members of this kinase family are known to be essential for eukaryotic cell cycle control. Due to a segmental duplication, this gene shares very high sequence identity with a neighboring gene. These two genes are frequently deleted or altered in neuroblastoma. The protein kinase encoded by this gene can be cleaved by caspases and may play a role in cell apoptosis. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2014]</obo:IAO_0000115>
		<dto:geneSynonym>CDC2L1</dto:geneSynonym>
		<dto:geneSynonym>CDK11</dto:geneSynonym>
		<dto:geneSynonym>PITSLREA</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200056 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200056">
		<rdfs:label rdf:datatype="&xsd;string">CDC7 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400137"/>
		<dto:entrez_xref>8317</dto:entrez_xref>
		<dto:geneSymbol>CDC7</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a cell division cycle protein with kinase activity that is critical for the G1/S transition. The yeast homolog is also essential for initiation of DNA replication as cell division occurs. Overexpression of this gene product may be associated with neoplastic transformation for some tumors. Multiple alternatively spliced transcript variants that encode the same protein have been detected. [provided by RefSeq, Aug 2008]</obo:IAO_0000115>
		<dto:geneSynonym>CDC7L1</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200057 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200057">
		<rdfs:label rdf:datatype="&xsd;string">CDK10 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491033"/>
		<dto:entrez_xref>8558</dto:entrez_xref>
		<dto:geneSymbol>CDK10</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene belongs to the CDK subfamily of the Ser/Thr protein kinase family. The CDK subfamily members are highly similar to the gene products of S. cerevisiae cdc28, and S. pombe cdc2, and are known to be essential for cell cycle progression. This kinase has been shown to play a role in cellular proliferation and its function is limited to cell cycle G2-M phase. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2009]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200058 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200058">
		<rdfs:label rdf:datatype="&xsd;string">CDK12 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400136"/>
		<dto:entrez_xref>51755</dto:entrez_xref>
		<dto:geneSymbol>CDK12</dto:geneSymbol>
		<dto:geneSynonym>CRK7</dto:geneSynonym>
		<dto:geneSynonym>CRKRS</dto:geneSynonym>
		<dto:geneSynonym>KIAA0904</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200059 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200059">
		<rdfs:label rdf:datatype="&xsd;string">CDK13 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400255"/>
		<dto:entrez_xref>8621</dto:entrez_xref>
		<dto:geneSymbol>CDK13</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is a member of the cyclin-dependent serine/threonine protein kinase family. Members of this family are well known for their essential roles as master switches in cell cycle control. The exact function of this protein has not yet been determined, but it may play a role in mRNA processing and may be involved in regulation of hematopoiesis. Alternatively spliced transcript variants have been described.[provided by RefSeq, Dec 2009]</obo:IAO_0000115>
		<dto:geneSynonym>CDC2L</dto:geneSynonym>
		<dto:geneSynonym>CDC2L5</dto:geneSynonym>
		<dto:geneSynonym>CHED</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200060 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200060">
		<rdfs:label rdf:datatype="&xsd;string">CDK14 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400256"/>
		<dto:entrez_xref>5218</dto:entrez_xref>
		<dto:geneSymbol>CDK14</dto:geneSymbol>
		<obo:IAO_0000115>PFTK1 is a member of the CDC2 (MIM 116940)-related protein kinase family (Yang and Chen, 2001 [PubMed 11313143]).[supplied by OMIM, Mar 2008]</obo:IAO_0000115>
		<dto:geneSynonym>KIAA0834</dto:geneSynonym>
		<dto:geneSynonym>PFTK1</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200061 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200061">
		<rdfs:label rdf:datatype="&xsd;string">CDK15 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400256"/>
		<dto:entrez_xref>65061</dto:entrez_xref>
		<dto:geneSymbol>CDK15</dto:geneSymbol>
		<dto:geneSynonym>ALS2CR7</dto:geneSynonym>
		<dto:geneSynonym>PFTK2</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200062 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200062">
		<rdfs:label rdf:datatype="&xsd;string">CDK16 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400256"/>
		<dto:entrez_xref>5127</dto:entrez_xref>
		<dto:geneSymbol>CDK16</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene belongs to the cdc2/cdkx subfamily of the ser/thr family of protein kinases. It may play a role in signal transduction cascades in terminally differentiated cells; in exocytosis; and in transport of secretory cargo from the endoplasmic reticulum. This gene is thought to escape X inactivation. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Dec 2009]</obo:IAO_0000115>
		<dto:geneSynonym>PCTAIRE1</dto:geneSynonym>
		<dto:geneSynonym>PCTK1</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200063 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200063">
		<rdfs:label rdf:datatype="&xsd;string">CDK17 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400256"/>
		<dto:entrez_xref>5128</dto:entrez_xref>
		<dto:geneSymbol>CDK17</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene belongs to the cdc2/cdkx subfamily of the ser/thr family of protein kinases. It has similarity to a rat protein that is thought to play a role in terminally differentiated neurons. Alternatively spliced transcript variants encoding different isoforms have been found. [provided by RefSeq, Jul 2010]</obo:IAO_0000115>
		<dto:geneSynonym>PCTAIRE2</dto:geneSynonym>
		<dto:geneSynonym>PCTK2</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200064 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200064">
		<rdfs:label rdf:datatype="&xsd;string">CDK18 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400256"/>
		<dto:entrez_xref>5129</dto:entrez_xref>
		<dto:geneSymbol>CDK18</dto:geneSymbol>
		<dto:geneSynonym>PCTAIRE3</dto:geneSynonym>
		<dto:geneSynonym>PCTK3</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200065 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200065">
		<rdfs:label rdf:datatype="&xsd;string">CDK19 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400257"/>
		<dto:entrez_xref>23097</dto:entrez_xref>
		<dto:geneSymbol>CDK19</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a protein that is one of the components of the Mediator co-activator complex. The Mediator complex is a multi-protein complex required for transcriptional activation by DNA binding transcription factors of genes transcribed by RNA polymerase II. The protein encoded by this gene is similar to cyclin-dependent kinase 8 which can also be a component of the Mediator complex. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2014]</obo:IAO_0000115>
		<dto:geneSynonym>CDC2L6</dto:geneSynonym>
		<dto:geneSynonym>CDK11</dto:geneSynonym>
		<dto:geneSynonym>KIAA1028</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200066 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200066">
		<rdfs:label rdf:datatype="&xsd;string">CDK1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400258"/>
		<dto:entrez_xref>983</dto:entrez_xref>
		<dto:geneSymbol>CDK1</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is a member of the Ser/Thr protein kinase family. This protein is a catalytic subunit of the highly conserved protein kinase complex known as M-phase promoting factor (MPF), which is essential for G1/S and G2/M phase transitions of eukaryotic cell cycle. Mitotic cyclins stably associate with this protein and function as regulatory subunits. The kinase activity of this protein is controlled by cyclin accumulation and destruction through the cell cycle. The phosphorylation and dephosphorylation of this protein also play important regulatory roles in cell cycle control. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2009]</obo:IAO_0000115>
		<dto:geneSynonym>CDC2</dto:geneSynonym>
		<dto:geneSynonym>CDC28A</dto:geneSynonym>
		<dto:geneSynonym>CDKN1</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200067 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200067">
		<rdfs:label rdf:datatype="&xsd;string">CDK20 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400259"/>
		<dto:entrez_xref>23552</dto:entrez_xref>
		<dto:geneSymbol>CDK20</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene contains a kinase domain most closely related to the cyclin-dependent protein kinases. The encoded kinase may activate cyclin-dependent kinase 2 and is involved in cell growth. Alternatively spliced transcript variants encoding distinct isoforms have been reported. [provided by RefSeq, Dec 2009]</obo:IAO_0000115>
		<dto:geneSynonym>CCRK</dto:geneSynonym>
		<dto:geneSynonym>CDCH</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200068 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200068">
		<rdfs:label rdf:datatype="&xsd;string">CDK2 gene</rdfs:label>
		<dto:entrez_xref>1017</dto:entrez_xref>
		<dto:geneSymbol>CDK2</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of a family of serine/threonine protein kinases that participate in cell cycle regulation. The encoded protein is the catalytic subunit of the cyclin-dependent protein kinase complex, which regulates progression through the cell cycle. Activity of this protein is especially critical during the G1 to S phase transition. This protein associates with and regulated by other subunits of the complex including cyclin A or E, CDK inhibitor p21Cip1 (CDKN1A), and p27Kip1 (CDKN1B). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2014]</obo:IAO_0000115>
		<dto:geneSynonym>CDKN2</dto:geneSynonym>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400258"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200069 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200069">
		<rdfs:label rdf:datatype="&xsd;string">CDK3 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400258"/>
		<dto:entrez_xref>1018</dto:entrez_xref>
		<dto:geneSymbol>CDK3</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the cyclin-dependent protein kinase family. The protein promotes entry into S phase, in part by activating members of the E2F family of transcription factors. The protein also associates with cyclin C and phosphorylates the retinoblastoma 1 protein to promote exit from G0. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>CDKN3</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200070 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200070">
		<rdfs:label rdf:datatype="&xsd;string">CDK4 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400260"/>
		<dto:entrez_xref>1019</dto:entrez_xref>
		<dto:geneSymbol>CDK4</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is a member of the Ser/Thr protein kinase family. This protein is highly similar to the gene products of S. cerevisiae cdc28 and S. pombe cdc2. It is a catalytic subunit of the protein kinase complex that is important for cell cycle G1 phase progression. The activity of this kinase is restricted to the G1-S phase, which is controlled by the regulatory subunits D-type cyclins and CDK inhibitor p16(INK4a). This kinase was shown to be responsible for the phosphorylation of retinoblastoma gene product (Rb). Mutations in this gene as well as in its related proteins including D-type cyclins, p16(INK4a) and Rb were all found to be associated with tumorigenesis of a variety of cancers. Multiple polyadenylation sites of this gene have been reported. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200071 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200071">
		<rdfs:label rdf:datatype="&xsd;string">CDK5 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400261"/>
		<dto:entrez_xref>1020</dto:entrez_xref>
		<dto:geneSymbol>CDK5</dto:geneSymbol>
		<dto:geneSynonym>CDKN5</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200072 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200072">
		<rdfs:label rdf:datatype="&xsd;string">CDK6 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400260"/>
		<dto:entrez_xref>1021</dto:entrez_xref>
		<dto:geneSymbol>CDK6</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is a member of the cyclin-dependent protein kinase (CDK) family. CDK family members are highly similar to the gene products of Saccharomyces cerevisiae cdc28, and Schizosaccharomyces pombe cdc2, and are known to be important regulators of cell cycle progression. This kinase is a catalytic subunit of the protein kinase complex that is important for cell cycle G1 phase progression and G1/S transition. The activity of this kinase first appears in mid-G1 phase, which is controlled by the regulatory subunits including D-type cyclins and members of INK4 family of CDK inhibitors. This kinase, as well as CDK4, has been shown to phosphorylate, and thus regulate the activity of, tumor suppressor protein Rb. Expression of this gene is up-regulated in some types of cancer. Multiple alternatively spliced variants, encoding the same protein, have been identified. [provided by RefSeq, Nov 2009]</obo:IAO_0000115>
		<dto:geneSynonym>CDKN6</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200073 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200073">
		<rdfs:label rdf:datatype="&xsd;string">CDK7 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400262"/>
		<dto:entrez_xref>1022</dto:entrez_xref>
		<dto:geneSymbol>CDK7</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is a member of the cyclin-dependent protein kinase (CDK) family. CDK family members are highly similar to the gene products of Saccharomyces cerevisiae cdc28, and Schizosaccharomyces pombe cdc2, and are known to be important regulators of cell cycle progression. This protein forms a trimeric complex with cyclin H and MAT1, which functions as a Cdk-activating kinase (CAK). It is an essential component of the transcription factor TFIIH, that is involved in transcription initiation and DNA repair. This protein is thought to serve as a direct link between the regulation of transcription and the cell cycle. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>CAK</dto:geneSynonym>
		<dto:geneSynonym>CAK1</dto:geneSynonym>
		<dto:geneSynonym>CDKN7</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200074 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200074">
		<rdfs:label rdf:datatype="&xsd;string">CDK8 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400257"/>
		<dto:entrez_xref>1024</dto:entrez_xref>
		<dto:geneSymbol>CDK8</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is a member of the cyclin-dependent protein kinase (CDK) family. CDK family members are highly similar to the gene products of Saccharomyces cerevisiae cdc28, and Schizosaccharomyces pombe cdc2, and are known to be important regulators of cell cycle progression. This kinase and its regulatory subunit cyclin C are components of the RNA polymerase II holoenzyme complex, which phosphorylates the carboxy-terminal domain (CTD) of the largest subunit of RNA polymerase II. This kinase has also been shown to regulate transcription by targeting the CDK7/cyclin H subunits of the general transcription initiation factor IIH (TFIIH), thus providing a link between the &apos;Mediator-like&apos; protein complexes and the basal transcription machinery. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200075 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200075">
		<rdfs:label rdf:datatype="&xsd;string">CDK9 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400263"/>
		<dto:entrez_xref>1025</dto:entrez_xref>
		<dto:geneSymbol>CDK9</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is a member of the cyclin-dependent protein kinase (CDK) family. CDK family members are highly similar to the gene products of S. cerevisiae cdc28, and S. pombe cdc2, and known as important cell cycle regulators. This kinase was found to be a component of the multiprotein complex TAK/P-TEFb, which is an elongation factor for RNA polymerase II-directed transcription and functions by phosphorylating the C-terminal domain of the largest subunit of RNA polymerase II. This protein forms a complex with and is regulated by its regulatory subunit cyclin T or cyclin K. HIV-1 Tat protein was found to interact with this protein and cyclin T, which suggested a possible involvement of this protein in AIDS. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>CDC2L4</dto:geneSynonym>
		<dto:geneSynonym>TAK</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200076 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200076">
		<rdfs:label rdf:datatype="&xsd;string">CDKL1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400138"/>
		<dto:entrez_xref>8814</dto:entrez_xref>
		<dto:geneSymbol>CDKL1</dto:geneSymbol>
		<obo:IAO_0000115>This gene product is a member of a large family of CDC2-related serine/threonine protein kinases. It accumulates primarily in the nucleus. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2013]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200077 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200077">
		<rdfs:label rdf:datatype="&xsd;string">CDKL2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400138"/>
		<dto:entrez_xref>8999</dto:entrez_xref>
		<dto:geneSymbol>CDKL2</dto:geneSymbol>
		<obo:IAO_0000115>This gene product is a member of a large family of CDC2-related serine/threonine protein kinases. It accumulates primarily in the cytoplasm, with lower levels in the nucleus. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200078 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200078">
		<rdfs:label rdf:datatype="&xsd;string">CDKL3 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400138"/>
		<dto:entrez_xref>51265</dto:entrez_xref>
		<dto:geneSymbol>CDKL3</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is a member of cyclin-dependent protein kinase (CDK) family. CDK family members are highly similar to the gene products of Saccharomyces cerevisiae cdc28, and Schizosaccharomyces pombe cdc2, and are known to be important regulators of cell cycle progression. This gene was identified as a gene absent in leukemic patients with chromosome 5q deletion. This loss may be an important determinant of dysmyelopoiesis. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>NKIAMRE</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200079 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200079">
		<rdfs:label rdf:datatype="&xsd;string">CDKL4 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400138"/>
		<dto:entrez_xref>344387</dto:entrez_xref>
		<dto:geneSymbol>CDKL4</dto:geneSymbol>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200080 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200080">
		<rdfs:label rdf:datatype="&xsd;string">CDKL5 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400138"/>
		<dto:entrez_xref>6792</dto:entrez_xref>
		<dto:geneSymbol>CDKL5</dto:geneSymbol>
		<obo:IAO_0000115>This gene is a member of Ser/Thr protein kinase family and encodes a phosphorylated protein with protein kinase activity. Mutations in this gene have been associated with X-linked infantile spasm syndrome (ISSX), also known as X-linked West syndrome, and Rett syndrome (RTT). Alternate transcriptional splice variants have been characterized. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>STK9</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200081 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200081">
		<rdfs:label rdf:datatype="&xsd;string">CERK gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400323"/>
		<dto:entrez_xref>64781</dto:entrez_xref>
		<dto:geneSymbol>CERK</dto:geneSymbol>
		<obo:IAO_0000115>CERK converts ceramide to ceramide 1-phosphate (C1P), a sphingolipid metabolite. Both CERK and C1P have been implicated in various cellular processes, including proliferation, apoptosis, phagocytosis, and inflammation (Kim et al., 2006 [PubMed 16488390]).[supplied by OMIM, Mar 2008]</obo:IAO_0000115>
		<dto:geneSynonym>KIAA1646</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200082 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200082">
		<rdfs:label rdf:datatype="&xsd;string">CHEK1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400264"/>
		<dto:entrez_xref>1111</dto:entrez_xref>
		<dto:geneSymbol>CHEK1</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene belongs to the Ser/Thr protein kinase family. It is required for checkpoint mediated cell cycle arrest in response to DNA damage or the presence of unreplicated DNA. This protein acts to integrate signals from ATM and ATR, two cell cycle proteins involved in DNA damage responses, that also associate with chromatin in meiotic prophase I. Phosphorylation of CDC25A protein phosphatase by this protein is required for cells to delay cell cycle progression in response to double-strand DNA breaks. Several alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Oct 2011]</obo:IAO_0000115>
		<dto:geneSynonym>CHK1</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200083 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200083">
		<rdfs:label rdf:datatype="&xsd;string">CHEK2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400139"/>
		<dto:entrez_xref>11200</dto:entrez_xref>
		<dto:geneSymbol>CHEK2</dto:geneSymbol>
		<obo:IAO_0000115>In response to DNA damage and replication blocks, cell cycle progression is halted through the control of critical cell cycle regulators. The protein encoded by this gene is a cell cycle checkpoint regulator and putative tumor suppressor. It contains a forkhead-associated protein interaction domain essential for activation in response to DNA damage and is rapidly phosphorylated in response to replication blocks and DNA damage. When activated, the encoded protein is known to inhibit CDC25C phosphatase, preventing entry into mitosis, and has been shown to stabilize the tumor suppressor protein p53, leading to cell cycle arrest in G1. In addition, this protein interacts with and phosphorylates BRCA1, allowing BRCA1 to restore survival after DNA damage. Mutations in this gene have been linked with Li-Fraumeni syndrome, a highly penetrant familial cancer phenotype usually associated with inherited mutations in TP53. Also, mutations in this gene are thought to confer a predisposition to sarcomas, breast cancer, and brain tumors. This nuclear protein is a member of the CDS1 subfamily of serine/threonine protein kinases. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012]</obo:IAO_0000115>
		<dto:geneSynonym>CDS1</dto:geneSynonym>
		<dto:geneSynonym>CHK2</dto:geneSynonym>
		<dto:geneSynonym>RAD53</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200084 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200084">
		<rdfs:label rdf:datatype="&xsd;string">CHKA gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491029"/>
		<dto:entrez_xref>1119</dto:entrez_xref>
		<dto:geneSymbol>CHKA</dto:geneSymbol>
		<obo:IAO_0000115>The major pathway for the biosynthesis of phosphatidylcholine occurs via the CDP-choline pathway. The protein encoded by this gene is the initial enzyme in the sequence and may play a regulatory role. The encoded protein also catalyzes the phosphorylation of ethanolamine. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>CHK</dto:geneSynonym>
		<dto:geneSynonym>CKI</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200085 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200085">
		<rdfs:label rdf:datatype="&xsd;string">CHKB gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491029"/>
		<dto:entrez_xref>1120</dto:entrez_xref>
		<dto:geneSymbol>CHKB</dto:geneSymbol>
		<obo:IAO_0000115>Choline kinase (CK) and ethanolamine kinase (EK) catalyze the phosphorylation of choline/ethanolamine to phosphocholine/phosphoethanolamine. This is the first enzyme in the biosynthesis of phosphatidylcholine/phosphatidylethanolamine in all animal cells. The highly purified CKs from mammalian sources and their recombinant gene products have been shown to have EK activity also, indicating that both activities reside on the same protein. The choline kinase-like protein encoded by CHKL belongs to the choline/ethanolamine kinase family; however, its exact function is not known. Read-through transcripts are expressed from this locus that include exons from the downstream CPT1B locus. [provided by RefSeq, Jun 2009]</obo:IAO_0000115>
		<dto:geneSynonym>CHETK</dto:geneSynonym>
		<dto:geneSynonym>CHKL</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200086 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200086">
		<rdfs:label rdf:datatype="&xsd;string">CLK1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400140"/>
		<dto:entrez_xref>1195</dto:entrez_xref>
		<dto:geneSymbol>CLK1</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the CDC2-like (or LAMMER) family of dual specificity protein kinases. In the nucleus, the encoded protein phosphorylates serine/arginine-rich proteins involved in pre-mRNA processing, releasing them into the nucleoplasm. The choice of splice sites during pre-mRNA processing may be regulated by the concentration of transacting factors, including serine/arginine rich proteins. Therefore, the encoded protein may play an indirect role in governing splice site selection. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2009]</obo:IAO_0000115>
		<dto:geneSynonym>CLK</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200087 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200087">
		<rdfs:label rdf:datatype="&xsd;string">CLK2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400140"/>
		<dto:entrez_xref>1196</dto:entrez_xref>
		<dto:geneSymbol>CLK2</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a dual specificity protein kinase that phosphorylates serine/threonine and tyrosine-containing substrates. Activity of this protein regulates serine- and arginine-rich (SR) proteins of the spliceosomal complex, thereby influencing alternative transcript splicing. Chromosomal translocations have been characterized between this locus and the PAFAH1B3 (platelet-activating factor acetylhydrolase 1b, catalytic subunit 3 (29kDa)) gene on chromosome 19, resulting in the production of a fusion protein. Note that this gene is distinct from the TELO2 gene (GeneID:9894), which shares the CLK2 alias, but encodes a protein that is involved in telomere length regulation. There is a pseudogene for this gene on chromosome 7. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2014]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200088 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200088">
		<rdfs:label rdf:datatype="&xsd;string">CLK3 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400140"/>
		<dto:entrez_xref>1198</dto:entrez_xref>
		<dto:geneSymbol>CLK3</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a protein belonging to the serine/threonine type protein kinase family. This protein is a nuclear dual-specificity kinase that regulates the intranuclear distribution of the serine/arginine-rich (SR) family of splicing factors. Two transcript variants encoding different isoforms have been found for this gene. Related pseudogenes are located on chromosomes 1 and 9. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200089 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200089">
		<rdfs:label rdf:datatype="&xsd;string">CLK4 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400140"/>
		<dto:entrez_xref>57396</dto:entrez_xref>
		<dto:geneSymbol>CLK4</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene belongs to the CDC2-like protein kinase (CLK) family. This protein kinase can interact with and phosphorylate the serine- and arginine-rich (SR) proteins, which are known to play an important role in the formation of spliceosomes, and thus may be involved in the regulation of alternative splicing. Studies in the Israeli sand rat Psammomys obesus suggested that the ubiquitin-like 5 (UBL5/BEACON), a highly conserved ubiquitin-like protein, may interact with and regulate the activity of this kinase. Multiple alternatively spliced transcript variants have been observed, but the full-length natures of which have not yet been determined. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200090 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200090">
		<rdfs:label rdf:datatype="&xsd;string">CSF1R gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400141"/>
		<dto:entrez_xref>1436</dto:entrez_xref>
		<dto:geneSymbol>CSF1R</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is the receptor for colony stimulating factor 1, a cytokine which controls the production, differentiation, and function of macrophages. This receptor mediates most if not all of the biological effects of this cytokine. Ligand binding activates the receptor kinase through a process of oligomerization and transphosphorylation. The encoded protein is a tyrosine kinase transmembrane receptor and member of the CSF1/PDGF receptor family of tyrosine-protein kinases. Mutations in this gene have been associated with a predisposition to myeloid malignancy. The first intron of this gene contains a transcriptionally inactive ribosomal protein L7 processed pseudogene oriented in the opposite direction. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2013]</obo:IAO_0000115>
		<dto:geneSynonym>FMS</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200091 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200091">
		<rdfs:label rdf:datatype="&xsd;string">CSNK2A1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400142"/>
		<dto:entrez_xref>1457</dto:entrez_xref>
		<dto:geneSymbol>CSNK2A1</dto:geneSymbol>
		<obo:IAO_0000115>Casein kinase II is a serine/threonine protein kinase that phosphorylates acidic proteins such as casein. It is involved in various cellular processes, including cell cycle control, apoptosis, and circadian rhythm. The kinase exists as a tetramer and is composed of an alpha, an alpha-prime, and two beta subunits. The alpha subunits contain the catalytic activity while the beta subunits undergo autophosphorylation. The protein encoded by this gene represents the alpha subunit. While this gene is found on chromosome 20, a related transcribed pseudogene is found on chromosome 11. Three transcript variants encoding two different proteins have been found for this gene. [provided by RefSeq, Jul 2014]</obo:IAO_0000115>
		<dto:geneSynonym>CK2A1</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200092 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200092">
		<rdfs:label rdf:datatype="&xsd;string">CSNK2A2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400142"/>
		<dto:entrez_xref>1459</dto:entrez_xref>
		<dto:geneSymbol>CSNK2A2</dto:geneSymbol>
		<dto:geneSynonym>CK2A2</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200093 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200093">
		<rdfs:label rdf:datatype="&xsd;string">CSNK2A3 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400142"/>
		<dto:entrez_xref>283106</dto:entrez_xref>
		<dto:geneSymbol>CSNK2A3</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a protein that is highly similar to the casein kinase II alpha protein. Casein kinase II is a serine/threonine protein kinase complex that phosphorylates numerous substrates including casein. The alpha subunit is the catalytic component of the complex. Mutations in this gene may be associated with a susceptibility to lung cancer. There are contradictory views among published reports of this gene as to whether or not it is a protein-coding gene or a processed pseudogene (PMIDs: 20625391, 20625391 and 10094393). [provided by RefSeq, Feb 2012]</obo:IAO_0000115>
		<dto:geneSynonym>CSNK2A1P</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200094 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200094">
		<rdfs:label rdf:datatype="&xsd;string">CSNK2B gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400142"/>
		<dto:entrez_xref>1460</dto:entrez_xref>
		<dto:geneSymbol>CSNK2B</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes the beta subunit of casein kinase II, a ubiquitous protein kinase which regulates metabolic pathways, signal transduction, transcription, translation, and replication. The enzyme is composed of three subunits, alpha, alpha prime and beta, which form a tetrameric holoenzyme. The alpha and alpha prime subunits are catalytic, while the beta subunit serves regulatory functions. The enzyme localizes to the endoplasmic reticulum and the Golgi apparatus. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2013]</obo:IAO_0000115>
		<dto:geneSynonym>CK2N</dto:geneSynonym>
		<dto:geneSynonym>G5A</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200095 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200095">
		<rdfs:label rdf:datatype="&xsd;string">CASK gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400143"/>
		<dto:entrez_xref>8573</dto:entrez_xref>
		<dto:geneSymbol>CASK</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a calcium/calmodulin-dependent serine protein kinase. The encoded protein is a MAGUK (membrane-associated guanylate kinase) protein family member. These proteins are scaffold proteins and the encoded protein is located at synapses in the brain. Mutations in this gene are associated with FG syndrome 4, mental retardation and microcephaly with pontine and cerebellar hypoplasia, and a form of X-linked mental retardation. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Mar 2010]</obo:IAO_0000115>
		<dto:geneSynonym>LIN2</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200096 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200096">
		<rdfs:label rdf:datatype="&xsd;string">CSK gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400144"/>
		<dto:entrez_xref>1445</dto:entrez_xref>
		<dto:geneSymbol>CSK</dto:geneSymbol>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200097 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200097">
		<rdfs:label rdf:datatype="&xsd;string">CIT gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400145"/>
		<dto:entrez_xref>11113</dto:entrez_xref>
		<dto:geneSymbol>CIT</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a serine/threonine-protein kinase that functions in cell division. Together with the kinesin KIF14, this protein localizes to the central spindle and midbody, and functions to promote efficient cytokinesis. This protein is involved in central nervous system development. Polymorphisms in this gene are associated with bipolar disorder and risk for schizophrenia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2011]</obo:IAO_0000115>
		<dto:geneSynonym>CRIK</dto:geneSynonym>
		<dto:geneSynonym>KIAA0949</dto:geneSynonym>
		<dto:geneSynonym>STK21</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200098 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200098">
		<rdfs:label rdf:datatype="&xsd;string">DAPK1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400146"/>
		<dto:entrez_xref>1612</dto:entrez_xref>
		<dto:geneSymbol>DAPK1</dto:geneSymbol>
		<obo:IAO_0000115>Death-associated protein kinase 1 is a positive mediator of gamma-interferon induced programmed cell death. DAPK1 encodes a structurally unique 160-kD calmodulin dependent serine-threonine kinase that carries 8 ankyrin repeats and 2 putative P-loop consensus sites. It is a tumor suppressor candidate. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2013]</obo:IAO_0000115>
		<dto:geneSynonym>DAPK</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200099 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200099">
		<rdfs:label rdf:datatype="&xsd;string">DAPK2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400146"/>
		<dto:entrez_xref>23604</dto:entrez_xref>
		<dto:geneSymbol>DAPK2</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a protein that belongs to the serine/threonine protein kinase family. This protein contains a N-terminal protein kinase domain followed by a conserved calmodulin-binding domain with significant similarity to that of death-associated protein kinase 1 (DAPK1), a positive regulator of programmed cell death. Overexpression of this gene was shown to induce cell apoptosis.  It uses multiple polyadenylation sites. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200100 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200100">
		<rdfs:label rdf:datatype="&xsd;string">DAPK3 gene</rdfs:label>
		<dto:entrez_xref>1613</dto:entrez_xref>
		<dto:geneSymbol>DAPK3</dto:geneSymbol>
		<obo:IAO_0000115>Death-associated protein kinase 3 (DAPK3) induces morphological changes in apoptosis when overexpressed in mammalian cells.  These results suggest that DAPK3 may play a role in the induction of apoptosis. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>ZIPK</dto:geneSynonym>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400146"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200101 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200101">
		<rdfs:label rdf:datatype="&xsd;string">DCK gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491008"/>
		<dto:entrez_xref>1633</dto:entrez_xref>
		<dto:geneSymbol>DCK</dto:geneSymbol>
		<obo:IAO_0000115> Deoxycytidine kinase (DCK) is required for the phosphorylation of several deoxyribonucleosides and their nucleoside analogs.  Deficiency of DCK is associated with resistance to antiviral and anticancer chemotherapeutic agents.  Conversely, increased deoxycytidine kinase activity is associated with increased activation of these compounds to cytotoxic nucleoside triphosphate derivatives.  DCK is clinically important because of its relationship to drug resistance and sensitivity. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200102 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200102">
		<rdfs:label rdf:datatype="&xsd;string">DCLK1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400147"/>
		<dto:entrez_xref>9201</dto:entrez_xref>
		<dto:geneSymbol>DCLK1</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the protein kinase superfamily and the doublecortin family. The protein encoded by this gene contains two N-terminal doublecortin domains, which bind microtubules and regulate microtubule polymerization, a C-terminal serine/threonine protein kinase domain, which shows substantial homology to Ca2+/calmodulin-dependent protein kinase, and a serine/proline-rich domain in between the doublecortin and the protein kinase domains, which mediates multiple protein-protein interactions. The microtubule-polymerizing activity of the encoded protein is independent of its protein kinase activity. The encoded protein is involved in several different cellular processes, including neuronal migration, retrograde transport, neuronal apoptosis and neurogenesis. This gene is up-regulated by brain-derived neurotrophic factor and associated with memory and general cognitive abilities. Multiple transcript variants generated by two alternative promoter usage and alternative splicing have been reported, but the full-length nature and biological validity of some variants have not been defined. These variants encode different isoforms, which are differentially expressed and have different kinase activities.[provided by RefSeq, Sep 2010]</obo:IAO_0000115>
		<dto:geneSynonym>DCAMKL1</dto:geneSynonym>
		<dto:geneSynonym>DCDC3A</dto:geneSynonym>
		<dto:geneSynonym>KIAA0369</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200103 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200103">
		<rdfs:label rdf:datatype="&xsd;string">DCLK2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400147"/>
		<dto:entrez_xref>166614</dto:entrez_xref>
		<dto:geneSymbol>DCLK2</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the protein kinase superfamily and the doublecortin family. The protein encoded by this gene contains two N-terminal doublecortin domains, which bind microtubules and regulate microtubule polymerization, a C-terminal serine/threonine protein kinase domain, which shows substantial homology to Ca2+/calmodulin-dependent protein kinase, and a serine/proline-rich domain in between the doublecortin and the protein kinase domains, which mediates multiple protein-protein interactions. The microtubule-polymerizing activity of the encoded protein is independent of its protein kinase activity. Mouse studies show that the DCX gene, another family member, and this gene share function in the establishment of hippocampal organization and that their absence results in a severe epileptic phenotype and lethality, as described in human patients with lissencephaly. Multiple alternatively spliced transcript variants have been identified. [provided by RefSeq, Sep 2010]</obo:IAO_0000115>
		<dto:geneSynonym>DCAMKL2</dto:geneSynonym>
		<dto:geneSynonym>DCDC3B</dto:geneSynonym>
		<dto:geneSynonym>DCK2</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200104 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200104">
		<rdfs:label rdf:datatype="&xsd;string">DCLK3 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400147"/>
		<dto:entrez_xref>85443</dto:entrez_xref>
		<dto:geneSymbol>DCLK3</dto:geneSymbol>
		<dto:geneSynonym>DCAMKL3</dto:geneSynonym>
		<dto:geneSynonym>DCDC3C</dto:geneSynonym>
		<dto:geneSynonym>KIAA1765</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200105 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200105">
		<rdfs:label rdf:datatype="&xsd;string">DDR1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400148"/>
		<dto:entrez_xref>780</dto:entrez_xref>
		<dto:geneSymbol>DDR1</dto:geneSymbol>
		<obo:IAO_0000115>Receptor tyrosine kinases play a key role in the communication of cells with their microenvironment. These kinases are involved in the regulation of cell growth, differentiation and metabolism. The protein encoded by this gene belongs to a subfamily of tyrosine kinase receptors with homology to Dictyostelium discoideum protein discoidin I in their extracellular domain, and that are activated by various types of collagen. Expression of this protein is restricted to epithelial cells, particularly in the kidney, lung, gastrointestinal tract, and brain. In addition, it has been shown to be significantly overexpressed in several human tumors. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Feb 2011]</obo:IAO_0000115>
		<dto:geneSynonym>CAK</dto:geneSynonym>
		<dto:geneSynonym>EDDR1</dto:geneSynonym>
		<dto:geneSynonym>NEP</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200106 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200106">
		<rdfs:label rdf:datatype="&xsd;string">DDR2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400148"/>
		<dto:entrez_xref>4921</dto:entrez_xref>
		<dto:geneSymbol>DDR2</dto:geneSymbol>
		<obo:IAO_0000115>Receptor tyrosine kinases (RTKs) play a key role in the communication of cells with their microenvironment. These molecules are involved in the regulation of cell growth, differentiation, and metabolism. In several cases the biochemical mechanism by which RTKs transduce signals across the membrane has been shown to be ligand induced receptor oligomerization and subsequent intracellular phosphorylation. This autophosphorylation leads to phosphorylation of cytosolic targets as well as association with other molecules, which are involved in pleiotropic effects of signal transduction. RTKs have a tripartite structure with extracellular, transmembrane, and cytoplasmic regions. This gene encodes a member of a novel subclass of RTKs and contains a distinct extracellular region encompassing a factor VIII-like domain. Alternative splicing in the 5&apos; UTR results in multiple transcript variants encoding the same protein. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>NTRKR3</dto:geneSynonym>
		<dto:geneSynonym>TKT</dto:geneSynonym>
		<dto:geneSynonym>TYRO10</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200107 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200107">
		<rdfs:label rdf:datatype="&xsd;string">DGKA gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491025"/>
		<dto:entrez_xref>1606</dto:entrez_xref>
		<dto:geneSymbol>DGKA</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene belongs to the eukaryotic diacylglycerol kinase family. It acts as a modulator that competes with protein kinase C for the second messenger diacylglycerol in intracellular signaling pathways. It also plays an important role in the resynthesis of phosphatidylinositols and phosphorylating diacylglycerol to phosphatidic acid. Alternative splicing occurs at this locus and four transcript variants encoding the same protein have been identified. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>DAGK</dto:geneSynonym>
		<dto:geneSynonym>DAGK1</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200108 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200108">
		<rdfs:label rdf:datatype="&xsd;string">DGKH gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491025"/>
		<dto:entrez_xref>160851</dto:entrez_xref>
		<dto:geneSymbol>DGKH</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the diacylglycerol kinase (DGK) enzyme family. Members of this family are involved in regulating intracellular concentrations of diacylglycerol and phosphatidic acid. Variation in this gene has been associated with bipolar disorder. Alternatively spliced transcript variants have been identified. [provided by RefSeq, Jul 2014]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200109 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200109">
		<rdfs:label rdf:datatype="&xsd;string">DGKQ gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491025"/>
		<dto:entrez_xref>1609</dto:entrez_xref>
		<dto:geneSymbol>DGKQ</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene contains three cysteine-rich domains, a proline-rich region, and a pleckstrin homology domain with an overlapping Ras-associating domain. It is localized in the speckle domains of the nucleus, and mediates the regeneration of phosphatidylinositol (PI) from diacylglycerol in the PI-cycle during cell signal transduction. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>DAGK4</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200110 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200110">
		<rdfs:label rdf:datatype="&xsd;string">DGUOK gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491008"/>
		<dto:entrez_xref>1716</dto:entrez_xref>
		<dto:geneSymbol>DGUOK</dto:geneSymbol>
		<obo:IAO_0000115>In mammalian cells, the phosphorylation of purine deoxyribonucleosides is mediated predominantly by two deoxyribonucleoside kinases, cytosolic deoxycytidine kinase and mitochondrial deoxyguanosine kinase. The protein encoded by this gene is responsible for phosphorylation of purine deoxyribonucleosides in the mitochondrial matrix. In addition, this protein phosphorylates several purine deoxyribonucleoside analogs used in the treatment of lymphoproliferative disorders, and this phosphorylation is critical for the effectiveness of the analogs. Alternative splice variants encoding different protein isoforms have been described for this gene. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>DGK</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200111 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200111">
		<rdfs:label rdf:datatype="&xsd;string">DMPK gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400265"/>
		<dto:entrez_xref>1760</dto:entrez_xref>
		<dto:geneSymbol>DMPK</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is a serine-threonine kinase that is closely related to other kinases that interact with members of the Rho family of small GTPases. Substrates for this enzyme include myogenin, the beta-subunit of the L-type calcium channels, and phospholemman. The 3&apos; untranslated region of this gene contains 5-37 copies of a CTG trinucleotide repeat. Expansion of this unstable motif to 50-5,000 copies causes myotonic dystrophy type I, which increases in severity with increasing repeat element copy number. Repeat expansion is associated with condensation of local chromatin structure that disrupts the expression of genes in this region. Several alternatively spliced transcript variants of this gene have been described, but the full-length nature of some of these variants has not been determined. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>DM1PK</dto:geneSynonym>
		<dto:geneSynonym>MDPK</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200112 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200112">
		<rdfs:label rdf:datatype="&xsd;string">DSTYK gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400149"/>
		<dto:entrez_xref>25778</dto:entrez_xref>
		<dto:geneSymbol>DSTYK</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a dual serine/threonine and tyrosine protein kinase which is expressed in multiple tissues. It is thought to function as a regulator of cell death. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2008]</obo:IAO_0000115>
		<dto:geneSynonym>KIAA0472</dto:geneSynonym>
		<dto:geneSynonym>RIP5</dto:geneSynonym>
		<dto:geneSynonym>RIPK5</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200113 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200113">
		<rdfs:label rdf:datatype="&xsd;string">DYRK1A gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400266"/>
		<dto:entrez_xref>1859</dto:entrez_xref>
		<dto:geneSymbol>DYRK1A</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the Dual-specificity tyrosine phosphorylation-regulated kinase (DYRK) family. This member contains a nuclear targeting signal sequence, a protein kinase domain, a leucine zipper motif, and a highly conservative 13-consecutive-histidine repeat. It catalyzes its autophosphorylation on serine/threonine and tyrosine residues. It may play a significant role in a signaling pathway regulating cell proliferation and may be involved in brain development. This gene is a homolog of Drosophila mnb (minibrain) gene and rat Dyrk gene. It is localized in the Down syndrome critical region of chromosome 21, and is considered to be a strong candidate gene for learning defects associated with Down syndrome. Alternative splicing of this gene generates several transcript variants differing from each other either in the 5&apos; UTR or in the 3&apos; coding region. These variants encode at least five different isoforms. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>DYRK</dto:geneSynonym>
		<dto:geneSynonym>MNB</dto:geneSynonym>
		<dto:geneSynonym>MNBH</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200114 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200114">
		<rdfs:label rdf:datatype="&xsd;string">DYRK1B gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400266"/>
		<dto:entrez_xref>9149</dto:entrez_xref>
		<dto:geneSymbol>DYRK1B</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of a family of nuclear-localized protein kinases. The encoded protein participates in the regulation of the cell cycle. Expression of this gene may be altered in tumor cells, and mutations in this gene were found to cause abdominal obesity-metabolic syndrome 3. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2014]</obo:IAO_0000115>
		<dto:geneSynonym>MIRK</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200115 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200115">
		<rdfs:label rdf:datatype="&xsd;string">DYRK2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400267"/>
		<dto:entrez_xref>8445</dto:entrez_xref>
		<dto:geneSymbol>DYRK2</dto:geneSymbol>
		<obo:IAO_0000115> DYRK2 belongs to a family of protein kinases whose members are presumed to be involved in cellular growth and/or development.  The family is defined by structural similarity of their kinase domains and their capability to autophosphorylate on tyrosine residues.  DYRK2 has demonstrated tyrosine autophosphorylation and catalyzed phosphorylation of histones H3 and H2B in vitro.  Two isoforms of DYRK2 have been isolated.  The predominant isoform, isoform 1, lacks a 5&apos; terminal insert. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200116 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200116">
		<rdfs:label rdf:datatype="&xsd;string">DYRK3 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400267"/>
		<dto:entrez_xref>8444</dto:entrez_xref>
		<dto:geneSymbol>DYRK3</dto:geneSymbol>
		<obo:IAO_0000115>This gene product belongs to the DYRK family of dual-specificity protein kinases that catalyze autophosphorylation on serine/threonine and tyrosine residues. The members of this family share structural similarity, however, differ in their substrate specificity, suggesting their involvement in different cellular functions. The encoded protein has been shown to autophosphorylate on tyrosine residue and catalyze phosphorylation of histones H3 and H2B in vitro. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200117 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200117">
		<rdfs:label rdf:datatype="&xsd;string">DYRK4 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400267"/>
		<dto:entrez_xref>8798</dto:entrez_xref>
		<dto:geneSymbol>DYRK4</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes an enzyme that belongs to a conserved family of serine/threonine protein kinases. Members of this dual specificity kinase family are thought to function in the regulation of cell differentiation and proliferation, survival, and in development. Alternate splicing results in multiple transcript variants. Additional alternatively spliced transcript variants of this gene have been described, but their full-length nature is not known. [provided by RefSeq, Aug 2013]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200118 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200118">
		<rdfs:label rdf:datatype="&xsd;string">EIF2AK1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400151"/>
		<dto:entrez_xref>27102</dto:entrez_xref>
		<dto:geneSymbol>EIF2AK1</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene acts at the level of translation initiation to downregulate protein synthesis in response to stress. The encoded protein is a kinase that can be inactivated by hemin. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2008]</obo:IAO_0000115>
		<dto:geneSynonym>HRI</dto:geneSynonym>
		<dto:geneSynonym>KIAA1369</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200119 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200119">
		<rdfs:label rdf:datatype="&xsd;string">EIF2AK2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400151"/>
		<dto:entrez_xref>5610</dto:entrez_xref>
		<dto:geneSymbol>EIF2AK2</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is a serine/threonine protein kinase that is activated by autophosphorylation after binding to dsRNA. The activated form of the encoded protein can phosphorylate translation initiation factor EIF2S1, which in turn inhibits protein synthesis. This protein is also activated by manganese ions and heparin. Three transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Oct 2011]</obo:IAO_0000115>
		<dto:geneSynonym>PKR</dto:geneSynonym>
		<dto:geneSynonym>PRKR</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200120 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200120">
		<rdfs:label rdf:datatype="&xsd;string">EIF2AK3 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400268"/>
		<dto:entrez_xref>9451</dto:entrez_xref>
		<dto:geneSymbol>EIF2AK3</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene phosphorylates the alpha subunit of eukaryotic translation-initiation factor 2 (EIF2), leading to its inactivation, and thus to a rapid reduction of translational initiation and repression of global protein synthesis. It is a type I membrane protein located in the endoplasmic reticulum (ER), where it is induced by ER stress caused by malfolded proteins. Mutations in this gene are associated with Wolcott-Rallison syndrome. [provided by RefSeq, Jan 2010]</obo:IAO_0000115>
		<dto:geneSynonym>PEK</dto:geneSynonym>
		<dto:geneSynonym>PERK</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200121 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200121">
		<rdfs:label rdf:datatype="&xsd;string">EIF2AK4 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400269"/>
		<dto:entrez_xref>440275</dto:entrez_xref>
		<dto:geneSymbol>EIF2AK4</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of a family of kinases that phosphorylate the alpha subunit of eukaryotic translation initiation factor-2 (EIF2), resulting in the downregulaton of protein synthesis. The encoded protein responds to amino acid deprivation by binding uncharged transfer RNAs. It may also be activated by glucose deprivation and viral infection. Mutations in this gene have been found in individuals suffering from autosomal recessive pulmonary venoocclusive-disease-2. [provided by RefSeq, Mar 2014]</obo:IAO_0000115>
		<dto:geneSynonym>GCN2</dto:geneSynonym>
		<dto:geneSynonym>KIAA1338</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200122 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200122">
		<rdfs:label rdf:datatype="&xsd;string">EEF2K gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400270"/>
		<dto:entrez_xref>101930123</dto:entrez_xref>
		<dto:entrez_xref>29904</dto:entrez_xref>
		<dto:geneSymbol>EEF2K</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a highly conserved protein kinase in the calmodulin-mediated signaling pathway that links activation of cell surface receptors to cell division. This kinase is involved in the regulation of protein synthesis. It phosphorylates eukaryotic elongation factor 2 (EEF2) and thus inhibits the EEF2 function. The activity of this kinase is increased in many cancers and may be a valid target for anti-cancer treatment. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200123 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200123">
		<rdfs:label rdf:datatype="&xsd;string">EFNA1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491040"/>
		<dto:entrez_xref>1942</dto:entrez_xref>
		<dto:geneSymbol>EFNA1</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the ephrin (EPH) family. The ephrins and EPH-related receptors comprise the largest subfamily of receptor protein-tyrosine kinases and have been implicated in mediating developmental events, especially in the nervous system and in erythropoiesis. Based on their structures and sequence relationships, ephrins are divided into the ephrin-A (EFNA) class, which are anchored to the membrane by a glycosylphosphatidylinositol linkage, and the ephrin-B (EFNB) class, which are transmembrane proteins. This gene encodes an EFNA class ephrin which binds to the EPHA2, EPHA4, EPHA5, EPHA6, and EPHA7 receptors. Two transcript variants that encode different isoforms were identified through sequence analysis. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>EPLG1</dto:geneSynonym>
		<dto:geneSynonym>LERK1</dto:geneSynonym>
		<dto:geneSynonym>TNFAIP4</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200124 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200124">
		<rdfs:label rdf:datatype="&xsd;string">EGFR gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400152"/>
		<dto:entrez_xref>1956</dto:entrez_xref>
		<dto:geneSymbol>EGFR</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is a transmembrane glycoprotein that is a member of the protein kinase superfamily. This protein is a receptor for members of the epidermal growth factor family. EGFR is a cell surface protein that binds to epidermal growth factor. Binding of the protein to a ligand induces receptor dimerization and tyrosine autophosphorylation and leads to cell proliferation. Mutations in this gene are associated with lung cancer. Multiple alternatively spliced transcript variants that encode different protein isoforms have been found for this gene. [provided by RefSeq, Jul 2010]</obo:IAO_0000115>
		<dto:geneSynonym>ERBB</dto:geneSynonym>
		<dto:geneSynonym>ERBB1</dto:geneSynonym>
		<dto:geneSynonym>HER1</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200125 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200125">
		<rdfs:label rdf:datatype="&xsd;string">EPHA1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400153"/>
		<dto:entrez_xref>2041</dto:entrez_xref>
		<dto:geneSymbol>EPHA1</dto:geneSymbol>
		<obo:IAO_0000115>This gene belongs to the ephrin receptor subfamily of the protein-tyrosine kinase family. EPH and EPH-related receptors have been implicated in mediating developmental events, particularly in the nervous system. Receptors in the EPH subfamily typically have a single kinase domain and an extracellular region containing a Cys-rich domain and 2 fibronectin type III repeats. The ephrin receptors are divided into 2 groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands. This gene is expressed in some human cancer cell lines and has been implicated in carcinogenesis. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>EPH</dto:geneSynonym>
		<dto:geneSynonym>EPHT</dto:geneSynonym>
		<dto:geneSynonym>EPHT1</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200126 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200126">
		<rdfs:label rdf:datatype="&xsd;string">EPHA2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400153"/>
		<dto:entrez_xref>1969</dto:entrez_xref>
		<dto:geneSymbol>EPHA2</dto:geneSymbol>
		<obo:IAO_0000115>This gene belongs to the ephrin receptor subfamily of the protein-tyrosine kinase family. EPH and EPH-related receptors have been implicated in mediating developmental events, particularly in the nervous system. Receptors in the EPH subfamily typically have a single kinase domain and an extracellular region containing a Cys-rich domain and 2 fibronectin type III repeats. The ephrin receptors are divided into 2 groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands. This gene encodes a protein that binds ephrin-A ligands. Mutations in this gene are the cause of certain genetically-related cataract disorders.[provided by RefSeq, May 2010]</obo:IAO_0000115>
		<dto:geneSynonym>ECK</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200127 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200127">
		<rdfs:label rdf:datatype="&xsd;string">EPHA3 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400153"/>
		<dto:entrez_xref>2042</dto:entrez_xref>
		<dto:geneSymbol>EPHA3</dto:geneSymbol>
		<obo:IAO_0000115>This gene belongs to the ephrin receptor subfamily of the protein-tyrosine kinase family. EPH and EPH-related receptors have been implicated in mediating developmental events, particularly in the nervous system. Receptors in the EPH subfamily typically have a single kinase domain and an extracellular region containing a Cys-rich domain and 2 fibronectin type III repeats. The ephrin receptors are divided into 2 groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands. This gene encodes a protein that binds ephrin-A ligands. Two alternatively spliced transcript variants have been described for this gene. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>ETK</dto:geneSynonym>
		<dto:geneSynonym>ETK1</dto:geneSynonym>
		<dto:geneSynonym>HEK</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200128 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200128">
		<rdfs:label rdf:datatype="&xsd;string">EPHA4 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400153"/>
		<dto:entrez_xref>2043</dto:entrez_xref>
		<dto:geneSymbol>EPHA4</dto:geneSymbol>
		<obo:IAO_0000115>This gene belongs to the ephrin receptor subfamily of the protein-tyrosine kinase family. EPH and EPH-related receptors have been implicated in mediating developmental events, particularly in the nervous system. Receptors in the EPH subfamily typically have a single kinase domain and an extracellular region containing a Cys-rich domain and 2 fibronectin type III repeats. The ephrin receptors are divided into 2 groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>HEK8</dto:geneSynonym>
		<dto:geneSynonym>SEK</dto:geneSynonym>
		<dto:geneSynonym>TYRO1</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200129 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200129">
		<rdfs:label rdf:datatype="&xsd;string">EPHA5 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400153"/>
		<dto:entrez_xref>2044</dto:entrez_xref>
		<dto:geneSymbol>EPHA5</dto:geneSymbol>
		<obo:IAO_0000115>This gene belongs to the ephrin receptor subfamily of the protein-tyrosine kinase family. EPH and EPH-related receptors have been implicated in mediating developmental events, particularly in the nervous system. Receptors in the EPH subfamily typically have a single kinase domain and an extracellular region containing a Cys-rich domain and 2 fibronectin type III repeats. The ephrin receptors are divided into 2 groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Aug 2013]</obo:IAO_0000115>
		<dto:geneSynonym>BSK</dto:geneSynonym>
		<dto:geneSynonym>EHK1</dto:geneSynonym>
		<dto:geneSynonym>HEK7</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200130 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200130">
		<rdfs:label rdf:datatype="&xsd;string">EPHA6 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400153"/>
		<dto:entrez_xref>285220</dto:entrez_xref>
		<dto:geneSymbol>EPHA6</dto:geneSymbol>
		<dto:geneSynonym>EHK2</dto:geneSynonym>
		<dto:geneSynonym>HEK12</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200131 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200131">
		<rdfs:label rdf:datatype="&xsd;string">EPHA7 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400153"/>
		<dto:entrez_xref>2045</dto:entrez_xref>
		<dto:geneSymbol>EPHA7</dto:geneSymbol>
		<obo:IAO_0000115>This gene belongs to the ephrin receptor subfamily of the protein-tyrosine kinase family. EPH and EPH-related receptors have been implicated in mediating developmental events, particularly in the nervous system. Receptors in the EPH subfamily typically have a single kinase domain and an extracellular region containing a Cys-rich domain and 2 fibronectin type III repeats. The ephrin receptors are divided into 2 groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands. Increased expression of this gene is associated with multiple forms of carcinoma. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2013]</obo:IAO_0000115>
		<dto:geneSynonym>EHK3</dto:geneSynonym>
		<dto:geneSynonym>HEK11</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200132 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200132">
		<rdfs:label rdf:datatype="&xsd;string">EPHA8 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400153"/>
		<dto:entrez_xref>2046</dto:entrez_xref>
		<dto:geneSymbol>EPHA8</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the ephrin receptor subfamily of the protein-tyrosine kinase family. EPH and EPH-related receptors have been implicated in mediating developmental events, particularly in the nervous system. Receptors in the EPH subfamily typically have a single kinase domain and an extracellular region containing a Cys-rich domain and 2 fibronectin type III repeats. The ephrin receptors are divided into 2 groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands. The protein encoded by this gene functions as a receptor for ephrin A2, A3 and A5 and plays a role in short-range contact-mediated axonal guidance during development of the mammalian nervous system. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>EEK</dto:geneSynonym>
		<dto:geneSynonym>HEK3</dto:geneSynonym>
		<dto:geneSynonym>KIAA1459</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200133 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200133">
		<rdfs:label rdf:datatype="&xsd;string">EPHA10 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400153"/>
		<dto:entrez_xref>284656</dto:entrez_xref>
		<dto:geneSymbol>EPHA10</dto:geneSymbol>
		<obo:IAO_0000115>Ephrin receptors, the largest subfamily of receptor tyrosine kinases (RTKs), and their ephrin ligands are important mediators of cell-cell communication regulating cell attachment, shape, and mobility in neuronal and epithelial cells (Aasheim et al., 2005 [PubMed 15777695]). See MIM 179610 for additional background on Eph receptors and ephrins.[supplied by OMIM, Mar 2008]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200134 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200134">
		<rdfs:label rdf:datatype="&xsd;string">EPHB1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400153"/>
		<dto:entrez_xref>2047</dto:entrez_xref>
		<dto:geneSymbol>EPHB1</dto:geneSymbol>
		<obo:IAO_0000115>Ephrin receptors and their ligands, the ephrins, mediate numerous developmental processes, particularly in the nervous system. Based on their structures and sequence relationships, ephrins are divided into the ephrin-A (EFNA) class, which are anchored to the membrane by a glycosylphosphatidylinositol linkage, and the ephrin-B (EFNB) class, which are transmembrane proteins. The Eph family of receptors are divided into 2 groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands. Ephrin receptors make up the largest subgroup of the receptor tyrosine kinase (RTK) family. The protein encoded by this gene is a receptor for ephrin-B family members. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>ELK</dto:geneSynonym>
		<dto:geneSynonym>EPHT2</dto:geneSynonym>
		<dto:geneSynonym>HEK6</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200135 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200135">
		<rdfs:label rdf:datatype="&xsd;string">EPHB2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400153"/>
		<dto:entrez_xref>2048</dto:entrez_xref>
		<dto:geneSymbol>EPHB2</dto:geneSymbol>
		<obo:IAO_0000115>Ephrin receptors and their ligands, the ephrins, mediate numerous developmental processes, particularly in the nervous system. Based on their structures and sequence relationships, ephrins are divided into the ephrin-A (EFNA) class, which are anchored to the membrane by a glycosylphosphatidylinositol linkage, and the ephrin-B (EFNB) class, which are transmembrane proteins. The Eph family of receptors are divided into 2 groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands. Ephrin receptors make up the largest subgroup of the receptor tyrosine kinase (RTK) family. The protein encoded by this gene is a receptor for ephrin-B family members. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>DRT</dto:geneSynonym>
		<dto:geneSynonym>EPHT3</dto:geneSynonym>
		<dto:geneSynonym>EPTH3</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200136 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200136">
		<rdfs:label rdf:datatype="&xsd;string">EPHB3 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400153"/>
		<dto:entrez_xref>2049</dto:entrez_xref>
		<dto:geneSymbol>EPHB3</dto:geneSymbol>
		<obo:IAO_0000115>Ephrin receptors and their ligands, the ephrins, mediate numerous developmental processes, particularly in the nervous system. Based on their structures and sequence relationships, ephrins are divided into the ephrin-A (EFNA) class, which are anchored to the membrane by a glycosylphosphatidylinositol linkage, and the ephrin-B (EFNB) class, which are transmembrane proteins. The Eph family of receptors are divided into two groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands. Ephrin receptors make up the largest subgroup of the receptor tyrosine kinase (RTK) family. This gene encodes a receptor for ephrin-B family members. [provided by RefSeq, Mar 2010]</obo:IAO_0000115>
		<dto:geneSynonym>ETK2</dto:geneSynonym>
		<dto:geneSynonym>HEK2</dto:geneSynonym>
		<dto:geneSynonym>TYRO6</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200137 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200137">
		<rdfs:label rdf:datatype="&xsd;string">EPHB4 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400153"/>
		<dto:entrez_xref>2050</dto:entrez_xref>
		<dto:geneSymbol>EPHB4</dto:geneSymbol>
		<obo:IAO_0000115>Ephrin receptors and their ligands, the ephrins, mediate numerous developmental processes, particularly in the nervous system. Based on their structures and sequence relationships, ephrins are divided into the ephrin-A (EFNA) class, which are anchored to the membrane by a glycosylphosphatidylinositol linkage, and the ephrin-B (EFNB) class, which are transmembrane proteins. The Eph family of receptors are divided into 2 groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands. Ephrin receptors make up the largest subgroup of the receptor tyrosine kinase (RTK) family. The protein encoded by this gene binds to ephrin-B2 and plays an essential role in vascular development. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>HTK</dto:geneSynonym>
		<dto:geneSynonym>MYK1</dto:geneSynonym>
		<dto:geneSynonym>TYRO11</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200138 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200138">
		<rdfs:label rdf:datatype="&xsd;string">EPHB6 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400153"/>
		<dto:entrez_xref>2051</dto:entrez_xref>
		<dto:geneSymbol>EPHB6</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of a family of transmembrane proteins that function as receptors for ephrin-B family proteins. Unlike other members of this family, the encoded protein does not contain a functional kinase domain. Activity of this protein can influence cell adhesion and migration. Expression of this gene is downregulated during tumor progression, suggesting that the protein may suppress tumor invasion and metastasis. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200139 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200139">
		<rdfs:label rdf:datatype="&xsd;string">ERBB2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400152"/>
		<dto:entrez_xref>2064</dto:entrez_xref>
		<dto:geneSymbol>ERBB2</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the epidermal growth factor (EGF) receptor family of receptor tyrosine kinases. This protein has no ligand binding domain of its own and therefore cannot bind growth factors. However, it does bind tightly to other ligand-bound EGF receptor family members to form a heterodimer, stabilizing ligand binding and enhancing kinase-mediated activation of downstream signalling pathways, such as those involving mitogen-activated protein kinase and phosphatidylinositol-3 kinase. Allelic variations at amino acid positions 654 and 655 of isoform a (positions 624 and 625 of isoform b) have been reported, with the most common allele, Ile654/Ile655, shown here. Amplification and/or overexpression of this gene has been reported in numerous cancers, including breast and ovarian tumors. Alternative splicing results in several additional transcript variants, some encoding different isoforms and others that have not been fully characterized. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>HER2</dto:geneSynonym>
		<dto:geneSynonym>MLN19</dto:geneSynonym>
		<dto:geneSynonym>NEU</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200140 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200140">
		<rdfs:label rdf:datatype="&xsd;string">ERBB3 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400152"/>
		<dto:entrez_xref>2065</dto:entrez_xref>
		<dto:geneSymbol>ERBB3</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the epidermal growth factor receptor (EGFR) family of receptor tyrosine kinases. This membrane-bound protein has a neuregulin binding domain but not an active kinase domain. It therefore can bind this ligand but not convey the signal into the cell through protein phosphorylation. However, it does form heterodimers with other EGF receptor family members which do have kinase activity. Heterodimerization leads to the activation of pathways which lead to cell proliferation or differentiation. Amplification of this gene and/or overexpression of its protein have been reported in numerous cancers, including prostate, bladder, and breast tumors. Alternate transcriptional splice variants encoding different isoforms have been characterized. One isoform lacks the intermembrane region and is secreted outside the cell. This form acts to modulate the activity of the membrane-bound form. Additional splice variants have also been reported, but they have not been thoroughly characterized. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>HER3</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200141 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200141">
		<rdfs:label rdf:datatype="&xsd;string">ERBB4 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400152"/>
		<dto:entrez_xref>2066</dto:entrez_xref>
		<dto:geneSymbol>ERBB4</dto:geneSymbol>
		<obo:IAO_0000115>This gene is a member of the Tyr protein kinase family and the epidermal growth factor receptor subfamily. It encodes a single-pass type I membrane protein with multiple cysteine rich domains, a transmembrane domain, a tyrosine kinase domain, a phosphotidylinositol-3 kinase binding site and a PDZ domain binding motif. The protein binds to and is activated by neuregulins and other factors and induces a variety of cellular responses including mitogenesis and differentiation. Multiple proteolytic events allow for the release of a cytoplasmic fragment and an extracellular fragment. Mutations in this gene have been associated with cancer. Alternatively spliced variants which encode different protein isoforms have been described; however, not all variants have been fully characterized. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>HER4</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200142 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200142">
		<rdfs:label rdf:datatype="&xsd;string">ERN1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400154"/>
		<dto:entrez_xref>2081</dto:entrez_xref>
		<dto:geneSymbol>ERN1</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is the ER to nucleus signalling 1 protein, a human homologue of the yeast Ire1 gene product. This protein possesses intrinsic kinase activity and an endoribonuclease activity and it is important in altering gene expression as a response to endoplasmic reticulum-based stress signals. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>IRE1</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200143 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200143">
		<rdfs:label rdf:datatype="&xsd;string">ERN2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400154"/>
		<dto:entrez_xref>10595</dto:entrez_xref>
		<dto:geneSymbol>ERN2</dto:geneSymbol>
		<dto:geneSynonym>IRE2</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200144 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200144">
		<rdfs:label rdf:datatype="&xsd;string">PTK2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400155"/>
		<dto:entrez_xref>5747</dto:entrez_xref>
		<dto:geneSymbol>PTK2</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a cytoplasmic protein tyrosine kinase which is found concentrated in the focal adhesions that form between cells growing in the presence of extracellular matrix constituents. The encoded protein is a member of the FAK subfamily of protein tyrosine kinases but lacks significant sequence similarity to kinases from other subfamilies. Activation of this gene may be an important early step in cell growth and intracellular signal transduction pathways triggered in response to certain neural peptides or to cell interactions with the extracellular matrix. Several transcript variants encoding different isoforms have been found for this gene, but the full-length natures of only three of them have been determined. [provided by RefSeq, Dec 2010]</obo:IAO_0000115>
		<dto:geneSynonym>FAK</dto:geneSynonym>
		<dto:geneSynonym>FAK1</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200145 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200145">
		<rdfs:label rdf:datatype="&xsd;string">PTK2B gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400155"/>
		<dto:entrez_xref>2185</dto:entrez_xref>
		<dto:geneSymbol>PTK2B</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a cytoplasmic protein tyrosine kinase which is involved in calcium-induced regulation of ion channels and activation of the map kinase signaling pathway. The encoded protein may represent an important signaling intermediate between neuropeptide-activated receptors or neurotransmitters that increase calcium flux and the downstream signals that regulate neuronal activity. The encoded protein undergoes rapid tyrosine phosphorylation and activation in response to increases in the intracellular calcium concentration, nicotinic acetylcholine receptor activation, membrane depolarization, or protein kinase C activation. This protein has been shown to bind CRK-associated substrate, nephrocystin, GTPase regulator associated with FAK, and the SH2 domain of GRB2. The encoded protein is a member of the FAK subfamily of protein tyrosine kinases but lacks significant sequence similarity to kinases from other subfamilies. Four transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>FAK2</dto:geneSynonym>
		<dto:geneSynonym>PYK2</dto:geneSynonym>
		<dto:geneSynonym>RAFTK</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200146 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200146">
		<rdfs:label rdf:datatype="&xsd;string">FASTK gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400156"/>
		<dto:entrez_xref>10922</dto:entrez_xref>
		<dto:geneSymbol>FASTK</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is a member of the serine/threonine protein kinase family. This kinase was shown to be activated rapidly during Fas-mediated apoptosis in Jurkat cells. In response to Fas receptor ligation, it phosphorylates TIA1, an apoptosis-promoting nuclear RNA-binding protein. The encoded protein is a strong inducer of lymphocyte apoptosis. Two transcript variants encoding different isoforms have been found for this gene. Other variants exist, but their full-length natures have not yet been determined. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200147 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200147">
		<rdfs:label rdf:datatype="&xsd;string">FER gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400157"/>
		<dto:entrez_xref>2241</dto:entrez_xref>
		<dto:geneSymbol>FER</dto:geneSymbol>
		<obo:IAO_0000115> Fer protein is a member of the FPS/FES family of nontransmembrane receptor tyrosine kinases. It regulates cell-cell adhesion and mediates signaling from the cell surface to the cytoskeleton via growth factor receptors. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>TYK3</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200148 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200148">
		<rdfs:label rdf:datatype="&xsd;string">FES gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400157"/>
		<dto:entrez_xref>2242</dto:entrez_xref>
		<dto:geneSymbol>FES</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes the human cellular counterpart of a feline sarcoma retrovirus protein with transforming capabilities. The gene product has tyrosine-specific protein kinase activity and that activity is required for maintenance of cellular transformation. Its chromosomal location has linked it to a specific translocation event identified in patients with acute promyelocytic leukemia but it is also involved in normal hematopoiesis as well as growth factor and cytokine receptor signaling. Alternative splicing results in multiple variants encoding different isoforms.[provided by RefSeq, Jan 2009]</obo:IAO_0000115>
		<dto:geneSynonym>FPS</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200149 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200149">
		<rdfs:label rdf:datatype="&xsd;string">FGFR1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400158"/>
		<dto:entrez_xref>2260</dto:entrez_xref>
		<dto:geneSymbol>FGFR1</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is a member of the fibroblast growth factor receptor (FGFR) family, where amino acid sequence is highly conserved between members and throughout evolution. FGFR family members differ from one another in their ligand affinities and tissue distribution. A full-length representative protein consists of an extracellular region, composed of three immunoglobulin-like domains, a single hydrophobic membrane-spanning segment and a cytoplasmic tyrosine kinase domain. The extracellular portion of the protein interacts with fibroblast growth factors, setting in motion a cascade of downstream signals, ultimately influencing mitogenesis and differentiation. This particular family member binds both acidic and basic fibroblast growth factors and is involved in limb induction. Mutations in this gene have been associated with Pfeiffer syndrome, Jackson-Weiss syndrome, Antley-Bixler syndrome, osteoglophonic dysplasia, and autosomal dominant Kallmann syndrome 2. Chromosomal aberrations involving this gene are associated with stem cell myeloproliferative disorder and stem cell leukemia lymphoma syndrome. Alternatively spliced variants which encode different protein isoforms have been described; however, not all variants have been fully characterized. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>BFGFR</dto:geneSynonym>
		<dto:geneSynonym>CEK</dto:geneSynonym>
		<dto:geneSynonym>FGFBR</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200150 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200150">
		<rdfs:label rdf:datatype="&xsd;string">FGFR2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400158"/>
		<dto:entrez_xref>2263</dto:entrez_xref>
		<dto:geneSymbol>FGFR2</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is a member of the fibroblast growth factor receptor family, where amino acid sequence is highly conserved between members and throughout evolution. FGFR family members differ from one another in their ligand affinities and tissue distribution. A full-length representative protein consists of an extracellular region, composed of three immunoglobulin-like domains, a single hydrophobic membrane-spanning segment and a cytoplasmic tyrosine kinase domain. The extracellular portion of the protein interacts with fibroblast growth factors, setting in motion a cascade of downstream signals, ultimately influencing mitogenesis and differentiation. This particular family member is a high-affinity receptor for acidic, basic and/or keratinocyte growth factor, depending on the isoform. Mutations in this gene are associated with Crouzon syndrome, Pfeiffer syndrome, Craniosynostosis, Apert syndrome, Jackson-Weiss syndrome, Beare-Stevenson cutis gyrata syndrome, Saethre-Chotzen syndrome, and syndromic craniosynostosis. Multiple alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Jan 2009]</obo:IAO_0000115>
		<dto:geneSynonym>BEK</dto:geneSynonym>
		<dto:geneSynonym>KGFR</dto:geneSynonym>
		<dto:geneSynonym>KSAM</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200151 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200151">
		<rdfs:label rdf:datatype="&xsd;string">FGFR3 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400158"/>
		<dto:entrez_xref>2261</dto:entrez_xref>
		<dto:geneSymbol>FGFR3</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the fibroblast growth factor receptor (FGFR) family, with its amino acid sequence being highly conserved between members and among divergent species. FGFR family members differ from one another in their ligand affinities and tissue distribution. A full-length representative protein would consist of an extracellular region, composed of three immunoglobulin-like domains, a single hydrophobic membrane-spanning segment and a cytoplasmic tyrosine kinase domain. The extracellular portion of the protein interacts with fibroblast growth factors, setting in motion a cascade of downstream signals, ultimately influencing mitogenesis and differentiation. This particular family member binds acidic and basic fibroblast growth hormone and plays a role in bone development and maintenance. Mutations in this gene lead to craniosynostosis and multiple types of skeletal dysplasia. Three alternatively spliced transcript variants that encode different protein isoforms have been described. [provided by RefSeq, Jul 2009]</obo:IAO_0000115>
		<dto:geneSynonym>JTK4</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200152 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200152">
		<rdfs:label rdf:datatype="&xsd;string">FGFR4 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400158"/>
		<dto:entrez_xref>2264</dto:entrez_xref>
		<dto:geneSymbol>FGFR4</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is a member of the fibroblast growth factor receptor family, where amino acid sequence is highly conserved between members and throughout evolution. FGFR family members differ from one another in their ligand affinities and tissue distribution. A full-length representative protein would consist of an extracellular region, composed of three immunoglobulin-like domains, a single hydrophobic membrane-spanning segment and a cytoplasmic tyrosine kinase domain. The extracellular portion of the protein interacts with fibroblast growth factors, setting in motion a cascade of downstream signals, ultimately influencing mitogenesis and differentiation. The genomic organization of this gene, compared to members 1-3, encompasses 18 exons rather than 19 or 20. Although alternative splicing has been observed, there is no evidence that the C-terminal half of the IgIII domain of this protein varies between three alternate forms, as indicated for members 1-3. This particular family member preferentially binds acidic fibroblast growth factor and, although its specific function is unknown, it is overexpressed in gynecological tumor samples, suggesting a role in breast and ovarian tumorigenesis. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>JTK2</dto:geneSynonym>
		<dto:geneSynonym>TKF</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200153 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200153">
		<rdfs:label rdf:datatype="&xsd;string">FGR gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400132"/>
		<dto:entrez_xref>2268</dto:entrez_xref>
		<dto:geneSymbol>FGR</dto:geneSymbol>
		<obo:IAO_0000115>This gene is a member of the Src family of protein tyrosine kinases (PTKs). The encoded protein contains N-terminal sites for myristylation and palmitylation, a PTK domain, and SH2 and SH3 domains which are involved in mediating protein-protein interactions with phosphotyrosine-containing and proline-rich motifs, respectively. The protein localizes to plasma membrane ruffles, and functions as a negative regulator of cell migration and adhesion triggered by the beta-2 integrin signal transduction pathway. Infection with Epstein-Barr virus results in the overexpression of this gene. Multiple alternatively spliced variants, encoding the same protein, have been identified. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>SRC2</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200154 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200154">
		<rdfs:label rdf:datatype="&xsd;string">FLT3 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400141"/>
		<dto:entrez_xref>2322</dto:entrez_xref>
		<dto:geneSymbol>FLT3</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a class III receptor tyrosine kinase that regulates hematopoiesis. The receptor consists of an extracellular domain composed of five immunoglobulin-like domains, one transmembrane region, and a cytoplasmic kinase domain split into two parts by a kinase-insert domain. The receptor is activated by binding of the fms-related tyrosine kinase 3 ligand to the extracellular domain, which induces homodimer formation in the plasma membrane leading to autophosphorylation of the receptor. The activated receptor kinase subsequently phosphorylates and activates multiple cytoplasmic effector molecules in pathways involved in apoptosis, proliferation, and differentiation of hematopoietic cells in bone marrow. Mutations that result in the constitutive activation of this receptor result in acute myeloid leukemia and acute lymphoblastic leukemia. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>CD135</dto:geneSynonym>
		<dto:geneSynonym>FLK2</dto:geneSynonym>
		<dto:geneSynonym>STK1</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200155 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200155">
		<rdfs:label rdf:datatype="&xsd;string">FRK gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400132"/>
		<dto:entrez_xref>2444</dto:entrez_xref>
		<dto:geneSymbol>FRK</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene belongs to the TYR family of protein kinases. This tyrosine kinase is a nuclear protein and may function during G1 and S phase of the cell cycle and suppress growth. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>PTK5</dto:geneSynonym>
		<dto:geneSynonym>RAK</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200156 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200156">
		<rdfs:label rdf:datatype="&xsd;string">FYN gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400132"/>
		<dto:entrez_xref>2534</dto:entrez_xref>
		<dto:geneSymbol>FYN</dto:geneSymbol>
		<obo:IAO_0000115>This gene is a member of the protein-tyrosine kinase oncogene family. It encodes a membrane-associated tyrosine kinase that has been implicated in the control of cell growth. The protein associates with the p85 subunit of phosphatidylinositol 3-kinase and interacts with the fyn-binding protein. Alternatively spliced transcript variants encoding distinct isoforms exist. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200157 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200157">
		<rdfs:label rdf:datatype="&xsd;string">PIKFYVE gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400323"/>
		<dto:entrez_xref>200576</dto:entrez_xref>
		<dto:geneSymbol>PIKFYVE</dto:geneSymbol>
		<obo:IAO_0000115>Phosphorylated derivatives of phosphatidylinositol (PtdIns) regulate cytoskeletal functions, membrane trafficking, and receptor signaling by recruiting protein complexes to cell- and endosomal-membranes. Humans have multiple PtdIns proteins that differ by the degree and position of phosphorylation of the inositol ring. This gene encodes an enzyme (PIKfyve; also known as phosphatidylinositol-3-phosphate 5-kinase type III or PIPKIII) that phosphorylates the D-5 position in PtdIns and phosphatidylinositol-3-phosphate (PtdIns3P) to make PtdIns5P and PtdIns(3,5)biphosphate. The D-5 position also can be phosphorylated by type I PtdIns4P-5-kinases (PIP5Ks) that are encoded by distinct genes and preferentially phosphorylate D-4 phosphorylated PtdIns. In contrast, PIKfyve preferentially phosphorylates D-3 phosphorylated PtdIns. In addition to being a lipid kinase, PIKfyve also has protein kinase activity. PIKfyve regulates endomembrane homeostasis and plays a role in the biogenesis of endosome carrier vesicles from early endosomes. Mutations in this gene cause corneal fleck dystrophy (CFD); an autosomal dominant disorder characterized by numerous small white flecks present in all layers of the corneal stroma. Histologically, these flecks appear to be keratocytes distended with lipid and mucopolysaccharide filled intracytoplasmic vacuoles. Alternative splicing results in multiple transcript variants encoding distinct isoforms.[provided by RefSeq, May 2010]</obo:IAO_0000115>
		<dto:geneSynonym>KIAA0981</dto:geneSynonym>
		<dto:geneSynonym>PIP5K3</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200158 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200158">
		<rdfs:label rdf:datatype="&xsd;string">GAK gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400115"/>
		<dto:entrez_xref>2580</dto:entrez_xref>
		<dto:geneSymbol>GAK</dto:geneSymbol>
		<obo:IAO_0000115>In all eukaryotes, the cell cycle is governed by cyclin-dependent protein kinases (CDKs), whose activities are regulated by cyclins and CDK inhibitors in a diverse array of mechanisms that involve the control of phosphorylation and dephosphorylation of Ser, Thr or Tyr residues. Cyclins are molecules that possess a consensus domain called the &apos;cyclin box.&apos; In mammalian cells, 9 cyclin species have been identified, and they are referred to as cyclins A through I. Cyclin G is a direct transcriptional target of the p53 tumor suppressor gene product and thus functions downstream of p53. GAK is an association partner of cyclin G and CDK5. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2013]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200159 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200159">
		<rdfs:label rdf:datatype="&xsd;string">GK2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491021"/>
		<dto:entrez_xref>2712</dto:entrez_xref>
		<dto:geneSymbol>GK2</dto:geneSymbol>
		<dto:geneSynonym>GKP2</dto:geneSynonym>
		<dto:geneSynonym>GKTA</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200160 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200160">
		<rdfs:label rdf:datatype="&xsd;string">GRK4 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400271"/>
		<dto:entrez_xref>2868</dto:entrez_xref>
		<dto:geneSymbol>GRK4</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the guanine nucleotide-binding protein (G protein)-coupled receptor kinase subfamily of the Ser/Thr protein kinase family. The protein phosphorylates the activated forms of G protein-coupled receptors thus initiating its deactivation. This gene has been linked to both genetic and acquired hypertension. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2013]</obo:IAO_0000115>
		<dto:geneSynonym>GPRK2L</dto:geneSynonym>
		<dto:geneSynonym>GPRK4</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200161 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200161">
		<rdfs:label rdf:datatype="&xsd;string">GRK5 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400271"/>
		<dto:entrez_xref>2869</dto:entrez_xref>
		<dto:geneSymbol>GRK5</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the guanine nucleotide-binding protein (G protein)-coupled receptor kinase subfamily of the Ser/Thr protein kinase family. The protein phosphorylates the activated forms of G protein-coupled receptors thus initiating their deactivation. It has also been shown to play a role in regulating the motility of polymorphonuclear leukocytes (PMNs). [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>GPRK5</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200162 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200162">
		<rdfs:label rdf:datatype="&xsd;string">GRK6 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400271"/>
		<dto:entrez_xref>2870</dto:entrez_xref>
		<dto:geneSymbol>GRK6</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the guanine nucleotide-binding protein (G protein)-coupled receptor kinase subfamily of the Ser/Thr protein kinase family. The protein phosphorylates the activated forms of G protein-coupled receptors thus initiating their deactivation. Several transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>GPRK6</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200163 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200163">
		<rdfs:label rdf:datatype="&xsd;string">GRK7 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400271"/>
		<dto:entrez_xref>131890</dto:entrez_xref>
		<dto:geneSymbol>GRK7</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the guanine nucleotide-binding protein (G protein)-coupled receptor kinase subfamily of the Ser/Thr protein kinase family. It is specifically expressed in the retina and the encoded protein has been shown to phosphorylate cone opsins and initiate their deactivation. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>GPRK7</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200164 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200164">
		<rdfs:label rdf:datatype="&xsd;string">GSK3A gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400272"/>
		<dto:entrez_xref>2931</dto:entrez_xref>
		<dto:geneSymbol>GSK3A</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a multifunctional Ser/Thr protein kinase that is implicated in the control of several regulatory proteins including glycogen synthase, and transcription factors, such as JUN. It also plays a role in the WNT and PI3K signaling pathways, as well as regulates the production of beta-amyloid peptides associated with Alzheimer&apos;s disease. [provided by RefSeq, Oct 2011]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200165 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200165">
		<rdfs:label rdf:datatype="&xsd;string">GSK3B gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400272"/>
		<dto:entrez_xref>2932</dto:entrez_xref>
		<dto:geneSymbol>GSK3B</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is a serine-threonine kinase, belonging to the glycogen synthase kinase subfamily. It is involved in energy metabolism, neuronal cell development, and body pattern formation. Polymorphisms in this gene have been implicated in modifying risk of Parkinson disease, and studies in mice show that overexpression of this gene may be relevant to the pathogenesis of Alzheimer disease. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Sep 2009]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200166 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200166">
		<rdfs:label rdf:datatype="&xsd;string">GUCY2C gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400125"/>
		<dto:entrez_xref>2984</dto:entrez_xref>
		<dto:geneSymbol>GUCY2C</dto:geneSymbol>
		<dto:geneSynonym>GUC2C</dto:geneSynonym>
		<dto:geneSynonym>STAR</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200167 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200167">
		<rdfs:label rdf:datatype="&xsd;string">GUCY2D gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400125"/>
		<dto:entrez_xref>3000</dto:entrez_xref>
		<dto:geneSymbol>GUCY2D</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a retina-specific guanylate cyclase, which is a member of the membrane guanylyl cyclase family. Like other membrane guanylyl cyclases, this enzyme has a hydrophobic amino-terminal signal sequence followed by a large extracellular domain, a single membrane spanning domain, a kinase homology domain, and a guanylyl cyclase catalytic domain. In contrast to other membrane guanylyl cyclases, this enzyme is not activated by natriuretic peptides. Mutations in this gene result in Leber congenital amaurosis and cone-rod dystrophy-6 diseases. [provided by RefSeq, Dec 2008]</obo:IAO_0000115>
		<dto:geneSynonym>CORD6</dto:geneSynonym>
		<dto:geneSynonym>GUC1A4</dto:geneSynonym>
		<dto:geneSynonym>GUC2D</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200168 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200168">
		<rdfs:label rdf:datatype="&xsd;string">GUCY2F gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400125"/>
		<dto:entrez_xref>2986</dto:entrez_xref>
		<dto:geneSymbol>GUCY2F</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is a guanylyl cyclase found predominantly in photoreceptors in the retina. The encoded protein is thought to be involved in resynthesis of cGMP after light activation of the visual signal transduction cascade, allowing a return to the dark state. This protein is a single-pass type I membrane protein. Defects in this gene may be a cause of X-linked retinitis pigmentosa. [provided by RefSeq, Dec 2008]</obo:IAO_0000115>
		<dto:geneSynonym>GUC2F</dto:geneSynonym>
		<dto:geneSynonym>RETGC2</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200169 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200169">
		<rdfs:label rdf:datatype="&xsd;string">MASTL gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400160"/>
		<dto:entrez_xref>84930</dto:entrez_xref>
		<dto:geneSymbol>MASTL</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a microtubule-associated serine/threonine kinase. Mutations at this locus have been associated with autosomal dominant thrombocytopenia, also known as thrombocytopenia-2. Alternatively spliced transcript variants have been described for this locus. [provided by RefSeq, Feb 2010]</obo:IAO_0000115>
		<dto:geneSynonym>GW</dto:geneSynonym>
		<dto:geneSynonym>GWL</dto:geneSynonym>
		<dto:geneSynonym>THC2</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200170 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200170">
		<rdfs:label rdf:datatype="&xsd;string">GSG2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400161"/>
		<dto:entrez_xref>83903</dto:entrez_xref>
		<dto:geneSymbol>GSG2</dto:geneSymbol>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200171 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200171">
		<rdfs:label rdf:datatype="&xsd;string">HCK gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400132"/>
		<dto:entrez_xref>3055</dto:entrez_xref>
		<dto:geneSymbol>HCK</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is a member of the Src family of tyrosine kinases. This protein is primarily hemopoietic, particularly in cells of the myeloid and B-lymphoid lineages. It may help couple the Fc receptor to the activation of the respiratory burst. In addition, it may play a role in neutrophil migration and in the degranulation of neutrophils. Multiple isoforms with different subcellular distributions are produced due to both alternative splicing and the use of alternative translation initiation codons, including a non-AUG (CUG) codon. [provided by RefSeq, Feb 2010]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200172 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200172">
		<rdfs:label rdf:datatype="&xsd;string">HIPK1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400273"/>
		<dto:entrez_xref>204851</dto:entrez_xref>
		<dto:geneSymbol>HIPK1</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene belongs to the Ser/Thr family of protein kinases and HIPK subfamily. It phosphorylates homeodomain transcription factors and may also function as a co-repressor for homeodomain transcription factors. Alternative splicing results in four transcript variants encoding four distinct isoforms. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>KIAA0630</dto:geneSynonym>
		<dto:geneSynonym>MYAK</dto:geneSynonym>
		<dto:geneSynonym>NBAK2</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200173 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200173">
		<rdfs:label rdf:datatype="&xsd;string">HIPK2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400273"/>
		<dto:entrez_xref>28996</dto:entrez_xref>
		<dto:geneSymbol>HIPK2</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a conserved serine/threonine kinase that is a member of the homeodomain-interacting protein kinase family. The encoded protein interacts with homeodomain transcription factors and many other transcription factors such as p53, and can function as both a corepressor and a coactivator depending on the transcription factor and its subcellular localization. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2011]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200174 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200174">
		<rdfs:label rdf:datatype="&xsd;string">HIPK3 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400273"/>
		<dto:entrez_xref>10114</dto:entrez_xref>
		<dto:geneSymbol>HIPK3</dto:geneSymbol>
		<dto:geneSynonym>DYRK6</dto:geneSynonym>
		<dto:geneSynonym>FIST3</dto:geneSynonym>
		<dto:geneSynonym>PKY</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200175 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200175">
		<rdfs:label rdf:datatype="&xsd;string">HIPK4 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400273"/>
		<dto:entrez_xref>147746</dto:entrez_xref>
		<dto:geneSymbol>HIPK4</dto:geneSymbol>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200176 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200176">
		<rdfs:label rdf:datatype="&xsd;string">HUNK gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491034"/>
		<dto:entrez_xref>30811</dto:entrez_xref>
		<dto:geneSymbol>HUNK</dto:geneSymbol>
		<dto:geneSynonym>MAKV</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200177 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200177">
		<rdfs:label rdf:datatype="&xsd;string">HK1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491017"/>
		<dto:entrez_xref>3098</dto:entrez_xref>
		<dto:geneSymbol>HK1</dto:geneSymbol>
		<obo:IAO_0000115>Hexokinases phosphorylate glucose to produce glucose-6-phosphate, the first step in most glucose metabolism pathways. This gene encodes a ubiquitous form of hexokinase which localizes to the outer membrane of mitochondria. Mutations in this gene have been associated with hemolytic anemia due to hexokinase deficiency. Alternative splicing of this gene results in five transcript variants which encode different isoforms, some of which are tissue-specific. Each isoform has a distinct N-terminus; the remainder of the protein is identical among all the isoforms. A sixth transcript variant has been described, but due to the presence of several stop codons, it is not thought to encode a protein. [provided by RefSeq, Apr 2009]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200178 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200178">
		<rdfs:label rdf:datatype="&xsd;string">GCK gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491017"/>
		<dto:entrez_xref>2645</dto:entrez_xref>
		<dto:geneSymbol>GCK</dto:geneSymbol>
		<obo:IAO_0000115>Hexokinases phosphorylate glucose to produce glucose-6-phosphate, the first step in most glucose metabolism pathways. Alternative splicing of this gene results in three tissue-specific forms of glucokinase, one found in pancreatic islet beta cells and two found in liver. The protein localizes to the outer membrane of mitochondria. In contrast to other forms of hexokinase, this enzyme is not inhibited by its product glucose-6-phosphate but remains active while glucose is abundant. Mutations in this gene have been associated with non-insulin dependent diabetes mellitus (NIDDM), maturity onset diabetes of the young, type 2 (MODY2) and persistent hyperinsulinemic hypoglycemia of infancy (PHHI). [provided by RefSeq, Apr 2009]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200179 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200179">
		<rdfs:label rdf:datatype="&xsd;string">ICK gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400162"/>
		<dto:entrez_xref>22858</dto:entrez_xref>
		<dto:geneSymbol>ICK</dto:geneSymbol>
		<obo:IAO_0000115>Eukaryotic protein kinases are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. This gene encodes an intestinal serine/threonine kinase harboring a dual phosphorylation site found in mitogen-activating protein (MAP) kinases. The protein localizes to the intestinal crypt region and is thought to be important in intestinal epithelial cell proliferation and differentiation. Alternative splicing has been observed at this locus and two variants, encoding the same isoform, have been identified. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>KIAA0936</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200180 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200180">
		<rdfs:label rdf:datatype="&xsd;string">IGF1R gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400163"/>
		<dto:entrez_xref>3480</dto:entrez_xref>
		<dto:geneSymbol>IGF1R</dto:geneSymbol>
		<obo:IAO_0000115>This receptor binds insulin-like growth factor with a high affinity. It has tyrosine kinase activity. The insulin-like growth factor I receptor plays a critical role in transformation events. Cleavage of the precursor generates alpha and beta subunits. It is highly overexpressed in most malignant tissues where it functions as an anti-apoptotic agent by enhancing cell survival. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, May 2014]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200181 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200181">
		<rdfs:label rdf:datatype="&xsd;string">CHUK gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400164"/>
		<dto:entrez_xref>1147</dto:entrez_xref>
		<dto:geneSymbol>CHUK</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the serine/threonine protein kinase family. The encoded protein, a component of a cytokine-activated protein complex that is an inhibitor of the essential transcription factor NF-kappa-B complex, phosphorylates sites that trigger the degradation of the inhibitor via the ubiquination pathway, thereby activating the transcription factor. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>IKKA</dto:geneSynonym>
		<dto:geneSynonym>TCF16</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200182 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200182">
		<rdfs:label rdf:datatype="&xsd;string">IKBKB gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400164"/>
		<dto:entrez_xref>3551</dto:entrez_xref>
		<dto:geneSymbol>IKBKB</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene phosphorylates the inhibitor in the inhibitor/NF-kappa-B complex, causing dissociation of the inhibitor and activation of NF-kappa-B. The encoded protein itself is found in a complex of proteins. Several transcript variants, some protein-coding and some not, have been found for this gene. [provided by RefSeq, Sep 2011]</obo:IAO_0000115>
		<dto:geneSynonym>IKKB</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200183 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200183">
		<rdfs:label rdf:datatype="&xsd;string">IKBKE gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400164"/>
		<dto:entrez_xref>9641</dto:entrez_xref>
		<dto:geneSymbol>IKBKE</dto:geneSymbol>
		<obo:IAO_0000115>IKBKE is a noncanonical I-kappa-B (see MIM 164008) kinase (IKK) that is essential for regulating antiviral signaling pathways. IKBKE has also been identified as a breast cancer (MIM 114480) oncogene and is amplified and overexpressed in over 30% of breast carcinomas and breast cancer cell lines (Hutti et al., 2009 [PubMed 19481526]).[supplied by OMIM, Oct 2009]</obo:IAO_0000115>
		<dto:geneSynonym>IKKE</dto:geneSynonym>
		<dto:geneSynonym>IKKI</dto:geneSynonym>
		<dto:geneSynonym>KIAA0151</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200184 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200184">
		<rdfs:label rdf:datatype="&xsd;string">ILK gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400274"/>
		<dto:entrez_xref>3611</dto:entrez_xref>
		<dto:geneSymbol>ILK</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a protein with a kinase-like domain and four ankyrin-like repeats. The encoded protein associates at the cell membrane with the cytoplasmic domain of beta integrins, where it regulates integrin-mediated signal transduction. Activity of this protein is important in the epithelial to mesenchymal transition, and over-expression of this gene is implicated in tumor growth and metastasis. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2013]</obo:IAO_0000115>
		<dto:geneSynonym>ILK1</dto:geneSynonym>
		<dto:geneSynonym>ILK2</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200185 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200185">
		<rdfs:label rdf:datatype="&xsd;string">INSRR gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400163"/>
		<dto:entrez_xref>3645</dto:entrez_xref>
		<dto:geneSymbol>INSRR</dto:geneSymbol>
		<dto:geneSynonym>IRR</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200186 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200186">
		<rdfs:label rdf:datatype="&xsd;string">INSR gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400163"/>
		<dto:entrez_xref>3643</dto:entrez_xref>
		<dto:geneSymbol>INSR</dto:geneSymbol>
		<obo:IAO_0000115>After removal of the precursor signal peptide, the insulin receptor precursor is post-translationally cleaved into two chains (alpha and beta) that are covalently linked. Binding of insulin to the insulin receptor (INSR) stimulates glucose uptake. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200187 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200187">
		<rdfs:label rdf:datatype="&xsd;string">ITPKA gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491019"/>
		<dto:entrez_xref>3706</dto:entrez_xref>
		<dto:geneSymbol>ITPKA</dto:geneSymbol>
		<obo:IAO_0000115>Regulates inositol phosphate metabolism by phosphorylation of second messenger inositol 1,4,5-trisphosphate to Ins(1,3,4,5)P4. The activity of the inositol 1,4,5-trisphosphate 3-kinase is responsible for regulating the levels of a large number of inositol polyphosphates that are important in cellular signaling. Both calcium/calmodulin and protein phosphorylation mechanisms control its activity. It is also a substrate for the cyclic AMP-dependent protein kinase, calcium/calmodulin- dependent protein kinase II, and protein kinase C in vitro.[provided by RefSeq, Apr 2011]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200188 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200188">
		<rdfs:label rdf:datatype="&xsd;string">ITPKB gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491019"/>
		<dto:entrez_xref>3707</dto:entrez_xref>
		<dto:geneSymbol>ITPKB</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this protein regulates inositol phosphate metabolism by phosphorylation of second messenger inositol 1,4,5-trisphosphate to Ins(1,3,4,5)P4. The activity of this encoded protein is responsible for regulating the levels of a large number of inositol polyphosphates that are important in cellular signaling. Both calcium/calmodulin and protein phosphorylation mechanisms control its activity. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200189 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200189">
		<rdfs:label rdf:datatype="&xsd;string">IPMK gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491019"/>
		<dto:entrez_xref>253430</dto:entrez_xref>
		<dto:geneSymbol>IPMK</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the inositol phosphokinase family. The encoded protein has 3-kinase, 5-kinase and 6-kinase activities on phosphorylated inositol substrates. The encoded protein plays an important role in the biosynthesis of inositol 1,3,4,5,6-pentakisphosphate, and has a preferred 5-kinase activity. This gene may play a role in nuclear mRNA export. Pseudogenes of this gene are located on the long arm of chromosome 13 and the short arm of chromosome 19. [provided by RefSeq, Dec 2010]</obo:IAO_0000115>
		<dto:geneSynonym>IMPK</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200190 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200190">
		<rdfs:label rdf:datatype="&xsd;string">IRAK1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400166"/>
		<dto:entrez_xref>3654</dto:entrez_xref>
		<dto:geneSymbol>IRAK1</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes the interleukin-1 receptor-associated kinase 1, one of two putative serine/threonine kinases that become associated with the interleukin-1 receptor (IL1R) upon stimulation. This gene is partially responsible for IL1-induced upregulation of the transcription factor NF-kappa B. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>IRAK</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200191 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200191">
		<rdfs:label rdf:datatype="&xsd;string">IRAK2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400166"/>
		<dto:entrez_xref>3656</dto:entrez_xref>
		<dto:geneSymbol>IRAK2</dto:geneSymbol>
		<obo:IAO_0000115>IRAK2 encodes the interleukin-1 receptor-associated kinase 2, one of two putative serine/threonine kinases that become associated with the interleukin-1 receptor (IL1R) upon stimulation. IRAK2 is reported to participate in the IL1-induced upregulation of NF-kappaB. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200192 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200192">
		<rdfs:label rdf:datatype="&xsd;string">IRAK3 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400166"/>
		<dto:entrez_xref>11213</dto:entrez_xref>
		<dto:geneSymbol>IRAK3</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the interleukin-1 receptor-associated kinase protein family. Members of this family are essential components of the Toll/IL-R immune signal transduction pathways. This protein is primarily expressed in monocytes and macrophages and functions as a negative regulator of Toll-like receptor signaling. Mutations in this gene are associated with a susceptibility to asthma. Alternate splicing results in multiple transcript variants. [provided by RefSeq, May 2010]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200193 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200193">
		<rdfs:label rdf:datatype="&xsd;string">IRAK4 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400166"/>
		<dto:entrez_xref>51135</dto:entrez_xref>
		<dto:geneSymbol>IRAK4</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a kinase that activates NF-kappaB in both the Toll-like receptor (TLR) and T-cell receptor (TCR) signaling pathways. The protein is essential for most innate immune responses. Mutations in this gene result in IRAK4 deficiency and recurrent invasive pneumococcal disease. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2011]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200194 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200194">
		<rdfs:label rdf:datatype="&xsd;string">ITK gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400133"/>
		<dto:entrez_xref>3702</dto:entrez_xref>
		<dto:geneSymbol>ITK</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes an intracellular tyrosine kinase expressed in T-cells. The protein contains both SH2 and SH3 domains which are often found in intracellular kinases. It is thought to play a role in T-cell proliferation and differentiation. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>EMT</dto:geneSynonym>
		<dto:geneSynonym>LYK</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200195 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200195">
		<rdfs:label rdf:datatype="&xsd;string">ITPK1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491020"/>
		<dto:entrez_xref>3705</dto:entrez_xref>
		<dto:geneSymbol>ITPK1</dto:geneSymbol>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200196 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200196">
		<rdfs:label rdf:datatype="&xsd;string">JAK1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400167"/>
		<dto:entrez_xref>3716</dto:entrez_xref>
		<dto:geneSymbol>JAK1</dto:geneSymbol>
		<obo:IAO_0000115>Janus kinase 1 (JAK1), is a member of a new class of protein-tyrosine kinases (PTK) characterized by the presence of a second phosphotransferase-related domain immediately N-terminal to the PTK domain. The second phosphotransferase domain bears all the hallmarks of a protein kinase, although its structure differs significantly from that of the PTK and threonine/serine kinase family members. JAK1 is a large, widely expressed membrane-associated phosphoprotein.  JAK1 is involved in the interferon-alpha/beta and -gamma signal transduction pathways. The reciprocal interdependence between JAK1 and TYK2 activities in the interferon-alpha pathway, and between JAK1 and JAK2 in the interferon-gamma pathway, may reflect a requirement for these kinases in the correct assembly of interferon receptor complexes. These kinases couple cytokine ligand binding to tyrosine phosphorylation of various known signaling proteins and of a unique family of transcription factors termed the signal transducers and activators of transcription, or STATs. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>JAK1A</dto:geneSynonym>
		<dto:geneSynonym>JAK1B</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200197 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200197">
		<rdfs:label rdf:datatype="&xsd;string">JAK2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400167"/>
		<dto:entrez_xref>3717</dto:entrez_xref>
		<dto:geneSymbol>JAK2</dto:geneSymbol>
		<obo:IAO_0000115>This gene product is a protein tyrosine kinase involved in a specific subset of cytokine receptor signaling pathways. It has been found to be constituitively associated with the prolactin receptor and is required for responses to gamma interferon. Mice that do not express an active protein for this gene exhibit embryonic lethality associated with the absence of definitive erythropoiesis. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200198 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200198">
		<rdfs:label rdf:datatype="&xsd;string">JAK3 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400167"/>
		<dto:entrez_xref>3718</dto:entrez_xref>
		<dto:geneSymbol>JAK3</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is a member of the Janus kinase (JAK) family of tyrosine kinases involved in cytokine receptor-mediated intracellular signal transduction. It is predominantly expressed in immune cells and transduces a signal in response to its activation via tyrosine phosphorylation by interleukin receptors. Mutations in this gene are associated with autosomal SCID (severe combined immunodeficiency disease). [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200199 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200199">
		<rdfs:label rdf:datatype="&xsd;string">PFKL gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_0349989"/>
		<dto:entrez_xref>5211</dto:entrez_xref>
		<dto:geneSymbol>PFKL</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes the liver (L) subunit of an enzyme that catalyzes the conversion of D-fructose 6-phosphate to D-fructose 1,6-bisphosphate, which is a key step in glucose metabolism (glycolysis). This enzyme is a tetramer that may be composed of different subunits encoded by distinct genes in different tissues. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2014]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200200 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200200">
		<rdfs:label rdf:datatype="&xsd;string">AK1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491001"/>
		<dto:entrez_xref>203</dto:entrez_xref>
		<dto:geneSymbol>AK1</dto:geneSymbol>
		<obo:IAO_0000115>Adenylate kinase is an enzyme involved in regulating the adenine nucleotide composition within a cell by catalyzing the reversible transfer of phosphate group among adinine nucleotides. Three isozymes of adenylate kinase have been identified in vertebrates, adenylate isozyme 1 (AK1), 2 (AK2) and 3 (AK3). AK1 is found in the cytosol of skeletal muscle, brain and erythrocytes, whereas AK2 and AK3 are found in the mitochondria of other tissues including liver and heart. AK1 was identified because of its association with a rare genetic disorder causing nonspherocytic hemolytic anemia where a mutation in the AK1 gene was found to reduce the catalytic activity of the enzyme. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200201 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200201">
		<rdfs:label rdf:datatype="&xsd;string">AK2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491004"/>
		<dto:entrez_xref>204</dto:entrez_xref>
		<dto:geneSymbol>AK2</dto:geneSymbol>
		<obo:IAO_0000115>Adenylate kinases are involved in regulating the adenine nucleotide composition within a cell by catalyzing the reversible transfer of phosphate groups among adenine nucleotides. Three isozymes of adenylate kinase, namely 1, 2, and 3, have been identified in vertebrates; this gene encodes isozyme 2. Expression of these isozymes is tissue-specific and developmentally regulated. Isozyme 2 is localized in the mitochondrial intermembrane space and may play a role in apoptosis. Mutations in this gene are the cause of reticular dysgenesis. Alternate splicing results in multiple transcript variants. Pseudogenes of this gene are found on chromosomes 1 and 2.[provided by RefSeq, Nov 2010]</obo:IAO_0000115>
		<dto:geneSynonym>ADK2</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200202 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200202">
		<rdfs:label rdf:datatype="&xsd;string">AK3 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491006"/>
		<dto:entrez_xref>50808</dto:entrez_xref>
		<dto:geneSymbol>AK3</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is a GTP:ATP phosphotransferase that is found in the mitochondrial matrix. Several transcript variants encoding a few different isoforms have been found for this gene. [provided by RefSeq, Dec 2010]</obo:IAO_0000115>
		<dto:geneSynonym>AK3L1</dto:geneSynonym>
		<dto:geneSynonym>AK6</dto:geneSynonym>
		<dto:geneSynonym>AKL3L</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200203 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200203">
		<rdfs:label rdf:datatype="&xsd;string">KALRN gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400168"/>
		<dto:entrez_xref>8997</dto:entrez_xref>
		<dto:geneSymbol>KALRN</dto:geneSymbol>
		<obo:IAO_0000115>Huntington&apos;s disease (HD), a neurodegenerative disorder characterized by loss of striatal neurons, is caused by an expansion of a polyglutamine tract in the HD protein huntingtin. This gene encodes a protein that interacts with the huntingtin-associated protein 1, which is a huntingtin binding protein that may function in vesicle trafficking. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>DUET</dto:geneSynonym>
		<dto:geneSynonym>DUO</dto:geneSynonym>
		<dto:geneSynonym>HAPIP</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200204 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200204">
		<rdfs:label rdf:datatype="&xsd;string">PRKACA gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400169"/>
		<dto:entrez_xref>5566</dto:entrez_xref>
		<dto:geneSymbol>PRKACA</dto:geneSymbol>
		<obo:IAO_0000115>cAMP is a signaling molecule important for a variety of cellular functions. cAMP exerts its effects by activating the cAMP-dependent protein kinase, which transduces the signal through phosphorylation of different target proteins. The inactive kinase holoenzyme is a tetramer composed of two regulatory and two catalytic subunits. cAMP causes the dissociation of the inactive holoenzyme into a dimer of regulatory subunits bound to four cAMP and two free monomeric catalytic subunits. Four different regulatory subunits and three catalytic subunits have been identified in humans. The protein encoded by this gene is a member of the Ser/Thr protein kinase family and is a catalytic subunit of cAMP-dependent protein kinase. Alternatively spliced transcript variants encoding distinct isoforms have been observed. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>PKACA</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200205 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200205">
		<rdfs:label rdf:datatype="&xsd;string">PRKACB gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400169"/>
		<dto:entrez_xref>5567</dto:entrez_xref>
		<dto:geneSymbol>PRKACB</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is a member of the serine/threonine protein kinase family. The encoded protein is a catalytic subunit of cAMP (cyclic AMP)-dependent protein kinase, which mediates signalling though cAMP. cAMP signaling is important to a number of processes, including cell proliferaton and differentiation. Multiple alternatively spliced transcript variants encoding distinct isoforms have been observed. [provided by RefSeq, Jul 2014]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200206 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200206">
		<rdfs:label rdf:datatype="&xsd;string">PRKACG gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400169"/>
		<dto:entrez_xref>5568</dto:entrez_xref>
		<dto:geneSymbol>PRKACG</dto:geneSymbol>
		<obo:IAO_0000115>Cyclic AMP-dependent protein kinase (PKA) consists of two catalytic subunits and a regulatory subunit dimer. This gene encodes the gamma form of its catalytic subunit. The gene is intronless and is thought to be a retrotransposon derived from the gene for the alpha form of the PKA catalytic subunit. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200207 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200207">
		<rdfs:label rdf:datatype="&xsd;string">CSNK1A1L gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400170"/>
		<dto:entrez_xref>122011</dto:entrez_xref>
		<dto:geneSymbol>CSNK1A1L</dto:geneSymbol>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200208 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200208">
		<rdfs:label rdf:datatype="&xsd;string">CSNK1A1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400170"/>
		<dto:entrez_xref>1452</dto:entrez_xref>
		<dto:geneSymbol>CSNK1A1</dto:geneSymbol>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200209 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200209">
		<rdfs:label rdf:datatype="&xsd;string">CSNK1D gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400170"/>
		<dto:entrez_xref>1453</dto:entrez_xref>
		<dto:geneSymbol>CSNK1D</dto:geneSymbol>
		<obo:IAO_0000115>This gene is a member of the casein kinase I (CKI) gene family whose members have been implicated in the control of cytoplasmic and nuclear processes, including DNA replication and repair. The encoded protein may also be involved in the regulation of apoptosis, circadian rhythm, microtubule dynamics, chromosome segregation, and p53-mediated effects on growth. The encoded protein is highly similar to the mouse and rat CK1 delta homologs. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Feb 2014]</obo:IAO_0000115>
		<dto:geneSynonym>HCKID</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200210 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200210">
		<rdfs:label rdf:datatype="&xsd;string">CSNK1E gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400170"/>
		<dto:entrez_xref>102800317</dto:entrez_xref>
		<dto:entrez_xref>1454</dto:entrez_xref>
		<dto:geneSymbol>CSNK1E</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is a serine/threonine protein kinase and a member of the casein kinase I protein family, whose members have been implicated in the control of cytoplasmic and nuclear processes, including DNA replication and repair. The encoded protein is found in the cytoplasm as a monomer and can phosphorylate a variety of proteins, including itself. This protein has been shown to phosphorylate period, a circadian rhythm protein. Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Feb 2014]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200211 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200211">
		<rdfs:label rdf:datatype="&xsd;string">CSNK1G1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400170"/>
		<dto:entrez_xref>53944</dto:entrez_xref>
		<dto:geneSymbol>CSNK1G1</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the casein kinase I gene family. The encoded protein is a serine/threonine kinase that phosphorylates acidic proteins, and participates in pathways for cell growth. [provided by RefSeq, Nov 2011]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200212 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200212">
		<rdfs:label rdf:datatype="&xsd;string">CSNK1G2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400170"/>
		<dto:entrez_xref>1455</dto:entrez_xref>
		<dto:geneSymbol>CSNK1G2</dto:geneSymbol>
		<dto:geneSynonym>CK1G2</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200213 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200213">
		<rdfs:label rdf:datatype="&xsd;string">CSNK1G3 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400170"/>
		<dto:entrez_xref>1456</dto:entrez_xref>
		<dto:geneSymbol>CSNK1G3</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of a family of serine/threonine protein kinases that phosphorylate caseins and other acidic proteins. A related protein in the African clawed frog participates in the transmission of Wnt/beta-catenin signaling. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Jul 2012]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200214 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200214">
		<rdfs:label rdf:datatype="&xsd;string">CAMK1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400171"/>
		<dto:entrez_xref>8536</dto:entrez_xref>
		<dto:geneSymbol>CAMK1</dto:geneSymbol>
		<obo:IAO_0000115>Calcium/calmodulin-dependent protein kinase I is expressed in many tissues and is a component of a calmodulin-dependent protein kinase cascade.  Calcium/calmodulin directly activates calcium/calmodulin-dependent protein kinase I by binding to the enzyme and indirectly promotes the phosphorylation and synergistic activation of the enzyme by calcium/calmodulin-dependent protein kinase I kinase. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200215 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200215">
		<rdfs:label rdf:datatype="&xsd;string">PNCK gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400171"/>
		<dto:entrez_xref>139728</dto:entrez_xref>
		<dto:geneSymbol>PNCK</dto:geneSymbol>
		<obo:IAO_0000115>PNCK is a member of the calcium/calmodulin-dependent protein kinase family of protein serine/threonine kinases (see CAMK1; MIM 604998) (Gardner et al., 2000 [PubMed 10673339]).[supplied by OMIM, Mar 2008]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200216 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200216">
		<rdfs:label rdf:datatype="&xsd;string">CAMK1D gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400171"/>
		<dto:entrez_xref>57118</dto:entrez_xref>
		<dto:geneSymbol>CAMK1D</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the Ca2+/calmodulin-dependent protein kinase 1 subfamily of serine/threonine kinases. The encoded protein may be involved in the regulation of granulocyte function through the chemokine signal transduction pathway. Alternatively spliced transcript variants encoding different isoforms of this gene have been described. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>CAMKID</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200217 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200217">
		<rdfs:label rdf:datatype="&xsd;string">CAMK1G gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400171"/>
		<dto:entrez_xref>57172</dto:entrez_xref>
		<dto:geneSymbol>CAMK1G</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a protein similar to calcium/calmodulin dependent protein kinase, however, its exact function is not known. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>CLICK3</dto:geneSynonym>
		<dto:geneSynonym>VWS1</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200218 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200218">
		<rdfs:label rdf:datatype="&xsd;string">CAMK2A gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400172"/>
		<dto:entrez_xref>815</dto:entrez_xref>
		<dto:geneSymbol>CAMK2A</dto:geneSymbol>
		<obo:IAO_0000115>The product of this gene belongs to the serine/threonine protein kinases family, and to the Ca(2+)/calmodulin-dependent protein kinases subfamily. Calcium signaling is crucial for several aspects of plasticity at glutamatergic synapses. This calcium calmodulin-dependent protein kinase is composed of four different chains: alpha, beta, gamma, and delta. The alpha chain encoded by this gene is required for hippocampal long-term potentiation (LTP) and spatial learning. In addition to its calcium-calmodulin (CaM)-dependent activity, this protein can undergo autophosphorylation, resulting in CaM-independent activity. Two transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Nov 2008]</obo:IAO_0000115>
		<dto:geneSynonym>CAMKA</dto:geneSynonym>
		<dto:geneSynonym>KIAA0968</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200219 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200219">
		<rdfs:label rdf:datatype="&xsd;string">CAMK2B gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400172"/>
		<dto:entrez_xref>816</dto:entrez_xref>
		<dto:geneSymbol>CAMK2B</dto:geneSymbol>
		<obo:IAO_0000115>The product of this gene belongs to the serine/threonine protein kinase family and to the Ca(2+)/calmodulin-dependent protein kinase subfamily. Calcium signaling is crucial for several aspects of plasticity at glutamatergic synapses. In mammalian cells, the enzyme is composed of four different chains: alpha, beta, gamma, and delta. The product of this gene is a beta chain. It is possible that distinct isoforms of this chain have different cellular localizations and interact differently with calmodulin. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2014]</obo:IAO_0000115>
		<dto:geneSynonym>CAM2</dto:geneSynonym>
		<dto:geneSynonym>CAMK2</dto:geneSynonym>
		<dto:geneSynonym>CAMKB</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200220 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200220">
		<rdfs:label rdf:datatype="&xsd;string">CAMK2D gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400172"/>
		<dto:entrez_xref>817</dto:entrez_xref>
		<dto:geneSymbol>CAMK2D</dto:geneSymbol>
		<obo:IAO_0000115>The product of this gene belongs to the serine/threonine protein kinase family and to the Ca(2+)/calmodulin-dependent protein kinase subfamily. Calcium signaling is crucial for several aspects of plasticity at glutamatergic synapses. In mammalian cells, the enzyme is composed of four different chains: alpha, beta, gamma, and delta. The product of this gene is a delta chain. Alternative splicing results in multiple transcript variants encoding distinct isoforms. Distinct isoforms of this chain have different expression patterns.[provided by RefSeq, Nov 2008]</obo:IAO_0000115>
		<dto:geneSynonym>CAMKD</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200221 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200221">
		<rdfs:label rdf:datatype="&xsd;string">CAMK2G gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400172"/>
		<dto:entrez_xref>818</dto:entrez_xref>
		<dto:geneSymbol>CAMK2G</dto:geneSymbol>
		<obo:IAO_0000115>The product of this gene is one of the four subunits of an enzyme which belongs to the serine/threonine protein kinase family, and to the Ca(2+)/calmodulin-dependent protein kinase subfamily. Calcium signaling is crucial for several aspects of plasticity at glutamatergic synapses. In mammalian cells the enzyme is composed of four different chains: alpha, beta, gamma, and delta. The product of this gene is a gamma chain. Many alternatively spliced transcripts encoding different isoforms have been described but the full-length nature of all the variants has not been determined.[provided by RefSeq, Mar 2011]</obo:IAO_0000115>
		<dto:geneSynonym>CAMK</dto:geneSynonym>
		<dto:geneSynonym>CAMK-II</dto:geneSynonym>
		<dto:geneSynonym>CAMKG</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200222 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200222">
		<rdfs:label rdf:datatype="&xsd;string">CAMK4 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400171"/>
		<dto:entrez_xref>814</dto:entrez_xref>
		<dto:geneSymbol>CAMK4</dto:geneSymbol>
		<obo:IAO_0000115>The product of this gene belongs to the serine/threonine protein kinase family, and to the Ca(2+)/calmodulin-dependent protein kinase subfamily. This enzyme is a multifunctional serine/threonine protein kinase with limited tissue distribution, that has been implicated in transcriptional regulation in lymphocytes, neurons and male germ cells. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>CAMK</dto:geneSynonym>
		<dto:geneSynonym>CAMK-GR</dto:geneSynonym>
		<dto:geneSynonym>CAMKIV</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200223 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200223">
		<rdfs:label rdf:datatype="&xsd;string">CKM gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491027"/>
		<dto:entrez_xref>1158</dto:entrez_xref>
		<dto:geneSymbol>CKM</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is a cytoplasmic enzyme involved in energy homeostasis and is an important serum marker for myocardial infarction. The encoded protein reversibly catalyzes the transfer of phosphate between ATP and various phosphogens such as creatine phosphate. It acts as a homodimer in striated muscle as well as in other tissues, and as a heterodimer with a similar brain isozyme in heart. The encoded protein is a member of the ATP:guanido phosphotransferase protein family. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>CKMM</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200224 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200224">
		<rdfs:label rdf:datatype="&xsd;string">PRKG1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400173"/>
		<dto:entrez_xref>5592</dto:entrez_xref>
		<dto:geneSymbol>PRKG1</dto:geneSymbol>
		<obo:IAO_0000115>Mammals have three different isoforms of cyclic GMP-dependent protein kinase (Ialpha, Ibeta, and II). These PRKG isoforms act as key mediators of the nitric oxide/cGMP signaling pathway and are important components of many signal transduction processes in diverse cell types. This PRKG1 gene on human chromosome 10 encodes the soluble Ialpha and Ibeta isoforms of PRKG by alternative transcript splicing. A separate gene on human chromosome 4, PRKG2, encodes the membrane-bound PRKG isoform II. The PRKG1 proteins play a central role in regulating cardiovascular and neuronal functions in addition to relaxing smooth muscle tone, preventing platelet aggregation, and modulating cell growth. This gene is most strongly expressed in all types of smooth muscle, platelets, cerebellar Purkinje cells, hippocampal neurons, and the lateral amygdala. Isoforms Ialpha and Ibeta have identical cGMP-binding and catalytic domains but differ in their leucine/isoleucine zipper and autoinhibitory sequences and therefore differ in their dimerization substrates and kinase enzyme activity. [provided by RefSeq, Sep 2011]</obo:IAO_0000115>
		<dto:geneSynonym>PRKG1B</dto:geneSynonym>
		<dto:geneSynonym>PRKGR1A</dto:geneSynonym>
		<dto:geneSynonym>PRKGR1B</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200225 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200225">
		<rdfs:label rdf:datatype="&xsd;string">PRKG2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400173"/>
		<dto:entrez_xref>5593</dto:entrez_xref>
		<dto:geneSymbol>PRKG2</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a protein that belongs to the serine/threonine protein kinase family of proteins. The encoded protein plays a role in the regulation of fluid balance in the intestine. A similar protein in mouse is thought to regulate differentiation and proliferation of cells in the colon. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Sep 2013]</obo:IAO_0000115>
		<dto:geneSynonym>PRKGR2</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200226 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200226">
		<rdfs:label rdf:datatype="&xsd;string">GUK1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491030"/>
		<dto:entrez_xref>2987</dto:entrez_xref>
		<dto:geneSymbol>GUK1</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is an enzyme that catalyzes the transfer of a phosphate group from ATP to guanosine monophosphate (GMP) to form guanosine diphosphate (GDP). The encoded protein is thought to be a good target for cancer chemotherapy. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2011]</obo:IAO_0000115>
		<dto:geneSynonym>GMK</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200227 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200227">
		<rdfs:label rdf:datatype="&xsd;string">KHK gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491032"/>
		<dto:entrez_xref>3795</dto:entrez_xref>
		<dto:geneSymbol>KHK</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes ketohexokinase that catalyzes conversion of fructose to fructose-1-phosphate. The product of this gene is the first enzyme with a specialized pathway that catabolizes dietary fructose. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200228 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200228">
		<rdfs:label rdf:datatype="&xsd;string">MVK gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491007"/>
		<dto:entrez_xref>4598</dto:entrez_xref>
		<dto:geneSymbol>MVK</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes the peroxisomal enzyme mevalonate kinase. Mevalonate is a key intermediate, and mevalonate kinase a key early enzyme, in isoprenoid and sterol synthesis. Mevalonate kinase deficiency caused by mutation of this gene results in mevalonic aciduria, a disease characterized psychomotor retardation, failure to thrive, hepatosplenomegaly, anemia and recurrent febrile crises. Defects in this gene also cause hyperimmunoglobulinaemia D and periodic fever syndrome, a disorder characterized by recurrent episodes of fever associated with lymphadenopathy, arthralgia, gastrointestinal dismay and skin rash. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200229 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200229">
		<rdfs:label rdf:datatype="&xsd;string">TK1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491015"/>
		<dto:entrez_xref>7083</dto:entrez_xref>
		<dto:geneSymbol>TK1</dto:geneSymbol>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200230 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200230">
		<rdfs:label rdf:datatype="&xsd;string">TK2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491008"/>
		<dto:entrez_xref>7084</dto:entrez_xref>
		<dto:geneSymbol>TK2</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a deoxyribonucleoside kinase that specifically phosphorylates thymidine, deoxycytidine, and deoxyuridine. The encoded enzyme localizes to the mitochondria and is required for mitochondrial DNA synthesis. Mutations in this gene are associated with a myopathic form of mitochondrial DNA depletion syndrome. Alternate splicing results in multiple transcript variants encoding distinct isoforms, some of which lack transit peptide, so are not localized to mitochondria. [provided by RefSeq, Dec 2012]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200231 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200231">
		<rdfs:label rdf:datatype="&xsd;string">KIT gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400141"/>
		<dto:entrez_xref>3815</dto:entrez_xref>
		<dto:geneSymbol>KIT</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes the human homolog of the proto-oncogene c-kit. C-kit was first identified as the cellular homolog of the feline sarcoma viral oncogene v-kit. This protein is a type 3 transmembrane receptor for MGF (mast cell growth factor, also known as stem cell factor). Mutations in this gene are associated with gastrointestinal stromal tumors, mast cell disease, acute myelogenous lukemia, and piebaldism. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>SCFR</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200232 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200232">
		<rdfs:label rdf:datatype="&xsd;string">CAMKK1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400275"/>
		<dto:entrez_xref>84254</dto:entrez_xref>
		<dto:geneSymbol>CAMKK1</dto:geneSymbol>
		<obo:IAO_0000115>The product of this gene belongs to the Serine/Threonine protein kinase family, and to the Ca(2+)/calmodulin-dependent protein kinase subfamily. This protein plays a role in the calcium/calmodulin-dependent (CaM) kinase cascade. Three transcript variants encoding two distinct isoforms have been identified for this gene. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>CAMKKA</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200233 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200233">
		<rdfs:label rdf:datatype="&xsd;string">CAMKK2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400275"/>
		<dto:entrez_xref>10645</dto:entrez_xref>
		<dto:geneSymbol>CAMKK2</dto:geneSymbol>
		<obo:IAO_0000115>The product of this gene belongs to the Serine/Threonine protein kinase family, and to the Ca(2+)/calmodulin-dependent protein kinase subfamily. The major isoform of this gene plays a role in the calcium/calmodulin-dependent (CaM) kinase cascade by phosphorylating the downstream kinases CaMK1 and CaMK4. Protein products of this gene also phosphorylate AMP-activated protein kinase (AMPK). This gene has its strongest expression in the brain and influences signalling cascades involved with learning and memory, neuronal differentiation and migration, neurite outgrowth, and synapse formation. Alternative splicing results in multiple transcript variants encoding distinct isoforms. The identified isoforms differ in their ability to undergo autophosphorylation and to phosphorylate downstream kinases. [provided by RefSeq, Jul 2012]</obo:IAO_0000115>
		<dto:geneSynonym>CAMKKB</dto:geneSynonym>
		<dto:geneSynonym>KIAA0787</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200234 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200234">
		<rdfs:label rdf:datatype="&xsd;string">PHKA1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491039"/>
		<dto:entrez_xref>5255</dto:entrez_xref>
		<dto:geneSymbol>PHKA1</dto:geneSymbol>
		<obo:IAO_0000115>Phosphorylase kinase is a polymer of 16 subunits, four each of alpha, beta, gamma and delta. The alpha subunit includes the skeletal muscle and hepatic isoforms, and the skeletal muscle isoform is encoded by this gene. The beta subunit is the same in both the muscle and hepatic isoforms, and encoded by one gene. The gamma subunit also includes the skeletal muscle and hepatic isoforms, which are encoded by two different genes. The delta subunit is a calmodulin and can be encoded by three different genes. The gamma subunits contain the active site of the enzyme, whereas the alpha and beta subunits have regulatory functions controlled by phosphorylation. The delta subunit mediates the dependence of the enzyme on calcium concentration. Mutations in this gene cause glycogen storage disease type 9D, also known as X-linked muscle glycogenosis. Alternatively spliced transcript variants encoding different isoforms have been identified in this gene. A pseudogene has been found on chromosome 1.[provided by RefSeq, Feb 2010]</obo:IAO_0000115>
		<dto:geneSynonym>PHKA</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200235 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200235">
		<rdfs:label rdf:datatype="&xsd;string">PHKA2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491039"/>
		<dto:entrez_xref>5256</dto:entrez_xref>
		<dto:geneSymbol>PHKA2</dto:geneSymbol>
		<obo:IAO_0000115>Phosphorylase kinase is a polymer of 16 subunits, four each of alpha, beta, gamma and delta. The alpha subunit includes the skeletal muscle and hepatic isoforms, and the hepatic isoform is encoded by this gene. The beta subunit is the same in both the muscle and hepatic isoforms, and encoded by one gene. The gamma subunit also includes the skeletal muscle and hepatic isoforms, which are encoded by two different genes. The delta subunit is a calmodulin and can be encoded by three different genes. The gamma subunits contain the active site of the enzyme, whereas the alpha and beta subunits have regulatory functions controlled by phosphorylation. The delta subunit mediates the dependence of the enzyme on calcium concentration. Mutations in this gene cause glycogen storage disease type 9A, also known as X-linked liver glycogenosis. Alternatively spliced transcript variants have been reported, but the full-length nature of these variants has not been determined.[provided by RefSeq, Feb 2010]</obo:IAO_0000115>
		<dto:geneSynonym>PHKLA</dto:geneSynonym>
		<dto:geneSynonym>PYK</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200236 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200236">
		<rdfs:label rdf:datatype="&xsd;string">PRKCA gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400276"/>
		<dto:entrez_xref>5578</dto:entrez_xref>
		<dto:geneSymbol>PRKCA</dto:geneSymbol>
		<obo:IAO_0000115>Protein kinase C (PKC) is a family of serine- and threonine-specific protein kinases that can be activated by calcium and the second messenger diacylglycerol. PKC family members phosphorylate a wide variety of protein targets and are known to be involved in diverse cellular signaling pathways. PKC family members also serve as major receptors for phorbol esters, a class of tumor promoters. Each member of the PKC family has a specific expression profile and is believed to play a distinct role in cells. The protein encoded by this gene is one of the PKC family members. This kinase has been reported to play roles in many different cellular processes, such as cell adhesion, cell transformation, cell cycle checkpoint, and cell volume control. Knockout studies in mice suggest that this kinase may be a fundamental regulator of cardiac contractility and Ca(2+) handling in myocytes. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>PKCA</dto:geneSynonym>
		<dto:geneSynonym>PRKACA</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200237 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200237">
		<rdfs:label rdf:datatype="&xsd;string">PRKCB gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400276"/>
		<dto:entrez_xref>5579</dto:entrez_xref>
		<dto:geneSymbol>PRKCB</dto:geneSymbol>
		<obo:IAO_0000115>Protein kinase C (PKC) is a family of serine- and threonine-specific protein kinases that can be activated by calcium and second messenger diacylglycerol. PKC family members phosphorylate a wide variety of protein targets and are known to be involved in diverse cellular signaling pathways. PKC family members also serve as major receptors for phorbol esters, a class of tumor promoters. Each member of the PKC family has a specific expression profile and is believed to play a distinct role in cells. The protein encoded by this gene is one of the PKC family members. This protein kinase has been reported to be involved in many different cellular functions, such as B cell activation, apoptosis induction, endothelial cell proliferation, and intestinal sugar absorption. Studies in mice also suggest that this kinase may also regulate neuronal functions and correlate fear-induced conflict behavior after stress. Alternatively spliced transcript variants encoding distinct isoforms have been reported. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>PKCB</dto:geneSynonym>
		<dto:geneSynonym>PRKCB1</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200238 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200238">
		<rdfs:label rdf:datatype="&xsd;string">PRKD1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400176"/>
		<dto:entrez_xref>5587</dto:entrez_xref>
		<dto:geneSymbol>PRKD1</dto:geneSymbol>
		<obo:IAO_0000115>PRKD1 is a serine/threonine kinase that regulates a variety of cellular functions, including membrane receptor signaling, transport at the Golgi, protection from oxidative stress at the mitochondria, gene transcription, and regulation of cell shape, motility, and adhesion (summary by Eiseler et al., 2009 [PubMed 19329994]).[supplied by OMIM, Nov 2010]</obo:IAO_0000115>
		<dto:geneSynonym>PKD</dto:geneSynonym>
		<dto:geneSynonym>PKD1</dto:geneSynonym>
		<dto:geneSynonym>PRKCM</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200239 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200239">
		<rdfs:label rdf:datatype="&xsd;string">PRKD2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400176"/>
		<dto:entrez_xref>25865</dto:entrez_xref>
		<dto:geneSymbol>PRKD2</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene belongs to the protein kinase D (PKD) family of serine/threonine protein kinases. This kinase can be activated by phorbol esters as well as by gastrin via the cholecystokinin B receptor (CCKBR) in gastric cancer cells. It can bind to diacylglycerol (DAG) in the trans-Golgi network (TGN) and may regulate basolateral membrane protein exit from TGN. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>PKD2</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200240 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200240">
		<rdfs:label rdf:datatype="&xsd;string">PRKD3 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400176"/>
		<dto:entrez_xref>23683</dto:entrez_xref>
		<dto:geneSymbol>PRKD3</dto:geneSymbol>
		<obo:IAO_0000115>Protein kinase C (PKC) is a family of serine- and threonine-specific protein kinases that can be activated by calcium and the second messenger diacylglycerol. PKC family members phosphorylate a wide variety of protein targets and are known to be involved in diverse cellular signaling pathways. PKC family members also serve as major receptors for phorbol esters, a class of tumor promoters. Each member of the PKC family has a specific expression profile and is believed to play a distinct role. The protein encoded by this gene is one of the PKC family members. This kinase can be activated rapidly by the agonists of G protein-coupled receptors. It resides in both cytoplasm and nucleus, and its nuclear accumulation is found to be dramatically enhanced in response to its activation. This kinase can also be activated after B-cell antigen receptor (BCR) engagement, which requires intact phopholipase C gamma and the involvement of other PKC family members. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>EPK2</dto:geneSynonym>
		<dto:geneSynonym>PRKCN</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200241 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200241">
		<rdfs:label rdf:datatype="&xsd;string">PRKCD gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400277"/>
		<dto:entrez_xref>5580</dto:entrez_xref>
		<dto:geneSymbol>PRKCD</dto:geneSymbol>
		<obo:IAO_0000115>Protein kinase C (PKC) is a family of serine- and threonine-specific protein kinases that can be activated by calcium and the second messenger diacylglycerol. PKC family members phosphorylate a wide variety of protein targets and are known to be involved in diverse cellular signaling pathways. PKC family members also serve as major receptors for phorbol esters, a class of tumor promoters. Each member of the PKC family has a specific expression profile and is believed to play distinct roles in cells. The protein encoded by this gene is one of the PKC family members. Studies both in human and mice demonstrate that this kinase is involved in B cell signaling and in the regulation of growth, apoptosis, and differentiation of a variety of cell types. Alternatively spliced transcript variants encoding the same protein have been observed. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200242 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200242">
		<rdfs:label rdf:datatype="&xsd;string">PRKCE gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400278"/>
		<dto:entrez_xref>5581</dto:entrez_xref>
		<dto:geneSymbol>PRKCE</dto:geneSymbol>
		<obo:IAO_0000115>Protein kinase C (PKC) is a family of serine- and threonine-specific protein kinases that can be activated by calcium and the second messenger diacylglycerol. PKC family members phosphorylate a wide variety of protein targets and are known to be involved in diverse cellular signaling pathways. PKC family members also serve as major receptors for phorbol esters, a class of tumor promoters. Each member of the PKC family has a specific expression profile and is believed to play a distinct role in cells. The protein encoded by this gene is one of the PKC family members. This kinase has been shown to be involved in many different cellular functions, such as neuron channel activation, apoptosis, cardioprotection from ischemia, heat shock response, as well as insulin exocytosis. Knockout studies in mice suggest that this kinase is important for lipopolysaccharide (LPS)-mediated signaling in activated macrophages and may also play a role in controlling anxiety-like behavior. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>PKCE</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200243 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200243">
		<rdfs:label rdf:datatype="&xsd;string">PRKCG gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400276"/>
		<dto:entrez_xref>5582</dto:entrez_xref>
		<dto:geneSymbol>PRKCG</dto:geneSymbol>
		<obo:IAO_0000115>Protein kinase C (PKC) is a family of serine- and threonine-specific protein kinases that can be activated by calcium and second messenger diacylglycerol. PKC family members phosphorylate a wide variety of protein targets and are known to be involved in diverse cellular signaling pathways. PKC also serve as major receptors for phorbol esters, a class of tumor promoters. Each member of the PKC family has a specific expression profile and is believed to play distinct roles in cells. The protein encoded by this gene is one of the PKC family members. This protein kinase is expressed solely in the brain and spinal cord and its localization is restricted to neurons. It has been demonstrated that several neuronal functions, including long term potentiation (LTP) and long term depression (LTD), specifically require this kinase. Knockout studies in mice also suggest that this kinase may be involved in neuropathic pain development. Defects in this protein have been associated with neurodegenerative disorder spinocerebellar ataxia-14 (SCA14). [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>PKCG</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200244 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200244">
		<rdfs:label rdf:datatype="&xsd;string">PRKCI gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400279"/>
		<dto:entrez_xref>5584</dto:entrez_xref>
		<dto:geneSymbol>PRKCI</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the protein kinase C (PKC) family of serine/threonine protein kinases. The PKC family comprises at least eight members, which are differentially expressed and are involved in a wide variety of cellular processes. This protein kinase is calcium-independent and phospholipid-dependent. It is not activated by phorbolesters or diacylglycerol. This kinase can be recruited to vesicle tubular clusters (VTCs) by direct interaction with the small GTPase RAB2, where this kinase phosphorylates glyceraldehyde-3-phosphate dehydrogenase (GAPD/GAPDH) and plays a role in microtubule dynamics in the early secretory pathway. This kinase is found to be necessary for BCL-ABL-mediated resistance to drug-induced apoptosis and therefore protects leukemia cells against drug-induced apoptosis. There is a single exon pseudogene mapped on chromosome X. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>DXS1179E</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200245 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200245">
		<rdfs:label rdf:datatype="&xsd;string">PRKCH gene</rdfs:label>
		<dto:entrez_xref>5583</dto:entrez_xref>
		<dto:geneSymbol>PRKCH</dto:geneSymbol>
		<obo:IAO_0000115>Protein kinase C (PKC) is a family of serine- and threonine-specific protein kinases that can be activated by calcium and the second messenger diacylglycerol. PKC family members phosphorylate a wide variety of protein targets and are known to be involved in diverse cellular signaling pathways. PKC family members also serve as major receptors for phorbol esters, a class of tumor promoters. Each member of the PKC family has a specific expression profile and is believed to play a distinct role in cells. The protein encoded by this gene is one of the PKC family members. It is a calcium-independent and phospholipids-dependent protein kinase. It is predominantly expressed in epithelial tissues and has been shown to reside specifically in the cell nucleus. This protein kinase can regulate keratinocyte differentiation by activating the MAP kinase MAPK13 (p38delta)-activated protein kinase cascade that targets CCAAT/enhancer-binding protein alpha (CEBPA). It is also found to mediate the transcription activation of the transglutaminase 1 (TGM1) gene. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>PKCL</dto:geneSynonym>
		<dto:geneSynonym>PRKCL</dto:geneSynonym>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400278"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200246 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200246">
		<rdfs:label rdf:datatype="&xsd;string">PRKCQ gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400277"/>
		<dto:entrez_xref>5588</dto:entrez_xref>
		<dto:geneSymbol>PRKCQ</dto:geneSymbol>
		<obo:IAO_0000115>Protein kinase C (PKC) is a family of serine- and threonine-specific protein kinases that can be activated by calcium and the second messenger diacylglycerol. PKC family members phosphorylate a wide variety of protein targets and are known to be involved in diverse cellular signaling pathways. PKC family members also serve as major receptors for phorbol esters, a class of tumor promoters. Each member of the PKC family has a specific expression profile and is believed to play a distinct role. The protein encoded by this gene is one of the PKC family members. It is a calcium-independent and phospholipid-dependent protein kinase. This kinase is important for T-cell activation. It is required for the activation of the transcription factors NF-kappaB and AP-1, and may link the T cell receptor (TCR) signaling complex to the activation of the transcription factors. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>PRKCT</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200247 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200247">
		<rdfs:label rdf:datatype="&xsd;string">PRKCZ gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400279"/>
		<dto:entrez_xref>5590</dto:entrez_xref>
		<dto:geneSymbol>PRKCZ</dto:geneSymbol>
		<obo:IAO_0000115>Protein kinase C (PKC) zeta is a member of the PKC family of serine/threonine kinases which are involved in a variety of cellular processes such as proliferation, differentiation and secretion. Unlike the classical PKC isoenzymes which are calcium-dependent, PKC zeta exhibits a kinase activity which is independent of calcium and diacylglycerol but not of phosphatidylserine. Furthermore, it is insensitive to typical PKC inhibitors and cannot be activated by phorbol ester. Unlike the classical PKC isoenzymes, it has only a single zinc finger module. These structural and biochemical properties indicate that the zeta subspecies is related to, but distinct from other isoenzymes of PKC. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>PKC2</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200248 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200248">
		<rdfs:label rdf:datatype="&xsd;string">PSKH1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400177"/>
		<dto:entrez_xref>5681</dto:entrez_xref>
		<dto:geneSymbol>PSKH1</dto:geneSymbol>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200249 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200249">
		<rdfs:label rdf:datatype="&xsd;string">PSKH2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400177"/>
		<dto:entrez_xref>85481</dto:entrez_xref>
		<dto:geneSymbol>PSKH2</dto:geneSymbol>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200250 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200250">
		<rdfs:label rdf:datatype="&xsd;string">PKM gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400324"/>
		<dto:entrez_xref>5315</dto:entrez_xref>
		<dto:geneSymbol>PKM</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a protein involved in glycolysis. The encoded protein is a pyruvate kinase that catalyzes the transfer of a phosphoryl group from phosphoenolpyruvate to ADP, generating ATP and pyruvate. This protein has been shown to interact with thyroid hormone and may mediate cellular metabolic effects induced by thyroid hormones. This protein has been found to bind Opa protein, a bacterial outer membrane protein involved in gonococcal adherence to and invasion of human cells, suggesting a role of this protein in bacterial pathogenesis. Several alternatively spliced transcript variants encoding a few distinct isoforms have been reported. [provided by RefSeq, May 2011]</obo:IAO_0000115>
		<dto:geneSynonym>OIP3</dto:geneSynonym>
		<dto:geneSynonym>PK2</dto:geneSynonym>
		<dto:geneSynonym>PK3</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200251 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200251">
		<rdfs:label rdf:datatype="&xsd;string">RPS6KA1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400280"/>
		<dto:entrez_xref>6195</dto:entrez_xref>
		<dto:geneSymbol>RPS6KA1</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the RSK (ribosomal S6 kinase) family of serine/threonine kinases. This kinase contains 2 nonidentical kinase catalytic domains and phosphorylates various substrates, including members of the mitogen-activated kinase (MAPK) signalling pathway. The activity of this protein has been implicated in controlling cell growth and differentiation. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>MAPKAPK1A</dto:geneSynonym>
		<dto:geneSynonym>RSK1</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200252 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200252">
		<rdfs:label rdf:datatype="&xsd;string">RPS6KA2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400280"/>
		<dto:entrez_xref>6196</dto:entrez_xref>
		<dto:geneSymbol>RPS6KA2</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the RSK (ribosomal S6 kinase) family of serine/threonine kinases. This kinase contains 2 non-identical kinase catalytic domains and phosphorylates various substrates, including members of the mitogen-activated kinase (MAPK) signalling pathway. The activity of this protein has been implicated in controlling cell growth and differentiation. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>MAPKAPK1C</dto:geneSynonym>
		<dto:geneSynonym>RSK3</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200253 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200253">
		<rdfs:label rdf:datatype="&xsd;string">RPS6KA3 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400280"/>
		<dto:entrez_xref>6197</dto:entrez_xref>
		<dto:geneSymbol>RPS6KA3</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the RSK (ribosomal S6 kinase) family of serine/threonine kinases. This kinase contains 2 non-identical kinase catalytic domains and phosphorylates various substrates, including members of the mitogen-activated kinase (MAPK) signalling pathway. The activity of this protein has been implicated in controlling cell growth and differentiation. Mutations in this gene have been associated with Coffin-Lowry syndrome (CLS). [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>ISPK1</dto:geneSynonym>
		<dto:geneSynonym>MAPKAPK1B</dto:geneSynonym>
		<dto:geneSynonym>RSK2</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200254 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200254">
		<rdfs:label rdf:datatype="&xsd;string">RPS6KA4 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400281"/>
		<dto:entrez_xref>8986</dto:entrez_xref>
		<dto:geneSymbol>RPS6KA4</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the RSK (ribosomal S6 kinase) family of serine/threonine kinases. This kinase contains 2 non-identical kinase catalytic domains and phosphorylates various substrates, including CREB1 and c-fos. Alternate transcriptional splice variants of this gene have been observed but have not been thoroughly characterized. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>MSK2</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200255 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200255">
		<rdfs:label rdf:datatype="&xsd;string">RPS6KA5 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400281"/>
		<dto:entrez_xref>9252</dto:entrez_xref>
		<dto:geneSymbol>RPS6KA5</dto:geneSymbol>
		<dto:geneSynonym>MSK1</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200256 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200256">
		<rdfs:label rdf:datatype="&xsd;string">RPS6KA6 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400280"/>
		<dto:entrez_xref>27330</dto:entrez_xref>
		<dto:geneSymbol>RPS6KA6</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of ribosomal S6 kinase family, serine-threonine protein kinases which are regulated by growth factors. The encoded protein may be distinct from other members of this family, however, as studies suggest it is not growth factor dependent and may not participate in the same signaling pathways. [provided by RefSeq, Jan 2010]</obo:IAO_0000115>
		<dto:geneSynonym>RSK4</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200257 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200257">
		<rdfs:label rdf:datatype="&xsd;string">RPS6KB1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400282"/>
		<dto:entrez_xref>6198</dto:entrez_xref>
		<dto:geneSymbol>RPS6KB1</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the ribosomal S6 kinase family of serine/threonine kinases. The encoded protein responds to mTOR (mammalian target of rapamycin) signaling to promote protein synthesis, cell growth, and cell proliferation. Activity of this gene has been associated with human cancer. Alternatively spliced transcript variants have been observed. The use of alternative translation start sites results in isoforms with longer or shorter N-termini which may differ in their subcellular localizations. There are two pseudogenes for this gene on chromosome 17. [provided by RefSeq, Jan 2013]</obo:IAO_0000115>
		<dto:geneSynonym>STK14A</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200258 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200258">
		<rdfs:label rdf:datatype="&xsd;string">RPS6KB2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400282"/>
		<dto:entrez_xref>6199</dto:entrez_xref>
		<dto:geneSymbol>RPS6KB2</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the RSK (ribosomal S6 kinase) family of serine/threonine kinases. This kinase contains 2 nonidentical kinase catalytic domains and phosphorylates the S6 ribosomal protein and eucaryotic translation initiation factor 4B (eIF4B). Phosphorylation of S6 leads to an increase in protein synthesis and cell proliferation. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>STK14B</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200259 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200259">
		<rdfs:label rdf:datatype="&xsd;string">RPS6KC1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400179"/>
		<dto:entrez_xref>26750</dto:entrez_xref>
		<dto:geneSymbol>RPS6KC1</dto:geneSymbol>
		<dto:geneSynonym>RPK118</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200260 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200260">
		<rdfs:label rdf:datatype="&xsd;string">KSR1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400126"/>
		<dto:entrez_xref>8844</dto:entrez_xref>
		<dto:geneSymbol>KSR1</dto:geneSymbol>
		<dto:geneSynonym>KSR</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200261 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200261">
		<rdfs:label rdf:datatype="&xsd;string">KSR2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400126"/>
		<dto:entrez_xref>283455</dto:entrez_xref>
		<dto:geneSymbol>KSR2</dto:geneSymbol>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200262 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200262">
		<rdfs:label rdf:datatype="&xsd;string">SYK gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400180"/>
		<dto:entrez_xref>6850</dto:entrez_xref>
		<dto:geneSymbol>SYK</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the family of non-receptor type Tyr protein kinases. This protein is widely expressed in hematopoietic cells and is involved in coupling activated immunoreceptors to downstream signaling events that mediate diverse cellular responses, including proliferation, differentiation, and phagocytosis. It is thought to be a modulator of epithelial cell growth and a potential tumour suppressor in human breast carcinomas. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2010]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200263 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200263">
		<rdfs:label rdf:datatype="&xsd;string">DTYMK gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491018"/>
		<dto:entrez_xref>1841</dto:entrez_xref>
		<dto:geneSymbol>DTYMK</dto:geneSymbol>
		<dto:geneSynonym>CDC8</dto:geneSynonym>
		<dto:geneSynonym>TMPK</dto:geneSynonym>
		<dto:geneSynonym>TYMK</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200264 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200264">
		<rdfs:label rdf:datatype="&xsd;string">LATS1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400181"/>
		<dto:entrez_xref>9113</dto:entrez_xref>
		<dto:geneSymbol>LATS1</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is a putative serine/threonine kinase that localizes to the mitotic apparatus and complexes with cell cycle controller CDC2 kinase in early mitosis. The protein is phosphorylated in a cell-cycle dependent manner, with late prophase phosphorylation remaining through metaphase. The N-terminal region of the protein binds CDC2 to form a complex showing reduced H1 histone kinase activity, indicating a role as a negative regulator of CDC2/cyclin A. In addition, the C-terminal kinase domain binds to its own N-terminal region, suggesting potential negative regulation through interference with complex formation via intramolecular binding. Biochemical and genetic data suggest a role as a tumor suppressor. This is supported by studies in knockout mice showing development of soft-tissue sarcomas, ovarian stromal cell tumors and a high sensitivity to carcinogenic treatments. Two protein-coding transcripts and one non-protein coding transcript have been found for this gene. [provided by RefSeq, Jul 2012]</obo:IAO_0000115>
		<dto:geneSynonym>WARTS</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200265 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200265">
		<rdfs:label rdf:datatype="&xsd;string">LATS2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400181"/>
		<dto:entrez_xref>26524</dto:entrez_xref>
		<dto:geneSymbol>LATS2</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a serine/threonine protein kinase belonging to the LATS tumor suppressor family. The protein localizes to centrosomes during interphase, and early and late metaphase. It interacts with the centrosomal proteins aurora-A and ajuba and is required for accumulation of gamma-tubulin and spindle formation at the onset of mitosis. It also interacts with a negative regulator of p53 and may function in a positive feedback loop with p53 that responds to cytoskeleton damage. Additionally, it can function as a co-repressor of androgen-responsive gene expression. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>KPM</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200266 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200266">
		<rdfs:label rdf:datatype="&xsd;string">LCK gene</rdfs:label>
		<dto:entrez_xref>3932</dto:entrez_xref>
		<dto:geneSymbol>LCK</dto:geneSymbol>
		<obo:IAO_0000115>This gene is a member of the Src family of protein tyrosine kinases (PTKs). The encoded protein is a key signaling molecule in the selection and maturation of developing T-cells. It contains N-terminal sites for myristylation and palmitylation, a PTK domain, and SH2 and SH3 domains which are involved in mediating protein-protein interactions with phosphotyrosine-containing and proline-rich motifs, respectively. The protein localizes to the plasma membrane and pericentrosomal vesicles, and binds to cell surface receptors, including CD4 and CD8, and other signaling molecules. Multiple alternatively spliced variants, encoding the same protein, have been described. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400132"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200267 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200267">
		<rdfs:label rdf:datatype="&xsd;string">LIMK1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400283"/>
		<dto:entrez_xref>3984</dto:entrez_xref>
		<dto:geneSymbol>LIMK1</dto:geneSymbol>
		<obo:IAO_0000115>There are approximately 40 known eukaryotic LIM proteins, so named for the LIM domains they contain. LIM domains are highly conserved cysteine-rich structures containing 2 zinc fingers. Although zinc fingers usually function by binding to DNA or RNA, the LIM motif probably mediates protein-protein interactions. LIM kinase-1 and LIM kinase-2 belong to a small subfamily with a unique combination of 2 N-terminal LIM motifs and a C-terminal protein kinase domain. LIMK1 is a serine/threonine kinase that regulates actin polymerization via phosphorylation and inactivation of the actin binding factor cofilin. This protein is ubiquitously expressed during development and plays a role in many cellular processes associated with cytoskeletal structure. This protein also stimulates axon growth and may play a role in brain development. LIMK1 hemizygosity is implicated in the impaired visuospatial constructive cognition of Williams syndrome. Alternative splicing results in multiple transcript variants encoding distinct isoforms.[provided by RefSeq, Feb 2011]</obo:IAO_0000115>
		<dto:geneSynonym>LIMK</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200268 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200268">
		<rdfs:label rdf:datatype="&xsd;string">LIMK2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400283"/>
		<dto:entrez_xref>3985</dto:entrez_xref>
		<dto:geneSymbol>LIMK2</dto:geneSymbol>
		<obo:IAO_0000115>There are approximately 40 known eukaryotic LIM proteins, so named for the LIM domains they contain. LIM domains are highly conserved cysteine-rich structures containing 2 zinc fingers. Although zinc fingers usually function by binding to DNA or RNA, the LIM motif probably mediates protein-protein interactions. LIM kinase-1 and LIM kinase-2 belong to a small subfamily with a unique combination of 2 N-terminal LIM motifs and a C-terminal protein kinase domain. The protein encoded by this gene is phosphorylated and activated by ROCK, a downstream effector of Rho, and the encoded protein, in turn, phosphorylates cofilin, inhibiting its actin-depolymerizing activity. It is thought that this pathway contributes to Rho-induced reorganization of the actin cytoskeleton. At least three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200269 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200269">
		<rdfs:label rdf:datatype="&xsd;string">AATK gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400183"/>
		<dto:entrez_xref>9625</dto:entrez_xref>
		<dto:geneSymbol>AATK</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene contains a tyrosine kinase domain at the N-terminus and a proline-rich domain at the C-terminus. This gene is induced during apoptosis, and expression of this gene may be a necessary pre-requisite for the induction of growth arrest and/or apoptosis of myeloid precursor cells. This gene has been shown to produce neuronal differentiation in a neuroblastoma cell line. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2011]</obo:IAO_0000115>
		<dto:geneSynonym>AATYK</dto:geneSynonym>
		<dto:geneSynonym>KIAA0641</dto:geneSynonym>
		<dto:geneSynonym>LMR1</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200270 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200270">
		<rdfs:label rdf:datatype="&xsd;string">LMTK2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400183"/>
		<dto:entrez_xref>22853</dto:entrez_xref>
		<dto:geneSymbol>LMTK2</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene belongs to the protein kinase superfamily and the protein tyrosine kinase family. It contains N-terminal transmembrane helices and a long C-terminal cytoplasmic tail with serine/threonine/tyrosine kinase activity. This protein interacts with several other proteins, such as Inhibitor-2 (Inh2), protein phosphatase-1 (PP1C), p35, and myosin VI. It phosporylates other proteins, and is itself also phosporylated when interacting with cyclin-dependent kinase 5 (cdk5)/p35 complex. This protein involves in nerve growth factor (NGF)-TrkA signalling, and also plays a critical role in endosomal membrane trafficking. Mouse studies suggested an essential role of this protein in spermatogenesis. [provided by RefSeq, Oct 2009]</obo:IAO_0000115>
		<dto:geneSynonym>AATYK2</dto:geneSynonym>
		<dto:geneSynonym>BREK</dto:geneSynonym>
		<dto:geneSynonym>KIAA1079</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200271 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200271">
		<rdfs:label rdf:datatype="&xsd;string">LMTK3 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400183"/>
		<dto:entrez_xref>114783</dto:entrez_xref>
		<dto:geneSymbol>LMTK3</dto:geneSymbol>
		<dto:geneSynonym>KIAA1883</dto:geneSynonym>
		<dto:geneSynonym>TYKLM3</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200272 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200272">
		<rdfs:label rdf:datatype="&xsd;string">LRRK1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400184"/>
		<dto:entrez_xref>79705</dto:entrez_xref>
		<dto:geneSymbol>LRRK1</dto:geneSymbol>
		<dto:geneSynonym>KIAA1790</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200273 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200273">
		<rdfs:label rdf:datatype="&xsd;string">LRRK2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400184"/>
		<dto:entrez_xref>120892</dto:entrez_xref>
		<dto:geneSymbol>LRRK2</dto:geneSymbol>
		<obo:IAO_0000115>This gene is a member of the leucine-rich repeat kinase family and encodes a protein with an ankryin repeat region, a leucine-rich repeat (LRR) domain, a kinase domain, a DFG-like motif, a RAS domain, a GTPase domain, a MLK-like domain, and a WD40 domain. The protein is present largely in the cytoplasm but also associates with the mitochondrial outer membrane. Mutations in this gene have been associated with Parkinson disease-8. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>PARK8</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200274 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200274">
		<rdfs:label rdf:datatype="&xsd;string">LTK gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400122"/>
		<dto:entrez_xref>4058</dto:entrez_xref>
		<dto:geneSymbol>LTK</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is a member of the ros/insulin receptor family of tyrosine kinases. Tyrosine-specific phosphorylation of proteins is a key to the control of diverse pathways leading to cell growth and differentiation. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2008]</obo:IAO_0000115>
		<dto:geneSynonym>TYK1</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200275 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200275">
		<rdfs:label rdf:datatype="&xsd;string">LYN gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400132"/>
		<dto:entrez_xref>4067</dto:entrez_xref>
		<dto:geneSymbol>LYN</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a tyrosine protein kinase, which maybe involved in the regulation of mast cell degranulation, and erythroid differentiation. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2011]</obo:IAO_0000115>
		<dto:geneSynonym>JTK8</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200276 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200276">
		<rdfs:label rdf:datatype="&xsd;string">MAP3K10 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400284"/>
		<dto:entrez_xref>4294</dto:entrez_xref>
		<dto:geneSymbol>MAP3K10</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is a member of the serine/threonine kinase family. This kinase has been shown to activate MAPK8/JNK and MKK4/SEK1, and this kinase itself can be phoshorylated, and thus activated by JNK kinases. This kinase functions preferentially on the JNK signaling pathway, and is reported to be involved in nerve growth factor (NGF) induced neuronal apoptosis. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>MLK2</dto:geneSynonym>
		<dto:geneSynonym>MST</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200277 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200277">
		<rdfs:label rdf:datatype="&xsd;string">MAP3K11 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400284"/>
		<dto:entrez_xref>4296</dto:entrez_xref>
		<dto:geneSymbol>MAP3K11</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is a member of the serine/threonine kinase family. This kinase contains a SH3 domain and a leucine zipper-basic motif. This kinase preferentially activates MAPK8/JNK kinase, and functions as a positive regulator of JNK signaling pathway. This kinase can directly phosphorylate, and activates IkappaB kinase alpha and beta, and is found to be involved in the transcription activity of NF-kappaB mediated by Rho family GTPases and CDC42. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>MLK3</dto:geneSynonym>
		<dto:geneSynonym>PTK1</dto:geneSynonym>
		<dto:geneSynonym>SPRK</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200278 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200278">
		<rdfs:label rdf:datatype="&xsd;string">MAP3K12 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400165"/>
		<dto:entrez_xref>7786</dto:entrez_xref>
		<dto:geneSymbol>MAP3K12</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the serine/threonine protein kinase family. This kinase contains a leucine-zipper domain and is predominately expressed in neuronal cells. The phosphorylation state of this kinase in synaptic terminals was shown to be regulated by membrane depolarization via calcineurin. This kinase forms heterodimers with leucine zipper containing transcription factors, such as cAMP responsive element binding protein (CREB) and MYC, and thus may play a regulatory role in PKA or retinoic acid induced neuronal differentiation. Alternatively spliced transcript variants encoding different proteins have been described.[provided by RefSeq, Jul 2010]</obo:IAO_0000115>
		<dto:geneSynonym>ZPK</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200279 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200279">
		<rdfs:label rdf:datatype="&xsd;string">MAP3K13 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400285"/>
		<dto:entrez_xref>9175</dto:entrez_xref>
		<dto:geneSymbol>MAP3K13</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is a member of serine/threonine protein kinase family. This kinase contains a dual leucine-zipper motif, and has been shown to form dimers/oligomers through its leucine-zipper motif. This kinase can phosphorylate and activate MAPK8/JNK, MAP2K7/MKK7, which suggests a role in the JNK signaling pathway. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>LZK</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200280 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200280">
		<rdfs:label rdf:datatype="&xsd;string">MAP3K14 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400185"/>
		<dto:entrez_xref>9020</dto:entrez_xref>
		<dto:geneSymbol>MAP3K14</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes mitogen-activated protein kinase kinase kinase 14, which is a serine/threonine protein-kinase. This kinase binds to TRAF2 and stimulates NF-kappaB activity. It shares sequence similarity with several other MAPKK kinases. It participates in an NF-kappaB-inducing signalling cascade common to receptors of the tumour-necrosis/nerve-growth factor (TNF/NGF) family and to the interleukin-1 type-I receptor. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>NIK</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200281 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200281">
		<rdfs:label rdf:datatype="&xsd;string">MAP3K15 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400186"/>
		<dto:entrez_xref>389840</dto:entrez_xref>
		<dto:geneSymbol>MAP3K15</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is a member of the mitogen-activated protein kinase (MAPK) family. These family members function in a protein kinase signal transduction cascade, where an activated MAPK kinase kinase (MAP3K) phosphorylates and activates a specific MAPK kinase (MAP2K), which then activates a specific MAPK. This MAP3K protein plays an essential role in apoptotic cell death triggered by cellular stresses. [provided by RefSeq, Jul 2010]</obo:IAO_0000115>
		<dto:geneSynonym>ASK3</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200282 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200282">
		<rdfs:label rdf:datatype="&xsd;string">MAP3K19 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400186"/>
		<dto:entrez_xref>80122</dto:entrez_xref>
		<dto:geneSymbol>MAP3K19</dto:geneSymbol>
		<dto:geneSynonym>RCK</dto:geneSynonym>
		<dto:geneSynonym>YSK4</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200283 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200283">
		<rdfs:label rdf:datatype="&xsd;string">MAP3K1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400186"/>
		<dto:entrez_xref>4214</dto:entrez_xref>
		<dto:geneSymbol>MAP3K1</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is a serine/threonine kinase and is part of some signal transduction cascades, including the ERK and JNK kinase pathways as well as the NF-kappa-B pathway. The encoded protein is activated by autophosphorylation and requires magnesium as a cofactor in phosphorylating other proteins. This protein has E3 ligase activity conferred by a plant homeodomain (PHD) in its N-terminus and phospho-kinase activity conferred by a kinase domain in its C-terminus. [provided by RefSeq, Mar 2012]</obo:IAO_0000115>
		<dto:geneSynonym>MAPKKK1</dto:geneSynonym>
		<dto:geneSynonym>MEKK</dto:geneSynonym>
		<dto:geneSynonym>MEKK1</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200284 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200284">
		<rdfs:label rdf:datatype="&xsd;string">MAP3K2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400186"/>
		<dto:entrez_xref>10746</dto:entrez_xref>
		<dto:geneSymbol>MAP3K2</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is a member of serine/threonine protein kinase family. This kinase preferentially activates other kinases involved in the MAP kinase signaling pathway. This kinase has been shown to directly phosphorylate and activate Ikappa B kinases, and thus plays a role in NF-kappa B signaling pathway. This kinase has also been found to bind and activate protein kinase C-related kinase 2, which suggests its involvement in a regulated signaling process. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>MAPKKK2</dto:geneSynonym>
		<dto:geneSynonym>MEKK2</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200285 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200285">
		<rdfs:label rdf:datatype="&xsd;string">MAP3K3 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400186"/>
		<dto:entrez_xref>4215</dto:entrez_xref>
		<dto:geneSymbol>MAP3K3</dto:geneSymbol>
		<obo:IAO_0000115>This gene product is a 626-amino acid polypeptide that is 96.5% identical to mouse Mekk3. Its catalytic domain is closely related to those of several other kinases, including mouse Mekk2, tobacco NPK, and yeast Ste11. Northern blot analysis revealed a 4.6-kb transcript that appears to be ubiquitously expressed. This protein directly regulates the stress-activated protein kinase (SAPK) and extracellular signal-regulated protein kinase (ERK) pathways by activating SEK and MEK1/2 respectively; it does not regulate the p38 pathway. In cotransfection assays, it enhanced transcription from a nuclear factor kappa-B (NFKB)-dependent reporter gene, consistent with a role in the SAPK pathway. Alternatively spliced transcript variants encoding distinct isoforms have been observed. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>MAPKKK3</dto:geneSynonym>
		<dto:geneSynonym>MEKK3</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200286 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200286">
		<rdfs:label rdf:datatype="&xsd;string">MAP3K4 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400186"/>
		<dto:entrez_xref>4216</dto:entrez_xref>
		<dto:geneSymbol>MAP3K4</dto:geneSymbol>
		<obo:IAO_0000115>The central core of each mitogen-activated protein kinase (MAPK) pathway is a conserved cascade of 3 protein kinases: an activated MAPK kinase kinase (MAPKKK) phosphorylates and activates a specific MAPK kinase (MAPKK), which then activates a specific MAPK. While the ERK MAPKs are activated by mitogenic stimulation, the CSBP2 and JNK MAPKs are activated by environmental stresses such as osmotic shock, UV irradiation, wound stress, and inflammatory factors. This gene encodes a MAPKKK, the MEKK4 protein, also called MTK1. This protein contains a protein kinase catalytic domain at the C terminus. The N-terminal nonkinase domain may contain a regulatory domain. Expression of MEKK4 in mammalian cells activated the CSBP2 and JNK MAPK pathways, but not the ERK pathway. In vitro kinase studies indicated that recombinant MEKK4 can specifically phosphorylate and activate PRKMK6 and SERK1, MAPKKs that activate CSBP2 and JNK, respectively but cannot phosphorylate PRKMK1, an MAPKK that activates ERKs. MEKK4 is a major mediator of environmental stresses that activate the CSBP2 MAPK pathway, and a minor mediator of the JNK pathway. Several alternatively spliced transcripts encoding distinct isoforms have been described. [provided by RefSeq, May 2014]</obo:IAO_0000115>
		<dto:geneSynonym>KIAA0213</dto:geneSynonym>
		<dto:geneSynonym>MAPKKK4</dto:geneSynonym>
		<dto:geneSynonym>MEKK4</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200287 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200287">
		<rdfs:label rdf:datatype="&xsd;string">MAP3K5 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400186"/>
		<dto:entrez_xref>4217</dto:entrez_xref>
		<dto:geneSymbol>MAP3K5</dto:geneSymbol>
		<obo:IAO_0000115>Mitogen-activated protein kinase (MAPK) signaling cascades include MAPK or extracellular signal-regulated kinase (ERK), MAPK kinase (MKK or MEK), and MAPK kinase kinase (MAPKKK or MEKK). MAPKK kinase/MEKK phosphorylates and activates its downstream protein kinase, MAPK kinase/MEK, which in turn activates MAPK. The kinases of these signaling cascades are highly conserved, and homologs exist in yeast, Drosophila, and mammalian cells. MAPKKK5 contains 1,374 amino acids with all 11 kinase subdomains. Northern blot analysis shows that MAPKKK5 transcript is abundantly expressed in human heart and pancreas. The MAPKKK5 protein phosphorylates and activates MKK4 (aliases SERK1, MAPKK4) in vitro, and activates c-Jun N-terminal kinase (JNK)/stress-activated protein kinase (SAPK) during transient expression in COS and 293 cells; MAPKKK5 does not activate MAPK/ERK. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>ASK1</dto:geneSynonym>
		<dto:geneSynonym>MAPKKK5</dto:geneSynonym>
		<dto:geneSynonym>MEKK5</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200288 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200288">
		<rdfs:label rdf:datatype="&xsd;string">MAP3K6 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400186"/>
		<dto:entrez_xref>9064</dto:entrez_xref>
		<dto:geneSymbol>MAP3K6</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a serine/threonine protein kinase that forms a component of protein kinase-mediated signal transduction cascades. The encoded kinase participates in the regulation of vascular endothelial growth factor (VEGF) expression. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014]</obo:IAO_0000115>
		<dto:geneSynonym>ASK2</dto:geneSynonym>
		<dto:geneSynonym>MAPKKK6</dto:geneSynonym>
		<dto:geneSynonym>MEKK6</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200289 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200289">
		<rdfs:label rdf:datatype="&xsd;string">MAP3K7 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400286"/>
		<dto:entrez_xref>6885</dto:entrez_xref>
		<dto:geneSymbol>MAP3K7</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is a member of the serine/threonine protein kinase family. This kinase mediates the signaling transduction induced by TGF beta and morphogenetic protein (BMP), and controls a variety of cell functions including transcription regulation and apoptosis. In response to IL-1, this protein forms a kinase complex including TRAF6, MAP3K7P1/TAB1 and MAP3K7P2/TAB2; this complex is required for the activation of nuclear factor kappa B. This kinase can also activate MAPK8/JNK, MAP2K4/MKK4, and thus plays a role in the cell response to environmental stresses. Four alternatively spliced transcript variants encoding distinct isoforms have been reported. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>TAK1</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200290 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200290">
		<rdfs:label rdf:datatype="&xsd;string">MAP3K8 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400185"/>
		<dto:entrez_xref>1326</dto:entrez_xref>
		<dto:geneSymbol>MAP3K8</dto:geneSymbol>
		<obo:IAO_0000115>This gene is an oncogene that encodes a member of the serine/threonine protein kinase family. The encoded protein localizes to the cytoplasm and can activate both the MAP kinase and JNK kinase pathways. This protein was shown to activate IkappaB kinases, and thus induce the nuclear production of NF-kappaB. This protein was also found to promote the production of TNF-alpha and IL-2 during T lymphocyte activation. This gene may also utilize a downstream in-frame translation start codon, and thus produce an isoform containing a shorter N-terminus. The shorter isoform has been shown to display weaker transforming activity. Alternate splicing results in multiple transcript variants that encode the same protein. [provided by RefSeq, Sep 2011]</obo:IAO_0000115>
		<dto:geneSynonym>COT</dto:geneSynonym>
		<dto:geneSynonym>ESTF</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200291 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200291">
		<rdfs:label rdf:datatype="&xsd;string">MAP3K9 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400284"/>
		<dto:entrez_xref>4293</dto:entrez_xref>
		<dto:geneSymbol>MAP3K9</dto:geneSymbol>
		<dto:geneSynonym>MLK1</dto:geneSynonym>
		<dto:geneSynonym>PRKE1</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200292 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200292">
		<rdfs:label rdf:datatype="&xsd;string">MLK4 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400165"/>
		<dto:entrez_xref>84451</dto:entrez_xref>
		<dto:geneSymbol>MLK4</dto:geneSymbol>
		<dto:geneSynonym>KIAA1804</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200293 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200293">
		<rdfs:label rdf:datatype="&xsd;string">MAP4K1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400287"/>
		<dto:entrez_xref>11184</dto:entrez_xref>
		<dto:geneSymbol>MAP4K1</dto:geneSymbol>
		<dto:geneSynonym>HPK1</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200294 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200294">
		<rdfs:label rdf:datatype="&xsd;string">MAP4K2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400287"/>
		<dto:entrez_xref>5871</dto:entrez_xref>
		<dto:geneSymbol>MAP4K2</dto:geneSymbol>
		<obo:IAO_0000115> The protein encoded by this gene is a member of the serine/threonine protein kinase family. Although this kinase is found in many tissues, its expression in lymphoid follicles is restricted to the cells of germinal centre, where it may participate in B-cell differentiation. This kinase can be activated by TNF-alpha, and has been shown to specifically activate MAP kinases. This kinase is also found to interact with TNF receptor-associated factor 2 (TRAF2), which is involved in the activation of MAP3K1/MEKK1. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>GCK</dto:geneSynonym>
		<dto:geneSynonym>RAB8IP</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200295 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200295">
		<rdfs:label rdf:datatype="&xsd;string">MAP4K3 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400287"/>
		<dto:entrez_xref>8491</dto:entrez_xref>
		<dto:geneSymbol>MAP4K3</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the mitogen-activated protein kinase kinase kinase kinase family. The encoded protein activates key effectors in cell signalling, among them c-Jun. Alternatively spliced transcripts encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Jul 2012]</obo:IAO_0000115>
		<dto:geneSynonym>RAB8IPL1</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200296 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200296">
		<rdfs:label rdf:datatype="&xsd;string">MAP4K4 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400288"/>
		<dto:entrez_xref>9448</dto:entrez_xref>
		<dto:geneSymbol>MAP4K4</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is a member of the serine/threonine protein kinase family. This kinase has been shown to specifically activate MAPK8/JNK. The activation of MAPK8 by this kinase is found to be inhibited by the dominant-negative mutants of MAP3K7/TAK1, MAP2K4/MKK4, and MAP2K7/MKK7, which suggests that this kinase may function through the MAP3K7-MAP2K4-MAP2K7 kinase cascade, and mediate the TNF-alpha signaling pathway. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>HGK</dto:geneSynonym>
		<dto:geneSynonym>KIAA0687</dto:geneSynonym>
		<dto:geneSynonym>NIK</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200297 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200297">
		<rdfs:label rdf:datatype="&xsd;string">MAP4K5 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400287"/>
		<dto:entrez_xref>11183</dto:entrez_xref>
		<dto:geneSymbol>MAP4K5</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the serine/threonine protein kinase family, that is highly similar to yeast SPS1/STE20 kinase. Yeast SPS1/STE20 functions near the beginning of the MAP kinase signal cascades that is essential for yeast pheromone response. This kinase was shown to activate Jun kinase in mammalian cells, which suggested a role in stress response. Two alternatively spliced transcript variants encoding the same protein have been described for this gene. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200298 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200298">
		<rdfs:label rdf:datatype="&xsd;string">MAK gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400162"/>
		<dto:entrez_xref>4117</dto:entrez_xref>
		<dto:geneSymbol>MAK</dto:geneSymbol>
		<obo:IAO_0000115>The product of this gene is a serine/threonine protein kinase related to kinases involved in cell cycle regulation. It is expressed almost exclusively in the testis, primarily in germ cells. Studies of the mouse and rat homologs have localized the kinase to the chromosomes during meiosis in spermatogenesis, specifically to the synaptonemal complex that exists while homologous chromosomes are paired. There is, however, a study of the mouse homolog that has identified high levels of expression in developing sensory epithelia so its function may be more generalized. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2011]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200299 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200299">
		<rdfs:label rdf:datatype="&xsd;string">MAPKAPK2 gene</rdfs:label>
		<dto:entrez_xref>9261</dto:entrez_xref>
		<dto:geneSymbol>MAPKAPK2</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the Ser/Thr protein kinase family. This kinase is regulated through direct phosphorylation by p38 MAP kinase. In conjunction with p38 MAP kinase, this kinase is known to be involved in many cellular processes including stress and inflammatory responses, nuclear export, gene expression regulation and cell proliferation. Heat shock protein HSP27 was shown to be one of the substrates of this kinase in vivo. Two transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400289"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200300 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200300">
		<rdfs:label rdf:datatype="&xsd;string">MAPKAPK3 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400289"/>
		<dto:entrez_xref>7867</dto:entrez_xref>
		<dto:geneSymbol>MAPKAPK3</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the Ser/Thr protein kinase family. This kinase functions as a mitogen-activated protein kinase (MAP kinase)- activated protein kinase. MAP kinases are also known as extracellular signal-regulated kinases (ERKs), act as an integration point for multiple biochemical signals. This kinase was shown to be activated by growth inducers and stress stimulation of cells. In vitro studies demonstrated that ERK, p38 MAP kinase and Jun N-terminal kinase were all able to phosphorylate and activate this kinase, which suggested the role of this kinase as an integrative element of signaling in both mitogen and stress responses. This kinase was reported to interact with, phosphorylate and repress the activity of E47, which is a basic helix-loop-helix transcription factor known to be involved in the regulation of tissue-specific gene expression and cell differentiation. Alternate splicing results in multiple transcript variants that encode the same protein. [provided by RefSeq, Sep 2011]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200301 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200301">
		<rdfs:label rdf:datatype="&xsd;string">MAPKAPK5 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400289"/>
		<dto:entrez_xref>8550</dto:entrez_xref>
		<dto:geneSymbol>MAPKAPK5</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is a tumor suppressor and member of the serine/threonine kinase family. In response to cellular stress and proinflammatory cytokines, this kinase is activated through its phosphorylation by MAP kinases including MAPK1/ERK, MAPK14/p38-alpha, and MAPK11/p38-beta. The encoded protein is found in the nucleus but translocates to the cytoplasm upon phosphorylation and activation. This kinase phosphorylates heat shock protein HSP27 at its physiologically relevant sites. Two alternately spliced transcript variants of this gene encoding distinct isoforms have been reported. [provided by RefSeq, Nov 2012]</obo:IAO_0000115>
		<dto:geneSynonym>PRAK</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200302 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200302">
		<rdfs:label rdf:datatype="&xsd;string">MARK1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400290"/>
		<dto:entrez_xref>4139</dto:entrez_xref>
		<dto:geneSymbol>MARK1</dto:geneSymbol>
		<dto:geneSynonym>KIAA1477</dto:geneSynonym>
		<dto:geneSynonym>MARK</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200303 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200303">
		<rdfs:label rdf:datatype="&xsd;string">MARK2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400290"/>
		<dto:entrez_xref>2011</dto:entrez_xref>
		<dto:geneSymbol>MARK2</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the Par-1 family of serine/threonine protein kinases. The protein is an important regulator of cell polarity in epithelial and neuronal cells, and also controls the stability of microtubules through phosphorylation and inactivation of several microtubule-associating proteins. The protein localizes to cell membranes. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2009]</obo:IAO_0000115>
		<dto:geneSynonym>EMK1</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200304 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200304">
		<rdfs:label rdf:datatype="&xsd;string">MARK3 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400290"/>
		<dto:entrez_xref>4140</dto:entrez_xref>
		<dto:geneSymbol>MARK3</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is activated by phosphorylation and in turn is involved in the phosphorylation of tau proteins MAP2 and MAP4. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2011]</obo:IAO_0000115>
		<dto:geneSynonym>CTAK1</dto:geneSynonym>
		<dto:geneSynonym>EMK2</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200305 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200305">
		<rdfs:label rdf:datatype="&xsd;string">MARK4 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400290"/>
		<dto:entrez_xref>57787</dto:entrez_xref>
		<dto:geneSymbol>MARK4</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the microtubule affinity-regulating kinase family. These protein kinases phosphorylate microtubule-associated proteins and regulate the transition between stable and dynamic microtubules. The encoded protein is associated with the centrosome throughout mitosis and may be involved in cell cycle control. Expression of this gene is a potential marker for cancer, and the encoded protein may also play a role in Alzheimer&apos;s disease. Pseudogenes of this gene are located on both the short and long arm of chromosome 3. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Dec 2010]</obo:IAO_0000115>
		<dto:geneSynonym>KIAA1860</dto:geneSynonym>
		<dto:geneSynonym>MARKL1</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200306 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200306">
		<rdfs:label rdf:datatype="&xsd;string">MAST1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400160"/>
		<dto:entrez_xref>22983</dto:entrez_xref>
		<dto:geneSymbol>MAST1</dto:geneSymbol>
		<dto:geneSynonym>KIAA0973</dto:geneSynonym>
		<dto:geneSynonym>SAST</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200307 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200307">
		<rdfs:label rdf:datatype="&xsd;string">MAST2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400160"/>
		<dto:entrez_xref>23139</dto:entrez_xref>
		<dto:geneSymbol>MAST2</dto:geneSymbol>
		<dto:geneSynonym>KIAA0807</dto:geneSynonym>
		<dto:geneSynonym>MAST205</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200308 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200308">
		<rdfs:label rdf:datatype="&xsd;string">MAST3 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400160"/>
		<dto:entrez_xref>23031</dto:entrez_xref>
		<dto:geneSymbol>MAST3</dto:geneSymbol>
		<dto:geneSynonym>KIAA0561</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200309 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200309">
		<rdfs:label rdf:datatype="&xsd;string">MAST4 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400160"/>
		<dto:entrez_xref>375449</dto:entrez_xref>
		<dto:geneSymbol>MAST4</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the microtubule-associated serine/threonine protein kinases. The proteins in this family contain a domain that gives the kinase the ability to determine its own scaffold to control the effects of their kinase activities. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Mar 2014]</obo:IAO_0000115>
		<dto:geneSynonym>KIAA0303</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200310 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200310">
		<rdfs:label rdf:datatype="&xsd;string">MATK gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400144"/>
		<dto:entrez_xref>4145</dto:entrez_xref>
		<dto:geneSymbol>MATK</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene has amino acid sequence similarity to Csk tyrosine kinase and has the structural features of the CSK subfamily: SRC homology SH2 and SH3 domains, a catalytic domain, a unique N terminus, lack of myristylation signals, lack of a negative regulatory phosphorylation site, and lack of an autophosphorylation site. This protein is thought to play a significant role in the signal transduction of hematopoietic cells. It is able to phosphorylate and inactivate Src family kinases, and may play an inhibitory role in the control of T-cell proliferation. This protein might be involved in signaling in some cases of breast cancer. Three alternatively spliced transcript variants that encode different isoforms have been described for this gene. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>CTK</dto:geneSynonym>
		<dto:geneSynonym>HYL</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200311 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200311">
		<rdfs:label rdf:datatype="&xsd;string">MELK gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400291"/>
		<dto:entrez_xref>9833</dto:entrez_xref>
		<dto:geneSymbol>MELK</dto:geneSymbol>
		<dto:geneSynonym>KIAA0175</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200312 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200312">
		<rdfs:label rdf:datatype="&xsd;string">MERTK gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400189"/>
		<dto:entrez_xref>10461</dto:entrez_xref>
		<dto:geneSymbol>MERTK</dto:geneSymbol>
		<obo:IAO_0000115>This gene is a member of the MER/AXL/TYRO3 receptor kinase family and encodes a transmembrane protein with two fibronectin type-III domains, two Ig-like C2-type (immunoglobulin-like) domains, and one tyrosine kinase domain. Mutations in this gene have been associated with disruption of the retinal pigment epithelium (RPE) phagocytosis pathway and onset of autosomal recessive retinitis pigmentosa (RP). [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>MER</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200313 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200313">
		<rdfs:label rdf:datatype="&xsd;string">MET gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400190"/>
		<dto:entrez_xref>4233</dto:entrez_xref>
		<dto:geneSymbol>MET</dto:geneSymbol>
		<obo:IAO_0000115>The proto-oncogene MET product is the hepatocyte growth factor receptor and encodes tyrosine-kinase activity. The primary single chain precursor protein is post-translationally cleaved to produce the alpha and beta subunits, which are disulfide linked to form the mature receptor. Various mutations in the MET gene are associated with papillary renal carcinoma. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200314 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200314">
		<rdfs:label rdf:datatype="&xsd;string">MINK1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400288"/>
		<dto:entrez_xref>50488</dto:entrez_xref>
		<dto:geneSymbol>MINK1</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a serine/threonine kinase belonging to the germinal center kinase (GCK) family. The protein is structurally similar to the kinases that are related to NIK and may belong to a distinct subfamily of NIK-related kinases within the GCK family. Studies of the mouse homolog indicate an up-regulation of expression in the course of postnatal mouse cerebral development and activation of the cJun N-terminal kinase (JNK) and the p38 pathways. Alternative splicing occurs at this locus and four transcript variants encoding distinct isoforms have been identified. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>B55</dto:geneSynonym>
		<dto:geneSynonym>MAP4K6</dto:geneSynonym>
		<dto:geneSynonym>MINK</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200315 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200315">
		<rdfs:label rdf:datatype="&xsd;string">MAPK1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400292"/>
		<dto:entrez_xref>5594</dto:entrez_xref>
		<dto:geneSymbol>MAPK1</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the MAP kinase family. MAP kinases, also known as extracellular signal-regulated kinases (ERKs), act as an integration point for multiple biochemical signals, and are involved in a wide variety of cellular processes such as proliferation, differentiation, transcription regulation and development. The activation of this kinase requires its phosphorylation by upstream kinases. Upon activation, this kinase translocates to the nucleus of the stimulated cells, where it phosphorylates nuclear targets. One study also suggests that this protein acts as a transcriptional repressor independent of its kinase activity. The encoded protein has been identified as a moonlighting protein based on its ability to perform mechanistically distinct functions. Two alternatively spliced transcript variants encoding the same protein, but differing in the UTRs, have been reported for this gene. [provided by RefSeq, Jan 2014]</obo:IAO_0000115>
		<dto:geneSynonym>ERK2</dto:geneSynonym>
		<dto:geneSynonym>PRKM1</dto:geneSynonym>
		<dto:geneSynonym>PRKM2</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200316 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200316">
		<rdfs:label rdf:datatype="&xsd;string">MAPK3 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400292"/>
		<dto:entrez_xref>5595</dto:entrez_xref>
		<dto:geneSymbol>MAPK3</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is a member of the MAP kinase family. MAP kinases, also known as extracellular signal-regulated kinases (ERKs), act in a signaling cascade that regulates various cellular processes such as proliferation, differentiation, and cell cycle progression in response to a variety of extracellular signals. This kinase is activated by upstream kinases, resulting in its translocation to the nucleus where it phosphorylates nuclear targets. Alternatively spliced transcript variants encoding different protein isoforms have been described. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>ERK1</dto:geneSynonym>
		<dto:geneSynonym>PRKM3</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200317 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200317">
		<rdfs:label rdf:datatype="&xsd;string">MAPK4 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400292"/>
		<dto:entrez_xref>5596</dto:entrez_xref>
		<dto:geneSymbol>MAPK4</dto:geneSymbol>
		<obo:IAO_0000115>Mitogen-activated protein kinase 4 is a member of the mitogen-activated protein kinase family. Tyrosine kinase growth factor receptors activate mitogen-activated protein kinases which then translocate into the nucleus and phosphorylate nuclear targets. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2014]</obo:IAO_0000115>
		<dto:geneSynonym>ERK4</dto:geneSynonym>
		<dto:geneSynonym>PRKM4</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200318 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200318">
		<rdfs:label rdf:datatype="&xsd;string">MAPK6 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400292"/>
		<dto:entrez_xref>5597</dto:entrez_xref>
		<dto:geneSymbol>MAPK6</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is a member of the Ser/Thr protein kinase family, and is most closely related to mitogen-activated protein kinases (MAP kinases). MAP kinases also known as extracellular signal-regulated kinases (ERKs), are activated through protein phosphorylation cascades and act as integration points for multiple biochemical signals. This kinase is localized in the nucleus, and has been reported to be activated in fibroblasts upon treatment with serum or phorbol esters. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>ERK3</dto:geneSynonym>
		<dto:geneSynonym>PRKM6</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200319 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200319">
		<rdfs:label rdf:datatype="&xsd;string">MAPK7 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400292"/>
		<dto:entrez_xref>5598</dto:entrez_xref>
		<dto:geneSymbol>MAPK7</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is a member of the MAP kinase family. MAP kinases act as an integration point for multiple biochemical signals, and are involved in a wide variety of cellular processes such as proliferation, differentiation, transcription regulation and development. This kinase is specifically activated by mitogen-activated protein kinase kinase 5 (MAP2K5/MEK5). It is involved in the downstream signaling processes of various receptor molecules including receptor type kinases, and G protein-coupled receptors. In response to extracelluar signals, this kinase translocates to cell nucleus, where it regulates gene expression by phosphorylating, and activating different transcription factors. Four alternatively spliced transcript variants of this gene encoding two distinct isoforms have been reported. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>BMK1</dto:geneSynonym>
		<dto:geneSynonym>ERK5</dto:geneSynonym>
		<dto:geneSynonym>PRKM7</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200320 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200320">
		<rdfs:label rdf:datatype="&xsd;string">MAPK8 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400293"/>
		<dto:entrez_xref>5599</dto:entrez_xref>
		<dto:geneSymbol>MAPK8</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is a member of the MAP kinase family. MAP kinases act as an integration point for multiple biochemical signals, and are involved in a wide variety of cellular processes such as proliferation, differentiation, transcription regulation and development. This kinase is activated by various cell stimuli, and targets specific transcription factors, and thus mediates immediate-early gene expression in response to cell stimuli. The activation of this kinase by tumor-necrosis factor alpha (TNF-alpha) is found to be required for TNF-alpha induced apoptosis. This kinase is also involved in UV radiation induced apoptosis, which is thought to be related to cytochrom c-mediated cell death pathway. Studies of the mouse counterpart of this gene suggested that this kinase play a key role in T cell proliferation, apoptosis and differentiation. Five alternatively spliced transcript variants encoding distinct isoforms have been reported. [provided by RefSeq, Jun 2013]</obo:IAO_0000115>
		<dto:geneSynonym>JNK1</dto:geneSynonym>
		<dto:geneSynonym>PRKM8</dto:geneSynonym>
		<dto:geneSynonym>SAPK1</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200321 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200321">
		<rdfs:label rdf:datatype="&xsd;string">MAPK9 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400293"/>
		<dto:entrez_xref>5601</dto:entrez_xref>
		<dto:geneSymbol>MAPK9</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is a member of the MAP kinase family. MAP kinases act as an integration point for multiple biochemical signals, and are involved in a wide variety of cellular processes such as proliferation, differentiation, transcription regulation and development. This kinase targets specific transcription factors, and thus mediates immediate-early gene expression in response to various cell stimuli. It is most closely related to MAPK8, both of which are involved in UV radiation induced apoptosis, thought to be related to the cytochrome c-mediated cell death pathway. This gene and MAPK8 are also known as c-Jun N-terminal kinases. This kinase blocks the ubiquitination of tumor suppressor p53, and thus it increases the stability of p53 in nonstressed cells. Studies of this gene&apos;s mouse counterpart suggest a key role in T-cell differentiation. Several alternatively spliced transcript variants encoding distinct isoforms have been reported. [provided by RefSeq, Sep 2008]</obo:IAO_0000115>
		<dto:geneSynonym>JNK2</dto:geneSynonym>
		<dto:geneSynonym>PRKM9</dto:geneSynonym>
		<dto:geneSynonym>SAPK1A</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200322 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200322">
		<rdfs:label rdf:datatype="&xsd;string">MAPK10 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400293"/>
		<dto:entrez_xref>5602</dto:entrez_xref>
		<dto:geneSymbol>MAPK10</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is a member of the MAP kinase family. MAP kinases act as an integration point for multiple biochemical signals, and are involved in a wide variety of cellular processes such as proliferation, differentiation, transcription regulation and development. This protein is a neuronal-specific form of c-Jun N-terminal kinases (JNKs). Through its phosphorylation and nuclear localization, this kinase plays regulatory roles in the signaling pathways during neuronal apoptosis. Beta-arrestin 2, a receptor-regulated MAP kinase scaffold protein, is found to interact with, and stimulate the phosphorylation of this kinase by MAP kinase kinase 4 (MKK4). Cyclin-dependent kianse 5 can phosphorylate, and inhibit the activity of this kinase, which may be important in preventing neuronal apoptosis. Four alternatively spliced transcript variants encoding distinct isoforms have been reported. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>JNK3</dto:geneSynonym>
		<dto:geneSynonym>JNK3A</dto:geneSynonym>
		<dto:geneSynonym>PRKM10</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200323 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200323">
		<rdfs:label rdf:datatype="&xsd;string">MAPK11 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400294"/>
		<dto:entrez_xref>5600</dto:entrez_xref>
		<dto:geneSymbol>MAPK11</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of a family of protein kinases that are involved in the integration of biochemical signals for a wide variety of cellular processes, including cell proliferation, differentiation, transcriptional regulation, and development. The encoded protein can be activated by proinflammatory cytokines and environmental stresses through phosphorylation by mitogen activated protein kinase kinases (MKKs). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2014]</obo:IAO_0000115>
		<dto:geneSynonym>PRKM11</dto:geneSynonym>
		<dto:geneSynonym>SAPK2</dto:geneSynonym>
		<dto:geneSynonym>SAPK2B</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200324 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200324">
		<rdfs:label rdf:datatype="&xsd;string">MAPK12 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400294"/>
		<dto:entrez_xref>6300</dto:entrez_xref>
		<dto:geneSymbol>MAPK12</dto:geneSymbol>
		<obo:IAO_0000115>Activation of members of the mitogen-activated protein kinase family is a major mechanism for transduction of extracellular signals. Stress-activated protein kinases are one subclass of MAP kinases. The protein encoded by this gene functions as a signal transducer during differentiation of myoblasts to myotubes. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>ERK6</dto:geneSynonym>
		<dto:geneSynonym>SAPK3</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200325 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200325">
		<rdfs:label rdf:datatype="&xsd;string">MAPK13 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400294"/>
		<dto:entrez_xref>5603</dto:entrez_xref>
		<dto:geneSymbol>MAPK13</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the mitogen-activated protein (MAP) kinase family. MAP kinases act as an integration point for multiple biochemical signals, and are involved in a wide variety of cellular processes such as proliferation, differentiation, transcription regulation and development. The encoded protein is a p38 MAP kinase and is activated by proinflammatory cytokines and cellular stress. Substrates of the encoded protein include the transcription factor ATF2 and the microtubule dynamics regulator stathmin. Alternatively spliced transcript variants have been observed for this gene. [provided by RefSeq, Jul 2012]</obo:IAO_0000115>
		<dto:geneSynonym>PRKM13</dto:geneSynonym>
		<dto:geneSynonym>SAPK4</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200326 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200326">
		<rdfs:label rdf:datatype="&xsd;string">MAPK14 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400294"/>
		<dto:entrez_xref>1432</dto:entrez_xref>
		<dto:geneSymbol>MAPK14</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is a member of the MAP kinase family. MAP kinases act as an integration point for multiple biochemical signals, and are involved in a wide variety of cellular processes such as proliferation, differentiation, transcription regulation and development. This kinase is activated by various environmental stresses and proinflammatory cytokines. The activation requires its phosphorylation by MAP kinase kinases (MKKs), or its autophosphorylation triggered by the interaction of MAP3K7IP1/TAB1 protein with this kinase. The substrates of this kinase include transcription regulator ATF2, MEF2C, and MAX, cell cycle regulator CDC25B, and tumor suppressor p53, which suggest the roles of this kinase in stress related transcription and cell cycle regulation, as well as in genotoxic stress response. Four alternatively spliced transcript variants of this gene encoding distinct isoforms have been reported. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>CSBP</dto:geneSynonym>
		<dto:geneSynonym>CSBP1</dto:geneSynonym>
		<dto:geneSynonym>CSBP2</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200327 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200327">
		<rdfs:label rdf:datatype="&xsd;string">MAPK15 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400295"/>
		<dto:entrez_xref>225689</dto:entrez_xref>
		<dto:geneSymbol>MAPK15</dto:geneSymbol>
		<dto:geneSynonym>ERK7</dto:geneSynonym>
		<dto:geneSynonym>ERK8</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200328 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200328">
		<rdfs:label rdf:datatype="&xsd;string">MKNK1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400296"/>
		<dto:entrez_xref>8569</dto:entrez_xref>
		<dto:geneSymbol>MKNK1</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a Ser/Thr protein kinase that interacts with, and is activated by ERK1 and p38 mitogen-activated protein kinases, and thus may play a role in the response to environmental stress and cytokines. This kinase may also regulate transcription by phosphorylating eIF4E via interaction with the C-terminal region of eIF4G. Alternatively spliced transcript variants have been noted for this gene. [provided by RefSeq, Jan 2012]</obo:IAO_0000115>
		<dto:geneSynonym>MNK1</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200329 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200329">
		<rdfs:label rdf:datatype="&xsd;string">MKNK2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400296"/>
		<dto:entrez_xref>2872</dto:entrez_xref>
		<dto:geneSymbol>MKNK2</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the calcium/calmodulin-dependent protein kinases (CAMK) Ser/Thr protein kinase family, which belongs to the protein kinase superfamily. This protein contains conserved DLG (asp-leu-gly) and ENIL (glu-asn-ile-leu) motifs, and an N-terminal polybasic region which binds importin A and the translation factor scaffold protein eukaryotic initiation factor 4G (eIF4G). This protein is one of the downstream kinases activated by mitogen-activated protein (MAP) kinases. It phosphorylates the eukaryotic initiation factor 4E (eIF4E), thus playing important roles in the initiation of mRNA translation, oncogenic transformation and malignant cell proliferation. In addition to eIF4E, this protein also interacts with von Hippel-Lindau tumor suppressor (VHL), ring-box 1 (Rbx1) and Cullin2 (Cul2), which are all components of the CBC(VHL) ubiquitin ligase E3 complex. Multiple alternatively spliced transcript variants have been found, but the full-length nature and biological activity of only two variants are determined. These two variants encode distinct isoforms which differ in activity and regulation, and in subcellular localization. [provided by RefSeq, Aug 2011]</obo:IAO_0000115>
		<dto:geneSynonym>GPRK7</dto:geneSynonym>
		<dto:geneSynonym>MNK2</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200330 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200330">
		<rdfs:label rdf:datatype="&xsd;string">MLKL gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400192"/>
		<dto:entrez_xref>197259</dto:entrez_xref>
		<dto:geneSymbol>MLKL</dto:geneSymbol>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200331 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200331">
		<rdfs:label rdf:datatype="&xsd;string">ZAK gene</rdfs:label>
		<dto:entrez_xref>51776</dto:entrez_xref>
		<dto:geneSymbol>ZAK</dto:geneSymbol>
		<obo:IAO_0000115>This gene is a member of the MAPKKK family of signal transduction molecules and encodes a protein with an N-terminal kinase catalytic domain, followed by a leucine zipper motif and a sterile-alpha motif (SAM). This magnesium-binding protein forms homodimers and is located in the cytoplasm. The protein mediates gamma radiation signaling leading to cell cycle arrest and activity of this protein plays a role in cell cycle checkpoint regulation in cells. The protein also has pro-apoptotic activity. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>MLTK</dto:geneSynonym>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400284"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200332 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200332">
		<rdfs:label rdf:datatype="&xsd;string">MOK gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400162"/>
		<dto:entrez_xref>5891</dto:entrez_xref>
		<dto:geneSymbol>MOK</dto:geneSymbol>
		<obo:IAO_0000115>This gene belongs to the MAP kinase superfamily. The gene was found to be regulated by caudal type transcription factor 2 (Cdx2) protein. The encoded protein, which is localized to epithelial cells in the intestinal crypt, may play a role in growth arrest and differentiation of cells of upper crypt and lower villus regions. Multiple alternatively spliced transcript variants encoding different isoforms have been observed for this gene. [provided by RefSeq, Dec 2012]</obo:IAO_0000115>
		<dto:geneSynonym>RAGE</dto:geneSynonym>
		<dto:geneSynonym>RAGE1</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200333 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200333">
		<rdfs:label rdf:datatype="&xsd;string">MOS gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400193"/>
		<dto:entrez_xref>4342</dto:entrez_xref>
		<dto:geneSymbol>MOS</dto:geneSymbol>
		<obo:IAO_0000115>MOS is a serine/threonine kinase that activates the MAP kinase cascade through direct phosphorylation of the MAP kinase activator MEK (MAP2K1; MIM 176872) (Prasad et al., 2008 [PubMed 18246541]).[supplied by OMIM, Jul 2009]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200334 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200334">
		<rdfs:label rdf:datatype="&xsd;string">MAP2K1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400194"/>
		<dto:entrez_xref>5604</dto:entrez_xref>
		<dto:geneSymbol>MAP2K1</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is a member of the dual specificity protein kinase family, which acts as a mitogen-activated protein (MAP) kinase kinase. MAP kinases, also known as extracellular signal-regulated kinases (ERKs), act as an integration point for multiple biochemical signals. This protein kinase lies upstream of MAP kinases and stimulates the enzymatic activity of MAP kinases upon wide variety of extra- and intracellular signals. As an essential component of MAP kinase signal transduction pathway, this kinase is involved in many cellular processes such as proliferation, differentiation, transcription regulation and development. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>MEK1</dto:geneSynonym>
		<dto:geneSynonym>PRKMK1</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200335 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200335">
		<rdfs:label rdf:datatype="&xsd;string">MAP2K2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400194"/>
		<dto:entrez_xref>5605</dto:entrez_xref>
		<dto:geneSymbol>MAP2K2</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is a dual specificity protein kinase that belongs to the MAP kinase kinase family. This kinase is known to play a critical role in mitogen growth factor signal transduction. It phosphorylates and thus activates MAPK1/ERK2 and MAPK2/ERK3. The activation of this kinase itself is dependent on the Ser/Thr phosphorylation by MAP kinase kinase kinases. Mutations in this gene cause cardiofaciocutaneous syndrome (CFC syndrome), a disease characterized by heart defects, mental retardation, and distinctive facial features similar to those found in Noonan syndrome. The inhibition or degradation of this kinase is also found to be involved in the pathogenesis of Yersinia and anthrax. A pseudogene, which is located on chromosome 7, has been identified for this gene. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>MEK2</dto:geneSynonym>
		<dto:geneSynonym>MKK2</dto:geneSynonym>
		<dto:geneSynonym>PRKMK2</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200336 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200336">
		<rdfs:label rdf:datatype="&xsd;string">MAP2K3 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400194"/>
		<dto:entrez_xref>5606</dto:entrez_xref>
		<dto:geneSymbol>MAP2K3</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is a dual specificity protein kinase that belongs to the MAP kinase kinase family. This kinase is activated by mitogenic and environmental stress, and participates in the MAP kinase-mediated signaling cascade. It phosphorylates and thus activates MAPK14/p38-MAPK. This kinase can be activated by insulin, and is necessary for the expression of glucose transporter. Expression of RAS oncogene is found to result in the accumulation of the active form of this kinase, which thus leads to the constitutive activation of MAPK14, and confers oncogenic transformation of primary cells. The inhibition of this kinase is involved in the pathogenesis of Yersina pseudotuberculosis. Multiple alternatively spliced transcript variants that encode distinct isoforms have been reported for this gene. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>MEK3</dto:geneSynonym>
		<dto:geneSynonym>MKK3</dto:geneSynonym>
		<dto:geneSynonym>PRKMK3</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200337 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200337">
		<rdfs:label rdf:datatype="&xsd;string">MAP2K4 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400194"/>
		<dto:entrez_xref>6416</dto:entrez_xref>
		<dto:geneSymbol>MAP2K4</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the mitogen-activated protein kinase (MAPK) family. Members of this family act as an integration point for multiple biochemical signals and are involved in a wide variety of cellular processes such as proliferation, differentiation, transcription regulation, and development. They form a three-tiered signaling module composed of MAPKKKs, MAPKKs, and MAPKs. This protein is phosphorylated at serine and threonine residues by MAPKKKs and subsequently phosphorylates downstream MAPK targets at threonine and tyrosine residues. A similar protein in mouse has been reported to play a role in liver organogenesis. A pseudogene of this gene is located on the long arm of chromosome X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013]</obo:IAO_0000115>
		<dto:geneSynonym>JNKK1</dto:geneSynonym>
		<dto:geneSynonym>MEK4</dto:geneSynonym>
		<dto:geneSynonym>MKK4</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200338 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200338">
		<rdfs:label rdf:datatype="&xsd;string">MAP2K5 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400194"/>
		<dto:entrez_xref>5607</dto:entrez_xref>
		<dto:geneSymbol>MAP2K5</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is a dual specificity protein kinase that belongs to the MAP kinase kinase family. This kinase specifically interacts with and activates MAPK7/ERK5. This kinase itself can be phosphorylated and activated by MAP3K3/MEKK3, as well as by atypical protein kinase C isoforms (aPKCs). The signal cascade mediated by this kinase is involved in growth factor stimulated cell proliferation and muscle cell differentiation. Three alternatively spliced transcript variants of this gene encoding distinct isoforms have been described. [provided by RefSeq, May 2011]</obo:IAO_0000115>
		<dto:geneSynonym>MEK5</dto:geneSynonym>
		<dto:geneSynonym>MKK5</dto:geneSynonym>
		<dto:geneSynonym>PRKMK5</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200339 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200339">
		<rdfs:label rdf:datatype="&xsd;string">MAP2K6 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400194"/>
		<dto:entrez_xref>5608</dto:entrez_xref>
		<dto:geneSymbol>MAP2K6</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the dual specificity protein kinase family, which functions as a mitogen-activated protein (MAP) kinase kinase. MAP kinases, also known as extracellular signal-regulated kinases (ERKs), act as an integration point for multiple biochemical signals. This protein phosphorylates and activates p38 MAP kinase in response to inflammatory cytokines or environmental stress. As an essential component of p38 MAP kinase mediated signal transduction pathway, this gene is involved in many cellular processes such as stress induced cell cycle arrest, transcription activation and apoptosis. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>MEK6</dto:geneSynonym>
		<dto:geneSynonym>MKK6</dto:geneSynonym>
		<dto:geneSynonym>PRKMK6</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200340 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200340">
		<rdfs:label rdf:datatype="&xsd;string">MAP2K7 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400194"/>
		<dto:entrez_xref>5609</dto:entrez_xref>
		<dto:geneSymbol>MAP2K7</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is a dual specificity protein kinase that belongs to the MAP kinase kinase family. This kinase specifically activates MAPK8/JNK1 and MAPK9/JNK2, and this kinase itself is phosphorylated and activated by MAP kinase kinase kinases including MAP3K1/MEKK1, MAP3K2/MEKK2,MAP3K3/MEKK5, and MAP4K2/GCK. This kinase is involved in the signal transduction mediating the cell responses to proinflammatory cytokines, and environmental stresses. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014]</obo:IAO_0000115>
		<dto:geneSynonym>JNKK2</dto:geneSynonym>
		<dto:geneSynonym>MEK7</dto:geneSynonym>
		<dto:geneSynonym>MKK7</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200341 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200341">
		<rdfs:label rdf:datatype="&xsd;string">CDC42BPA gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400265"/>
		<dto:entrez_xref>8476</dto:entrez_xref>
		<dto:geneSymbol>CDC42BPA</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is a member of the Serine/Threonine protein kinase family. This kinase contains multiple functional domains. Its kinase domain is highly similar to that of the myotonic dystrophy protein kinase (DMPK). This kinase also contains a Rac interactive binding (CRIB) domain, and has been shown to bind CDC42. It may function as a CDC42 downstream effector mediating CDC42 induced peripheral actin formation, and promoting cytoskeletal reorganization. Multiple alternatively spliced transcript variants have been described, and the full-length nature of two of them has been reported. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>KIAA0451</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200342 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200342">
		<rdfs:label rdf:datatype="&xsd;string">CDC42BPB gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400265"/>
		<dto:entrez_xref>9578</dto:entrez_xref>
		<dto:geneSymbol>CDC42BPB</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the serine/threonine protein kinase family. The encoded protein contains a Cdc42/Rac-binding p21 binding domain resembling that of PAK kinase. The kinase domain of this protein is most closely related to that of myotonic dystrophy kinase-related ROK. Studies of the similar gene in rat suggested that this kinase may act as a downstream effector of Cdc42 in cytoskeletal reorganization. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>KIAA1124</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200343 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200343">
		<rdfs:label rdf:datatype="&xsd;string">CDC42BPG gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400265"/>
		<dto:entrez_xref>55561</dto:entrez_xref>
		<dto:geneSymbol>CDC42BPG</dto:geneSymbol>
		<dto:geneSynonym>DMPK2</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200344 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200344">
		<rdfs:label rdf:datatype="&xsd;string">MST4 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400297"/>
		<dto:entrez_xref>51765</dto:entrez_xref>
		<dto:geneSymbol>MST4</dto:geneSymbol>
		<obo:IAO_0000115>The product of this gene is a member of the GCK group III family of kinases, which are a subset of the Ste20-like kinases. The encoded protein contains an amino-terminal kinase domain, and a carboxy-terminal regulatory domain that mediates homodimerization. The protein kinase localizes to the Golgi apparatus and is specifically activated by binding to the Golgi matrix protein GM130. It is also cleaved by caspase-3 in vitro, and may function in the apoptotic pathway. Several alternatively spliced transcript variants of this gene have been described, but the full-length nature of some of these variants has not been determined. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>MASK</dto:geneSynonym>
		<dto:geneSynonym>MST4</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200345 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200345">
		<rdfs:label rdf:datatype="&xsd;string">MTOR gene</rdfs:label>
		<dto:entrez_xref>2475</dto:entrez_xref>
		<dto:geneSymbol>MTOR</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene belongs to a family of phosphatidylinositol kinase-related kinases. These kinases mediate cellular responses to stresses such as DNA damage and nutrient deprivation. This protein acts as the target for the cell-cycle arrest and immunosuppressive effects of the FKBP12-rapamycin complex. The ANGPTL7 gene is located in an intron of this gene. [provided by RefSeq, Sep 2008]</obo:IAO_0000115>
		<dto:geneSynonym>FRAP</dto:geneSynonym>
		<dto:geneSynonym>FRAP1</dto:geneSynonym>
		<dto:geneSynonym>FRAP2</dto:geneSynonym>
		<dto:geneSynonym>RAFT1</dto:geneSynonym>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491035"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200346 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200346">
		<rdfs:label rdf:datatype="&xsd;string">MUSK gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400195"/>
		<dto:entrez_xref>4593</dto:entrez_xref>
		<dto:geneSymbol>MUSK</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a muscle-specific tyrosine kinase receptor. The encoded protein may play a role in clustering of the acetylcholine receptor in the postsynaptic neuromuscular junction. Mutations in this gene have been associated with congenital myasthenic syndrome. Alternatively spliced transcript variants have been described.[provided by RefSeq, Oct 2009]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200347 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200347">
		<rdfs:label rdf:datatype="&xsd;string">MYLK2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400196"/>
		<dto:entrez_xref>85366</dto:entrez_xref>
		<dto:geneSymbol>MYLK2</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a myosin light chain kinase, a calcium/calmodulin dependent enzyme, that is exclusively expressed in adult skeletal muscle. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200348 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200348">
		<rdfs:label rdf:datatype="&xsd;string">MYLK3 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400196"/>
		<dto:entrez_xref>91807</dto:entrez_xref>
		<dto:geneSymbol>MYLK3</dto:geneSymbol>
		<obo:IAO_0000115>Phosphorylation of cardiac myosin heavy chains (see MYH7B, MIM 609928) and light chains (see MYL2, MIM 160781) by a kinase, such as MYLK3, potentiates the force and rate of cross-bridge recruitment in cardiac myocytes (Chan et al., 2008 [PubMed 18202317]).[supplied by OMIM, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>MLCK</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200349 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200349">
		<rdfs:label rdf:datatype="&xsd;string">MYLK4 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400196"/>
		<dto:entrez_xref>340156</dto:entrez_xref>
		<dto:geneSymbol>MYLK4</dto:geneSymbol>
		<dto:geneSynonym>SGK085</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200350 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200350">
		<rdfs:label rdf:datatype="&xsd;string">MYLK gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400196"/>
		<dto:entrez_xref>4638</dto:entrez_xref>
		<dto:geneSymbol>MYLK</dto:geneSymbol>
		<obo:IAO_0000115>This gene, a muscle member of the immunoglobulin gene superfamily, encodes myosin light chain kinase which is a calcium/calmodulin dependent enzyme. This kinase phosphorylates myosin regulatory light chains to facilitate myosin interaction with actin filaments to produce contractile activity. This gene encodes both smooth muscle and nonmuscle isoforms. In addition, using a separate promoter in an intron in the 3&apos; region, it encodes telokin, a small protein identical in sequence to the C-terminus of myosin light chain kinase, that is independently expressed in smooth muscle and functions to stabilize unphosphorylated myosin filaments. A pseudogene is located on the p arm of chromosome 3. Four transcript variants that produce four isoforms of the calcium/calmodulin dependent enzyme have been identified as well as two transcripts that produce two isoforms of telokin. Additional variants have been identified but lack full length transcripts. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>MLCK</dto:geneSynonym>
		<dto:geneSynonym>MLCK1</dto:geneSynonym>
		<dto:geneSynonym>MYLK1</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200351 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200351">
		<rdfs:label rdf:datatype="&xsd;string">MYO3A gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400298"/>
		<dto:entrez_xref>53904</dto:entrez_xref>
		<dto:geneSymbol>MYO3A</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene belongs to the myosin superfamily. Myosins are actin-dependent motor proteins and are categorized into conventional myosins (class II) and unconventional myosins (classes I and III through XV) based on their variable C-terminal cargo-binding domains. Class III myosins, such as this one, have a kinase domain N-terminal to the conserved N-terminal motor domains and are expressed in photoreceptors. The protein encoded by this gene plays an important role in hearing in humans. Three different recessive, loss of function mutations in the encoded protein have been shown to cause nonsyndromic progressive hearing loss. Expression of this gene is highly restricted, with the strongest expression in retina and cochlea. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200352 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200352">
		<rdfs:label rdf:datatype="&xsd;string">MYO3B gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400298"/>
		<dto:entrez_xref>140469</dto:entrez_xref>
		<dto:geneSymbol>MYO3B</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes one of the class III myosins. Myosins are ATPases, activated by actin, that move along actin filaments in the cell. This class of myosins are characterized by an amino-terminal kinase domain and shown to be present in photoreceptors. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Mar 2014]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200353 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200353">
		<rdfs:label rdf:datatype="&xsd;string">NEK10 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400197"/>
		<dto:entrez_xref>152110</dto:entrez_xref>
		<dto:geneSymbol>NEK10</dto:geneSymbol>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200354 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200354">
		<rdfs:label rdf:datatype="&xsd;string">NEK11 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400197"/>
		<dto:entrez_xref>79858</dto:entrez_xref>
		<dto:geneSymbol>NEK11</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the never in mitosis gene A family of kinases. The encoded protein localizes to the nucleoli, and may function with NEK2A in the S-phase checkpoint. The encoded protein appears to play roles in DNA replication and response to genotoxic stress. Alternatively spliced transcript variants have been described.[provided by RefSeq, Mar 2009]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200355 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200355">
		<rdfs:label rdf:datatype="&xsd;string">NEK1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400197"/>
		<dto:entrez_xref>4750</dto:entrez_xref>
		<dto:geneSymbol>NEK1</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is a serine/threonine kinase involved in cell cycle regulation. The encoded protein is found in a centrosomal complex with FEZ1, a neuronal protein that plays a role in axonal development. Defects in this gene are a cause of polycystic kidney disease (PKD). Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2010]</obo:IAO_0000115>
		<dto:geneSynonym>KIAA1901</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200356 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200356">
		<rdfs:label rdf:datatype="&xsd;string">NEK2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400197"/>
		<dto:entrez_xref>4751</dto:entrez_xref>
		<dto:geneSymbol>NEK2</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a serine/threonine-protein kinase that is involved in mitotic regulation. This protein is localized to the centrosome, and undetectable during G1 phase, but accumulates progressively throughout the S phase, reaching maximal levels in late G2 phase. Alternatively spliced transcript variants encoding different isoforms with distinct C-termini have been noted for this gene. [provided by RefSeq, Feb 2011]</obo:IAO_0000115>
		<dto:geneSynonym>NEK2A</dto:geneSynonym>
		<dto:geneSynonym>NLK1</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200357 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200357">
		<rdfs:label rdf:datatype="&xsd;string">NEK3 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400197"/>
		<dto:entrez_xref>4752</dto:entrez_xref>
		<dto:geneSymbol>NEK3</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the NimA (never in mitosis A) family of serine/threonine protein kinases. The encoded protein differs from other NimA family members in that it is not cell cycle regulated and is found primarily in the cytoplasm. The kinase is activated by prolactin stimulation, leading to phosphorylation of VAV2 guanine nucleotide exchange factor, paxillin, and activation of the RAC1 GTPase. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Mar 2009]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200358 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200358">
		<rdfs:label rdf:datatype="&xsd;string">NEK4 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400197"/>
		<dto:entrez_xref>6787</dto:entrez_xref>
		<dto:geneSymbol>NEK4</dto:geneSymbol>
		<dto:geneSynonym>STK2</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200359 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200359">
		<rdfs:label rdf:datatype="&xsd;string">NEK5 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400197"/>
		<dto:entrez_xref>341676</dto:entrez_xref>
		<dto:geneSymbol>NEK5</dto:geneSymbol>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200360 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200360">
		<rdfs:label rdf:datatype="&xsd;string">NEK6 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400197"/>
		<dto:entrez_xref>10783</dto:entrez_xref>
		<dto:geneSymbol>NEK6</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is a kinase required for progression through the metaphase portion of mitosis. Inhibition of the encoded protein can lead to apoptosis. This protein also can enhance tumorigenesis by suppressing tumor cell senescence. Several transcript variants encoding a few different isoforms have been found for this gene. [provided by RefSeq, Oct 2011]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200361 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200361">
		<rdfs:label rdf:datatype="&xsd;string">NEK7 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400197"/>
		<dto:entrez_xref>140609</dto:entrez_xref>
		<dto:geneSymbol>NEK7</dto:geneSymbol>
		<obo:IAO_0000115>NIMA-related kinases share high amino acid sequence identity with the gene product of the Aspergillus nidulans &apos;never in mitosis A&apos; gene, which controls initiation of mitosis.[supplied by OMIM, Jul 2002]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200362 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200362">
		<rdfs:label rdf:datatype="&xsd;string">NEK8 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400197"/>
		<dto:entrez_xref>284086</dto:entrez_xref>
		<dto:geneSymbol>NEK8</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the serine/threionine protein kinase family related to NIMA (never in mitosis, gene A) of Aspergillus nidulans. The encoded protein may play a role in cell cycle progression from G2 to M phase. Mutations in the related mouse gene are associated with a disease phenotype that closely parallels the juvenile autosomal recessive form of polycystic kidney disease in humans. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>JCK</dto:geneSynonym>
		<dto:geneSynonym>NEK12A</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200363 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200363">
		<rdfs:label rdf:datatype="&xsd;string">NEK9 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400197"/>
		<dto:entrez_xref>91754</dto:entrez_xref>
		<dto:geneSymbol>NEK9</dto:geneSymbol>
		<dto:geneSynonym>KIAA1995</dto:geneSynonym>
		<dto:geneSynonym>NEK8</dto:geneSynonym>
		<dto:geneSynonym>NERCC</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200364 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200364">
		<rdfs:label rdf:datatype="&xsd;string">IKBKG gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400102"/>
		<dto:entrez_xref>8517</dto:entrez_xref>
		<dto:geneSymbol>IKBKG</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes the regulatory subunit of the inhibitor of kappaB kinase (IKK) complex, which activates NF-kappaB resulting in activation of genes involved in inflammation, immunity, cell survival, and other pathways. Mutations in this gene result in incontinentia pigmenti, hypohidrotic ectodermal dysplasia, and several other types of immunodeficiencies. Multiple transcript variants encoding different isoforms have been found for this gene. A pseudogene highly similar to this locus is located in an adjacent region of the X chromosome. [provided by RefSeq, Aug 2011]</obo:IAO_0000115>
		<dto:geneSynonym>FIP3</dto:geneSynonym>
		<dto:geneSynonym>NEMO</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200365 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200365">
		<rdfs:label rdf:datatype="&xsd;string">NIM1K gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400299"/>
		<dto:entrez_xref>167359</dto:entrez_xref>
		<dto:geneSymbol>NIM1K</dto:geneSymbol>
		<dto:geneSynonym>NIM1</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200366 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200366">
		<rdfs:label rdf:datatype="&xsd;string">NLK gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400300"/>
		<dto:entrez_xref>51701</dto:entrez_xref>
		<dto:geneSymbol>NLK</dto:geneSymbol>
		<dto:geneSynonym>LAK1</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200367 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200367">
		<rdfs:label rdf:datatype="&xsd;string">NRBP2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400198"/>
		<dto:entrez_xref>340371</dto:entrez_xref>
		<dto:geneSymbol>NRBP2</dto:geneSymbol>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200368 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200368">
		<rdfs:label rdf:datatype="&xsd;string">NRBP1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400198"/>
		<dto:entrez_xref>29959</dto:entrez_xref>
		<dto:geneSymbol>NRBP1</dto:geneSymbol>
		<dto:geneSynonym>BCON3</dto:geneSynonym>
		<dto:geneSynonym>NRBP</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200369 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200369">
		<rdfs:label rdf:datatype="&xsd;string">NRK gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400187"/>
		<dto:entrez_xref>203447</dto:entrez_xref>
		<dto:geneSymbol>NRK</dto:geneSymbol>
		<obo:IAO_0000115>The mouse ortholog of this gene encodes a protein kinase required for JNK activation. The encoded protein may be involved in the induction of actin polymerization in late embryogenesis.[provided by RefSeq, Jun 2010]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200370 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200370">
		<rdfs:label rdf:datatype="&xsd;string">SCYL1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400199"/>
		<dto:entrez_xref>57410</dto:entrez_xref>
		<dto:geneSymbol>SCYL1</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a transcriptional regulator belonging to the SCY1-like family of kinase-like proteins. The protein has a divergent N-terminal kinase domain that is thought to be catalytically inactive, and can bind specific DNA sequences through its C-terminal domain. It activates transcription of the telomerase reverse transcriptase and DNA polymerase beta genes. The protein has been localized to the nucleus, and also to the cytoplasm and centrosomes during mitosis. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>CVAK90</dto:geneSynonym>
		<dto:geneSynonym>GKLP</dto:geneSynonym>
		<dto:geneSynonym>NTKL</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200371 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200371">
		<rdfs:label rdf:datatype="&xsd;string">NTRK1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400200"/>
		<dto:entrez_xref>4914</dto:entrez_xref>
		<dto:geneSymbol>NTRK1</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the neurotrophic tyrosine kinase receptor (NTKR) family. This kinase is a membrane-bound receptor that, upon neurotrophin binding, phosphorylates itself and members of the MAPK pathway. The presence of this kinase leads to cell differentiation and may play a role in specifying sensory neuron subtypes. Mutations in this gene have been associated with congenital insensitivity to pain, anhidrosis, self-mutilating behavior, mental retardation and cancer. Alternate transcriptional splice variants of this gene have been found, but only three have been characterized to date. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>MTC</dto:geneSynonym>
		<dto:geneSynonym>TRK</dto:geneSynonym>
		<dto:geneSynonym>TRKA</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200372 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200372">
		<rdfs:label rdf:datatype="&xsd;string">NTRK2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400200"/>
		<dto:entrez_xref>4915</dto:entrez_xref>
		<dto:geneSymbol>NTRK2</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the neurotrophic tyrosine receptor kinase (NTRK) family. This kinase is a membrane-bound receptor that, upon neurotrophin binding, phosphorylates itself and members of the MAPK pathway. Signalling through this kinase leads to cell differentiation. Mutations in this gene have been associated with obesity and mood disorders. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2014]</obo:IAO_0000115>
		<dto:geneSynonym>TRKB</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200373 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200373">
		<rdfs:label rdf:datatype="&xsd;string">NTRK3 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400200"/>
		<dto:entrez_xref>4916</dto:entrez_xref>
		<dto:geneSymbol>NTRK3</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the neurotrophic tyrosine receptor kinase (NTRK) family. This kinase is a membrane-bound receptor that, upon neurotrophin binding, phosphorylates itself and members of the MAPK pathway. Signalling through this kinase leads to cell differentiation and may play a role in the development of proprioceptive neurons that sense body position. Mutations in this gene have been associated with medulloblastomas, secretory breast carcinomas and other cancers. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2011]</obo:IAO_0000115>
		<dto:geneSynonym>TRKC</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200374 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200374">
		<rdfs:label rdf:datatype="&xsd;string">NUAK1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400301"/>
		<dto:entrez_xref>9891</dto:entrez_xref>
		<dto:geneSymbol>NUAK1</dto:geneSymbol>
		<dto:geneSynonym>ARK5</dto:geneSynonym>
		<dto:geneSynonym>KIAA0537</dto:geneSynonym>
		<dto:geneSynonym>OMPHK1</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200375 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200375">
		<rdfs:label rdf:datatype="&xsd;string">NUAK2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400301"/>
		<dto:entrez_xref>81788</dto:entrez_xref>
		<dto:geneSymbol>NUAK2</dto:geneSymbol>
		<dto:geneSynonym>OMPHK2</dto:geneSynonym>
		<dto:geneSynonym>SNARK</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200376 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200376">
		<rdfs:label rdf:datatype="&xsd;string">OBSCN gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400168"/>
		<dto:entrez_xref>84033</dto:entrez_xref>
		<dto:geneSymbol>OBSCN</dto:geneSymbol>
		<obo:IAO_0000115>The obscurin gene spans more than 150 kb, contains over 80 exons and encodes a protein of approximately 720 kDa. The encoded protein contains 68 Ig domains, 2 fibronectin domains, 1 calcium/calmodulin-binding domain, 1 RhoGEF domain with an associated PH domain, and 2 serine-threonine kinase domains. This protein belongs to the family of giant sacromeric signaling proteins that includes titin and nebulin, and may have a role in the organization of myofibrils during assembly and may mediate interactions between the sarcoplasmic reticulum and myofibrils. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>KIAA1556</dto:geneSynonym>
		<dto:geneSynonym>KIAA1639</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200377 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200377">
		<rdfs:label rdf:datatype="&xsd;string">OXSR1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400302"/>
		<dto:entrez_xref>9943</dto:entrez_xref>
		<dto:geneSymbol>OXSR1</dto:geneSymbol>
		<obo:IAO_0000115>The product of this gene belongs to the Ser/Thr protein kinase family of proteins. It regulates downstream kinases in response to environmental stress, and may play a role in regulating the actin cytoskeleton. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>KIAA1101</dto:geneSynonym>
		<dto:geneSynonym>OSR1</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200378 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200378">
		<rdfs:label rdf:datatype="&xsd;string">PIK3C2A gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491010"/>
		<dto:entrez_xref>5286</dto:entrez_xref>
		<dto:geneSymbol>PIK3C2A</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene belongs to the phosphoinositide 3-kinase (PI3K) family. PI3-kinases play roles in signaling pathways involved in cell proliferation, oncogenic transformation, cell survival, cell migration, and intracellular protein trafficking. This protein contains a lipid kinase catalytic domain as well as a C-terminal C2 domain, a characteristic of class II PI3-kinases. C2 domains act as calcium-dependent phospholipid binding motifs that mediate translocation of proteins to membranes, and may also mediate protein-protein interactions. The PI3-kinase activity of this protein is not sensitive to nanomolar levels of the inhibitor wortmanin. This protein was shown to be able to be activated by insulin and may be involved in integrin-dependent signaling. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200379 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200379">
		<rdfs:label rdf:datatype="&xsd;string">PIK3C2B gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491009"/>
		<dto:entrez_xref>5287</dto:entrez_xref>
		<dto:geneSymbol>PIK3C2B</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene belongs to the phosphoinositide 3-kinase (PI3K) family. PI3-kinases play roles in signaling pathways involved in cell proliferation, oncogenic transformation, cell survival, cell migration, and intracellular protein trafficking. This protein contains a lipid kinase catalytic domain as well as a C-terminal C2 domain, a characteristic of class II PI3-kinases. C2 domains act as calcium-dependent phospholipid binding motifs that mediate translocation of proteins to membranes, and may also mediate protein-protein interactions. The PI3-kinase activity of this protein is sensitive to low nanomolar levels of the inhibitor wortmanin. The C2 domain of this protein was shown to bind phospholipids but not Ca2+, which suggests that this enzyme may function in a calcium-independent manner. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200380 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200380">
		<rdfs:label rdf:datatype="&xsd;string">PIK3C2G gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491009"/>
		<dto:entrez_xref>5288</dto:entrez_xref>
		<dto:geneSymbol>PIK3C2G</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene belongs to the phosphoinositide 3-kinase (PI3K) family. PI3-kinases play roles in signaling pathways involved in cell proliferation, oncogenic transformation, cell survival, cell migration, and intracellular protein trafficking. This protein contains a lipid kinase catalytic domain as well as a C-terminal C2 domain, a characteristic of class II PI3-kinases. C2 domains act as calcium-dependent phospholipid binding motifs that mediate translocation of proteins to membranes, and may also mediate protein-protein interactions. This gene may play a role in several diseases, including type II diabetes. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2014]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200381 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200381">
		<rdfs:label rdf:datatype="&xsd;string">PI4K2A gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491005"/>
		<dto:entrez_xref>55361</dto:entrez_xref>
		<dto:geneSymbol>PI4K2A</dto:geneSymbol>
		<obo:IAO_0000115>Phosphatidylinositolpolyphosphates (PtdInsPs) are centrally involved in many biologic processes, ranging from cell growth and organization of the actin cytoskeleton to endo- and exocytosis. PI4KII phosphorylates PtdIns at the D-4 position, an essential step in the biosynthesis of PtdInsPs (Barylko et al., 2001 [PubMed 11244087]).[supplied by OMIM, Mar 2008]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200382 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200382">
		<rdfs:label rdf:datatype="&xsd;string">PIK3R1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491031"/>
		<dto:entrez_xref>5295</dto:entrez_xref>
		<dto:geneSymbol>PIK3R1</dto:geneSymbol>
		<obo:IAO_0000115>Phosphatidylinositol 3-kinase phosphorylates the inositol ring of phosphatidylinositol at the 3-prime position. The enzyme comprises a 110 kD catalytic subunit and a regulatory subunit of either 85, 55, or 50 kD. This gene encodes the 85 kD regulatory subunit. Phosphatidylinositol 3-kinase plays an important role in the metabolic actions of insulin, and a mutation in this gene has been associated with insulin resistance. Alternative splicing of this gene results in four transcript variants encoding different isoforms. [provided by RefSeq, Jun 2011]</obo:IAO_0000115>
		<dto:geneSynonym>GRB1</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200383 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200383">
		<rdfs:label rdf:datatype="&xsd;string">SCYL3 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400199"/>
		<dto:entrez_xref>57147</dto:entrez_xref>
		<dto:geneSymbol>SCYL3</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a protein with a kinase domain and four HEAT repeats. The encoded protein interacts with the C-terminal domain of ezrin, an ERM protein, and may play a role in cell adhesion and migration. Alternative splicing results in multiple transcript variants encoding multiple isoforms. [provided by RefSeq, Jun 2012]</obo:IAO_0000115>
		<dto:geneSynonym>PACE1</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200384 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200384">
		<rdfs:label rdf:datatype="&xsd;string">PAK1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400303"/>
		<dto:entrez_xref>5058</dto:entrez_xref>
		<dto:geneSymbol>PAK1</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a family member of serine/threonine p21-activating kinases, known as PAK proteins. These proteins are critical effectors that link RhoGTPases to cytoskeleton reorganization and nuclear signaling, and they serve as targets for the small GTP binding proteins Cdc42 and Rac. This specific family member regulates cell motility and morphology. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2010]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200385 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200385">
		<rdfs:label rdf:datatype="&xsd;string">PAK2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400303"/>
		<dto:entrez_xref>5062</dto:entrez_xref>
		<dto:geneSymbol>PAK2</dto:geneSymbol>
		<obo:IAO_0000115>The p21 activated kinases (PAK) are critical effectors that link Rho GTPases to cytoskeleton reorganization and nuclear signaling. The PAK proteins are a family of serine/threonine kinases that serve as targets for the small GTP binding proteins, CDC42 and RAC1, and have been implicated in a wide range of biological activities. The protein encoded by this gene is activated by proteolytic cleavage during caspase-mediated apoptosis, and may play a role in regulating the apoptotic events in the dying cell. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200386 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200386">
		<rdfs:label rdf:datatype="&xsd;string">PAK3 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400303"/>
		<dto:entrez_xref>5063</dto:entrez_xref>
		<dto:geneSymbol>PAK3</dto:geneSymbol>
		<obo:IAO_0000115>PAK proteins are critical effectors that link Rho GTPases to cytoskeleton reorganization and nuclear signaling. PAK proteins, a family of serine/threonine p21-activating kinases, serve as targets for the small GTP binding proteins Cdc42 and RAC and have been implicated in a wide range of biological activities. The protein encoded by this gene forms an activated complex with GTP-bound RAS-like (P21), CDC2 and RAC1 proteins which then catalyzes a variety of targets. This protein may be necessary for dendritic development and for the rapid cytoskeletal reorganization in dendritic spines associated with synaptic plasticity. Defects in this gene are the cause of non-syndromic mental retardation X-linked type 30 (MRX30), also called X-linked mental retardation type 47 (MRX47). Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>OPHN3</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200387 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200387">
		<rdfs:label rdf:datatype="&xsd;string">PAK4 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400304"/>
		<dto:entrez_xref>10298</dto:entrez_xref>
		<dto:geneSymbol>PAK4</dto:geneSymbol>
		<obo:IAO_0000115>PAK proteins, a family of serine/threonine p21-activating kinases, include PAK1, PAK2, PAK3 and PAK4. PAK proteins are critical effectors that link Rho GTPases to cytoskeleton reorganization and nuclear signaling. They serve as targets for the small GTP binding proteins Cdc42 and Rac and have been implicated in a wide range of biological activities. PAK4 interacts specifically with the GTP-bound form of Cdc42Hs and weakly activates the JNK family of MAP kinases. PAK4 is a mediator of filopodia formation and may play a role in the reorganization of the actin cytoskeleton. Multiple alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>KIAA1142</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200388 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200388">
		<rdfs:label rdf:datatype="&xsd;string">PAK6 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400304"/>
		<dto:entrez_xref>56924</dto:entrez_xref>
		<dto:geneSymbol>PAK6</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of a family of p21-stimulated serine/threonine protein kinases, which contain an amino-terminal Cdc42/Rac interactive binding (CRIB) domain and a carboxyl-terminal kinase domain. These kinases function in a number of cellular processes, including cytoskeleton rearrangement, apoptosis, and the mitogen-activated protein (MAP) kinase signaling pathway. The protein encoded by this gene interacts with androgen receptor (AR) and translocates to the nucleus, where it is involved in transcriptional regulation. Changes in expression of this gene have been linked to prostate cancer. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2013]</obo:IAO_0000115>
		<dto:geneSynonym>PAK5</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200389 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200389">
		<rdfs:label rdf:datatype="&xsd;string">PAK7 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400304"/>
		<dto:entrez_xref>57144</dto:entrez_xref>
		<dto:geneSymbol>PAK7</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is a member of the PAK family of Ser/Thr protein kinases. PAK family members are known to be effectors of Rac/Cdc42 GTPases, which have been implicated in the regulation of cytoskeletal dynamics, proliferation, and cell survival signaling. This kinase contains a CDC42/Rac1 interactive binding (CRIB) motif, and has been shown to bind CDC42 in the presence of GTP. This kinase is predominantly expressed in brain. It is capable of promoting neurite outgrowth, and thus may play a role in neurite development. This kinase is associated with microtubule networks and induces microtubule stabilization. The subcellular localization of this kinase is tightly regulated during cell cycle progression. Alternatively spliced transcript variants encoding the same protein have been described. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>KIAA1264</dto:geneSynonym>
		<dto:geneSynonym>PAK5</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200390 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200390">
		<rdfs:label rdf:datatype="&xsd;string">PAN3 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400201"/>
		<dto:entrez_xref>255967</dto:entrez_xref>
		<dto:geneSymbol>PAN3</dto:geneSymbol>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200391 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200391">
		<rdfs:label rdf:datatype="&xsd;string">PANK1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491028"/>
		<dto:entrez_xref>53354</dto:entrez_xref>
		<dto:geneSymbol>PANK1</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the pantothenate kinase family. Pantothenate kinases are key regulatory enzymes in the biosynthesis of coenzyme A (CoA). The encoded protein catalyzes the first and rate-limiting enzymatic reaction in CoA biosynthesis and is regulated by CoA through feedback inhibition. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. This gene and an intronic miRNA on the same strand are co-regulated by the tumor suppressor p53 (see PMID 20833636). [provided by RefSeq, Apr 2011]</obo:IAO_0000115>
		<dto:geneSynonym>PANK</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200392 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200392">
		<rdfs:label rdf:datatype="&xsd;string">PASK gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400305"/>
		<dto:entrez_xref>23178</dto:entrez_xref>
		<dto:geneSymbol>PASK</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the serine/threonine kinase family that contains two PAS domains. Expression of this gene is regulated by glucose, and the encoded protein plays a role in the regulation of insulin gene expression. Downregulation of this gene may play a role in type 2 diabetes. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Nov 2011]</obo:IAO_0000115>
		<dto:geneSynonym>KIAA0135</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200393 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200393">
		<rdfs:label rdf:datatype="&xsd;string">PCK2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491022"/>
		<dto:entrez_xref>5106</dto:entrez_xref>
		<dto:geneSymbol>PCK2</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a mitochondrial enzyme that catalyzes the conversion of oxaloacetate to phosphoenolpyruvate in the presence of guanosine triphosphate (GTP). A cytosolic form of this protein is encoded by a different gene and is the key enzyme of gluconeogenesis in the liver. Alternatively spliced transcript variants have been described. [provided by RefSeq, Apr 2014]</obo:IAO_0000115>
		<dto:geneSynonym>PEPCK2</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200394 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200394">
		<rdfs:label rdf:datatype="&xsd;string">PDIK1L gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400202"/>
		<dto:entrez_xref>149420</dto:entrez_xref>
		<dto:geneSymbol>PDIK1L</dto:geneSymbol>
		<dto:geneSynonym>CLIK1L</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200395 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200395">
		<rdfs:label rdf:datatype="&xsd;string">PDK1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400131"/>
		<dto:entrez_xref>5163</dto:entrez_xref>
		<dto:geneSymbol>PDK1</dto:geneSymbol>
		<obo:IAO_0000115>Pyruvate dehydrogenase (PDH) is a mitochondrial multienzyme complex that catalyzes the oxidative decarboxylation of pyruvate and is one of the major enzymes responsible for the regulation of homeostasis of carbohydrate fuels in mammals. The enzymatic activity is regulated by a phosphorylation/dephosphorylation cycle. Phosphorylation of PDH by a specific pyruvate dehydrogenase kinase (PDK) results in inactivation. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jun 2013]</obo:IAO_0000115>
		<dto:geneSynonym>PDHK1</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200396 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200396">
		<rdfs:label rdf:datatype="&xsd;string">PDK2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400306"/>
		<dto:entrez_xref>5164</dto:entrez_xref>
		<dto:geneSymbol>PDK2</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the pyruvate dehydrogenase kinase family. The encoded protein phosphorylates pyruvate dehydrogenase, down-regulating the activity of the mitochondrial pyruvate dehydrogenase complex. Overexpression of this gene may play a role in both cancer and diabetes. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Dec 2010]</obo:IAO_0000115>
		<dto:geneSynonym>PDHK2</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200397 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200397">
		<rdfs:label rdf:datatype="&xsd;string">PDK3 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400131"/>
		<dto:entrez_xref>5165</dto:entrez_xref>
		<dto:geneSymbol>PDK3</dto:geneSymbol>
		<obo:IAO_0000115>The pyruvate dehydrogenase (PDH) complex is a nuclear-encoded mitochondrial multienzyme complex that catalyzes the overall conversion of pyruvate to acetyl-CoA and CO(2). It provides the primary link between glycolysis and the tricarboxylic acid (TCA) cycle, and thus is one of the major enzymes responsible for the regulation of glucose metabolism. The enzymatic activity of PDH is regulated by a phosphorylation/dephosphorylation cycle, and phosphorylation results in inactivation of PDH. The protein encoded by this gene is one of the three pyruvate dehydrogenase kinases that inhibits the PDH complex by phosphorylation of the E1 alpha subunit. This gene is predominantly expressed in the heart and skeletal muscles. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2010]</obo:IAO_0000115>
		<dto:geneSynonym>PDHK3</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200398 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200398">
		<rdfs:label rdf:datatype="&xsd;string">PDK4 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400131"/>
		<dto:entrez_xref>5166</dto:entrez_xref>
		<dto:geneSymbol>PDK4</dto:geneSymbol>
		<obo:IAO_0000115>This gene is a member of the PDK/BCKDK protein kinase family and encodes a mitochondrial protein with a histidine kinase domain. This protein is located in the matrix of the mitrochondria and inhibits the pyruvate dehydrogenase complex by phosphorylating one of its subunits, thereby contributing to the regulation of glucose metabolism. Expression of this gene is regulated by glucocorticoids, retinoic acid and insulin. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>PDHK4</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200399 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200399">
		<rdfs:label rdf:datatype="&xsd;string">PDPK1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400307"/>
		<dto:entrez_xref>5170</dto:entrez_xref>
		<dto:geneSymbol>PDPK1</dto:geneSymbol>
		<dto:geneSynonym>PDK1</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200400 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200400">
		<rdfs:label rdf:datatype="&xsd;string">PDPK2P gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400102"/>
		<dto:entrez_xref>653650</dto:entrez_xref>
		<dto:geneSymbol>PDPK2P</dto:geneSymbol>
		<dto:geneSynonym>PDPK2</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200401 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200401">
		<rdfs:label rdf:datatype="&xsd;string">PDXK gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491011"/>
		<dto:entrez_xref>8566</dto:entrez_xref>
		<dto:geneSymbol>PDXK</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene phosphorylates vitamin B6, a step required for the conversion of vitamin B6 to pyridoxal-5-phosphate, an important cofactor in intermediary metabolism. The encoded protein is cytoplasmic and probably acts as a homodimer. Alternatively spliced transcript variants have been described, but their biological validity has not been determined. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>C21orf124</dto:geneSynonym>
		<dto:geneSynonym>C21orf97</dto:geneSynonym>
		<dto:geneSynonym>PKH</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200402 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200402">
		<rdfs:label rdf:datatype="&xsd;string">PEAK1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400204"/>
		<dto:entrez_xref>79834</dto:entrez_xref>
		<dto:geneSymbol>PEAK1</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a non-receptor tyrosine kinase that is a member of the new kinase family three (NFK3) family. In migrating cells, the encoded protein is associated with the actin cytoskeleton and focal adhesions and promotes developing focal adhesion elongation. This protein may play a role in the regulation of cell migration, proliferation and cancer metastasis. [provided by RefSeq, Mar 2014]</obo:IAO_0000115>
		<dto:geneSynonym>KIAA2002</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200403 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200403">
		<rdfs:label rdf:datatype="&xsd;string">PDGFRA gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400141"/>
		<dto:entrez_xref>5156</dto:entrez_xref>
		<dto:geneSymbol>PDGFRA</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a cell surface tyrosine kinase receptor for members of the platelet-derived growth factor family. These growth factors are mitogens for cells of mesenchymal origin. The identity of the growth factor bound to a receptor monomer determines whether the functional receptor is a homodimer or a heterodimer, composed of both platelet-derived growth factor receptor alpha and beta polypeptides. Studies suggest that this gene plays a role in organ development, wound healing, and tumor progression. Mutations in this gene have been associated with idiopathic hypereosinophilic syndrome, somatic and familial gastrointestinal stromal tumors, and a variety of other cancers. [provided by RefSeq, Mar 2012]</obo:IAO_0000115>
		<dto:geneSynonym>PDGFR2</dto:geneSynonym>
		<dto:geneSynonym>RHEPDGFRA</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200404 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200404">
		<rdfs:label rdf:datatype="&xsd;string">PDGFRB gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400141"/>
		<dto:entrez_xref>5159</dto:entrez_xref>
		<dto:geneSymbol>PDGFRB</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a cell surface tyrosine kinase receptor for members of the platelet-derived growth factor family. These growth factors are mitogens for cells of mesenchymal origin. The identity of the growth factor bound to a receptor monomer determines whether the functional receptor is a homodimer or a heterodimer, composed of both platelet-derived growth factor receptor alpha and beta polypeptides. This gene is flanked on chromosome 5 by the genes for granulocyte-macrophage colony-stimulating factor and macrophage-colony stimulating factor receptor; all three genes may be implicated in the 5-q syndrome. A translocation between chromosomes 5 and 12, that fuses this gene to that of the translocation, ETV6, leukemia gene, results in chronic myeloproliferative disorder with eosinophilia. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>PDGFR</dto:geneSynonym>
		<dto:geneSynonym>PDGFR1</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200405 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200405">
		<rdfs:label rdf:datatype="&xsd;string">PGK1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491013"/>
		<dto:entrez_xref>5230</dto:entrez_xref>
		<dto:geneSymbol>PGK1</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is a glycolytic enzyme that catalyzes the conversion of 1,3-diphosphoglycerate to 3-phosphoglycerate. The encoded protein may also act as a cofactor for polymerase alpha. Additionally, this protein is secreted by tumor cells where it participates in angiogenesis by functioning to reduce disulfide bonds in the serine protease, plasmin, which consequently leads to the release of the tumor blood vessel inhibitor angiostatin. The encoded protein has been identified as a moonlighting protein based on its ability to perform mechanistically distinct functions. Deficiency of the enzyme is associated with a wide range of clinical phenotypes hemolytic anemia and neurological impairment. Pseudogenes of this gene have been defined on chromosomes 19, 21 and the X chromosome. [provided by RefSeq, Jan 2014]</obo:IAO_0000115>
		<dto:geneSynonym>PGKA</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200406 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200406">
		<rdfs:label rdf:datatype="&xsd;string">PHKG1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400205"/>
		<dto:entrez_xref>5260</dto:entrez_xref>
		<dto:geneSymbol>PHKG1</dto:geneSymbol>
		<obo:IAO_0000115>This gene is a member of the Ser/Thr protein kinase family and encodes a protein with one protein kinase domain and two calmodulin-binding domains. This protein is the catalytic member of a 16 subunit protein kinase complex which contains equimolar ratios of 4 subunit types. The complex is a crucial glycogenolytic regulatory enzyme. This gene has two pseudogenes at chromosome 7q11.21 and one at chromosome 11p11.12. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2012]</obo:IAO_0000115>
		<dto:geneSynonym>PHKG</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200407 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200407">
		<rdfs:label rdf:datatype="&xsd;string">PHKG2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400205"/>
		<dto:entrez_xref>5261</dto:entrez_xref>
		<dto:geneSymbol>PHKG2</dto:geneSymbol>
		<obo:IAO_0000115>Phosphorylase kinase is a polymer of 16 subunits, four each of alpha, beta, gamma and delta. The alpha subunit includes the skeletal muscle and hepatic isoforms, encoded by two different genes. The beta subunit is the same in both the muscle and hepatic isoforms, and encoded by one gene. The gamma subunit also includes the skeletal muscle and hepatic isoforms, and the hepatic isoform is encoded by this gene. The delta subunit is a calmodulin and can be encoded by three different genes. The gamma subunits contain the active site of the enzyme, whereas the alpha and beta subunits have regulatory functions controlled by phosphorylation. The delta subunit mediates the dependence of the enzyme on calcium concentration. Mutations in this gene cause glycogen storage disease type 9C, also known as autosomal liver glycogenosis. Alternatively spliced transcript variants encoding different isoforms have been identified in this gene.[provided by RefSeq, Feb 2010]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200408 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200408">
		<rdfs:label rdf:datatype="&xsd;string">PIK3R4 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400206"/>
		<dto:entrez_xref>30849</dto:entrez_xref>
		<dto:geneSymbol>PIK3R4</dto:geneSymbol>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200409 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200409">
		<rdfs:label rdf:datatype="&xsd;string">PIP4K2A gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400323"/>
		<dto:entrez_xref>5305</dto:entrez_xref>
		<dto:geneSymbol>PIP4K2A</dto:geneSymbol>
		<obo:IAO_0000115>Phosphatidylinositol-5,4-bisphosphate, the precursor to second messengers of the phosphoinositide signal transduction pathways, is thought to be involved in the regulation of secretion, cell proliferation, differentiation, and motility. The protein encoded by this gene is one of a family of enzymes capable of catalyzing the phosphorylation of phosphatidylinositol-5-phosphate on the fourth hydroxyl of the myo-inositol ring to form phosphatidylinositol-5,4-bisphosphate. The amino acid sequence of this enzyme does not show homology to other kinases, but the recombinant protein does exhibit kinase activity. This gene is a member of the phosphatidylinositol-5-phosphate 4-kinase family. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>PIP5K2</dto:geneSynonym>
		<dto:geneSynonym>PIP5K2A</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200410 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200410">
		<rdfs:label rdf:datatype="&xsd;string">PIP4K2B gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400323"/>
		<dto:entrez_xref>8396</dto:entrez_xref>
		<dto:geneSymbol>PIP4K2B</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene catalyzes the phosphorylation of phosphatidylinositol-5-phosphate on the fourth hydroxyl of the myo-inositol ring to form phosphatidylinositol-5,4-bisphosphate. This gene is a member of the phosphatidylinositol-5-phosphate 4-kinase family. The encoded protein sequence does not show similarity to other kinases, but the protein does exhibit kinase activity. Additionally, the encoded protein interacts with p55 TNF receptor. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>PIP5K2B</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200411 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200411">
		<rdfs:label rdf:datatype="&xsd;string">PIP4K2C gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400323"/>
		<dto:entrez_xref>79837</dto:entrez_xref>
		<dto:geneSymbol>PIP4K2C</dto:geneSymbol>
		<dto:geneSynonym>PIP5K2C</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200412 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200412">
		<rdfs:label rdf:datatype="&xsd;string">PI4KA gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491003"/>
		<dto:entrez_xref>5297</dto:entrez_xref>
		<dto:geneSymbol>PI4KA</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a phosphatidylinositol (PI) 4-kinase which catalyzes the first committed step in the biosynthesis of phosphatidylinositol 4,5-bisphosphate. The mammalian PI 4-kinases have been classified into two types, II and III, based on their molecular mass, and modulation by detergent and adenosine. The protein encoded by this gene is a type III enzyme that is not inhibited by adenosine. [provided by RefSeq, Sep 2014]</obo:IAO_0000115>
		<dto:geneSynonym>PIK4</dto:geneSynonym>
		<dto:geneSynonym>PIK4CA</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200413 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200413">
		<rdfs:label rdf:datatype="&xsd;string">PI4KB gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491009"/>
		<dto:entrez_xref>5298</dto:entrez_xref>
		<dto:geneSymbol>PI4KB</dto:geneSymbol>
		<dto:geneSynonym>PIK4CB</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200414 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200414">
		<rdfs:label rdf:datatype="&xsd;string">PIP5K1A gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400323"/>
		<dto:entrez_xref>8394</dto:entrez_xref>
		<dto:geneSymbol>PIP5K1A</dto:geneSymbol>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200415 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200415">
		<rdfs:label rdf:datatype="&xsd;string">PIP5K1B gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400323"/>
		<dto:entrez_xref>8395</dto:entrez_xref>
		<dto:geneSymbol>PIP5K1B</dto:geneSymbol>
		<dto:geneSynonym>STM7</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200416 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200416">
		<rdfs:label rdf:datatype="&xsd;string">PIP5K1C gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491012"/>
		<dto:entrez_xref>23396</dto:entrez_xref>
		<dto:geneSymbol>PIP5K1C</dto:geneSymbol>
		<obo:IAO_0000115>This locus encodes a type I phosphatidylinositol 4-phosphate 5-kinase. The encoded protein catalyzes phosphorylation of phosphatidylinositol 4-phosphate, producing phosphatidylinositol 4,5-bisphosphate. This enzyme is found at synapses and has been found to play roles in endocytosis and cell migration. Mutations at this locus have been associated with lethal congenital contractural syndrome. Alternatively spliced transcript variants encoding different isoforms have been described.[provided by RefSeq, Sep 2010]</obo:IAO_0000115>
		<dto:geneSynonym>KIAA0589</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200417 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200417">
		<rdfs:label rdf:datatype="&xsd;string">PIM1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400207"/>
		<dto:entrez_xref>5292</dto:entrez_xref>
		<dto:geneSymbol>PIM1</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene belongs to the Ser/Thr protein kinase family, and PIM subfamily. This gene is expressed primarily in B-lymphoid and myeloid cell lines, and is overexpressed in hematopoietic malignancies and in prostate cancer. It plays a role in signal transduction in blood cells, contributing to both cell proliferation and survival, and thus provides a selective advantage in tumorigenesis. Both the human and orthologous mouse genes have been reported to encode two isoforms (with preferential cellular localization) resulting from the use of alternative in-frame translation initiation codons, the upstream non-AUG (CUG) and downstream AUG codons (PMIDs:16186805, 1825810).[provided by RefSeq, Aug 2011]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200418 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200418">
		<rdfs:label rdf:datatype="&xsd;string">PIM2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400207"/>
		<dto:entrez_xref>11040</dto:entrez_xref>
		<dto:geneSymbol>PIM2</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a protooncogene that acts as a serine/threonine protein kinase. Studies determined the encoded protein functions to prevent apoptosis and to promote cell survival.[provided by RefSeq, Nov 2009]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200419 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200419">
		<rdfs:label rdf:datatype="&xsd;string">PIM3 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400207"/>
		<dto:entrez_xref>415116</dto:entrez_xref>
		<dto:geneSymbol>PIM3</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene belongs to the Ser/Thr protein kinase family, and PIM subfamily. This gene is overexpressed in hematological and epithelial tumors and is associated with MYC coexpression. It plays a role in the regulation of signal transduction cascades, contributing to both cell proliferation and survival, and provides a selective advantage in tumorigenesis. [provided by RefSeq, Jun 2012]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200420 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200420">
		<rdfs:label rdf:datatype="&xsd;string">PINK1 gene</rdfs:label>
		<dto:entrez_xref>65018</dto:entrez_xref>
		<dto:geneSymbol>PINK1</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a serine/threonine protein kinase that localizes to mitochondria. It is thought to protect cells from stress-induced mitochondrial dysfunction. Mutations in this gene cause one form of autosomal recessive early-onset Parkinson disease. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400208"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200421 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200421">
		<rdfs:label rdf:datatype="&xsd;string">PIK3C3 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491009"/>
		<dto:entrez_xref>5289</dto:entrez_xref>
		<dto:geneSymbol>PIK3C3</dto:geneSymbol>
		<dto:geneSynonym>VPS34</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200422 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200422">
		<rdfs:label rdf:datatype="&xsd;string">PIK3CA gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491009"/>
		<dto:entrez_xref>5290</dto:entrez_xref>
		<dto:geneSymbol>PIK3CA</dto:geneSymbol>
		<obo:IAO_0000115>Phosphatidylinositol 3-kinase is composed of an 85 kDa regulatory subunit and a 110 kDa catalytic subunit. The protein encoded by this gene represents the catalytic subunit, which uses ATP to phosphorylate PtdIns, PtdIns4P and PtdIns(4,5)P2. This gene has been found to be oncogenic and has been implicated in cervical cancers. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200423 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200423">
		<rdfs:label rdf:datatype="&xsd;string">PIK3CB gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491009"/>
		<dto:entrez_xref>5291</dto:entrez_xref>
		<dto:geneSymbol>PIK3CB</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes an isoform of the catalytic subunit of phosphoinositide 3-kinase (PI3K). These kinases are important in signaling pathways involving receptors on the outer membrane of eukaryotic cells and are named for their catalytic subunit. The encoded protein is the catalytic subunit for PI3Kbeta (PI3KB). PI3KB has been shown to be part of the activation pathway in neutrophils which have bound immune complexes at sites of injury or infection. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2011]</obo:IAO_0000115>
		<dto:geneSynonym>PIK3C1</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200424 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200424">
		<rdfs:label rdf:datatype="&xsd;string">PIK3CD gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491009"/>
		<dto:entrez_xref>5293</dto:entrez_xref>
		<dto:geneSymbol>PIK3CD</dto:geneSymbol>
		<obo:IAO_0000115>Phosphoinositide 3-kinases (PI3Ks) phosphorylate inositol lipids and are involved in the immune response. The protein encoded by this gene is a class I PI3K found primarily in leukocytes. Like other class I PI3Ks (p110-alpha p110-beta, and p110-gamma), the encoded protein binds p85 adapter proteins and GTP-bound RAS. However, unlike the other class I PI3Ks, this protein phosphorylates itself, not p85 protein.[provided by RefSeq, Jul 2010]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200425 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200425">
		<rdfs:label rdf:datatype="&xsd;string">PIK3CG gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491009"/>
		<dto:entrez_xref>5294</dto:entrez_xref>
		<dto:geneSymbol>PIK3CG</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a protein that belongs to the pi3/pi4-kinase family of proteins. The gene product is an enzyme that phosphorylates phosphoinositides on the 3-hydroxyl group of the inositol ring. It is an important modulator of extracellular signals, including those elicited by E-cadherin-mediated cell-cell adhesion, which plays an important role in maintenance of the structural and functional integrity of epithelia. In addition to its role in promoting assembly of adherens junctions, the protein is thought to play a pivotal role in the regulation of cytotoxicity in NK cells. The gene is located in a commonly deleted segment of chromosome 7 previously identified in myeloid leukemias. Several transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Sep 2013]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200426 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200426">
		<rdfs:label rdf:datatype="&xsd;string">PKDCC gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400209"/>
		<dto:entrez_xref>91461</dto:entrez_xref>
		<dto:geneSymbol>PKDCC</dto:geneSymbol>
		<dto:geneSynonym>SGK493</dto:geneSynonym>
		<dto:geneSynonym>VLK</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200427 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200427">
		<rdfs:label rdf:datatype="&xsd;string">PKN1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400210"/>
		<dto:entrez_xref>5585</dto:entrez_xref>
		<dto:geneSymbol>PKN1</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene belongs to the protein kinase C superfamily. This kinase is activated by Rho family of small G proteins and may mediate the Rho-dependent signaling pathway. This kinase can be activated by phospholipids and by limited proteolysis. The 3-phosphoinositide dependent protein kinase-1 (PDPK1/PDK1) is reported to phosphorylate this kinase, which may mediate insulin signals to the actin cytoskeleton. The proteolytic activation of this kinase by caspase-3 or related proteases during apoptosis suggests its role in signal transduction related to apoptosis. Alternatively spliced transcript variants encoding distinct isoforms have been observed. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>PAK1</dto:geneSynonym>
		<dto:geneSynonym>PKN</dto:geneSynonym>
		<dto:geneSynonym>PRK1</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200428 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200428">
		<rdfs:label rdf:datatype="&xsd;string">PKN2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400210"/>
		<dto:entrez_xref>5586</dto:entrez_xref>
		<dto:geneSymbol>PKN2</dto:geneSymbol>
		<dto:geneSynonym>PRK2</dto:geneSynonym>
		<dto:geneSynonym>PRKCL2</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200429 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200429">
		<rdfs:label rdf:datatype="&xsd;string">PKN3 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400210"/>
		<dto:entrez_xref>29941</dto:entrez_xref>
		<dto:geneSymbol>PKN3</dto:geneSymbol>
		<dto:geneSynonym>PKNBETA</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200430 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200430">
		<rdfs:label rdf:datatype="&xsd;string">PLK1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400211"/>
		<dto:entrez_xref>5347</dto:entrez_xref>
		<dto:geneSymbol>PLK1</dto:geneSymbol>
		<dto:geneSynonym>PLK</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200431 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200431">
		<rdfs:label rdf:datatype="&xsd;string">PLK2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400211"/>
		<dto:entrez_xref>10769</dto:entrez_xref>
		<dto:geneSymbol>PLK2</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is a member of the polo family of serine/threonine protein kinases that have a role in normal cell division. This gene is most abundantly expressed in testis, spleen and fetal tissues, and its expression is inducible by serum, suggesting that it may also play an important role in cells undergoing rapid cell division. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2011]</obo:IAO_0000115>
		<dto:geneSynonym>SNK</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200432 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200432">
		<rdfs:label rdf:datatype="&xsd;string">PLK3 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400211"/>
		<dto:entrez_xref>1263</dto:entrez_xref>
		<dto:geneSymbol>PLK3</dto:geneSymbol>
		<obo:IAO_0000115>Cytokine-inducible kinase is a putative serine/threonine kinase.  CNK contains both a catalytic domain and a putative regulatory domain.  It may play a role in regulation of cell cycle progression and tumorigenesis. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>CNK</dto:geneSynonym>
		<dto:geneSynonym>FNK</dto:geneSynonym>
		<dto:geneSynonym>PRK</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200433 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200433">
		<rdfs:label rdf:datatype="&xsd;string">PLK4 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400211"/>
		<dto:entrez_xref>10733</dto:entrez_xref>
		<dto:geneSymbol>PLK4</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the polo family of serine/threonine protein kinases. The protein localizes to centrioles, complex microtubule-based structures found in centrosomes, and regulates centriole duplication during the cell cycle. Three alternatively spliced transcript variants that encode different protein isoforms have been found for this gene. [provided by RefSeq, Jun 2010]</obo:IAO_0000115>
		<dto:geneSynonym>SAK</dto:geneSynonym>
		<dto:geneSynonym>STK18</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200434 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200434">
		<rdfs:label rdf:datatype="&xsd;string">PLK5 gene</rdfs:label>
		<dto:entrez_xref>126520</dto:entrez_xref>
		<dto:geneSymbol>PLK5</dto:geneSymbol>
		<dto:geneSynonym>PLK5P</dto:geneSynonym>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400308"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200435 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200435">
		<rdfs:label rdf:datatype="&xsd;string">PKMYT1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400212"/>
		<dto:entrez_xref>9088</dto:entrez_xref>
		<dto:geneSymbol>PKMYT1</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the serine/threonine protein kinase family. The encoded protein is a membrane-associated kinase that negatively regulates the G2/M transition of the cell cycle by phosphorylating and inactivating cyclin-dependent kinase 1. The activity of the encoded protein is regulated by polo-like kinase 1. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, May 2012]</obo:IAO_0000115>
		<dto:geneSynonym>MYT1</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200436 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200436">
		<rdfs:label rdf:datatype="&xsd;string">PRKDC gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400309"/>
		<dto:entrez_xref>5591</dto:entrez_xref>
		<dto:geneSymbol>PRKDC</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes the catalytic subunit of the DNA-dependent protein kinase (DNA-PK). It functions with the Ku70/Ku80 heterodimer protein in DNA double strand break repair and recombination. The protein encoded is a member of the PI3/PI4-kinase family.[provided by RefSeq, Jul 2010]</obo:IAO_0000115>
		<dto:geneSynonym>HYRC</dto:geneSynonym>
		<dto:geneSynonym>HYRC1</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200437 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200437">
		<rdfs:label rdf:datatype="&xsd;string">PRKRA gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491041"/>
		<dto:entrez_xref>8575</dto:entrez_xref>
		<dto:geneSymbol>PRKRA</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a protein kinase activated by double-stranded RNA which mediates the effects of interferon in response to viral infection. Mutations in this gene have been associated with dystonia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2008]</obo:IAO_0000115>
		<dto:geneSynonym>PACT</dto:geneSynonym>
		<dto:geneSynonym>RAX</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200438 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200438">
		<rdfs:label rdf:datatype="&xsd;string">PRKX gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400169"/>
		<dto:entrez_xref>5613</dto:entrez_xref>
		<dto:geneSymbol>PRKX</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a serine threonine protein kinase that has similarity to the catalytic subunit of cyclic AMP dependent protein kinases. The encoded protein is developmentally regulated and may be involved in renal epithelial morphogenesis. This protein may also be involved in macrophage and granulocyte maturation. Abnormal recombination between this gene and a related pseudogene on chromosome Y is a frequent cause of sex reversal disorder in XX males and XY females. Pseudogenes of this gene are found on chromosomes X, 15 and Y. [provided by RefSeq, Feb 2010]</obo:IAO_0000115>
		<dto:geneSynonym>PKX1</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200439 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200439">
		<rdfs:label rdf:datatype="&xsd;string">PRKY gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400169"/>
		<dto:entrez_xref>5616</dto:entrez_xref>
		<dto:geneSymbol>PRKY</dto:geneSymbol>
		<obo:IAO_0000115>This gene is similar to the protein kinase, X-linked gene in the pseudoautosomal region of the X chromosome. The gene is classified as a transcribed pseudogene because it has lost a coding exon that results in all transcripts being candidates for nonsense-mediated decay (NMD) and unlikely to express a protein. Abnormal recombination between this gene and a related gene on chromosome X is a frequent cause of XX males and XY females. [provided by RefSeq, Jul 2010]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200440 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200440">
		<rdfs:label rdf:datatype="&xsd;string">PRPF4B gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400150"/>
		<dto:entrez_xref>8899</dto:entrez_xref>
		<dto:geneSymbol>PRPF4B</dto:geneSymbol>
		<obo:IAO_0000115>Pre-mRNA splicing occurs in two sequential transesterification steps, and the protein encoded by this gene is thought to be involved in pre-mRNA splicing and in signal transduction. This protein belongs to a kinase family that includes serine/arginine-rich protein-specific kinases and cyclin-dependent kinases (CDKs). This protein is regarded as a CDK-like kinase (Clk) with homology to mitogen-activated protein kinases (MAPKs). [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>KIAA0536</dto:geneSynonym>
		<dto:geneSynonym>PRP4</dto:geneSynonym>
		<dto:geneSynonym>PRP4H</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200441 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200441">
		<rdfs:label rdf:datatype="&xsd;string">TP53RK gene</rdfs:label>
		<dto:entrez_xref>112858</dto:entrez_xref>
		<dto:geneSymbol>TP53RK</dto:geneSymbol>
		<dto:geneSynonym>C20orf64</dto:geneSynonym>
		<dto:geneSynonym>PRPK</dto:geneSynonym>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400213"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200442 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200442">
		<rdfs:label rdf:datatype="&xsd;string">PTK6 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400132"/>
		<dto:entrez_xref>5753</dto:entrez_xref>
		<dto:geneSymbol>PTK6</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is a cytoplasmic nonreceptor protein kinase which may function as an intracellular signal transducer in epithelial tissues. Overexpression of this gene in mammary epithelial cells leads to sensitization of the cells to epidermal growth factor and results in a partially transformed phenotype. Expression of this gene has been detected at low levels in some breast tumors but not in normal breast tissue. The encoded protein has been shown to undergo autophosphorylation. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2012]</obo:IAO_0000115>
		<dto:geneSynonym>BRK</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200443 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200443">
		<rdfs:label rdf:datatype="&xsd;string">PTK7 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400214"/>
		<dto:entrez_xref>5754</dto:entrez_xref>
		<dto:geneSymbol>PTK7</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the receptor protein tyrosine kinase family of proteins that transduce extracellular signals across the cell membrane. The encoded protein lacks detectable catalytic tyrosine kinase activity, is involved in the Wnt signaling pathway and plays a role in multiple cellular processes including polarity and adhesion. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Jul 2012]</obo:IAO_0000115>
		<dto:geneSynonym>CCK4</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200444 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200444">
		<rdfs:label rdf:datatype="&xsd;string">PXK gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400215"/>
		<dto:entrez_xref>54899</dto:entrez_xref>
		<dto:geneSymbol>PXK</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a phox (PX) domain-containing protein which may be involved in synaptic transmission and the ligand-induced internalization and degradation of epidermal growth factors. Variations in this gene may be associated with susceptibility to systemic lupus erythematosus (SLE). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2014]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200445 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200445">
		<rdfs:label rdf:datatype="&xsd;string">RAF1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400126"/>
		<dto:entrez_xref>5894</dto:entrez_xref>
		<dto:geneSymbol>RAF1</dto:geneSymbol>
		<obo:IAO_0000115>This gene is the cellular homolog of viral raf gene (v-raf). The encoded protein is a MAP kinase kinase kinase (MAP3K), which functions downstream of the Ras family of membrane associated GTPases to which it binds directly. Once activated, the cellular RAF1 protein can phosphorylate to activate the dual specificity protein kinases MEK1 and MEK2, which in turn phosphorylate to activate the serine/threonine specific protein kinases, ERK1 and ERK2. Activated ERKs are pleiotropic effectors of cell physiology and play an important role in the control of gene expression involved in the cell division cycle, apoptosis, cell differentiation and cell migration. Mutations in this gene are associated with Noonan syndrome 5 and LEOPARD syndrome 2. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>RAF</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200446 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200446">
		<rdfs:label rdf:datatype="&xsd;string">RET gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400216"/>
		<dto:entrez_xref>5979</dto:entrez_xref>
		<dto:geneSymbol>RET</dto:geneSymbol>
		<obo:IAO_0000115>This gene, a member of the cadherin superfamily, encodes one of the receptor tyrosine kinases, which are cell-surface molecules that transduce signals for cell growth and differentiation. This gene plays a crucial role in neural crest development, and it can undergo oncogenic activation in vivo and in vitro by cytogenetic rearrangement. Mutations in this gene are associated with the disorders multiple endocrine neoplasia, type IIA, multiple endocrine neoplasia, type IIB, Hirschsprung disease, and medullary thyroid carcinoma. Two transcript variants encoding different isoforms have been found for this gene. Additional transcript variants have been described but their biological validity has not been confirmed. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>CDHF12</dto:geneSynonym>
		<dto:geneSynonym>CDHR16</dto:geneSynonym>
		<dto:geneSynonym>PTC</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200448 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200448">
		<rdfs:label rdf:datatype="&xsd;string">RIOK2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400311"/>
		<dto:entrez_xref>55781</dto:entrez_xref>
		<dto:geneSymbol>RIOK2</dto:geneSymbol>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200450 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200450">
		<rdfs:label rdf:datatype="&xsd;string">RIPK1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400124"/>
		<dto:entrez_xref>8737</dto:entrez_xref>
		<dto:geneSymbol>RIPK1</dto:geneSymbol>
		<dto:geneSynonym>RIP</dto:geneSynonym>
		<dto:geneSynonym>RIP1</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200451 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200451">
		<rdfs:label rdf:datatype="&xsd;string">RIPK2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400124"/>
		<dto:entrez_xref>8767</dto:entrez_xref>
		<dto:geneSymbol>RIPK2</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the receptor-interacting protein (RIP) family of serine/threonine protein kinases. The encoded protein contains a C-terminal caspase activation and recruitment domain (CARD), and is a component of signaling complexes in both the innate and adaptive immune pathways. It is a potent activator of NF-kappaB and inducer of apoptosis in response to various stimuli. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>CARDIAK</dto:geneSynonym>
		<dto:geneSynonym>RICK</dto:geneSynonym>
		<dto:geneSynonym>RIP2</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200452 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200452">
		<rdfs:label rdf:datatype="&xsd;string">RIPK3 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400124"/>
		<dto:entrez_xref>11035</dto:entrez_xref>
		<dto:geneSymbol>RIPK3</dto:geneSymbol>
		<obo:IAO_0000115>The product of this gene is a member of the receptor-interacting protein (RIP) family of serine/threonine protein kinases, and contains a C-terminal domain unique from other RIP family members. The encoded protein is predominantly localized to the cytoplasm, and can undergo nucleocytoplasmic shuttling dependent on novel nuclear localization and export signals. It is a component of the tumor necrosis factor (TNF) receptor-I signaling complex, and can induce apoptosis and weakly activate the NF-kappaB transcription factor. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>RIP3</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200453 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200453">
		<rdfs:label rdf:datatype="&xsd;string">RIPK4 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400124"/>
		<dto:entrez_xref>54101</dto:entrez_xref>
		<dto:geneSymbol>RIPK4</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is a serine/threonine protein kinase that interacts with protein kinase C-delta. The encoded protein can also activate NFkappaB and is required for keratinocyte differentiation. This kinase undergoes autophosphorylation. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>ANKRD3</dto:geneSynonym>
		<dto:geneSynonym>DIK</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200454 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200454">
		<rdfs:label rdf:datatype="&xsd;string">GRK1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400271"/>
		<dto:entrez_xref>6011</dto:entrez_xref>
		<dto:geneSymbol>GRK1</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the guanine nucleotide-binding protein (G protein)-coupled receptor kinase subfamily of the Ser/Thr protein kinase family. The protein phosphorylates rhodopsin and initiates its deactivation. Defects in GRK1 are known to cause Oguchi disease 2 (also known as stationary night blindness Oguchi type-2). [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>RHOK</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200455 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200455">
		<rdfs:label rdf:datatype="&xsd;string">RNASEL gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400218"/>
		<dto:entrez_xref>6041</dto:entrez_xref>
		<dto:geneSymbol>RNASEL</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a component of the interferon-regulated 2-5A system that functions in the antiviral and antiproliferative roles of interferons. Mutations in this gene have been associated with predisposition to prostate cancer and this gene is a candidate for the hereditary prostate cancer 1 (HPC1) allele. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>RNS4</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200456 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200456">
		<rdfs:label rdf:datatype="&xsd;string">ROCK1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400313"/>
		<dto:entrez_xref>6093</dto:entrez_xref>
		<dto:geneSymbol>ROCK1</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a protein serine/threonine kinase that is activated when bound to the GTP-bound form of Rho. The small GTPase Rho regulates formation of focal adhesions and stress fibers of fibroblasts, as well as adhesion and aggregation of platelets and lymphocytes by shuttling between the inactive GDP-bound form and the active GTP-bound form. Rho is also essential in cytokinesis and plays a role in transcriptional activation by serum response factor. This protein, a downstream effector of Rho, phosphorylates and activates LIM kinase, which in turn, phosphorylates cofilin, inhibiting its actin-depolymerizing activity. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200457 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200457">
		<rdfs:label rdf:datatype="&xsd;string">ROCK2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400313"/>
		<dto:entrez_xref>9475</dto:entrez_xref>
		<dto:geneSymbol>ROCK2</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is a serine/threonine kinase that regulates cytokinesis, smooth muscle contraction, the formation of actin stress fibers and focal adhesions, and the activation of the c-fos serum response element. This protein, which is an isozyme of ROCK1 is a target for the small GTPase Rho. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>KIAA0619</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200458 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200458">
		<rdfs:label rdf:datatype="&xsd;string">MST1R gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400190"/>
		<dto:entrez_xref>4486</dto:entrez_xref>
		<dto:geneSymbol>MST1R</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a cell surface receptor for macrophage-stimulating protein (MSP) with tyrosine kinase activity. The mature form of this protein is a heterodimer of disulfide-linked alpha and beta subunits, generated by proteolytic cleavage of a single-chain precursor. The beta subunit undergoes tyrosine phosphorylation upon stimulation by MSP. This protein is expressed on the ciliated epithelia of the mucociliary transport apparatus of the lung, and together with MSP, thought to be involved in host defense. Alternatively spliced transcript variants encoding different isoforms with different structural and biochemical properties have been described (PMID:8816464). [provided by RefSeq, Oct 2011]</obo:IAO_0000115>
		<dto:geneSynonym>PTK8</dto:geneSynonym>
		<dto:geneSynonym>RON</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200459 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200459">
		<rdfs:label rdf:datatype="&xsd;string">ROR1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400219"/>
		<dto:entrez_xref>4919</dto:entrez_xref>
		<dto:geneSymbol>ROR1</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a receptor tyrosine kinase-like orphan receptor that modulates neurite growth in the central nervous system. The encoded protein is a glycosylated type I membrane protein that belongs to the ROR subfamily of cell surface receptors. It is a pseudokinase that lacks catalytic activity and may interact with the non-canonical Wnt signalling pathway. This gene is highly expressed during early embryonic development but expressed at very low levels in adult tissues. Increased expression of this gene is associated with B-cell chronic lymphocytic leukaemia. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jun 2012]</obo:IAO_0000115>
		<dto:geneSynonym>NTRKR1</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200460 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200460">
		<rdfs:label rdf:datatype="&xsd;string">ROR2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400219"/>
		<dto:entrez_xref>4920</dto:entrez_xref>
		<dto:geneSymbol>ROR2</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is a receptor protein tyrosine kinase and type I transmembrane protein that belongs to the ROR subfamily of cell surface receptors.  The protein may be involved in the early formation of the chondrocytes and may be required for cartilage and growth plate development.  Mutations in this gene can cause brachydactyly type B, a skeletal disorder characterized by hypoplasia/aplasia of distal phalanges and nails. In addition, mutations in this gene can cause the autosomal recessive form of Robinow syndrome, which is characterized by skeletal dysplasia with generalized limb bone shortening, segmental defects of the spine, brachydactyly, and a dysmorphic facial appearance. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>NTRKR2</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200461 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200461">
		<rdfs:label rdf:datatype="&xsd;string">ROS1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400220"/>
		<dto:entrez_xref>6098</dto:entrez_xref>
		<dto:geneSymbol>ROS1</dto:geneSymbol>
		<obo:IAO_0000115>This proto-oncogene, highly-expressed in a variety of tumor cell lines, belongs to the sevenless subfamily of tyrosine kinase insulin receptor genes. The protein encoded by this gene is a type I integral membrane protein with tyrosine kinase activity. The protein may function as a growth or differentiation factor receptor. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>MCF3</dto:geneSynonym>
		<dto:geneSynonym>ROS</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200462 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200462">
		<rdfs:label rdf:datatype="&xsd;string">RPS6KL1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400179"/>
		<dto:entrez_xref>83694</dto:entrez_xref>
		<dto:geneSymbol>RPS6KL1</dto:geneSymbol>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200463 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200463">
		<rdfs:label rdf:datatype="&xsd;string">RYK gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400221"/>
		<dto:entrez_xref>6259</dto:entrez_xref>
		<dto:geneSymbol>RYK</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is an atypical member of the family of growth factor receptor protein tyrosine kinases, differing from other members at a number of conserved residues in the activation and nucleotide binding domains. This gene product belongs to a subfamily whose members do not appear to be regulated by phosphorylation in the activation segment. It has been suggested that mediation of biological activity by recruitment of a signaling-competent auxiliary protein may occur through an as yet uncharacterized mechanism. The encoded protein has a leucine-rich extracellular domain with a WIF-type Wnt binding region, a single transmembrane domain, and an intracellular tyrosine kinase domain. This protein is involved in stimulating Wnt signaling pathways such as the regulation of axon pathfinding. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Feb 2012]</obo:IAO_0000115>
		<dto:geneSynonym>JTK5A</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200464 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200464">
		<rdfs:label rdf:datatype="&xsd;string">SBK1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400222"/>
		<dto:entrez_xref>388228</dto:entrez_xref>
		<dto:geneSymbol>SBK1</dto:geneSymbol>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200465 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200465">
		<rdfs:label rdf:datatype="&xsd;string">SBK2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400222"/>
		<dto:entrez_xref>646643</dto:entrez_xref>
		<dto:geneSymbol>SBK2</dto:geneSymbol>
		<dto:geneSynonym>SGK069</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200466 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200466">
		<rdfs:label rdf:datatype="&xsd;string">SBK3 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400222"/>
		<dto:entrez_xref>100130827</dto:entrez_xref>
		<dto:geneSymbol>SBK3</dto:geneSymbol>
		<dto:geneSynonym>SGK110</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200467 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200467">
		<rdfs:label rdf:datatype="&xsd;string">SCYL2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400199"/>
		<dto:entrez_xref>55681</dto:entrez_xref>
		<dto:geneSymbol>SCYL2</dto:geneSymbol>
		<dto:geneSynonym>CVAK104</dto:geneSynonym>
		<dto:geneSynonym>KIAA1360</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200468 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200468">
		<rdfs:label rdf:datatype="&xsd;string">POMK gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400218"/>
		<dto:entrez_xref>84197</dto:entrez_xref>
		<dto:geneSymbol>POMK</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a protein that may be involved in the presentation of the laminin-binding O-linked carbohydrate chain of alpha-dystroglycan (a-DG), which forms transmembrane linkages between the extracellular matrix and the exoskeleton. Some pathogens use this O-linked carbohydrate unit for host entry. Loss of function compound heterozygous mutations in this gene were found in a human patient affected by the Walker-Warburg syndrome (WWS) phenotype. Mice lacking this gene contain misplaced neurons (heterotopia) in some regions of the brain, possibly from defects in neuronal migration. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2013]</obo:IAO_0000115>
		<dto:geneSynonym>SGK196</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200469 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200469">
		<rdfs:label rdf:datatype="&xsd;string">SGK223 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400204"/>
		<dto:entrez_xref>157285</dto:entrez_xref>
		<dto:geneSymbol>SGK223</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes an enzyme that belongs to the tyrosine protein kinase family. A similar protein in rat binds to Rho family GTPase 2 (Rnd2) and regulates neurite outgrowth via activation of Ras homolog gene family, member A (RhoA). [provided by RefSeq, Mar 2014]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200470 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200470">
		<rdfs:label rdf:datatype="&xsd;string">SGK494 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400223"/>
		<dto:entrez_xref>124923</dto:entrez_xref>
		<dto:geneSymbol>SGK494</dto:geneSymbol>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200471 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200471">
		<rdfs:label rdf:datatype="&xsd;string">SGK1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400224"/>
		<dto:entrez_xref>6446</dto:entrez_xref>
		<dto:geneSymbol>SGK1</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a serine/threonine protein kinase that plays an important role in cellular stress response. This kinase activates certain potassium, sodium, and chloride channels, suggesting an involvement in the regulation of processes such as cell survival, neuronal excitability, and renal sodium excretion. High levels of expression of this gene may contribute to conditions such as hypertension and diabetic nephropathy. Several alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Jan 2009]</obo:IAO_0000115>
		<dto:geneSynonym>SGK</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200472 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200472">
		<rdfs:label rdf:datatype="&xsd;string">SGK2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400224"/>
		<dto:entrez_xref>10110</dto:entrez_xref>
		<dto:geneSymbol>SGK2</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a serine/threonine protein kinase. Although this gene product is similar to serum- and glucocorticoid-induced protein kinase (SGK), this gene is not induced by serum or glucocorticoids. This gene is induced in response to signals that activate phosphatidylinositol 3-kinase, which is also true for SGK. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2010]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200473 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200473">
		<rdfs:label rdf:datatype="&xsd;string">SGK3 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400224"/>
		<dto:entrez_xref>100533105</dto:entrez_xref>
		<dto:entrez_xref>23678</dto:entrez_xref>
		<dto:geneSymbol>SGK3</dto:geneSymbol>
		<obo:IAO_0000115>This gene is a member of the Ser/Thr protein kinase family and encodes a phosphoprotein with a PX (phox homology) domain. The protein phosphorylates several target proteins and has a role in neutral amino acid transport and activation of potassium and chloride channels. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>CISK</dto:geneSynonym>
		<dto:geneSynonym>SGKL</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200474 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200474">
		<rdfs:label rdf:datatype="&xsd;string">STKLD1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400225"/>
		<dto:entrez_xref>169436</dto:entrez_xref>
		<dto:geneSymbol>STKLD1</dto:geneSymbol>
		<dto:geneSynonym>C9orf96</dto:geneSynonym>
		<dto:geneSynonym>SGK071</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200475 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200475">
		<rdfs:label rdf:datatype="&xsd;string">SIK1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400314"/>
		<dto:entrez_xref>102724428</dto:entrez_xref>
		<dto:entrez_xref>150094</dto:entrez_xref>
		<dto:geneSymbol>SIK1</dto:geneSymbol>
		<dto:geneSynonym>SIK</dto:geneSynonym>
		<dto:geneSynonym>SNF1LK</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200476 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200476">
		<rdfs:label rdf:datatype="&xsd;string">SIK2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400314"/>
		<dto:entrez_xref>23235</dto:entrez_xref>
		<dto:geneSymbol>SIK2</dto:geneSymbol>
		<dto:geneSynonym>KIAA0781</dto:geneSynonym>
		<dto:geneSynonym>QIK</dto:geneSynonym>
		<dto:geneSynonym>SNF1LK2</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200477 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200477">
		<rdfs:label rdf:datatype="&xsd;string">SIK3 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400314"/>
		<dto:entrez_xref>23387</dto:entrez_xref>
		<dto:geneSymbol>SIK3</dto:geneSymbol>
		<dto:geneSynonym>KIAA0999</dto:geneSynonym>
		<dto:geneSynonym>QSK</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200478 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200478">
		<rdfs:label rdf:datatype="&xsd;string">SLK gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400315"/>
		<dto:entrez_xref>9748</dto:entrez_xref>
		<dto:geneSymbol>SLK</dto:geneSymbol>
		<dto:geneSynonym>KIAA0204</dto:geneSynonym>
		<dto:geneSynonym>STK2</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200479 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200479">
		<rdfs:label rdf:datatype="&xsd;string">SMG1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400129"/>
		<dto:entrez_xref>23049</dto:entrez_xref>
		<dto:geneSymbol>SMG1</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a protein involved in nonsense-mediated mRNA decay (NMD) as part of the mRNA surveillance complex. The protein has kinase activity and is thought to function in NMD by phosphorylating the regulator of nonsense transcripts 1 protein. Alternatively spliced transcript variants have been described, but their full-length nature has yet to be determined. [provided by RefSeq, Mar 2013]</obo:IAO_0000115>
		<dto:geneSynonym>ATX</dto:geneSynonym>
		<dto:geneSynonym>KIAA0421</dto:geneSynonym>
		<dto:geneSynonym>LIP</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200480 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200480">
		<rdfs:label rdf:datatype="&xsd;string">SNRK gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491038"/>
		<dto:entrez_xref>54861</dto:entrez_xref>
		<dto:geneSymbol>SNRK</dto:geneSymbol>
		<obo:IAO_0000115>SNRK is a member of the sucrose nonfermenting (SNF)-related kinase family of serine/threonine kinases (Kertesz et al., 2002 [PubMed 12234663]).[supplied by OMIM, Apr 2009]</obo:IAO_0000115>
		<dto:geneSynonym>KIAA0096</dto:geneSynonym>
		<dto:geneSynonym>SNFRK</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200481 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200481">
		<rdfs:label rdf:datatype="&xsd;string">SPEG gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400168"/>
		<dto:entrez_xref>10290</dto:entrez_xref>
		<dto:geneSymbol>SPEG</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a protein with similarity to members of the myosin light chain kinase family. This protein family is required for myocyte cytoskeletal development. Studies in mouse have determined that a lack of this protein affected myocardial development. Multiple alternatively spliced transcript variants have been reported for this gene, but the full-length nature of only two variants that encode different protein isoforms has been defined. [provided by RefSeq, Mar 2010]</obo:IAO_0000115>
		<dto:geneSynonym>APEG1</dto:geneSynonym>
		<dto:geneSynonym>KIAA1297</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200482 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200482">
		<rdfs:label rdf:datatype="&xsd;string">SPHK1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400323"/>
		<dto:entrez_xref>8877</dto:entrez_xref>
		<dto:geneSymbol>SPHK1</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene catalyzes the phosphorylation of sphingosine to form sphingosine-1-phosphate (S1P), a lipid mediator with both intra- and extracellular functions. Intracellularly, S1P regulates proliferation and survival, and extracellularly, it is a ligand for cell surface G protein-coupled receptors. This protein, and its product S1P, play a key role in TNF-alpha signaling and the NF-kappa-B activation pathway important in inflammatory, antiapoptotic, and immune processes. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2011]</obo:IAO_0000115>
		<dto:geneSynonym>SPHK</dto:geneSynonym>
		<dto:geneSynonym>SPK</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200483 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200483">
		<rdfs:label rdf:datatype="&xsd;string">SPHK2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400323"/>
		<dto:entrez_xref>56848</dto:entrez_xref>
		<dto:geneSymbol>SPHK2</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes one of two sphingosine kinase isozymes that catalyze the phosphorylation of sphingosine into sphingosine 1-phosphate. Sphingosine 1-phosphate mediates many cellular processes including migration, proliferation and apoptosis, and also plays a role in several types of cancer by promoting angiogenesis and tumorigenesis. The encoded protein may play a role in breast cancer proliferation and chemoresistance. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Aug 2011]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200484 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200484">
		<rdfs:label rdf:datatype="&xsd;string">SRC gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400132"/>
		<dto:entrez_xref>6714</dto:entrez_xref>
		<dto:geneSymbol>SRC</dto:geneSymbol>
		<obo:IAO_0000115>This gene is highly similar to the v-src gene of Rous sarcoma virus. This proto-oncogene may play a role in the regulation of embryonic development and cell growth. The protein encoded by this gene is a tyrosine-protein kinase whose activity can be inhibited by phosphorylation by c-SRC kinase. Mutations in this gene could be involved in the malignant progression of colon cancer. Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>SRC1</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200485 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200485">
		<rdfs:label rdf:datatype="&xsd;string">SRMS gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400132"/>
		<dto:entrez_xref>6725</dto:entrez_xref>
		<dto:geneSymbol>SRMS</dto:geneSymbol>
		<dto:geneSynonym>C20orf148</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200486 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200486">
		<rdfs:label rdf:datatype="&xsd;string">SRPK1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400226"/>
		<dto:entrez_xref>6732</dto:entrez_xref>
		<dto:geneSymbol>SRPK1</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a serine/arginine protein kinase specific for the SR (serine/arginine-rich domain) family of splicing factors. The protein localizes to the nucleus and the cytoplasm. It is thought to play a role in regulation of both constitutive and alternative splicing by regulating intracellular localization of splicing factors. Alternative splicing of this gene results in multiple transcript variants. Additional alternatively spliced transcript variants have been described for this gene, but their full length nature have not been determined.[provided by RefSeq, Jul 2010]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200487 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200487">
		<rdfs:label rdf:datatype="&xsd;string">SRPK2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400226"/>
		<dto:entrez_xref>6733</dto:entrez_xref>
		<dto:geneSymbol>SRPK2</dto:geneSymbol>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200488 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200488">
		<rdfs:label rdf:datatype="&xsd;string">SRPK3 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400226"/>
		<dto:entrez_xref>26576</dto:entrez_xref>
		<dto:geneSymbol>SRPK3</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a protein kinase similar to a protein kinase which is specific for the SR (serine/arginine-rich domain) family of splicing factors. A highly similar protein has been shown to play a role in muscle development in mice. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2009]</obo:IAO_0000115>
		<dto:geneSynonym>MSSK1</dto:geneSynonym>
		<dto:geneSynonym>STK23</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200489 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200489">
		<rdfs:label rdf:datatype="&xsd;string">STK17A gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400146"/>
		<dto:entrez_xref>9263</dto:entrez_xref>
		<dto:geneSymbol>STK17A</dto:geneSymbol>
		<obo:IAO_0000115>This gene is a member of the DAP kinase-related apoptosis-inducing protein kinase family and encodes an autophosphorylated nuclear protein with a protein kinase domain. The protein has apoptosis-inducing activity. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>DRAK1</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200490 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200490">
		<rdfs:label rdf:datatype="&xsd;string">STK17B gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400146"/>
		<dto:entrez_xref>9262</dto:entrez_xref>
		<dto:geneSymbol>STK17B</dto:geneSymbol>
		<dto:geneSynonym>DRAK2</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200491 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200491">
		<rdfs:label rdf:datatype="&xsd;string">STK32A gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400227"/>
		<dto:entrez_xref>202374</dto:entrez_xref>
		<dto:geneSymbol>STK32A</dto:geneSymbol>
		<dto:geneSynonym>YANK1</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200492 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200492">
		<rdfs:label rdf:datatype="&xsd;string">STK32B gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400227"/>
		<dto:entrez_xref>55351</dto:entrez_xref>
		<dto:geneSymbol>STK32B</dto:geneSymbol>
		<dto:geneSynonym>YANK2</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200493 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200493">
		<rdfs:label rdf:datatype="&xsd;string">STK32C gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400227"/>
		<dto:entrez_xref>282974</dto:entrez_xref>
		<dto:geneSymbol>STK32C</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is a member of the serine/threonine protein kinase family. The specific function of this kinase is not known. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>YANK3</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200494 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200494">
		<rdfs:label rdf:datatype="&xsd;string">STK38L gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400181"/>
		<dto:entrez_xref>23012</dto:entrez_xref>
		<dto:geneSymbol>STK38L</dto:geneSymbol>
		<dto:geneSynonym>KIAA0965</dto:geneSynonym>
		<dto:geneSynonym>NDR2</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200495 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200495">
		<rdfs:label rdf:datatype="&xsd;string">STK10 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400315"/>
		<dto:entrez_xref>6793</dto:entrez_xref>
		<dto:geneSymbol>STK10</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the Ste20 family of serine/threonine protein kinases, and is similar to several known polo-like kinase kinases. The protein can associate with and phosphorylate polo-like kinase 1, and overexpression of a kinase-dead version of the protein interferes with normal cell cycle progression. The kinase can also negatively regulate interleukin 2 expression in T-cells via the mitogen activated protein kinase kinase 1 pathway. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>LOK</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200496 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200496">
		<rdfs:label rdf:datatype="&xsd;string">STK11 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400316"/>
		<dto:entrez_xref>6794</dto:entrez_xref>
		<dto:geneSymbol>STK11</dto:geneSymbol>
		<obo:IAO_0000115>This gene, which encodes a member of the serine/threonine kinase family, regulates cell polarity and functions as a tumor suppressor. Mutations in this gene have been associated with Peutz-Jeghers syndrome, an autosomal dominant disorder characterized by the growth of polyps in the gastrointestinal tract, pigmented macules on the skin and mouth, and other neoplasms. Alternate transcriptional splice variants of this gene have been observed but have not been thoroughly characterized. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>LKB1</dto:geneSynonym>
		<dto:geneSynonym>PJS</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200497 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200497">
		<rdfs:label rdf:datatype="&xsd;string">STK16 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400115"/>
		<dto:entrez_xref>8576</dto:entrez_xref>
		<dto:geneSymbol>STK16</dto:geneSymbol>
		<dto:geneSynonym>MPSK1</dto:geneSynonym>
		<dto:geneSynonym>PKL12</dto:geneSynonym>
		<dto:geneSynonym>TSF1</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200498 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200498">
		<rdfs:label rdf:datatype="&xsd;string">STK24 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400297"/>
		<dto:entrez_xref>8428</dto:entrez_xref>
		<dto:geneSymbol>STK24</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a serine/threonine protein kinase that functions upstream of mitogen-activated protein kinase (MAPK) signaling. The encoded protein is cleaved into two chains by caspases; the N-terminal fragment (MST3/N) translocates to the nucleus and promotes programmed cells death. There is a pseudogene for this gene on chromosome X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2013]</obo:IAO_0000115>
		<dto:geneSynonym>MST3</dto:geneSynonym>
		<dto:geneSynonym>STK3</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200499 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200499">
		<rdfs:label rdf:datatype="&xsd;string">STK25 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400297"/>
		<dto:entrez_xref>10494</dto:entrez_xref>
		<dto:geneSymbol>STK25</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the germinal centre kinase III (GCK III) subfamily of the sterile 20 superfamily of kinases. The encoded enzyme plays a role in serine-threonine liver kinase B1 (LKB1) signaling pathway to regulate neuronal polarization and morphology of the Golgi apparatus. The protein is translocated from the Golgi apparatus to the nucleus in response to chemical anoxia and plays a role in regulation of cell death. A pseudogene associated with this gene is located on chromosome 18. Multiple alternatively spliced transcript variants have been observed for this gene. [provided by RefSeq, Dec 2012]</obo:IAO_0000115>
		<dto:geneSynonym>SOK1</dto:geneSynonym>
		<dto:geneSynonym>YSK1</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200500 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200500">
		<rdfs:label rdf:datatype="&xsd;string">STK31 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400218"/>
		<dto:entrez_xref>56164</dto:entrez_xref>
		<dto:geneSymbol>STK31</dto:geneSymbol>
		<obo:IAO_0000115>This gene is similar to a mouse gene that encodes a putative protein kinase with a tudor domain, and shows testis-specific expression. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>SGK396</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200501 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200501">
		<rdfs:label rdf:datatype="&xsd;string">STK33 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400135"/>
		<dto:entrez_xref>65975</dto:entrez_xref>
		<dto:geneSymbol>STK33</dto:geneSymbol>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200502 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200502">
		<rdfs:label rdf:datatype="&xsd;string">STK35 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400202"/>
		<dto:entrez_xref>140901</dto:entrez_xref>
		<dto:geneSymbol>STK35</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is a kinase that is predominantly found in the nucleus. However, it can interact with PDLIM1/CLP-36 in the cytoplasm and localize to actin stress fibers. The encoded protein may be a regulator of actin stress fibers in nonmuscle cells. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>CLIK1</dto:geneSynonym>
		<dto:geneSynonym>PDIK1</dto:geneSynonym>
		<dto:geneSynonym>STK35L1</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200503 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200503">
		<rdfs:label rdf:datatype="&xsd;string">STK36 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400228"/>
		<dto:entrez_xref>27148</dto:entrez_xref>
		<dto:geneSymbol>STK36</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the serine/threonine kinase family of enzymes. This family member is similar to a Drosophila protein that plays a key role in the Hedgehog signaling pathway. This human protein is a positive regulator of the GLI zinc-finger transcription factors. Knockout studies of the homologous mouse gene suggest that defects in this human gene may lead to congenital hydrocephalus, possibly due to a functional defect in motile cilia. Because Hedgehog signaling is frequently activated in certain kinds of gastrointestinal cancers, it has been suggested that this gene is a target for the treatment of these cancers. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Aug 2011]</obo:IAO_0000115>
		<dto:geneSynonym>KIAA1278</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200504 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200504">
		<rdfs:label rdf:datatype="&xsd;string">STK38 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400181"/>
		<dto:entrez_xref>11329</dto:entrez_xref>
		<dto:geneSymbol>STK38</dto:geneSymbol>
		<dto:geneSynonym>NDR1</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200505 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200505">
		<rdfs:label rdf:datatype="&xsd;string">STK39 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400302"/>
		<dto:entrez_xref>27347</dto:entrez_xref>
		<dto:geneSymbol>STK39</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a serine/threonine kinase that is thought to function in the cellular stress response pathway. The kinase is activated in response to hypotonic stress, leading to phosphorylation of several cation-chloride-coupled cotransporters. The catalytically active kinase specifically activates the p38 MAP kinase pathway, and its interaction with p38 decreases upon cellular stress, suggesting that this kinase may serve as an intermediate in the response to cellular stress. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>SPAK</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200506 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200506">
		<rdfs:label rdf:datatype="&xsd;string">STK3 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400317"/>
		<dto:entrez_xref>6788</dto:entrez_xref>
		<dto:geneSymbol>STK3</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a serine/threonine protein kinase activated by proapoptotic molecules indicating the encoded protein functions as a growth suppressor. Cleavage of the protein product by caspase removes the inhibitory C-terminal portion. The N-terminal portion is transported to the nucleus where it homodimerizes to form the active kinase which promotes the condensation of chromatin during apoptosis. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2012]</obo:IAO_0000115>
		<dto:geneSynonym>KRS1</dto:geneSynonym>
		<dto:geneSynonym>MST2</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200507 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200507">
		<rdfs:label rdf:datatype="&xsd;string">STK40 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400229"/>
		<dto:entrez_xref>83931</dto:entrez_xref>
		<dto:geneSymbol>STK40</dto:geneSymbol>
		<dto:geneSynonym>SGK495</dto:geneSynonym>
		<dto:geneSynonym>SHIK</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200508 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200508">
		<rdfs:label rdf:datatype="&xsd;string">STK4 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400317"/>
		<dto:entrez_xref>6789</dto:entrez_xref>
		<dto:geneSymbol>STK4</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is a cytoplasmic kinase that is structurally similar to the yeast Ste20p kinase, which acts upstream of the stress-induced mitogen-activated protein kinase cascade. The encoded protein can phosphorylate myelin basic protein and undergoes autophosphorylation. A caspase-cleaved fragment of the encoded protein has been shown to be capable of phosphorylating histone H2B. The particular phosphorylation catalyzed by this protein has been correlated with apoptosis, and it&apos;s possible that this protein induces the chromatin condensation observed in this process. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>KRS2</dto:geneSynonym>
		<dto:geneSynonym>MST1</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200509 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200509">
		<rdfs:label rdf:datatype="&xsd;string">STRADA gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400187"/>
		<dto:entrez_xref>92335</dto:entrez_xref>
		<dto:geneSymbol>STRADA</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene contains a STE20-like kinase domain, but lacks several residues that are critical for catalytic activity, so it is termed a &apos;pseudokinase&apos;. The protein forms a heterotrimeric complex with serine/threonine kinase 11 (STK11, also known as LKB1) and the scaffolding protein calcium binding protein 39 (CAB39, also known as MO25). The protein activates STK11 leading to the phosphorylation of both proteins and excluding STK11 from the nucleus. The protein is necessary for STK11-induced G1 cell cycle arrest. A mutation in this gene has been shown to result in polyhydramnios, megalencephaly, and symptomatic epilepsy (PMSE) syndrome. Multiple transcript variants encoding different isoforms have been found for this gene. Additional transcript variants have been described but their full-length nature is not known. [provided by RefSeq, Sep 2009]</obo:IAO_0000115>
		<dto:geneSynonym>LYK5</dto:geneSynonym>
		<dto:geneSynonym>STRAD</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200510 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200510">
		<rdfs:label rdf:datatype="&xsd;string">STRADB gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400187"/>
		<dto:entrez_xref>55437</dto:entrez_xref>
		<dto:geneSymbol>STRADB</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a protein that belongs to the serine/threonine protein kinase STE20 subfamily. One of the active site residues in the protein kinase domain of this protein is altered, and it is thus a pseudokinase. This protein is a component of a complex involved in the activation of serine/threonine kinase 11, a master kinase that regulates cell polarity and energy-generating metabolism. This complex regulates the relocation of this kinase from the nucleus to the cytoplasm, and it is essential for G1 cell cycle arrest mediated by this kinase. The protein encoded by this gene can also interact with the X chromosome-linked inhibitor of apoptosis protein, and this interaction enhances the anti-apoptotic activity of this protein via the JNK1 signal transduction pathway. Two pseudogenes, located on chromosomes 1 and 7, have been found for this gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2011]</obo:IAO_0000115>
		<dto:geneSynonym>ALS2CR2</dto:geneSynonym>
		<dto:geneSynonym>ILPIP</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200511 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200511">
		<rdfs:label rdf:datatype="&xsd;string">STYK1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400230"/>
		<dto:entrez_xref>55359</dto:entrez_xref>
		<dto:geneSymbol>STYK1</dto:geneSymbol>
		<obo:IAO_0000115>Receptor protein tyrosine kinases, like STYK1, play important roles in diverse cellular and developmental processes, such as cell proliferation, differentiation, and survival (Liu et al., 2004 [PubMed 15150103]).[supplied by OMIM, Mar 2008]</obo:IAO_0000115>
		<dto:geneSynonym>NOK</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200512 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200512">
		<rdfs:label rdf:datatype="&xsd;string">TAB1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491041"/>
		<dto:entrez_xref>10454</dto:entrez_xref>
		<dto:geneSymbol>TAB1</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene was identified as a regulator of the MAP kinase kinase kinase MAP3K7/TAK1, which is known to mediate various intracellular signaling pathways, such as those induced by TGF beta, interleukin 1, and WNT-1. This protein interacts and thus activates TAK1 kinase. It has been shown that the C-terminal portion of this protein is sufficient for binding and activation of TAK1, while a portion of the N-terminus acts as a dominant-negative inhibitor of TGF beta, suggesting that this protein may function as a mediator between TGF beta receptors and TAK1. This protein can also interact with and activate the mitogen-activated protein kinase 14 (MAPK14/p38alpha), and thus represents an alternative activation pathway, in addition to the MAPKK pathways, which contributes to the biological responses of MAPK14 to various stimuli. Alternatively spliced transcript variants encoding distinct isoforms have been reported. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>MAP3K7IP1</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200513 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200513">
		<rdfs:label rdf:datatype="&xsd;string">TAF1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400231"/>
		<dto:entrez_xref>6872</dto:entrez_xref>
		<dto:geneSymbol>TAF1</dto:geneSymbol>
		<obo:IAO_0000115>Initiation of transcription by RNA polymerase II requires the activities of more than 70 polypeptides. The protein that coordinates these activities is the basal transcription factor TFIID, which binds to the core promoter to position the polymerase properly, serves as the scaffold for assembly of the remainder of the transcription complex, and acts as a channel for regulatory signals. TFIID is composed of the TATA-binding protein (TBP) and a group of evolutionarily conserved proteins known as TBP-associated factors or TAFs. TAFs may participate in basal transcription, serve as coactivators, function in promoter recognition or modify general transcription factors (GTFs) to facilitate complex assembly and transcription initiation. This gene encodes the largest subunit of TFIID. This subunit binds to core promoter sequences encompassing the transcription start site. It also binds to activators and other transcriptional regulators, and these interactions affect the rate of transcription initiation. This subunit contains two independent protein kinase domains at the N- and C-terminals, but also possesses acetyltransferase activity and can act as a ubiquitin-activating/conjugating enzyme. Mutations in this gene result in Dystonia 3, torsion, X-linked, a dystonia-parkinsonism disorder. Alternative splicing of this gene results in multiple transcript variants. This gene is part of a complex transcription unit (TAF1/DYT3), wherein some transcript variants share exons with TAF1 as well as additional downstream DYT3 exons. [provided by RefSeq, Oct 2013]</obo:IAO_0000115>
		<dto:geneSynonym>BA2R</dto:geneSynonym>
		<dto:geneSynonym>CCG1</dto:geneSynonym>
		<dto:geneSynonym>CCGS</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200514 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200514">
		<rdfs:label rdf:datatype="&xsd;string">TAOK1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400318"/>
		<dto:entrez_xref>57551</dto:entrez_xref>
		<dto:geneSymbol>TAOK1</dto:geneSymbol>
		<dto:geneSynonym>KIAA1361</dto:geneSynonym>
		<dto:geneSynonym>MAP3K16</dto:geneSynonym>
		<dto:geneSynonym>MARKK</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200515 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200515">
		<rdfs:label rdf:datatype="&xsd;string">TAOK2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400318"/>
		<dto:entrez_xref>9344</dto:entrez_xref>
		<dto:geneSymbol>TAOK2</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a serine/threonine protein kinase that is involved in many different processes, including, cell signaling, microtubule organization and stability, and apoptosis. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Oct 2011]</obo:IAO_0000115>
		<dto:geneSynonym>KIAA0881</dto:geneSynonym>
		<dto:geneSynonym>MAP3K17</dto:geneSynonym>
		<dto:geneSynonym>PSK</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200516 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200516">
		<rdfs:label rdf:datatype="&xsd;string">TAOK3 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400318"/>
		<dto:entrez_xref>51347</dto:entrez_xref>
		<dto:geneSymbol>TAOK3</dto:geneSymbol>
		<dto:geneSynonym>DPK</dto:geneSynonym>
		<dto:geneSynonym>JIK</dto:geneSynonym>
		<dto:geneSynonym>KDS</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200517 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200517">
		<rdfs:label rdf:datatype="&xsd;string">TBCK gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400232"/>
		<dto:entrez_xref>93627</dto:entrez_xref>
		<dto:geneSymbol>TBCK</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a protein that contains a protein kinase domain, a Rhodanase-like domain and the Tre-2/Bub2/Cdc16 (TBC) domain. The encoded protein is thought to play a role in actin organization, cell growth and cell proliferation by regulating the mammalian target of the rapamycin (mTOR) signaling pathway. This protein may also be involved in the transcriptional regulation of the components of the mTOR complex. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2014]</obo:IAO_0000115>
		<dto:geneSynonym>TBCKL</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200518 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200518">
		<rdfs:label rdf:datatype="&xsd;string">TBK1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400164"/>
		<dto:entrez_xref>29110</dto:entrez_xref>
		<dto:geneSymbol>TBK1</dto:geneSymbol>
		<obo:IAO_0000115>The NF-kappa-B (NFKB) complex of proteins is inhibited by I-kappa-B (IKB) proteins, which inactivate NFKB by trapping it in the cytoplasm. Phosphorylation of serine residues on the IKB proteins by IKB kinases marks them for destruction via the ubiquitination pathway, thereby allowing activation and nuclear translocation of the NFKB complex. The protein encoded by this gene is similar to IKB kinases and can mediate NFKB activation in response to certain growth factors. [provided by RefSeq, Oct 2010]</obo:IAO_0000115>
		<dto:geneSynonym>NAK</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200519 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200519">
		<rdfs:label rdf:datatype="&xsd;string">TEC gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400133"/>
		<dto:entrez_xref>7006</dto:entrez_xref>
		<dto:geneSymbol>TEC</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene belongs to the Tec family of non-receptor protein-tyrosine kinases containing a pleckstrin homology domain. Tec family kinases are involved in the intracellular signaling mechanisms of cytokine receptors, lymphocyte surface antigens, heterotrimeric G-protein coupled receptors, and integrin molecules. They are also key players in the regulation of the immune functions. Tec kinase is an integral component of T cell signaling and has a distinct role in T cell activation. This gene may be associated with myelodysplastic syndrome. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>PSCTK4</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200520 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200520">
		<rdfs:label rdf:datatype="&xsd;string">TESK1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400319"/>
		<dto:entrez_xref>7016</dto:entrez_xref>
		<dto:geneSymbol>TESK1</dto:geneSymbol>
		<obo:IAO_0000115>This gene product is a serine/threonine protein kinase that contains an N-terminal protein kinase domain and a C-terminal proline-rich domain. Its protein kinase domain is most closely related to those of the LIM motif-containing protein kinases (LIMKs). The encoded protein can phosphorylate myelin basic protein and histone in vitro. The testicular germ cell-specific expression and developmental pattern of expression of the mouse gene suggests that this gene plays an important role at and after the meiotic phase of spermatogenesis. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200521 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200521">
		<rdfs:label rdf:datatype="&xsd;string">TESK2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400182"/>
		<dto:entrez_xref>10420</dto:entrez_xref>
		<dto:geneSymbol>TESK2</dto:geneSymbol>
		<obo:IAO_0000115>This gene product is a serine/threonine protein kinase that contains an N-terminal protein kinase domain that is structurally similar to the kinase domains of testis-specific protein kinase-1 and the LIM motif-containing protein kinases (LIMKs). Its overall structure is most related to the former, indicating that it belongs to the TESK subgroup of the LIMK/TESK family of protein kinases. This gene is predominantly expressed in testis and prostate. The developmental expression pattern of the rat gene in testis suggests an important role for this gene in meitoic stages and/or early stages of spermiogenesis. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200522 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200522">
		<rdfs:label rdf:datatype="&xsd;string">TEX14 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400233"/>
		<dto:entrez_xref>56155</dto:entrez_xref>
		<dto:geneSymbol>TEX14</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is necessary for intercellular bridges in germ cells, which are required for spermatogenesis. Three transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Jan 2011]</obo:IAO_0000115>
		<dto:geneSynonym>SGK307</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200523 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200523">
		<rdfs:label rdf:datatype="&xsd;string">TGFBR1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400246"/>
		<dto:entrez_xref>7046</dto:entrez_xref>
		<dto:geneSymbol>TGFBR1</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene forms a heteromeric complex with type II TGF-beta receptors when bound to TGF-beta, transducing the TGF-beta signal from the cell surface to the cytoplasm. The encoded protein is a serine/threonine protein kinase. Mutations in this gene have been associated with Loeys-Dietz aortic aneurysm syndrome (LDAS). Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2008]</obo:IAO_0000115>
		<dto:geneSynonym>ALK5</dto:geneSynonym>
		<dto:geneSynonym>SKR4</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200524 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200524">
		<rdfs:label rdf:datatype="&xsd;string">TGFBR2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400252"/>
		<dto:entrez_xref>7048</dto:entrez_xref>
		<dto:geneSymbol>TGFBR2</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the Ser/Thr protein kinase family and the TGFB receptor subfamily. The encoded protein is a transmembrane protein that has a protein kinase domain, forms a heterodimeric complex with another receptor protein, and binds TGF-beta. This receptor/ligand complex phosphorylates proteins, which then enter the nucleus and regulate the transcription of a subset of genes related to cell proliferation. Mutations in this gene have been associated with Marfan Syndrome, Loeys-Deitz Aortic Aneurysm Syndrome, and the development of various types of tumors. Alternatively spliced transcript variants encoding different isoforms have been characterized. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200525 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200525">
		<rdfs:label rdf:datatype="&xsd;string">TIE1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400234"/>
		<dto:entrez_xref>7075</dto:entrez_xref>
		<dto:geneSymbol>TIE1</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the tyrosine protein kinase family. The encoded protein plays a critical role in angiogenesis and blood vessel stability by inhibiting angiopoietin 1 signaling through the endothelial receptor tyrosine kinase Tie2. Ectodomain cleavage of the encoded protein relieves inhibition of Tie2 and is mediated by multiple factors including vascular endothelial growth factor. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Nov 2011]</obo:IAO_0000115>
		<dto:geneSynonym>TIE</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200526 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200526">
		<rdfs:label rdf:datatype="&xsd;string">TEK gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400234"/>
		<dto:entrez_xref>7010</dto:entrez_xref>
		<dto:geneSymbol>TEK</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a receptor that belongs to the protein tyrosine kinase Tie2 family. The encoded protein possesses a unique extracellular region that contains two immunoglobulin-like domains, three epidermal growth factor (EGF)-like domains and three fibronectin type III repeats. The ligand angiopoietin-1 binds to this receptor and mediates a signaling pathway that functions in embryonic vascular development. Mutations in this gene are associated with inherited venous malformations of the skin and mucous membranes. Alternative splicing results in multiple transcript variants. Additional alternatively spliced transcript variants of this gene have been described, but their full-length nature is not known. [provided by RefSeq, Feb 2014]</obo:IAO_0000115>
		<dto:geneSynonym>TIE2</dto:geneSynonym>
		<dto:geneSynonym>VMCM</dto:geneSynonym>
		<dto:geneSynonym>VMCM1</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200527 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200527">
		<rdfs:label rdf:datatype="&xsd;string">TTN gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400196"/>
		<dto:entrez_xref>7273</dto:entrez_xref>
		<dto:geneSymbol>TTN</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a large abundant protein of striated muscle. The product of this gene is divided into two regions, a N-terminal I-band and a C-terminal A-band. The I-band, which is the elastic part of the molecule, contains two regions of tandem immunoglobulin domains on either side of a PEVK region that is rich in proline, glutamate, valine and lysine. The A-band, which is thought to act as a protein-ruler, contains a mixture of immunoglobulin and fibronectin repeats, and possesses kinase activity. An N-terminal Z-disc region and a C-terminal M-line region bind to the Z-line and M-line of the sarcomere, respectively, so that a single titin molecule spans half the length of a sarcomere. Titin also contains binding sites for muscle associated proteins so it serves as an adhesion template for the assembly of contractile machinery in muscle cells. It has also been identified as a structural protein for chromosomes. Alternative splicing of this gene results in multiple transcript variants. Considerable variability exists in the I-band, the M-line and the Z-disc regions of titin. Variability in the I-band region contributes to the differences in elasticity of different titin isoforms and, therefore, to the differences in elasticity of different muscle types. Mutations in this gene are associated with familial hypertrophic cardiomyopathy 9, and autoantibodies to titin are produced in patients with the autoimmune disease scleroderma. [provided by RefSeq, Feb 2012]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200528 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200528">
		<rdfs:label rdf:datatype="&xsd;string">TLK1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400235"/>
		<dto:entrez_xref>9874</dto:entrez_xref>
		<dto:geneSymbol>TLK1</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is a serine/threonine kinase that may be involved in the regulation of chromatin assembly. The encoded protein is only active when it is phosphorylated, and this phosphorylation is cell cycle-dependent, with the maximal activity of this protein coming during S phase. The catalytic activity of this protein is diminished by DNA damage and by blockage of DNA replication. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2011]</obo:IAO_0000115>
		<dto:geneSynonym>KIAA0137</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200529 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200529">
		<rdfs:label rdf:datatype="&xsd;string">TLK2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400235"/>
		<dto:entrez_xref>11011</dto:entrez_xref>
		<dto:geneSymbol>TLK2</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a nuclear serine/threonine kinase that was first identified in Arabidopsis. The encoded protein is thought to function in the regulation of chromatin assembly in the S phase of the cell cycle by regulating the levels of a histone H3/H4 chaperone. This protein is associated with double-strand break repair of DNA damage caused by radiation. Pseudogenes of this gene are present on chromosomes 10 and 17. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Sep 2013]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200530 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200530">
		<rdfs:label rdf:datatype="&xsd;string">TNNI3K gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400320"/>
		<dto:entrez_xref>100526835</dto:entrez_xref>
		<dto:entrez_xref>51086</dto:entrez_xref>
		<dto:geneSymbol>TNNI3K</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a protein that belongs to the MAP kinase kinase kinase (MAPKKK) family of protein kinases. The protein contains ankyrin repeat, protein kinase and serine-rich domains and is thought to play a role in cardiac physiology. [provided by RefSeq, Sep 2012]</obo:IAO_0000115>
		<dto:geneSynonym>CARK</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200531 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200531">
		<rdfs:label rdf:datatype="&xsd;string">TNIK gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400288"/>
		<dto:entrez_xref>23043</dto:entrez_xref>
		<dto:geneSymbol>TNIK</dto:geneSymbol>
		<obo:IAO_0000115>Germinal center kinases (GCKs), such as TNIK, are characterized by an N-terminal kinase domain and a C-terminal GCK domain that serves a regulatory function (Fu et al., 1999 [PubMed 10521462]).[supplied by OMIM, Mar 2008]</obo:IAO_0000115>
		<dto:geneSynonym>KIAA0551</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200532 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200532">
		<rdfs:label rdf:datatype="&xsd;string">TNK1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400118"/>
		<dto:entrez_xref>8711</dto:entrez_xref>
		<dto:geneSymbol>TNK1</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene belongs to the tyrosine protein kinase family. Tyrosine protein kinases are important regulators of intracellular signal transduction pathways, mediating cellular proliferation, survival, and development. This gene is highly expressed in fetal tissues and at lower levels in few adult tissues, thus may function in signaling pathways utilized broadly during fetal development, and more selectively in adult tissues. It plays a negative regulatory role in the Ras-Raf1-MAPK pathway, and knockout mice have been shown to develop spontaneous tumors, suggesting a role as a tumor suppressor gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2011]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200533 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200533">
		<rdfs:label rdf:datatype="&xsd;string">PBK gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400236"/>
		<dto:entrez_xref>55872</dto:entrez_xref>
		<dto:geneSymbol>PBK</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a serine/threonine protein kinase related to the dual specific mitogen-activated protein kinase kinase (MAPKK) family. Evidence suggests that mitotic phosphorylation is required for its catalytic activity. The encoded protein may be involved in the activation of lymphoid cells and support testicular functions, with a suggested role in the process of spermatogenesis. Overexpression of this gene has been implicated in tumorigenesis. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013]</obo:IAO_0000115>
		<dto:geneSynonym>TOPK</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200534 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200534">
		<rdfs:label rdf:datatype="&xsd;string">TPK1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491023"/>
		<dto:entrez_xref>27010</dto:entrez_xref>
		<dto:geneSymbol>TPK1</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a protein, that exists as a homodimer, which catalyzes the conversion of thiamine to thiamine pyrophosphate. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200535 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200535">
		<rdfs:label rdf:datatype="&xsd;string">TRIB1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400237"/>
		<dto:entrez_xref>10221</dto:entrez_xref>
		<dto:geneSymbol>TRIB1</dto:geneSymbol>
		<dto:geneSynonym>C8FW</dto:geneSynonym>
		<dto:geneSynonym>GIG2</dto:geneSynonym>
		<dto:geneSynonym>TRB1</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200536 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200536">
		<rdfs:label rdf:datatype="&xsd;string">TRIB2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400237"/>
		<dto:entrez_xref>28951</dto:entrez_xref>
		<dto:geneSymbol>TRIB2</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes one of three members of the Tribbles family. The Tribbles members share a Trb domain, which is homologous to protein serine-threonine kinases, but lacks the active site lysine and probably lacks a catalytic function. The Tribbles proteins interact and modulate the activity of signal transduction pathways in a number of physiological and pathological processes. This Tribbles member induces apoptosis of cells mainly of the hematopoietic origin. It has been identified as a protein up-regulated by inflammatory stimuli in myeloid (THP-1) cells, and also as an oncogene that inactivates the transcription factor C/EBPalpha (CCAAT/enhancer-binding protein alpha) and causes acute myelogenous leukemia. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Mar 2009]</obo:IAO_0000115>
		<dto:geneSynonym>TRB2</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200537 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200537">
		<rdfs:label rdf:datatype="&xsd;string">TRIB3 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400237"/>
		<dto:entrez_xref>57761</dto:entrez_xref>
		<dto:geneSymbol>TRIB3</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is a putative protein kinase that is induced by the transcription factor NF-kappaB. The encoded protein is a negative regulator of NF-kappaB and can also sensitize cells to TNF- and TRAIL-induced apoptosis. In addition, this protein can negatively regulate the cell survival serine-threonine kinase AKT1. Differential promoter usage and alternate splicing result in multiple transcript variants. [provided by RefSeq, Jul 2014]</obo:IAO_0000115>
		<dto:geneSynonym>C20orf97</dto:geneSynonym>
		<dto:geneSynonym>NIPK</dto:geneSynonym>
		<dto:geneSynonym>SKIP3</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200538 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200538">
		<rdfs:label rdf:datatype="&xsd;string">TRIO gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400168"/>
		<dto:entrez_xref>7204</dto:entrez_xref>
		<dto:geneSymbol>TRIO</dto:geneSymbol>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200539 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200539">
		<rdfs:label rdf:datatype="&xsd;string">TRPM6 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400321"/>
		<dto:entrez_xref>140803</dto:entrez_xref>
		<dto:geneSymbol>TRPM6</dto:geneSymbol>
		<obo:IAO_0000115>This gene is predominantly expressed in the kidney and colon, and encodes a protein containing an ion channel domain and a protein kinase domain. It is crucial for magnesium homeostasis, and plays an essential role in epithelial magnesium transport and in the active magnesium absorption in the gut and kidney. Mutations in this gene are associated with hypomagnesemia with secondary hypocalcemia. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Apr 2010]</obo:IAO_0000115>
		<dto:geneSynonym>CHAK2</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200540 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200540">
		<rdfs:label rdf:datatype="&xsd;string">TSSK1B gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400238"/>
		<dto:entrez_xref>83942</dto:entrez_xref>
		<dto:geneSymbol>TSSK1B</dto:geneSymbol>
		<obo:IAO_0000115>TSSK1 belongs to a family of serine/threonine kinases highly expressed in testis (Hao et al., 2004 [PubMed 15044604]).[supplied by OMIM, Mar 2008]</obo:IAO_0000115>
		<dto:geneSynonym>SPOGA1</dto:geneSynonym>
		<dto:geneSynonym>SPOGA4</dto:geneSynonym>
		<dto:geneSynonym>STK22A</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200541 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200541">
		<rdfs:label rdf:datatype="&xsd;string">TSSK2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400238"/>
		<dto:entrez_xref>23617</dto:entrez_xref>
		<dto:geneSymbol>TSSK2</dto:geneSymbol>
		<obo:IAO_0000115>TSSK2 belongs to a family of serine/threonine kinases highly expressed in testis (Hao et al., 2004 [PubMed 15044604]).[supplied by OMIM, Mar 2008]</obo:IAO_0000115>
		<dto:geneSynonym>DGSG</dto:geneSynonym>
		<dto:geneSynonym>SPOGA2</dto:geneSynonym>
		<dto:geneSynonym>STK22B</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200542 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200542">
		<rdfs:label rdf:datatype="&xsd;string">TSSK3 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400238"/>
		<dto:entrez_xref>81629</dto:entrez_xref>
		<dto:geneSymbol>TSSK3</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a kinase expressed exclusively in the testis that is thought to play a role in either germ cell differentiation or mature sperm function. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>SPOGA3</dto:geneSynonym>
		<dto:geneSynonym>STK22C</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200543 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200543">
		<rdfs:label rdf:datatype="&xsd;string">TSSK4 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400238"/>
		<dto:entrez_xref>283629</dto:entrez_xref>
		<dto:geneSymbol>TSSK4</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the testis-specific serine/threonine kinase family. The encoded protein is thought to be involved in spermatogenesis via stimulation of the CREB/CRE responsive pathway through phosphorylation of the cAMP responsive element binding protein transcription factor. Alternative splicing results in multiple transcript variants.[provided by RefSeq, May 2010]</obo:IAO_0000115>
		<dto:geneSynonym>C14orf20</dto:geneSynonym>
		<dto:geneSynonym>STK22E</dto:geneSynonym>
		<dto:geneSynonym>TSSK5</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200544 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200544">
		<rdfs:label rdf:datatype="&xsd;string">TSSK6 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400238"/>
		<dto:entrez_xref>83983</dto:entrez_xref>
		<dto:geneSymbol>TSSK6</dto:geneSymbol>
		<obo:IAO_0000115>This intronless gene encodes a member of the CAMK (calcium/calmodulin-dependent) serine/threonine protein kinase family. The encoded kinase has a broad expression pattern but is described as testis-specific due to effects on fertility. Male mice which lack the gene encoding a highly similar protein are sterile and have morphologically abnormal sperm. [provided by RefSeq, Jan 2012]</obo:IAO_0000115>
		<dto:geneSynonym>SSTK</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200545 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200545">
		<rdfs:label rdf:datatype="&xsd;string">TTBK1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400239"/>
		<dto:entrez_xref>84630</dto:entrez_xref>
		<dto:geneSymbol>TTBK1</dto:geneSymbol>
		<dto:geneSynonym>BDTK</dto:geneSynonym>
		<dto:geneSynonym>KIAA1855</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200546 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200546">
		<rdfs:label rdf:datatype="&xsd;string">TTBK2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400239"/>
		<dto:entrez_xref>146057</dto:entrez_xref>
		<dto:geneSymbol>TTBK2</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a serine-threonine kinase that putatively phosphorylates tau and tubulin proteins. Mutations in this gene cause spinocerebellar ataxia type 11 (SCA11); a neurodegenerative disease characterized by progressive ataxia and atrophy of the cerebellum and brainstem. [provided by RefSeq, Aug 2009]</obo:IAO_0000115>
		<dto:geneSynonym>KIAA0847</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200547 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200547">
		<rdfs:label rdf:datatype="&xsd;string">TTK gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400240"/>
		<dto:entrez_xref>7272</dto:entrez_xref>
		<dto:geneSymbol>TTK</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a dual specificity protein kinase with the ability to phosphorylate tyrosine, serine and threonine. Associated with cell proliferation, this protein is essential for chromosome alignment at the centromere during mitosis and is required for centrosome duplication. It has been found to be a critical mitotic checkpoint protein for accurate segregation of chromosomes during mitosis. Tumorigenesis may occur when this protein fails to degrade and produces excess centrosomes resulting in aberrant mitotic spindles. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2009]</obo:IAO_0000115>
		<dto:geneSynonym>MPS1</dto:geneSynonym>
		<dto:geneSynonym>MPS1L1</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200548 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200548">
		<rdfs:label rdf:datatype="&xsd;string">TXK gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400133"/>
		<dto:entrez_xref>7294</dto:entrez_xref>
		<dto:geneSymbol>TXK</dto:geneSymbol>
		<dto:geneSynonym>PTK4</dto:geneSynonym>
		<dto:geneSynonym>RLK</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200549 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200549">
		<rdfs:label rdf:datatype="&xsd;string">TYK2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400167"/>
		<dto:entrez_xref>7297</dto:entrez_xref>
		<dto:geneSymbol>TYK2</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the tyrosine kinase and, more specifically, the Janus kinases (JAKs) protein families. This protein associates with the cytoplasmic domain of type I and type II cytokine receptors and promulgate cytokine signals by phosphorylating receptor subunits. It is also component of both the type I and type III interferon signaling pathways. As such, it may play a role in anti-viral immunity. A mutation in this gene has been associated with hyperimmunoglobulin E syndrome (HIES) - a primary immunodeficiency characterized by elevated serum immunoglobulin E. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200550 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200550">
		<rdfs:label rdf:datatype="&xsd;string">TYRO3 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400189"/>
		<dto:entrez_xref>7301</dto:entrez_xref>
		<dto:geneSymbol>TYRO3</dto:geneSymbol>
		<obo:IAO_0000115>The gene is part of a 3-member transmembrane receptor kinase receptor family with a processed pseudogene distal on chromosome 15. The encoded protein is activated by the products of the growth arrest-specific gene 6 and protein S genes and is involved in controlling cell survival and proliferation, spermatogenesis, immunoregulation and phagocytosis. The encoded protein has also been identified as a cell entry factor for Ebola and Marburg viruses. [provided by RefSeq, May 2010]</obo:IAO_0000115>
		<dto:geneSynonym>BYK</dto:geneSynonym>
		<dto:geneSynonym>DTK</dto:geneSynonym>
		<dto:geneSynonym>RSE</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200551 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200551">
		<rdfs:label rdf:datatype="&xsd;string">UCK1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491024"/>
		<dto:entrez_xref>83549</dto:entrez_xref>
		<dto:geneSymbol>UCK1</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a uridine-cytidine kinase that catalyzes the phosphorylation of uridine and cytidine to uridine monophosphate (UMP) and cytidine monophosphate (CMP) but not the phosphorylation of deoxyribonucleosides or purine ribonucleosides. This enzyme can also phosphorylate uridine and cytidine analogs and uses both ATP and GTP as a phosphate donor. Alternative splicing results in multiple splice variants encoding distinct isoforms. [provided by RefSeq, May 2012]</obo:IAO_0000115>
		<dto:geneSynonym>URK1</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200552 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200552">
		<rdfs:label rdf:datatype="&xsd;string">UCK2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491024"/>
		<dto:entrez_xref>7371</dto:entrez_xref>
		<dto:geneSymbol>UCK2</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a pyrimidine ribonucleoside kinase. The encoded protein (EC 2.7.1.48) catalyzes phosphorylation of uridine and cytidine to uridine monophosphate (UMP) and cytidine monophosphate (CMP), respectively.[provided by RefSeq, Oct 2010]</obo:IAO_0000115>
		<dto:geneSynonym>UMPK</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200553 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200553">
		<rdfs:label rdf:datatype="&xsd;string">AXL gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400189"/>
		<dto:entrez_xref>558</dto:entrez_xref>
		<dto:geneSymbol>AXL</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is a member of the Tyro3-Axl-Mer (TAM) receptor tyrosine kinase subfamily. The encoded protein possesses an extracellular domain which is composed of two immunoglobulin-like motifs at the N-terminal, followed by two fibronectin type-III motifs. It transduces signals from the extracellular matrix into the cytoplasm by binding to the vitamin K-dependent protein growth arrest-specific 6 (Gas6). This gene may be involved in several cellular functions including growth, migration, aggregation and anti-inflammation in multiple cell types. Alternative splicing results in multiple transcript variants of this gene. [provided by RefSeq, Jul 2013]</obo:IAO_0000115>
		<dto:geneSynonym>UFO</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200554 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200554">
		<rdfs:label rdf:datatype="&xsd;string">UHMK1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400241"/>
		<dto:entrez_xref>127933</dto:entrez_xref>
		<dto:geneSymbol>UHMK1</dto:geneSymbol>
		<obo:IAO_0000115>The gene encodes a serine/threonine protein kinase that promotes cell cycle progression through G1 by phosphorylation of the cyclin-dependent kinase inhibitor 1B (p27Kip1), which causes nuclear export and degradation. The encoded protein is also thought to function in the adult nervous system and the gene has been associated with schizophrenia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2010]</obo:IAO_0000115>
		<dto:geneSynonym>KIS</dto:geneSynonym>
		<dto:geneSynonym>KIST</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200555 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200555">
		<rdfs:label rdf:datatype="&xsd;string">ULK1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400228"/>
		<dto:entrez_xref>8408</dto:entrez_xref>
		<dto:geneSymbol>ULK1</dto:geneSymbol>
		<dto:geneSynonym>KIAA0722</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200556 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200556">
		<rdfs:label rdf:datatype="&xsd;string">ULK2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400228"/>
		<dto:entrez_xref>9706</dto:entrez_xref>
		<dto:geneSymbol>ULK2</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a protein that is similar to a serine/threonine kinase in C. elegans which is involved in axonal elongation. The structure of this protein is similar to the C. elegans protein in that both proteins have an N-terminal kinase domain, a central proline/serine rich (PS) domain, and a C-terminal (C) domain. The gene is located within the Smith-Magenis syndrome region on chromosome 17. Alternatively spliced transcript variants encoding the same protein have been identified. [provided by RefSeq, Dec 2008]</obo:IAO_0000115>
		<dto:geneSynonym>KIAA0623</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200557 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200557">
		<rdfs:label rdf:datatype="&xsd;string">ULK3 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400228"/>
		<dto:entrez_xref>25989</dto:entrez_xref>
		<dto:geneSymbol>ULK3</dto:geneSymbol>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200558 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200558">
		<rdfs:label rdf:datatype="&xsd;string">ULK4 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400228"/>
		<dto:entrez_xref>54986</dto:entrez_xref>
		<dto:geneSymbol>ULK4</dto:geneSymbol>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200559 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200559">
		<rdfs:label rdf:datatype="&xsd;string">FLT1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400242"/>
		<dto:entrez_xref>2321</dto:entrez_xref>
		<dto:geneSymbol>FLT1</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the vascular endothelial growth factor receptor (VEGFR) family. VEGFR family members are receptor tyrosine kinases (RTKs) which contain an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and a tyrosine kinase (TK) domain within the cytoplasmic domain. This protein binds to VEGFR-A, VEGFR-B and placental growth factor and plays an important role in angiogenesis and vasculogenesis. Expression of this receptor is found in vascular endothelial cells, placental trophoblast cells and peripheral blood monocytes. Multiple transcript variants encoding different isoforms have been found for this gene. Isoforms include a full-length transmembrane receptor isoform and shortened, soluble isoforms. The soluble isoforms are associated with the onset of pre-eclampsia.[provided by RefSeq, May 2009]</obo:IAO_0000115>
		<dto:geneSynonym>FLT</dto:geneSynonym>
		<dto:geneSynonym>FRT</dto:geneSynonym>
		<dto:geneSynonym>VEGFR1</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200560 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200560">
		<rdfs:label rdf:datatype="&xsd;string">KDR gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400242"/>
		<dto:entrez_xref>3791</dto:entrez_xref>
		<dto:geneSymbol>KDR</dto:geneSymbol>
		<obo:IAO_0000115>Vascular endothelial growth factor (VEGF) is a major growth factor for endothelial cells. This gene encodes one of the two receptors of the VEGF. This receptor, known as kinase insert domain receptor, is a type III receptor tyrosine kinase. It functions as the main mediator of VEGF-induced endothelial proliferation, survival, migration, tubular morphogenesis and sprouting. The signalling and trafficking of this receptor are regulated by multiple factors, including Rab GTPase, P2Y purine nucleotide receptor, integrin alphaVbeta3, T-cell protein tyrosine phosphatase, etc.. Mutations of this gene are implicated in infantile capillary hemangiomas. [provided by RefSeq, May 2009]</obo:IAO_0000115>
		<dto:geneSynonym>FLK1</dto:geneSynonym>
		<dto:geneSynonym>VEGFR2</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200561 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200561">
		<rdfs:label rdf:datatype="&xsd;string">FLT4 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400242"/>
		<dto:entrez_xref>2324</dto:entrez_xref>
		<dto:geneSymbol>FLT4</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a tyrosine kinase receptor for vascular endothelial growth factors C and D. The protein is thought to be involved in lymphangiogenesis and maintenance of the lymphatic endothelium. Mutations in this gene cause hereditary lymphedema type IA. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>VEGFR3</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200562 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200562">
		<rdfs:label rdf:datatype="&xsd;string">VRK1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400243"/>
		<dto:entrez_xref>7443</dto:entrez_xref>
		<dto:geneSymbol>VRK1</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the vaccinia-related kinase (VRK) family of serine/threonine protein kinases. This gene is widely expressed in human tissues and has increased expression in actively dividing cells, such as those in testis, thymus, fetal liver, and carcinomas. Its protein localizes to the nucleus and has been shown to promote the stability and nuclear accumulation of a transcriptionally active p53 molecule and, in vitro, to phosphorylate Thr18 of p53 and reduce p53 ubiquitination. This gene, therefore, may regulate cell proliferation. This protein also phosphorylates histone, casein, and the transcription factors ATF2 (activating transcription factor 2) and c-JUN. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200563 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200563">
		<rdfs:label rdf:datatype="&xsd;string">VRK2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400243"/>
		<dto:entrez_xref>7444</dto:entrez_xref>
		<dto:geneSymbol>VRK2</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the vaccinia-related kinase (VRK) family of serine/threonine protein kinases. The encoded protein acts as an effector of signaling pathways that regulate apoptosis and tumor cell growth. Variants in this gene have been associated with schizophrenia. Alternative splicing results in multiple transcript variants that differ in their subcellular localization and biological activity. [provided by RefSeq, Jan 2014]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200564 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200564">
		<rdfs:label rdf:datatype="&xsd;string">VRK3 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400243"/>
		<dto:entrez_xref>51231</dto:entrez_xref>
		<dto:geneSymbol>VRK3</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the vaccinia-related kinase (VRK) family of serine/threonine protein kinases. In both human and mouse, this gene has substitutions at several residues within the ATP binding motifs that in other kinases have been shown to be required for catalysis. In vitro assays indicate the protein lacks phosphorylation activity. The protein, however, likely retains its substrate binding capability. This gene is widely expressed in human tissues and its protein localizes to the nucleus. Alternative splicing results in multiple transcripts encoding different isoforms. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200565 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200565">
		<rdfs:label rdf:datatype="&xsd;string">WEE1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400212"/>
		<dto:entrez_xref>7465</dto:entrez_xref>
		<dto:geneSymbol>WEE1</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a nuclear protein, which is a tyrosine kinase belonging to the Ser/Thr family of protein kinases. This protein catalyzes the inhibitory tyrosine phosphorylation of CDC2/cyclin B kinase, and appears to coordinate the transition between DNA replication and mitosis by protecting the nucleus from cytoplasmically activated CDC2 kinase. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200566 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200566">
		<rdfs:label rdf:datatype="&xsd;string">WEE2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400212"/>
		<dto:entrez_xref>494551</dto:entrez_xref>
		<dto:geneSymbol>WEE2</dto:geneSymbol>
		<dto:geneSynonym>WEE1B</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200567 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200567">
		<rdfs:label rdf:datatype="&xsd;string">WNK1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400244"/>
		<dto:entrez_xref>65125</dto:entrez_xref>
		<dto:geneSymbol>WNK1</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the WNK subfamily of serine/threonine protein kinases. The encoded protein may be a key regulator of blood pressure by controlling the transport of sodium and chloride ions. Mutations in this gene have been associated with pseudohypoaldosteronism type II and hereditary sensory neuropathy type II. Alternatively spliced transcript variants encoding different isoforms have been described but the full-length nature of all of them has yet to be determined.[provided by RefSeq, May 2010]</obo:IAO_0000115>
		<dto:geneSynonym>HSN2</dto:geneSynonym>
		<dto:geneSynonym>KDP</dto:geneSynonym>
		<dto:geneSynonym>KIAA0344</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200568 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200568">
		<rdfs:label rdf:datatype="&xsd;string">WNK2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400244"/>
		<dto:entrez_xref>65268</dto:entrez_xref>
		<dto:geneSymbol>WNK2</dto:geneSymbol>
		<obo:IAO_0000115>The protein encoded by this gene is a cytoplasmic serine-threonine kinase that belongs to the protein kinase superfamily. The protein plays an important role in the regulation of electrolyte homeostasis, cell signaling survival, and proliferation. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2013]</obo:IAO_0000115>
		<dto:geneSynonym>KIAA1760</dto:geneSynonym>
		<dto:geneSynonym>PRKWNK2</dto:geneSynonym>
		<dto:geneSynonym>SDCCAG43</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200569 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200569">
		<rdfs:label rdf:datatype="&xsd;string">WNK3 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400244"/>
		<dto:entrez_xref>65267</dto:entrez_xref>
		<dto:geneSymbol>WNK3</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a protein belonging to the &apos;with no lysine&apos; family of serine-threonine protein kinases. These family members lack the catalytic lysine in subdomain II, and instead have a conserved lysine in subdomain I. This family member functions as a positive regulator of the transcellular Ca2+ transport pathway, and it plays a role in the increase of cell survival in a caspase-3-dependent pathway. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2010]</obo:IAO_0000115>
		<dto:geneSynonym>KIAA1566</dto:geneSynonym>
		<dto:geneSynonym>PRKWNK3</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200570 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200570">
		<rdfs:label rdf:datatype="&xsd;string">WNK4 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400244"/>
		<dto:entrez_xref>65266</dto:entrez_xref>
		<dto:geneSymbol>WNK4</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes a member of the WNK family of serine-threonine protein kinases. The kinase is part of the tight junction complex in kidney cells, and regulates the balance between NaCl reabsorption and K(+) secretion. The kinase regulates the activities of several types of ion channels, cotransporters, and exchangers involved in electrolyte flux in epithelial cells. Mutations in this gene result in pseudohypoaldosteronism type IIB.[provided by RefSeq, Sep 2009]</obo:IAO_0000115>
		<dto:geneSynonym>PRKWNK4</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200571 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200571">
		<rdfs:label rdf:datatype="&xsd;string">YES1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400132"/>
		<dto:entrez_xref>7525</dto:entrez_xref>
		<dto:geneSymbol>YES1</dto:geneSymbol>
		<obo:IAO_0000115>This gene is the cellular homolog of the Yamaguchi sarcoma virus oncogene. The encoded protein has tyrosine kinase activity and belongs to the src family of proteins. This gene lies in close proximity to thymidylate synthase gene on chromosome 18, and a corresponding pseudogene has been found on chromosome 22. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>YES</dto:geneSynonym>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200572 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200572">
		<rdfs:label rdf:datatype="&xsd;string">ZAP70 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400180"/>
		<dto:entrez_xref>7535</dto:entrez_xref>
		<dto:geneSymbol>ZAP70</dto:geneSymbol>
		<obo:IAO_0000115>This gene encodes an enzyme belonging to the protein tyrosine kinase family, and it plays a role in T-cell development and lymphocyte activation. This enzyme, which is phosphorylated on tyrosine residues upon T-cell antigen receptor (TCR) stimulation, functions in the initial step of TCR-mediated signal transduction in combination with the Src family kinases, Lck and Fyn. This enzyme is also essential for thymocyte development. Mutations in this gene cause selective T-cell defect, a severe combined immunodeficiency disease characterized by a selective absence of CD8-positive T-cells. Two transcript variants that encode different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]</obo:IAO_0000115>
		<dto:geneSynonym>SRK</dto:geneSynonym>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491041"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200573 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200573">
		<rdfs:label rdf:datatype="&xsd;string">ETNK1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491041"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200574 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200574">
		<rdfs:label rdf:datatype="&xsd;string">ETNK2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491041"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200575 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200575">
		<rdfs:label rdf:datatype="&xsd;string">GALK2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491041"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200576 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200576">
		<rdfs:label rdf:datatype="&xsd;string">GALK1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491041"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200577 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200577">
		<rdfs:label rdf:datatype="&xsd;string">FUK gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491041"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200578 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200578">
		<rdfs:label rdf:datatype="&xsd;string">IDNK gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491041"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200579 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200579">
		<rdfs:label rdf:datatype="&xsd;string">CMPK2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491041"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200580 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200580">
		<rdfs:label rdf:datatype="&xsd;string">FGGY gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491041"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200581 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200581">
		<rdfs:label rdf:datatype="&xsd;string">FN3K gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491041"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200582 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200582">
		<rdfs:label rdf:datatype="&xsd;string">GK3P gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491041"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200583 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200583">
		<rdfs:label rdf:datatype="&xsd;string">GLYCTK gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491041"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200584 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200584">
		<rdfs:label rdf:datatype="&xsd;string">GK5 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491041"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200585 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200585">
		<rdfs:label rdf:datatype="&xsd;string">GK gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491041"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200586 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200586">
		<rdfs:label rdf:datatype="&xsd;string">HKDC1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491041"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200587 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200587">
		<rdfs:label rdf:datatype="&xsd;string">HK3 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491041"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200588 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200588">
		<rdfs:label rdf:datatype="&xsd;string">HK2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491041"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200589 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200589">
		<rdfs:label rdf:datatype="&xsd;string">ITPKC gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491041"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200590 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200590">
		<rdfs:label rdf:datatype="&xsd;string">IP6K2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491041"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200591 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200591">
		<rdfs:label rdf:datatype="&xsd;string">AK8 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491041"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200592 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200592">
		<rdfs:label rdf:datatype="&xsd;string">IP6K1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491041"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200593 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200593">
		<rdfs:label rdf:datatype="&xsd;string">IP6K3 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491041"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200594 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200594">
		<rdfs:label rdf:datatype="&xsd;string">NMRK1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491041"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200595 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200595">
		<rdfs:label rdf:datatype="&xsd;string">PANK4 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491041"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200596 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200596">
		<rdfs:label rdf:datatype="&xsd;string">CMPK1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491041"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200597 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200597">
		<rdfs:label rdf:datatype="&xsd;string">AK6 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491041"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200598 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200598">
		<rdfs:label rdf:datatype="&xsd;string">AK5 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491041"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200599 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200599">
		<rdfs:label rdf:datatype="&xsd;string">CKB gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491041"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200600 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200600">
		<rdfs:label rdf:datatype="&xsd;string">CKMT1A gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491041"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200601 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200601">
		<rdfs:label rdf:datatype="&xsd;string">AK9 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491041"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200602 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200602">
		<rdfs:label rdf:datatype="&xsd;string">AK4 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491041"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200603 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200603">
		<rdfs:label rdf:datatype="&xsd;string">CKMT2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491041"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200604 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200604">
		<rdfs:label rdf:datatype="&xsd;string">FN3KRP gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491041"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200605 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200605">
		<rdfs:label rdf:datatype="&xsd;string">NADK gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491041"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200606 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200606">
		<rdfs:label rdf:datatype="&xsd;string">NADK2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491041"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200607 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200607">
		<rdfs:label rdf:datatype="&xsd;string">NAGK gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491041"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200608 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200608">
		<rdfs:label rdf:datatype="&xsd;string">NME1-NME2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491041"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200609 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200609">
		<rdfs:label rdf:datatype="&xsd;string">NME5 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491041"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200610 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200610">
		<rdfs:label rdf:datatype="&xsd;string">NME2P1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491041"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200611 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200611">
		<rdfs:label rdf:datatype="&xsd;string">NME3 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491041"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200612 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200612">
		<rdfs:label rdf:datatype="&xsd;string">NME6 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491041"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200613 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200613">
		<rdfs:label rdf:datatype="&xsd;string">NME1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491041"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200614 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200614">
		<rdfs:label rdf:datatype="&xsd;string">NME4 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491041"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200615 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200615">
		<rdfs:label rdf:datatype="&xsd;string">NMRK2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491041"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200616 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200616">
		<rdfs:label rdf:datatype="&xsd;string">PGK2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491041"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200617 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200617">
		<rdfs:label rdf:datatype="&xsd;string">PCK1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491041"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200618 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200618">
		<rdfs:label rdf:datatype="&xsd;string">PFKM gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491041"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200619 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200619">
		<rdfs:label rdf:datatype="&xsd;string">PFKP gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491041"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200620 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200620">
		<rdfs:label rdf:datatype="&xsd;string">PRPS1L1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491041"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200621 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200621">
		<rdfs:label rdf:datatype="&xsd;string">PRPS2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491041"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200622 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200622">
		<rdfs:label rdf:datatype="&xsd;string">PRPS1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491041"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200623 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200623">
		<rdfs:label rdf:datatype="&xsd;string">PSTK gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491041"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200624 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200624">
		<rdfs:label rdf:datatype="&xsd;string">SHPK gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491041"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200625 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200625">
		<rdfs:label rdf:datatype="&xsd;string">RBKS gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491041"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200626 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200626">
		<rdfs:label rdf:datatype="&xsd;string">TBCK gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491041"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200627 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200627">
		<rdfs:label rdf:datatype="&xsd;string">UCKL1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491041"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03200628 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03200628">
		<rdfs:label rdf:datatype="&xsd;string">XYLB gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491041"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400101 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400101">
		<rdfs:label rdf:datatype="&xsd;string">Kinase gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_00200000"/>
		<obo:IAO_0000115>In biochemistry, a kinase is an enzyme that catalyzes the transfer of phosphate groups from high-energy, phosphate-donating molecules to specific substrates.</obo:IAO_0000115>
		<rdfs:isDefinedBy>https://en.wikipedia.org/wiki/Kinase</rdfs:isDefinedBy>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400102 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400102">
		<rdfs:label rdf:datatype="&xsd;string">Protein kinase gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400101"/>
		<obo:IAO_0000115>A protein kinase is a kinase enzyme that modifies other proteins by chemically adding phosphate groups to them (phosphorylation).</obo:IAO_0000115>
		<rdfs:isDefinedBy>https://en.wikipedia.org/wiki/Protein_kinase</rdfs:isDefinedBy>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400103 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400103">
		<rdfs:label rdf:datatype="&xsd;string">Non-protein kinase gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400101"/>
		<obo:IAO_0000115>A non-protein kinase is a kinase enzyme that modifies any non-protein substrates by chemically adding phosphate groups to them.</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400104 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400104">
		<rdfs:label rdf:datatype="&xsd;string">Other group gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400102"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400105 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400105">
		<rdfs:label rdf:datatype="&xsd;string">CAMK group gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400102"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400106 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400106">
		<rdfs:label rdf:datatype="&xsd;string">TK group gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400102"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400107 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400107">
		<rdfs:label rdf:datatype="&xsd;string">TKL group gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400102"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400108 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400108">
		<rdfs:label rdf:datatype="&xsd;string">Atypical group gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400102"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400109 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400109">
		<rdfs:label rdf:datatype="&xsd;string">AGC group gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400102"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400110 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400110">
		<rdfs:label rdf:datatype="&xsd;string">RGC group gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400102"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400111 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400111">
		<rdfs:label rdf:datatype="&xsd;string">CMGC group gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400102"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400112 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400112">
		<rdfs:label rdf:datatype="&xsd;string">CK1 group gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400102"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400113 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400113">
		<rdfs:label rdf:datatype="&xsd;string">STE group gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400102"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400115 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400115">
		<rdfs:label rdf:datatype="&xsd;string">NAK family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400104"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400116 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400116">
		<rdfs:label rdf:datatype="&xsd;string">CAMKL family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400105"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400117 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400117">
		<rdfs:label rdf:datatype="&xsd;string">ABL family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400106"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400118 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400118">
		<rdfs:label rdf:datatype="&xsd;string">ACK family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400106"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400119 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400119">
		<rdfs:label rdf:datatype="&xsd;string">STKR family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400107"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400120 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400120">
		<rdfs:label rdf:datatype="&xsd;string">ABC1 family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400108"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400121 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400121">
		<rdfs:label rdf:datatype="&xsd;string">AKT family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400109"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400122 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400122">
		<rdfs:label rdf:datatype="&xsd;string">ALK family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400106"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400123 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400123">
		<rdfs:label rdf:datatype="&xsd;string">Alpha family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400108"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400124 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400124">
		<rdfs:label rdf:datatype="&xsd;string">RIPK family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400107"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400125 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400125">
		<rdfs:label rdf:datatype="&xsd;string">RGC family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400110"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400126 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400126">
		<rdfs:label rdf:datatype="&xsd;string">RAF family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400107"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400127 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400127">
		<rdfs:label rdf:datatype="&xsd;string">GRK family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400109"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400129 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400129">
		<rdfs:label rdf:datatype="&xsd;string">PIKK family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400108"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400130 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400130">
		<rdfs:label rdf:datatype="&xsd;string">AUR family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400104"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400131 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400131">
		<rdfs:label rdf:datatype="&xsd;string">PDHK family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400108"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400132 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400132">
		<rdfs:label rdf:datatype="&xsd;string">SRC family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400106"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400133 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400133">
		<rdfs:label rdf:datatype="&xsd;string">TEC family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400106"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400134 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400134">
		<rdfs:label rdf:datatype="&xsd;string">BUB family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400104"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400135 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400135">
		<rdfs:label rdf:datatype="&xsd;string">CAMK-UNIQUE family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400105"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400136 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400136">
		<rdfs:label rdf:datatype="&xsd;string">CDK family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400111"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400137 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400137">
		<rdfs:label rdf:datatype="&xsd;string">CDC7 family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400104"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400138 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400138">
		<rdfs:label rdf:datatype="&xsd;string">CDKL family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400111"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400139 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400139">
		<rdfs:label rdf:datatype="&xsd;string">RAD53 family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400105"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400140 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400140">
		<rdfs:label rdf:datatype="&xsd;string">CLK family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400111"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400141 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400141">
		<rdfs:label rdf:datatype="&xsd;string">PDGFR family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400106"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400142 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400142">
		<rdfs:label rdf:datatype="&xsd;string">CK2 family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400111"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400143 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400143">
		<rdfs:label rdf:datatype="&xsd;string">CASK family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400105"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400144 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400144">
		<rdfs:label rdf:datatype="&xsd;string">CSK family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400106"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400145 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400145">
		<rdfs:label rdf:datatype="&xsd;string">DMPK family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400109"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400146 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400146">
		<rdfs:label rdf:datatype="&xsd;string">DAPK family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400105"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400147 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400147">
		<rdfs:label rdf:datatype="&xsd;string">DCAMKL family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400105"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400148 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400148">
		<rdfs:label rdf:datatype="&xsd;string">DDR family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400106"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400149 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400149">
		<rdfs:label rdf:datatype="&xsd;string">SGK496 family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400104"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400150 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400150">
		<rdfs:label rdf:datatype="&xsd;string">DYRK family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400111"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400151 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400151">
		<rdfs:label rdf:datatype="&xsd;string">PEK family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400104"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400152 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400152">
		<rdfs:label rdf:datatype="&xsd;string">EGFR family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400106"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400153 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400153">
		<rdfs:label rdf:datatype="&xsd;string">EPH family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400106"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400154 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400154">
		<rdfs:label rdf:datatype="&xsd;string">IRE family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400104"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400155 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400155">
		<rdfs:label rdf:datatype="&xsd;string">FAK family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400106"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400156 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400156">
		<rdfs:label rdf:datatype="&xsd;string">FAST family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400108"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400157 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400157">
		<rdfs:label rdf:datatype="&xsd;string">FER family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400106"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400158 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400158">
		<rdfs:label rdf:datatype="&xsd;string">FGFR family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400106"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400159 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400159">
		<rdfs:label rdf:datatype="&xsd;string">GSK family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400111"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400160 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400160">
		<rdfs:label rdf:datatype="&xsd;string">MAST family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400109"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400161 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400161">
		<rdfs:label rdf:datatype="&xsd;string">HASPIN family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400104"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400162 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400162">
		<rdfs:label rdf:datatype="&xsd;string">RCK family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400111"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400163 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400163">
		<rdfs:label rdf:datatype="&xsd;string">INSR family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400106"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400164 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400164">
		<rdfs:label rdf:datatype="&xsd;string">IKK family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400104"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400165 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400165">
		<rdfs:label rdf:datatype="&xsd;string">MLK family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400107"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400166 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400166">
		<rdfs:label rdf:datatype="&xsd;string">IRAK family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400107"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400167 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400167">
		<rdfs:label rdf:datatype="&xsd;string">JAKA family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400106"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400168 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400168">
		<rdfs:label rdf:datatype="&xsd;string">TRIO family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400105"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400169 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400169">
		<rdfs:label rdf:datatype="&xsd;string">PKA family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400109"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400170 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400170">
		<rdfs:label rdf:datatype="&xsd;string">CK1 family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400112"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400171 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400171">
		<rdfs:label rdf:datatype="&xsd;string">CAMK1 family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400105"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400172 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400172">
		<rdfs:label rdf:datatype="&xsd;string">CAMK2 family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400105"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400173 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400173">
		<rdfs:label rdf:datatype="&xsd;string">PKG family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400109"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400174 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400174">
		<rdfs:label rdf:datatype="&xsd;string">CAMKK family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400104"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400175 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400175">
		<rdfs:label rdf:datatype="&xsd;string">PKC family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400109"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400176 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400176">
		<rdfs:label rdf:datatype="&xsd;string">PKD family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400105"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400177 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400177">
		<rdfs:label rdf:datatype="&xsd;string">PSK family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400105"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400178 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400178">
		<rdfs:label rdf:datatype="&xsd;string">RSK family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400109"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400179 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400179">
		<rdfs:label rdf:datatype="&xsd;string">RSKL family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400109"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400180 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400180">
		<rdfs:label rdf:datatype="&xsd;string">SYK family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400106"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400181 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400181">
		<rdfs:label rdf:datatype="&xsd;string">NDR family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400109"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400182 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400182">
		<rdfs:label rdf:datatype="&xsd;string">LISK family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400107"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400183 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400183">
		<rdfs:label rdf:datatype="&xsd;string">LMR family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400106"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400184 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400184">
		<rdfs:label rdf:datatype="&xsd;string">LRRK family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400107"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400185 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400185">
		<rdfs:label rdf:datatype="&xsd;string">STE-UNIQUE family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400113"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400186 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400186">
		<rdfs:label rdf:datatype="&xsd;string">STE11 family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400113"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400187 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400187">
		<rdfs:label rdf:datatype="&xsd;string">STE20 family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400113"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400188 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400188">
		<rdfs:label rdf:datatype="&xsd;string">MAPKAPK family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400105"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400189 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400189">
		<rdfs:label rdf:datatype="&xsd;string">AXL family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400106"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400190 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400190">
		<rdfs:label rdf:datatype="&xsd;string">MET family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400106"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400191 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400191">
		<rdfs:label rdf:datatype="&xsd;string">MAPK family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400111"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400192 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400192">
		<rdfs:label rdf:datatype="&xsd;string">TKL-UNIQUE family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400107"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400193 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400193">
		<rdfs:label rdf:datatype="&xsd;string">MOS family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400104"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400194 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400194">
		<rdfs:label rdf:datatype="&xsd;string">STE7 family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400113"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400195 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400195">
		<rdfs:label rdf:datatype="&xsd;string">MUSK family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400106"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400196 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400196">
		<rdfs:label rdf:datatype="&xsd;string">MLCK family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400105"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400197 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400197">
		<rdfs:label rdf:datatype="&xsd;string">NEK family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400104"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400198 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400198">
		<rdfs:label rdf:datatype="&xsd;string">NRBP family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400104"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400199 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400199">
		<rdfs:label rdf:datatype="&xsd;string">SCY1 family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400104"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400200 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400200">
		<rdfs:label rdf:datatype="&xsd;string">TRK family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400106"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400201 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400201">
		<rdfs:label rdf:datatype="&xsd;string">PAN3 family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400104"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400202 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400202">
		<rdfs:label rdf:datatype="&xsd;string">NKF4 family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400104"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400203 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400203">
		<rdfs:label rdf:datatype="&xsd;string">PDK1 family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400109"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400204 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400204">
		<rdfs:label rdf:datatype="&xsd;string">NKF3 family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400104"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400205 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400205">
		<rdfs:label rdf:datatype="&xsd;string">PHK family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400105"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400206 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400206">
		<rdfs:label rdf:datatype="&xsd;string">VPS15 family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400104"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400207 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400207">
		<rdfs:label rdf:datatype="&xsd;string">PIM family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400105"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400208 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400208">
		<rdfs:label rdf:datatype="&xsd;string">NKF2 family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400104"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400209 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400209">
		<rdfs:label rdf:datatype="&xsd;string">SGK493 family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400104"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400210 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400210">
		<rdfs:label rdf:datatype="&xsd;string">PKN family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400109"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400211 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400211">
		<rdfs:label rdf:datatype="&xsd;string">PLK family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400104"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400212 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400212">
		<rdfs:label rdf:datatype="&xsd;string">WEE family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400104"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400213 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400213">
		<rdfs:label rdf:datatype="&xsd;string">BUD32 family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400104"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400214 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400214">
		<rdfs:label rdf:datatype="&xsd;string">CCK4 family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400106"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400215 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400215">
		<rdfs:label rdf:datatype="&xsd;string">SLOB family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400104"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400216 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400216">
		<rdfs:label rdf:datatype="&xsd;string">RET family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400106"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400217 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400217">
		<rdfs:label rdf:datatype="&xsd;string">RIO family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400108"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400218 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400218">
		<rdfs:label rdf:datatype="&xsd;string">Other-UNIQUE family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400104"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400219 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400219">
		<rdfs:label rdf:datatype="&xsd;string">ROR family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400106"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400220 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400220">
		<rdfs:label rdf:datatype="&xsd;string">SEV family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400106"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400221 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400221">
		<rdfs:label rdf:datatype="&xsd;string">RYK family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400106"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400222 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400222">
		<rdfs:label rdf:datatype="&xsd;string">NKF1 family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400104"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400223 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400223">
		<rdfs:label rdf:datatype="&xsd;string">RSKR family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400109"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400224 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400224">
		<rdfs:label rdf:datatype="&xsd;string">SGK family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400109"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400225 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400225">
		<rdfs:label rdf:datatype="&xsd;string">SGK071 family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400104"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400226 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400226">
		<rdfs:label rdf:datatype="&xsd;string">SRPK family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400111"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400227 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400227">
		<rdfs:label rdf:datatype="&xsd;string">YANK family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400109"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400228 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400228">
		<rdfs:label rdf:datatype="&xsd;string">ULK family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400104"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400229 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400229">
		<rdfs:label rdf:datatype="&xsd;string">SGK495 family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400105"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400230 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400230">
		<rdfs:label rdf:datatype="&xsd;string">TK-UNIQUE family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400106"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400231 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400231">
		<rdfs:label rdf:datatype="&xsd;string">TAF1 family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400108"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400232 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400232">
		<rdfs:label rdf:datatype="&xsd;string">TBCK family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400104"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400233 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400233">
		<rdfs:label rdf:datatype="&xsd;string">NKF5 family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400104"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400234 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400234">
		<rdfs:label rdf:datatype="&xsd;string">TIE family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400106"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400235 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400235">
		<rdfs:label rdf:datatype="&xsd;string">TLK family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400104"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400236 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400236">
		<rdfs:label rdf:datatype="&xsd;string">TOPK family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400104"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400237 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400237">
		<rdfs:label rdf:datatype="&xsd;string">TRBL family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400105"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400238 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400238">
		<rdfs:label rdf:datatype="&xsd;string">TSSK family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400105"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400239 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400239">
		<rdfs:label rdf:datatype="&xsd;string">TTBK family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400112"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400240 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400240">
		<rdfs:label rdf:datatype="&xsd;string">TTK family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400104"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400241 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400241">
		<rdfs:label rdf:datatype="&xsd;string">KIS family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400104"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400242 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400242">
		<rdfs:label rdf:datatype="&xsd;string">VEGFR family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400106"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400243 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400243">
		<rdfs:label rdf:datatype="&xsd;string">VRK family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400112"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400244 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400244">
		<rdfs:label rdf:datatype="&xsd;string">WNK family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400104"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400245 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400245">
		<rdfs:label rdf:datatype="&xsd;string">AMPK subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400116"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400246 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400246">
		<rdfs:label rdf:datatype="&xsd;string">STKR Type 1 subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400119"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400247 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400247">
		<rdfs:label rdf:datatype="&xsd;string">ABC1-B subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400120"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400248 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400248">
		<rdfs:label rdf:datatype="&xsd;string">ABC1-C subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400120"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400249 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400249">
		<rdfs:label rdf:datatype="&xsd;string">ABC1-A subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400120"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400250 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400250">
		<rdfs:label rdf:datatype="&xsd;string">BARK subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400127"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400251 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400251">
		<rdfs:label rdf:datatype="&xsd;string">ATR subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400129"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400252 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400252">
		<rdfs:label rdf:datatype="&xsd;string">STKR Type 2 subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400119"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400253 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400253">
		<rdfs:label rdf:datatype="&xsd;string">BRSK subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400116"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400254 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400254">
		<rdfs:label rdf:datatype="&xsd;string">PITSLRE subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400136"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400255 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400255">
		<rdfs:label rdf:datatype="&xsd;string">CRK7 subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400136"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400256 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400256">
		<rdfs:label rdf:datatype="&xsd;string">TAIRE subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400136"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400257 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400257">
		<rdfs:label rdf:datatype="&xsd;string">CDK8 subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400136"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400258 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400258">
		<rdfs:label rdf:datatype="&xsd;string">CDK1 subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400136"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400259 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400259">
		<rdfs:label rdf:datatype="&xsd;string">CCRK subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400136"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400260 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400260">
		<rdfs:label rdf:datatype="&xsd;string">CDK4 subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400136"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400261 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400261">
		<rdfs:label rdf:datatype="&xsd;string">CDK5 subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400136"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400262 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400262">
		<rdfs:label rdf:datatype="&xsd;string">CDK7 subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400136"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400263 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400263">
		<rdfs:label rdf:datatype="&xsd;string">CDK9 subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400136"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400264 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400264">
		<rdfs:label rdf:datatype="&xsd;string">CHK1 subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400116"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400265 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400265">
		<rdfs:label rdf:datatype="&xsd;string">GEK subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400145"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400266 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400266">
		<rdfs:label rdf:datatype="&xsd;string">Dyrk1 subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400150"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400267 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400267">
		<rdfs:label rdf:datatype="&xsd;string">Dyrk2 subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400150"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400268 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400268">
		<rdfs:label rdf:datatype="&xsd;string">PEK subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400151"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400269 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400269">
		<rdfs:label rdf:datatype="&xsd;string">GCN2 subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400151"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400270 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400270">
		<rdfs:label rdf:datatype="&xsd;string">EEF2K subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400123"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400271 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400271">
		<rdfs:label rdf:datatype="&xsd;string">GRK subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400127"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400272 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400272">
		<rdfs:label rdf:datatype="&xsd;string">GSK subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400159"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400273 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400273">
		<rdfs:label rdf:datatype="&xsd;string">HIPK subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400150"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400274 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400274">
		<rdfs:label rdf:datatype="&xsd;string">ILK subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400165"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400275 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400275">
		<rdfs:label rdf:datatype="&xsd;string">Meta subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400174"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400276 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400276">
		<rdfs:label rdf:datatype="&xsd;string">PKC alpha subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400175"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400277 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400277">
		<rdfs:label rdf:datatype="&xsd;string">PKC delta subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400175"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400278 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400278">
		<rdfs:label rdf:datatype="&xsd;string">PKC eta subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400175"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400279 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400279">
		<rdfs:label rdf:datatype="&xsd;string">PKC iota subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400175"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400280 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400280">
		<rdfs:label rdf:datatype="&xsd;string">RSK subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400178"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400281 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400281">
		<rdfs:label rdf:datatype="&xsd;string">MSK subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400178"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400282 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400282">
		<rdfs:label rdf:datatype="&xsd;string">P70 subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400178"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400283 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400283">
		<rdfs:label rdf:datatype="&xsd;string">LIMK subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400182"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400284 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400284">
		<rdfs:label rdf:datatype="&xsd;string">MLK subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400165"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400285 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400285">
		<rdfs:label rdf:datatype="&xsd;string">LZK subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400165"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400286 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400286">
		<rdfs:label rdf:datatype="&xsd;string">TAK1 subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400165"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400287 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400287">
		<rdfs:label rdf:datatype="&xsd;string">KHS subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400187"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400288 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400288">
		<rdfs:label rdf:datatype="&xsd;string">MSN subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400187"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400289 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400289">
		<rdfs:label rdf:datatype="&xsd;string">MAPKAPK subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400188"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400290 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400290">
		<rdfs:label rdf:datatype="&xsd;string">MARK subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400116"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400291 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400291">
		<rdfs:label rdf:datatype="&xsd;string">MELK subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400116"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400292 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400292">
		<rdfs:label rdf:datatype="&xsd;string">ERK subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400191"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400293 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400293">
		<rdfs:label rdf:datatype="&xsd;string">JNK subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400191"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400294 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400294">
		<rdfs:label rdf:datatype="&xsd;string">P38 subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400191"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400295 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400295">
		<rdfs:label rdf:datatype="&xsd;string">Erk7 subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400191"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400296 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400296">
		<rdfs:label rdf:datatype="&xsd;string">MNK subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400188"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400297 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400297">
		<rdfs:label rdf:datatype="&xsd;string">YSK subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400187"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400298 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400298">
		<rdfs:label rdf:datatype="&xsd;string">NinaC subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400187"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400299 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400299">
		<rdfs:label rdf:datatype="&xsd;string">NIM1 subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400116"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400300 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400300">
		<rdfs:label rdf:datatype="&xsd;string">NMO subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400191"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400301 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400301">
		<rdfs:label rdf:datatype="&xsd;string">NuaK subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400116"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400302 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400302">
		<rdfs:label rdf:datatype="&xsd;string">FRAY subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400187"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400303 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400303">
		<rdfs:label rdf:datatype="&xsd;string">PAKA subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400187"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400304 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400304">
		<rdfs:label rdf:datatype="&xsd;string">PAKB subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400187"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400305 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400305">
		<rdfs:label rdf:datatype="&xsd;string">PASK subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400116"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400306 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400306">
		<rdfs:label rdf:datatype="&xsd;string">PDHK subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400131"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400307 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400307">
		<rdfs:label rdf:datatype="&xsd;string">PDK1 subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400203"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400308 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400308">
		<rdfs:label rdf:datatype="&xsd;string">PLK2 subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400211"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400309 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400309">
		<rdfs:label rdf:datatype="&xsd;string">DNAPK subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400129"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400311 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400311">
		<rdfs:label rdf:datatype="&xsd;string">RIO2 subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400217"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400313 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400313">
		<rdfs:label rdf:datatype="&xsd;string">ROCK subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400145"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400314 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400314">
		<rdfs:label rdf:datatype="&xsd;string">QIK subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400116"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400315 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400315">
		<rdfs:label rdf:datatype="&xsd;string">SLK subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400187"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400316 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400316">
		<rdfs:label rdf:datatype="&xsd;string">LKB subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400116"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400317 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400317">
		<rdfs:label rdf:datatype="&xsd;string">MST subfamily&gt; gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400187"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400318 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400318">
		<rdfs:label rdf:datatype="&xsd;string">TAO subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400187"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400319 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400319">
		<rdfs:label rdf:datatype="&xsd;string">TESK subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400182"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400320 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400320">
		<rdfs:label rdf:datatype="&xsd;string">HH498 subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400165"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400321 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400321">
		<rdfs:label rdf:datatype="&xsd;string">ChaK subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400123"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400322 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400322">
		<rdfs:label rdf:datatype="&xsd;string">Nucleoside kinase gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400103"/>
		<obo:IAO_0000115>A Nucleoside kinase is a kinase enzyme that catalyzes the phosphorylation of a nucleoside substrate.</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400323 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400323">
		<rdfs:label rdf:datatype="&xsd;string">Lipid kinase gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400103"/>
		<obo:IAO_0000115>A lipid kinase is a kinase enzyme that catalyzes the phosphorylation of a lipid substrate.</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400324 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400324">
		<rdfs:label rdf:datatype="&xsd;string">Other small molecule kinase gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400103"/>
		<obo:IAO_0000115>Other small molecule kinase is a kinase enzyme that catalyzes the phosphorylation of a small molecule substrate other than a carbohydrate, nucleoside, nucleotide, lipid, etc.</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400325 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400325">
		<rdfs:label rdf:datatype="&xsd;string">Carbohydrate kinase gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400103"/>
		<obo:IAO_0000115>A carbohydrate kinase is a kinase enzyme that catalyzes the phosphorylation of a carbohydrate substrate.</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03400326 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03400326">
		<rdfs:label rdf:datatype="&xsd;string">Nucleotide kinase gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400103"/>
		<obo:IAO_0000115>A Nucleotide kinase is a kinase enzyme that catalyzes the phosphorylation of a nucleotide substrate.</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03490993 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03490993">
		<rdfs:label rdf:datatype="&xsd;string">TBCK gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400232"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03491001 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03491001">
		<rdfs:label rdf:datatype="&xsd;string">AK1 subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491014"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03491002 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03491002">
		<rdfs:label rdf:datatype="&xsd;string">ATP-dependent PFK group I subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491016"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03491003 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03491003">
		<rdfs:label rdf:datatype="&xsd;string">Type III PI4K subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491009"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03491004 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03491004">
		<rdfs:label rdf:datatype="&xsd;string">AK2 subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491014"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03491005 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03491005">
		<rdfs:label rdf:datatype="&xsd;string">Type II PI4K subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491009"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03491006 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03491006">
		<rdfs:label rdf:datatype="&xsd;string">AK3 subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491014"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03491007 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03491007">
		<rdfs:label rdf:datatype="&xsd;string">Mevalonate kinase subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491026"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03491008 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03491008">
		<rdfs:label rdf:datatype="&xsd;string">DCK/DGK family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400322"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03491009 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03491009">
		<rdfs:label rdf:datatype="&xsd;string">PI3/PI4 kinase family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400323"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03491010 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03491010">
		<rdfs:label rdf:datatype="&xsd;string">Phosphoinositide 3-kinase (PI3K) family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400323"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03491011 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03491011">
		<rdfs:label rdf:datatype="&xsd;string">Pyridoxine kinase family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400324"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03491012 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03491012">
		<rdfs:label rdf:datatype="&xsd;string">Type I phosphatidylinositol-4-phosphate 5-kinase family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400323"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03491013 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03491013">
		<rdfs:label rdf:datatype="&xsd;string">Phosphoglycerate kinase family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400324"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03491014 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03491014">
		<rdfs:label rdf:datatype="&xsd;string">Adenylate kinase family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400326"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03491015 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03491015">
		<rdfs:label rdf:datatype="&xsd;string">Thymidine kinase family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400322"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03491016 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03491016">
		<rdfs:label rdf:datatype="&xsd;string">Phosphofructokinase type A (PFKA) family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400325"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03491017 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03491017">
		<rdfs:label rdf:datatype="&xsd;string">Hexokinase family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400325"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03491018 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03491018">
		<rdfs:label rdf:datatype="&xsd;string">Thymidylate kinase family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400326"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03491019 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03491019">
		<rdfs:label rdf:datatype="&xsd;string">Inositol phosphokinase (IPK) family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400323"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03491020 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03491020">
		<rdfs:label rdf:datatype="&xsd;string">ITPK1 family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400323"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03491021 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03491021">
		<rdfs:label rdf:datatype="&xsd;string">FGGY kinase family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400324"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03491022 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03491022">
		<rdfs:label rdf:datatype="&xsd;string">Phosphoenolpyruvate carboxykinase [GTP] family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400324"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03491023 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03491023">
		<rdfs:label rdf:datatype="&xsd;string">Thiamine pyrophosphokinase family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400324"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03491024 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03491024">
		<rdfs:label rdf:datatype="&xsd;string">Uridine kinase family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400322"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03491025 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03491025">
		<rdfs:label rdf:datatype="&xsd;string">Diacylglycerol kinase family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400323"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03491026 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03491026">
		<rdfs:label rdf:datatype="&xsd;string">GHMP kinase family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400324"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03491027 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03491027">
		<rdfs:label rdf:datatype="&xsd;string">ATP:guanido phosphotransferase family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400324"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03491028 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03491028">
		<rdfs:label rdf:datatype="&xsd;string">Type II pantothenate kinase family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400324"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03491029 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03491029">
		<rdfs:label rdf:datatype="&xsd;string">Choline/ethanolamine kinase family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400324"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03491030 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03491030">
		<rdfs:label rdf:datatype="&xsd;string">Guanylate kinase family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400326"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03491031 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03491031">
		<rdfs:label rdf:datatype="&xsd;string">PI3K p85 subunit family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400323"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03491032 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03491032">
		<rdfs:label rdf:datatype="&xsd;string">Carbohydrate kinase PfkB family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400325"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03491033 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03491033">
		<rdfs:label rdf:datatype="&xsd;string">CDK10 subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400136"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03491034 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03491034">
		<rdfs:label rdf:datatype="&xsd;string">HUNK subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400116"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03491035 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03491035">
		<rdfs:label rdf:datatype="&xsd;string">FRAP subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400129"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03491036 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03491036">
		<rdfs:label rdf:datatype="&xsd;string">RIO3 subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400217"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03491037 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03491037">
		<rdfs:label rdf:datatype="&xsd;string">RIO1 subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400217"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03491038 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03491038">
		<rdfs:label rdf:datatype="&xsd;string">SNRK subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400116"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03491039 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03491039">
		<rdfs:label rdf:datatype="&xsd;string">Phosphorylase b kinase regulatory chain family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400102"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03491040 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03491040">
		<rdfs:label rdf:datatype="&xsd;string">Ephrin family gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400106"/>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03491041 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03491041">
		<rdfs:label rdf:datatype="&xsd;string">Unclassified protein gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400101"/>
		<obo:IAO_0000115>A probable kinase protein that is not yet classified into either protein kinase or non-protein kinase.</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03491042 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03491042">
		<rdfs:label rdf:datatype="&xsd;string">RIOK3 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491036"/>
		<dto:geneSymbol>RIOK3</dto:geneSymbol>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03491043 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03491043">
		<rdfs:label rdf:datatype="&xsd;string">RIOK1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491037"/>
		<dto:geneSymbol>RIOK1</dto:geneSymbol>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03491044 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03491044">
		<rdfs:label rdf:datatype="&xsd;string">PKLR gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400324"/>
		<dto:geneSymbol>PKLR</dto:geneSymbol>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03491045 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03491045">
		<rdfs:label rdf:datatype="&xsd;string">PANK3 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491028"/>
		<dto:geneSymbol>PANK3</dto:geneSymbol>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03491046 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03491046">
		<rdfs:label rdf:datatype="&xsd;string">PANK2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491028"/>
		<dto:geneSymbol>PANK2</dto:geneSymbol>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03491047 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03491047">
		<rdfs:label rdf:datatype="&xsd;string">PFKFB1 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400325"/>
		<dto:geneSymbol>PFKFB1</dto:geneSymbol>
		<dto:geneSymbol>PFKFB1</dto:geneSymbol>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03491048 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03491048">
		<rdfs:label rdf:datatype="&xsd;string">PFKFB2 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400325"/>
		<dto:geneSymbol>PFKFB2</dto:geneSymbol>
		<dto:geneSymbol>PFKFB2</dto:geneSymbol>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_03491049 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_03491049">
		<rdfs:label rdf:datatype="&xsd;string">PFKFB3 gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03400325"/>
		<dto:geneSymbol>PFKFB3</dto:geneSymbol>
	</owl:Class>

	<!-- http://www.drugtargetontology.org/dto/DTO_0349989 -->

	<owl:Class rdf:about="http://www.drugtargetontology.org/dto/DTO_0349989">
		<rdfs:label rdf:datatype="&xsd;string">Eukaryotic two domain clade &quot;E&quot; sub-subfamily gene</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.drugtargetontology.org/dto/DTO_03491002"/>
	</owl:Class>

</rdf:RDF>